<full-text-retrieval-response xmlns="http://www.elsevier.com/xml/svapi/article/dtd" xmlns:bk="http://www.elsevier.com/xml/bk/dtd" xmlns:cals="http://www.elsevier.com/xml/common/cals/dtd" xmlns:ce="http://www.elsevier.com/xml/common/dtd" xmlns:ja="http://www.elsevier.com/xml/ja/dtd" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:sa="http://www.elsevier.com/xml/common/struct-aff/dtd" xmlns:sb="http://www.elsevier.com/xml/common/struct-bib/dtd" xmlns:tb="http://www.elsevier.com/xml/common/table/dtd" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xocs="http://www.elsevier.com/xml/xocs/dtd" xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:dcterms="http://purl.org/dc/terms/" xmlns:prism="http://prismstandard.org/namespaces/basic/2.0/" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance"><coredata><prism:url>https://api.elsevier.com/content/article/pii/S022352341930371X</prism:url><dc:identifier>doi:10.1016/j.ejmech.2019.04.053</dc:identifier><eid>1-s2.0-S022352341930371X</eid><prism:doi>10.1016/j.ejmech.2019.04.053</prism:doi><pii>S0223-5234(19)30371-X</pii><dc:title>Targeting tropomyosin receptor kinase for cancer therapy </dc:title><prism:publicationName>European Journal of Medicinal Chemistry</prism:publicationname><prism:aggregationType>Journal</prism:aggregationtype><pubType>rev</pubtype><prism:issn>02235234</prism:issn><prism:volume>175</prism:volume><prism:startingPage>129</prism:startingpage><prism:endingPage>148</prism:endingpage><prism:pageRange>129-148</prism:pagerange><dc:format>text/xml</dc:format><prism:coverDate>2019-08-01</prism:coverdate><prism:coverDisplayDate>1 August 2019</prism:coverdisplaydate><prism:copyright>Â© 2019 Published by Elsevier Masson SAS.</prism:copyright><prism:publisher>Published by Elsevier Masson SAS.</prism:publisher><dc:creator>Miao, Qi</dc:creator><dc:creator>Ma, Kun</dc:creator><dc:creator>Chen, Dong</dc:creator><dc:creator>Wu, Xiaoxing</dc:creator><dc:creator>Jiang, Sheng</dc:creator><dc:description>
                  
                     NTRKs and their expression product tropomyosin receptor kinases (Trks) are widely distributed in mammals. While neural growth factor (NGF)-induced normal Trk activation plays a key role in nerve growth, NTRK alternations occurring in tumor cells were highly correlated to tumor progression and invasion. Recent clinical data from several pan-Trk inhibitors have demonstrated potential and broad applications in various cancers. This intrigues us to summarize the development of inhibitors targeting Trks with different mechanisms of action and their applications in cancer therapy. We believe that this perspective would be of great help in investigating novel anticancer drugs with better therapeutic index.
               </dc:description><openaccess>0</openaccess><openaccessArticle>false</openaccessarticle><openaccessType/></openaccesstype><openArchiveArticle>false</openarchivearticle><openaccessSponsorName/></openaccesssponsorname><openaccessSponsorType/></openaccesssponsortype><openaccessUserLicense/></openaccessuserlicense><dcterms:subject>Tropomyosin receptor kinase</dcterms:subject><dcterms:subject>Neoplasm</dcterms:subject><dcterms:subject>Receptor kinase inhibitor</dcterms:subject><dcterms:subject>Gene alterations</dcterms:subject><link href="https://api.elsevier.com/content/article/pii/S022352341930371X" rel="self"/></link><link href="https://www.sciencedirect.com/science/article/pii/S022352341930371X" rel="scidir"/></link></coredata><objects><object ref="gr6" category="standard" type="IMAGE-DOWNSAMPLED" multimediatype="JPEG image file" mimetype="image/jpeg" width="378" height="139" size="11553">https://api.elsevier.com/content/object/eid/1-s2.0-S022352341930371X-gr6.jpg?httpAccept=%2A%2F%2A</object><object ref="gr33" category="standard" type="IMAGE-DOWNSAMPLED" multimediatype="JPEG image file" mimetype="image/jpeg" width="222" height="121" size="4859">https://api.elsevier.com/content/object/eid/1-s2.0-S022352341930371X-gr33.jpg?httpAccept=%2A%2F%2A</object><object ref="gr45" category="standard" type="IMAGE-DOWNSAMPLED" multimediatype="JPEG image file" mimetype="image/jpeg" width="178" height="221" size="6529">https://api.elsevier.com/content/object/eid/1-s2.0-S022352341930371X-gr45.jpg?httpAccept=%2A%2F%2A</object><object ref="gr30" category="standard" type="IMAGE-DOWNSAMPLED" multimediatype="JPEG image file" mimetype="image/jpeg" width="623" height="108" size="15494">https://api.elsevier.com/content/object/eid/1-s2.0-S022352341930371X-gr30.jpg?httpAccept=%2A%2F%2A</object><object ref="gr9" category="standard" type="IMAGE-DOWNSAMPLED" multimediatype="JPEG image file" mimetype="image/jpeg" width="600" height="309" size="35011">https://api.elsevier.com/content/object/eid/1-s2.0-S022352341930371X-gr9.jpg?httpAccept=%2A%2F%2A</object><object ref="gr2" category="standard" type="IMAGE-DOWNSAMPLED" multimediatype="JPEG image file" mimetype="image/jpeg" width="512" height="187" size="13273">https://api.elsevier.com/content/object/eid/1-s2.0-S022352341930371X-gr2.jpg?httpAccept=%2A%2F%2A</object><object ref="gr29" category="standard" type="IMAGE-DOWNSAMPLED" multimediatype="JPEG image file" mimetype="image/jpeg" width="511" height="206" size="14592">https://api.elsevier.com/content/object/eid/1-s2.0-S022352341930371X-gr29.jpg?httpAccept=%2A%2F%2A</object><object ref="gr46" category="standard" type="IMAGE-DOWNSAMPLED" multimediatype="JPEG image file" mimetype="image/jpeg" width="178" height="160" size="5232">https://api.elsevier.com/content/object/eid/1-s2.0-S022352341930371X-gr46.jpg?httpAccept=%2A%2F%2A</object><object ref="gr13" category="standard" type="IMAGE-DOWNSAMPLED" multimediatype="JPEG image file" mimetype="image/jpeg" width="511" height="176" size="20751">https://api.elsevier.com/content/object/eid/1-s2.0-S022352341930371X-gr13.jpg?httpAccept=%2A%2F%2A</object><object ref="gr19" category="standard" type="IMAGE-DOWNSAMPLED" multimediatype="JPEG image file" mimetype="image/jpeg" width="512" height="234" size="17712">https://api.elsevier.com/content/object/eid/1-s2.0-S022352341930371X-gr19.jpg?httpAccept=%2A%2F%2A</object><object ref="gr37" category="standard" type="IMAGE-DOWNSAMPLED" multimediatype="JPEG image file" mimetype="image/jpeg" width="513" height="394" size="51504">https://api.elsevier.com/content/object/eid/1-s2.0-S022352341930371X-gr37.jpg?httpAccept=%2A%2F%2A</object><object ref="gr1" category="standard" type="IMAGE-DOWNSAMPLED" multimediatype="JPEG image file" mimetype="image/jpeg" width="513" height="574" size="75676">https://api.elsevier.com/content/object/eid/1-s2.0-S022352341930371X-gr1.jpg?httpAccept=%2A%2F%2A</object><object ref="gr14" category="standard" type="IMAGE-DOWNSAMPLED" multimediatype="JPEG image file" mimetype="image/jpeg" width="511" height="214" size="22913">https://api.elsevier.com/content/object/eid/1-s2.0-S022352341930371X-gr14.jpg?httpAccept=%2A%2F%2A</object><object ref="gr43" category="standard" type="IMAGE-DOWNSAMPLED" multimediatype="JPEG image file" mimetype="image/jpeg" width="312" height="175" size="7444">https://api.elsevier.com/content/object/eid/1-s2.0-S022352341930371X-gr43.jpg?httpAccept=%2A%2F%2A</object><object ref="gr20" category="standard" type="IMAGE-DOWNSAMPLED" multimediatype="JPEG image file" mimetype="image/jpeg" width="512" height="169" size="16697">https://api.elsevier.com/content/object/eid/1-s2.0-S022352341930371X-gr20.jpg?httpAccept=%2A%2F%2A</object><object ref="gr32" category="standard" type="IMAGE-DOWNSAMPLED" multimediatype="JPEG image file" mimetype="image/jpeg" width="378" height="275" size="16303">https://api.elsevier.com/content/object/eid/1-s2.0-S022352341930371X-gr32.jpg?httpAccept=%2A%2F%2A</object><object ref="gr38" category="standard" type="IMAGE-DOWNSAMPLED" multimediatype="JPEG image file" mimetype="image/jpeg" width="222" height="109" size="5474">https://api.elsevier.com/content/object/eid/1-s2.0-S022352341930371X-gr38.jpg?httpAccept=%2A%2F%2A</object><object ref="gr25" category="standard" type="IMAGE-DOWNSAMPLED" multimediatype="JPEG image file" mimetype="image/jpeg" width="557" height="369" size="51283">https://api.elsevier.com/content/object/eid/1-s2.0-S022352341930371X-gr25.jpg?httpAccept=%2A%2F%2A</object><object ref="gr26" category="standard" type="IMAGE-DOWNSAMPLED" multimediatype="JPEG image file" mimetype="image/jpeg" width="556" height="511" size="49462">https://api.elsevier.com/content/object/eid/1-s2.0-S022352341930371X-gr26.jpg?httpAccept=%2A%2F%2A</object><object ref="gr41" category="standard" type="IMAGE-DOWNSAMPLED" multimediatype="JPEG image file" mimetype="image/jpeg" width="311" height="173" size="8035">https://api.elsevier.com/content/object/eid/1-s2.0-S022352341930371X-gr41.jpg?httpAccept=%2A%2F%2A</object><object ref="gr42" category="standard" type="IMAGE-DOWNSAMPLED" multimediatype="JPEG image file" mimetype="image/jpeg" width="513" height="338" size="48295">https://api.elsevier.com/content/object/eid/1-s2.0-S022352341930371X-gr42.jpg?httpAccept=%2A%2F%2A</object><object ref="gr47" category="standard" type="IMAGE-DOWNSAMPLED" multimediatype="JPEG image file" mimetype="image/jpeg" width="177" height="69" size="4759">https://api.elsevier.com/content/object/eid/1-s2.0-S022352341930371X-gr47.jpg?httpAccept=%2A%2F%2A</object><object ref="gr27" category="standard" type="IMAGE-DOWNSAMPLED" multimediatype="JPEG image file" mimetype="image/jpeg" width="512" height="172" size="15218">https://api.elsevier.com/content/object/eid/1-s2.0-S022352341930371X-gr27.jpg?httpAccept=%2A%2F%2A</object><object ref="fx1" category="standard" type="IMAGE-DOWNSAMPLED" multimediatype="JPEG image file" mimetype="image/jpeg" width="459" height="200" size="22779">https://api.elsevier.com/content/object/eid/1-s2.0-S022352341930371X-fx1.jpg?httpAccept=%2A%2F%2A</object><object ref="gr7" category="standard" type="IMAGE-DOWNSAMPLED" multimediatype="JPEG image file" mimetype="image/jpeg" width="511" height="405" size="20923">https://api.elsevier.com/content/object/eid/1-s2.0-S022352341930371X-gr7.jpg?httpAccept=%2A%2F%2A</object><object ref="gr16" category="standard" type="IMAGE-DOWNSAMPLED" multimediatype="JPEG image file" mimetype="image/jpeg" width="556" height="155" size="17768">https://api.elsevier.com/content/object/eid/1-s2.0-S022352341930371X-gr16.jpg?httpAccept=%2A%2F%2A</object><object ref="gr3" category="standard" type="IMAGE-DOWNSAMPLED" multimediatype="JPEG image file" mimetype="image/jpeg" width="511" height="167" size="15610">https://api.elsevier.com/content/object/eid/1-s2.0-S022352341930371X-gr3.jpg?httpAccept=%2A%2F%2A</object><object ref="gr12" category="standard" type="IMAGE-DOWNSAMPLED" multimediatype="JPEG image file" mimetype="image/jpeg" width="511" height="177" size="21555">https://api.elsevier.com/content/object/eid/1-s2.0-S022352341930371X-gr12.jpg?httpAccept=%2A%2F%2A</object><object ref="gr28" category="standard" type="IMAGE-DOWNSAMPLED" multimediatype="JPEG image file" mimetype="image/jpeg" width="511" height="139" size="14841">https://api.elsevier.com/content/object/eid/1-s2.0-S022352341930371X-gr28.jpg?httpAccept=%2A%2F%2A</object><object ref="gr4" category="standard" type="IMAGE-DOWNSAMPLED" multimediatype="JPEG image file" mimetype="image/jpeg" width="556" height="118" size="14001">https://api.elsevier.com/content/object/eid/1-s2.0-S022352341930371X-gr4.jpg?httpAccept=%2A%2F%2A</object><object ref="gr18" category="standard" type="IMAGE-DOWNSAMPLED" multimediatype="JPEG image file" mimetype="image/jpeg" width="556" height="199" size="19229">https://api.elsevier.com/content/object/eid/1-s2.0-S022352341930371X-gr18.jpg?httpAccept=%2A%2F%2A</object><object ref="gr40" category="standard" type="IMAGE-DOWNSAMPLED" multimediatype="JPEG image file" mimetype="image/jpeg" width="311" height="215" size="8078">https://api.elsevier.com/content/object/eid/1-s2.0-S022352341930371X-gr40.jpg?httpAccept=%2A%2F%2A</object><object ref="gr10" category="standard" type="IMAGE-DOWNSAMPLED" multimediatype="JPEG image file" mimetype="image/jpeg" width="556" height="216" size="20195">https://api.elsevier.com/content/object/eid/1-s2.0-S022352341930371X-gr10.jpg?httpAccept=%2A%2F%2A</object><object ref="gr44" category="standard" type="IMAGE-DOWNSAMPLED" multimediatype="JPEG image file" mimetype="image/jpeg" width="311" height="145" size="6683">https://api.elsevier.com/content/object/eid/1-s2.0-S022352341930371X-gr44.jpg?httpAccept=%2A%2F%2A</object><object ref="gr36" category="standard" type="IMAGE-DOWNSAMPLED" multimediatype="JPEG image file" mimetype="image/jpeg" width="222" height="136" size="5551">https://api.elsevier.com/content/object/eid/1-s2.0-S022352341930371X-gr36.jpg?httpAccept=%2A%2F%2A</object><object ref="gr39" category="standard" type="IMAGE-DOWNSAMPLED" multimediatype="JPEG image file" mimetype="image/jpeg" width="178" height="228" size="7457">https://api.elsevier.com/content/object/eid/1-s2.0-S022352341930371X-gr39.jpg?httpAccept=%2A%2F%2A</object><object ref="gr15" category="standard" type="IMAGE-DOWNSAMPLED" multimediatype="JPEG image file" mimetype="image/jpeg" width="511" height="314" size="24190">https://api.elsevier.com/content/object/eid/1-s2.0-S022352341930371X-gr15.jpg?httpAccept=%2A%2F%2A</object><object ref="gr34" category="standard" type="IMAGE-DOWNSAMPLED" multimediatype="JPEG image file" mimetype="image/jpeg" width="222" height="112" size="4304">https://api.elsevier.com/content/object/eid/1-s2.0-S022352341930371X-gr34.jpg?httpAccept=%2A%2F%2A</object><object ref="gr8" category="standard" type="IMAGE-DOWNSAMPLED" multimediatype="JPEG image file" mimetype="image/jpeg" width="378" height="743" size="92030">https://api.elsevier.com/content/object/eid/1-s2.0-S022352341930371X-gr8.jpg?httpAccept=%2A%2F%2A</object><object ref="gr17" category="standard" type="IMAGE-DOWNSAMPLED" multimediatype="JPEG image file" mimetype="image/jpeg" width="378" height="185" size="12933">https://api.elsevier.com/content/object/eid/1-s2.0-S022352341930371X-gr17.jpg?httpAccept=%2A%2F%2A</object><object ref="gr22" category="standard" type="IMAGE-DOWNSAMPLED" multimediatype="JPEG image file" mimetype="image/jpeg" width="511" height="189" size="17461">https://api.elsevier.com/content/object/eid/1-s2.0-S022352341930371X-gr22.jpg?httpAccept=%2A%2F%2A</object><object ref="gr23" category="standard" type="IMAGE-DOWNSAMPLED" multimediatype="JPEG image file" mimetype="image/jpeg" width="511" height="170" size="20469">https://api.elsevier.com/content/object/eid/1-s2.0-S022352341930371X-gr23.jpg?httpAccept=%2A%2F%2A</object><object ref="gr11" category="standard" type="IMAGE-DOWNSAMPLED" multimediatype="JPEG image file" mimetype="image/jpeg" width="379" height="203" size="13800">https://api.elsevier.com/content/object/eid/1-s2.0-S022352341930371X-gr11.jpg?httpAccept=%2A%2F%2A</object><object ref="gr24" category="standard" type="IMAGE-DOWNSAMPLED" multimediatype="JPEG image file" mimetype="image/jpeg" width="511" height="337" size="29301">https://api.elsevier.com/content/object/eid/1-s2.0-S022352341930371X-gr24.jpg?httpAccept=%2A%2F%2A</object><object ref="gr21" category="standard" type="IMAGE-DOWNSAMPLED" multimediatype="JPEG image file" mimetype="image/jpeg" width="512" height="155" size="17194">https://api.elsevier.com/content/object/eid/1-s2.0-S022352341930371X-gr21.jpg?httpAccept=%2A%2F%2A</object><object ref="gr5" category="standard" type="IMAGE-DOWNSAMPLED" multimediatype="JPEG image file" mimetype="image/jpeg" width="511" height="151" size="16457">https://api.elsevier.com/content/object/eid/1-s2.0-S022352341930371X-gr5.jpg?httpAccept=%2A%2F%2A</object><object ref="gr31" category="standard" type="IMAGE-DOWNSAMPLED" multimediatype="JPEG image file" mimetype="image/jpeg" width="311" height="168" size="8959">https://api.elsevier.com/content/object/eid/1-s2.0-S022352341930371X-gr31.jpg?httpAccept=%2A%2F%2A</object><object ref="gr35" category="standard" type="IMAGE-DOWNSAMPLED" multimediatype="JPEG image file" mimetype="image/jpeg" width="600" height="164" size="22523">https://api.elsevier.com/content/object/eid/1-s2.0-S022352341930371X-gr35.jpg?httpAccept=%2A%2F%2A</object><object ref="gr6" category="thumbnail" type="IMAGE-THUMBNAIL" multimediatype="GIF image file" mimetype="image/gif" width="219" height="81" size="2701">https://api.elsevier.com/content/object/eid/1-s2.0-S022352341930371X-gr6.sml?httpAccept=%2A%2F%2A</object><object ref="gr33" category="thumbnail" type="IMAGE-THUMBNAIL" multimediatype="GIF image file" mimetype="image/gif" width="219" height="119" size="2532">https://api.elsevier.com/content/object/eid/1-s2.0-S022352341930371X-gr33.sml?httpAccept=%2A%2F%2A</object><object ref="gr45" category="thumbnail" type="IMAGE-THUMBNAIL" multimediatype="GIF image file" mimetype="image/gif" width="132" height="164" size="2204">https://api.elsevier.com/content/object/eid/1-s2.0-S022352341930371X-gr45.sml?httpAccept=%2A%2F%2A</object><object ref="gr30" category="thumbnail" type="IMAGE-THUMBNAIL" multimediatype="GIF image file" mimetype="image/gif" width="219" height="38" size="2626">https://api.elsevier.com/content/object/eid/1-s2.0-S022352341930371X-gr30.sml?httpAccept=%2A%2F%2A</object><object ref="gr9" category="thumbnail" type="IMAGE-THUMBNAIL" multimediatype="GIF image file" mimetype="image/gif" width="219" height="113" size="3805">https://api.elsevier.com/content/object/eid/1-s2.0-S022352341930371X-gr9.sml?httpAccept=%2A%2F%2A</object><object ref="gr2" category="thumbnail" type="IMAGE-THUMBNAIL" multimediatype="GIF image file" mimetype="image/gif" width="219" height="80" size="2953">https://api.elsevier.com/content/object/eid/1-s2.0-S022352341930371X-gr2.sml?httpAccept=%2A%2F%2A</object><object ref="gr29" category="thumbnail" type="IMAGE-THUMBNAIL" multimediatype="GIF image file" mimetype="image/gif" width="219" height="88" size="3115">https://api.elsevier.com/content/object/eid/1-s2.0-S022352341930371X-gr29.sml?httpAccept=%2A%2F%2A</object><object ref="gr46" category="thumbnail" type="IMAGE-THUMBNAIL" multimediatype="GIF image file" mimetype="image/gif" width="183" height="164" size="2895">https://api.elsevier.com/content/object/eid/1-s2.0-S022352341930371X-gr46.sml?httpAccept=%2A%2F%2A</object><object ref="gr13" category="thumbnail" type="IMAGE-THUMBNAIL" multimediatype="GIF image file" mimetype="image/gif" width="219" height="75" size="3088">https://api.elsevier.com/content/object/eid/1-s2.0-S022352341930371X-gr13.sml?httpAccept=%2A%2F%2A</object><object ref="gr19" category="thumbnail" type="IMAGE-THUMBNAIL" multimediatype="GIF image file" mimetype="image/gif" width="219" height="100" size="2603">https://api.elsevier.com/content/object/eid/1-s2.0-S022352341930371X-gr19.sml?httpAccept=%2A%2F%2A</object><object ref="gr37" category="thumbnail" type="IMAGE-THUMBNAIL" multimediatype="GIF image file" mimetype="image/gif" width="214" height="164" size="14550">https://api.elsevier.com/content/object/eid/1-s2.0-S022352341930371X-gr37.sml?httpAccept=%2A%2F%2A</object><object ref="gr1" category="thumbnail" type="IMAGE-THUMBNAIL" multimediatype="GIF image file" mimetype="image/gif" width="146" height="163" size="8989">https://api.elsevier.com/content/object/eid/1-s2.0-S022352341930371X-gr1.sml?httpAccept=%2A%2F%2A</object><object ref="gr14" category="thumbnail" type="IMAGE-THUMBNAIL" multimediatype="GIF image file" mimetype="image/gif" width="219" height="92" size="3208">https://api.elsevier.com/content/object/eid/1-s2.0-S022352341930371X-gr14.sml?httpAccept=%2A%2F%2A</object><object ref="gr43" category="thumbnail" type="IMAGE-THUMBNAIL" multimediatype="GIF image file" mimetype="image/gif" width="219" height="123" size="2349">https://api.elsevier.com/content/object/eid/1-s2.0-S022352341930371X-gr43.sml?httpAccept=%2A%2F%2A</object><object ref="gr20" category="thumbnail" type="IMAGE-THUMBNAIL" multimediatype="GIF image file" mimetype="image/gif" width="219" height="72" size="2350">https://api.elsevier.com/content/object/eid/1-s2.0-S022352341930371X-gr20.sml?httpAccept=%2A%2F%2A</object><object ref="gr32" category="thumbnail" type="IMAGE-THUMBNAIL" multimediatype="GIF image file" mimetype="image/gif" width="219" height="159" size="4025">https://api.elsevier.com/content/object/eid/1-s2.0-S022352341930371X-gr32.sml?httpAccept=%2A%2F%2A</object><object ref="gr38" category="thumbnail" type="IMAGE-THUMBNAIL" multimediatype="GIF image file" mimetype="image/gif" width="219" height="107" size="2756">https://api.elsevier.com/content/object/eid/1-s2.0-S022352341930371X-gr38.sml?httpAccept=%2A%2F%2A</object><object ref="gr25" category="thumbnail" type="IMAGE-THUMBNAIL" multimediatype="GIF image file" mimetype="image/gif" width="219" height="145" size="15320">https://api.elsevier.com/content/object/eid/1-s2.0-S022352341930371X-gr25.sml?httpAccept=%2A%2F%2A</object><object ref="gr26" category="thumbnail" type="IMAGE-THUMBNAIL" multimediatype="GIF image file" mimetype="image/gif" width="178" height="163" size="4515">https://api.elsevier.com/content/object/eid/1-s2.0-S022352341930371X-gr26.sml?httpAccept=%2A%2F%2A</object><object ref="gr41" category="thumbnail" type="IMAGE-THUMBNAIL" multimediatype="GIF image file" mimetype="image/gif" width="219" height="122" size="2589">https://api.elsevier.com/content/object/eid/1-s2.0-S022352341930371X-gr41.sml?httpAccept=%2A%2F%2A</object><object ref="gr42" category="thumbnail" type="IMAGE-THUMBNAIL" multimediatype="GIF image file" mimetype="image/gif" width="219" height="144" size="14297">https://api.elsevier.com/content/object/eid/1-s2.0-S022352341930371X-gr42.sml?httpAccept=%2A%2F%2A</object><object ref="gr47" category="thumbnail" type="IMAGE-THUMBNAIL" multimediatype="GIF image file" mimetype="image/gif" width="219" height="86" size="3200">https://api.elsevier.com/content/object/eid/1-s2.0-S022352341930371X-gr47.sml?httpAccept=%2A%2F%2A</object><object ref="gr27" category="thumbnail" type="IMAGE-THUMBNAIL" multimediatype="GIF image file" mimetype="image/gif" width="219" height="74" size="2259">https://api.elsevier.com/content/object/eid/1-s2.0-S022352341930371X-gr27.sml?httpAccept=%2A%2F%2A</object><object ref="fx1" category="thumbnail" type="IMAGE-THUMBNAIL" multimediatype="GIF image file" mimetype="image/gif" width="219" height="95" size="5834">https://api.elsevier.com/content/object/eid/1-s2.0-S022352341930371X-fx1.sml?httpAccept=%2A%2F%2A</object><object ref="gr7" category="thumbnail" type="IMAGE-THUMBNAIL" multimediatype="GIF image file" mimetype="image/gif" width="207" height="164" size="3772">https://api.elsevier.com/content/object/eid/1-s2.0-S022352341930371X-gr7.sml?httpAccept=%2A%2F%2A</object><object ref="gr16" category="thumbnail" type="IMAGE-THUMBNAIL" multimediatype="GIF image file" mimetype="image/gif" width="219" height="61" size="2264">https://api.elsevier.com/content/object/eid/1-s2.0-S022352341930371X-gr16.sml?httpAccept=%2A%2F%2A</object><object ref="gr3" category="thumbnail" type="IMAGE-THUMBNAIL" multimediatype="GIF image file" mimetype="image/gif" width="219" height="72" size="2478">https://api.elsevier.com/content/object/eid/1-s2.0-S022352341930371X-gr3.sml?httpAccept=%2A%2F%2A</object><object ref="gr12" category="thumbnail" type="IMAGE-THUMBNAIL" multimediatype="GIF image file" mimetype="image/gif" width="219" height="76" size="3131">https://api.elsevier.com/content/object/eid/1-s2.0-S022352341930371X-gr12.sml?httpAccept=%2A%2F%2A</object><object ref="gr28" category="thumbnail" type="IMAGE-THUMBNAIL" multimediatype="GIF image file" mimetype="image/gif" width="219" height="60" size="2194">https://api.elsevier.com/content/object/eid/1-s2.0-S022352341930371X-gr28.sml?httpAccept=%2A%2F%2A</object><object ref="gr4" category="thumbnail" type="IMAGE-THUMBNAIL" multimediatype="GIF image file" mimetype="image/gif" width="219" height="47" size="2735">https://api.elsevier.com/content/object/eid/1-s2.0-S022352341930371X-gr4.sml?httpAccept=%2A%2F%2A</object><object ref="gr18" category="thumbnail" type="IMAGE-THUMBNAIL" multimediatype="GIF image file" mimetype="image/gif" width="219" height="78" size="2335">https://api.elsevier.com/content/object/eid/1-s2.0-S022352341930371X-gr18.sml?httpAccept=%2A%2F%2A</object><object ref="gr40" category="thumbnail" type="IMAGE-THUMBNAIL" multimediatype="GIF image file" mimetype="image/gif" width="219" height="151" size="2570">https://api.elsevier.com/content/object/eid/1-s2.0-S022352341930371X-gr40.sml?httpAccept=%2A%2F%2A</object><object ref="gr10" category="thumbnail" type="IMAGE-THUMBNAIL" multimediatype="GIF image file" mimetype="image/gif" width="219" height="85" size="2659">https://api.elsevier.com/content/object/eid/1-s2.0-S022352341930371X-gr10.sml?httpAccept=%2A%2F%2A</object><object ref="gr44" category="thumbnail" type="IMAGE-THUMBNAIL" multimediatype="GIF image file" mimetype="image/gif" width="219" height="102" size="2090">https://api.elsevier.com/content/object/eid/1-s2.0-S022352341930371X-gr44.sml?httpAccept=%2A%2F%2A</object><object ref="gr36" category="thumbnail" type="IMAGE-THUMBNAIL" multimediatype="GIF image file" mimetype="image/gif" width="219" height="135" size="2800">https://api.elsevier.com/content/object/eid/1-s2.0-S022352341930371X-gr36.sml?httpAccept=%2A%2F%2A</object><object ref="gr39" category="thumbnail" type="IMAGE-THUMBNAIL" multimediatype="GIF image file" mimetype="image/gif" width="128" height="164" size="2509">https://api.elsevier.com/content/object/eid/1-s2.0-S022352341930371X-gr39.sml?httpAccept=%2A%2F%2A</object><object ref="gr15" category="thumbnail" type="IMAGE-THUMBNAIL" multimediatype="GIF image file" mimetype="image/gif" width="219" height="134" size="3548">https://api.elsevier.com/content/object/eid/1-s2.0-S022352341930371X-gr15.sml?httpAccept=%2A%2F%2A</object><object ref="gr34" category="thumbnail" type="IMAGE-THUMBNAIL" multimediatype="GIF image file" mimetype="image/gif" width="219" height="111" size="2278">https://api.elsevier.com/content/object/eid/1-s2.0-S022352341930371X-gr34.sml?httpAccept=%2A%2F%2A</object><object ref="gr8" category="thumbnail" type="IMAGE-THUMBNAIL" multimediatype="GIF image file" mimetype="image/gif" width="83" height="163" size="9245">https://api.elsevier.com/content/object/eid/1-s2.0-S022352341930371X-gr8.sml?httpAccept=%2A%2F%2A</object><object ref="gr17" category="thumbnail" type="IMAGE-THUMBNAIL" multimediatype="GIF image file" mimetype="image/gif" width="219" height="107" size="2859">https://api.elsevier.com/content/object/eid/1-s2.0-S022352341930371X-gr17.sml?httpAccept=%2A%2F%2A</object><object ref="gr22" category="thumbnail" type="IMAGE-THUMBNAIL" multimediatype="GIF image file" mimetype="image/gif" width="219" height="81" size="2551">https://api.elsevier.com/content/object/eid/1-s2.0-S022352341930371X-gr22.sml?httpAccept=%2A%2F%2A</object><object ref="gr23" category="thumbnail" type="IMAGE-THUMBNAIL" multimediatype="GIF image file" mimetype="image/gif" width="219" height="73" size="3010">https://api.elsevier.com/content/object/eid/1-s2.0-S022352341930371X-gr23.sml?httpAccept=%2A%2F%2A</object><object ref="gr11" category="thumbnail" type="IMAGE-THUMBNAIL" multimediatype="GIF image file" mimetype="image/gif" width="219" height="118" size="3371">https://api.elsevier.com/content/object/eid/1-s2.0-S022352341930371X-gr11.sml?httpAccept=%2A%2F%2A</object><object ref="gr24" category="thumbnail" type="IMAGE-THUMBNAIL" multimediatype="GIF image file" mimetype="image/gif" width="219" height="144" size="3862">https://api.elsevier.com/content/object/eid/1-s2.0-S022352341930371X-gr24.sml?httpAccept=%2A%2F%2A</object><object ref="gr21" category="thumbnail" type="IMAGE-THUMBNAIL" multimediatype="GIF image file" mimetype="image/gif" width="219" height="66" size="2631">https://api.elsevier.com/content/object/eid/1-s2.0-S022352341930371X-gr21.sml?httpAccept=%2A%2F%2A</object><object ref="gr5" category="thumbnail" type="IMAGE-THUMBNAIL" multimediatype="GIF image file" mimetype="image/gif" width="219" height="65" size="2710">https://api.elsevier.com/content/object/eid/1-s2.0-S022352341930371X-gr5.sml?httpAccept=%2A%2F%2A</object><object ref="gr31" category="thumbnail" type="IMAGE-THUMBNAIL" multimediatype="GIF image file" mimetype="image/gif" width="219" height="118" size="2797">https://api.elsevier.com/content/object/eid/1-s2.0-S022352341930371X-gr31.sml?httpAccept=%2A%2F%2A</object><object ref="gr35" category="thumbnail" type="IMAGE-THUMBNAIL" multimediatype="GIF image file" mimetype="image/gif" width="219" height="60" size="2476">https://api.elsevier.com/content/object/eid/1-s2.0-S022352341930371X-gr35.sml?httpAccept=%2A%2F%2A</object><object ref="gr6" category="high" type="IMAGE-HIGH-RES" multimediatype="JPEG image file" mimetype="image/jpeg" width="1673" height="615" size="83857">https://api.elsevier.com/content/object/eid/1-s2.0-S022352341930371X-gr6_lrg.jpg?httpAccept=%2A%2F%2A</object><object ref="gr33" category="high" type="IMAGE-HIGH-RES" multimediatype="JPEG image file" mimetype="image/jpeg" width="986" height="537" size="37621">https://api.elsevier.com/content/object/eid/1-s2.0-S022352341930371X-gr33_lrg.jpg?httpAccept=%2A%2F%2A</object><object ref="gr45" category="high" type="IMAGE-HIGH-RES" multimediatype="JPEG image file" mimetype="image/jpeg" width="792" height="984" size="51057">https://api.elsevier.com/content/object/eid/1-s2.0-S022352341930371X-gr45_lrg.jpg?httpAccept=%2A%2F%2A</object><object ref="gr30" category="high" type="IMAGE-HIGH-RES" multimediatype="JPEG image file" mimetype="image/jpeg" width="2757" height="480" size="114436">https://api.elsevier.com/content/object/eid/1-s2.0-S022352341930371X-gr30_lrg.jpg?httpAccept=%2A%2F%2A</object><object ref="gr9" category="high" type="IMAGE-HIGH-RES" multimediatype="JPEG image file" mimetype="image/jpeg" width="2657" height="1369" size="282177">https://api.elsevier.com/content/object/eid/1-s2.0-S022352341930371X-gr9_lrg.jpg?httpAccept=%2A%2F%2A</object><object ref="gr2" category="high" type="IMAGE-HIGH-RES" multimediatype="JPEG image file" mimetype="image/jpeg" width="2267" height="827" size="103184">https://api.elsevier.com/content/object/eid/1-s2.0-S022352341930371X-gr2_lrg.jpg?httpAccept=%2A%2F%2A</object><object ref="gr29" category="high" type="IMAGE-HIGH-RES" multimediatype="JPEG image file" mimetype="image/jpeg" width="2265" height="914" size="118310">https://api.elsevier.com/content/object/eid/1-s2.0-S022352341930371X-gr29_lrg.jpg?httpAccept=%2A%2F%2A</object><object ref="gr46" category="high" type="IMAGE-HIGH-RES" multimediatype="JPEG image file" mimetype="image/jpeg" width="789" height="708" size="42709">https://api.elsevier.com/content/object/eid/1-s2.0-S022352341930371X-gr46_lrg.jpg?httpAccept=%2A%2F%2A</object><object ref="gr13" category="high" type="IMAGE-HIGH-RES" multimediatype="JPEG image file" mimetype="image/jpeg" width="2264" height="779" size="159043">https://api.elsevier.com/content/object/eid/1-s2.0-S022352341930371X-gr13_lrg.jpg?httpAccept=%2A%2F%2A</object><object ref="gr19" category="high" type="IMAGE-HIGH-RES" multimediatype="JPEG image file" mimetype="image/jpeg" width="2266" height="1034" size="135023">https://api.elsevier.com/content/object/eid/1-s2.0-S022352341930371X-gr19_lrg.jpg?httpAccept=%2A%2F%2A</object><object ref="gr37" category="high" type="IMAGE-HIGH-RES" multimediatype="JPEG image file" mimetype="image/jpeg" width="2272" height="1743" size="481839">https://api.elsevier.com/content/object/eid/1-s2.0-S022352341930371X-gr37_lrg.jpg?httpAccept=%2A%2F%2A</object><object ref="gr1" category="high" type="IMAGE-HIGH-RES" multimediatype="JPEG image file" mimetype="image/jpeg" width="2272" height="2544" size="656724">https://api.elsevier.com/content/object/eid/1-s2.0-S022352341930371X-gr1_lrg.jpg?httpAccept=%2A%2F%2A</object><object ref="gr14" category="high" type="IMAGE-HIGH-RES" multimediatype="JPEG image file" mimetype="image/jpeg" width="2264" height="946" size="175368">https://api.elsevier.com/content/object/eid/1-s2.0-S022352341930371X-gr14_lrg.jpg?httpAccept=%2A%2F%2A</object><object ref="gr43" category="high" type="IMAGE-HIGH-RES" multimediatype="JPEG image file" mimetype="image/jpeg" width="1381" height="774" size="59649">https://api.elsevier.com/content/object/eid/1-s2.0-S022352341930371X-gr43_lrg.jpg?httpAccept=%2A%2F%2A</object><object ref="gr20" category="high" type="IMAGE-HIGH-RES" multimediatype="JPEG image file" mimetype="image/jpeg" width="2266" height="747" size="132203">https://api.elsevier.com/content/object/eid/1-s2.0-S022352341930371X-gr20_lrg.jpg?httpAccept=%2A%2F%2A</object><object ref="gr32" category="high" type="IMAGE-HIGH-RES" multimediatype="JPEG image file" mimetype="image/jpeg" width="1673" height="1216" size="124617">https://api.elsevier.com/content/object/eid/1-s2.0-S022352341930371X-gr32_lrg.jpg?httpAccept=%2A%2F%2A</object><object ref="gr38" category="high" type="IMAGE-HIGH-RES" multimediatype="JPEG image file" mimetype="image/jpeg" width="986" height="483" size="43162">https://api.elsevier.com/content/object/eid/1-s2.0-S022352341930371X-gr38_lrg.jpg?httpAccept=%2A%2F%2A</object><object ref="gr25" category="high" type="IMAGE-HIGH-RES" multimediatype="JPEG image file" mimetype="image/jpeg" width="2469" height="1636" size="495497">https://api.elsevier.com/content/object/eid/1-s2.0-S022352341930371X-gr25_lrg.jpg?httpAccept=%2A%2F%2A</object><object ref="gr26" category="high" type="IMAGE-HIGH-RES" multimediatype="JPEG image file" mimetype="image/jpeg" width="2461" height="2260" size="386309">https://api.elsevier.com/content/object/eid/1-s2.0-S022352341930371X-gr26_lrg.jpg?httpAccept=%2A%2F%2A</object><object ref="gr41" category="high" type="IMAGE-HIGH-RES" multimediatype="JPEG image file" mimetype="image/jpeg" width="1378" height="768" size="63408">https://api.elsevier.com/content/object/eid/1-s2.0-S022352341930371X-gr41_lrg.jpg?httpAccept=%2A%2F%2A</object><object ref="gr42" category="high" type="IMAGE-HIGH-RES" multimediatype="JPEG image file" mimetype="image/jpeg" width="2272" height="1497" size="466813">https://api.elsevier.com/content/object/eid/1-s2.0-S022352341930371X-gr42_lrg.jpg?httpAccept=%2A%2F%2A</object><object ref="gr47" category="high" type="IMAGE-HIGH-RES" multimediatype="JPEG image file" mimetype="image/jpeg" width="787" height="308" size="31252">https://api.elsevier.com/content/object/eid/1-s2.0-S022352341930371X-gr47_lrg.jpg?httpAccept=%2A%2F%2A</object><object ref="gr27" category="high" type="IMAGE-HIGH-RES" multimediatype="JPEG image file" mimetype="image/jpeg" width="2267" height="763" size="122348">https://api.elsevier.com/content/object/eid/1-s2.0-S022352341930371X-gr27_lrg.jpg?httpAccept=%2A%2F%2A</object><object ref="fx1" category="high" type="IMAGE-HIGH-RES" multimediatype="JPEG image file" mimetype="image/jpeg" width="2032" height="886" size="151517">https://api.elsevier.com/content/object/eid/1-s2.0-S022352341930371X-fx1_lrg.jpg?httpAccept=%2A%2F%2A</object><object ref="gr7" category="high" type="IMAGE-HIGH-RES" multimediatype="JPEG image file" mimetype="image/jpeg" width="2265" height="1797" size="175823">https://api.elsevier.com/content/object/eid/1-s2.0-S022352341930371X-gr7_lrg.jpg?httpAccept=%2A%2F%2A</object><object ref="gr16" category="high" type="IMAGE-HIGH-RES" multimediatype="JPEG image file" mimetype="image/jpeg" width="2461" height="684" size="138717">https://api.elsevier.com/content/object/eid/1-s2.0-S022352341930371X-gr16_lrg.jpg?httpAccept=%2A%2F%2A</object><object ref="gr3" category="high" type="IMAGE-HIGH-RES" multimediatype="JPEG image file" mimetype="image/jpeg" width="2264" height="741" size="121918">https://api.elsevier.com/content/object/eid/1-s2.0-S022352341930371X-gr3_lrg.jpg?httpAccept=%2A%2F%2A</object><object ref="gr12" category="high" type="IMAGE-HIGH-RES" multimediatype="JPEG image file" mimetype="image/jpeg" width="2264" height="785" size="163522">https://api.elsevier.com/content/object/eid/1-s2.0-S022352341930371X-gr12_lrg.jpg?httpAccept=%2A%2F%2A</object><object ref="gr28" category="high" type="IMAGE-HIGH-RES" multimediatype="JPEG image file" mimetype="image/jpeg" width="2265" height="618" size="116787">https://api.elsevier.com/content/object/eid/1-s2.0-S022352341930371X-gr28_lrg.jpg?httpAccept=%2A%2F%2A</object><object ref="gr4" category="high" type="IMAGE-HIGH-RES" multimediatype="JPEG image file" mimetype="image/jpeg" width="2461" height="523" size="106716">https://api.elsevier.com/content/object/eid/1-s2.0-S022352341930371X-gr4_lrg.jpg?httpAccept=%2A%2F%2A</object><object ref="gr18" category="high" type="IMAGE-HIGH-RES" multimediatype="JPEG image file" mimetype="image/jpeg" width="2464" height="883" size="152509">https://api.elsevier.com/content/object/eid/1-s2.0-S022352341930371X-gr18_lrg.jpg?httpAccept=%2A%2F%2A</object><object ref="gr40" category="high" type="IMAGE-HIGH-RES" multimediatype="JPEG image file" mimetype="image/jpeg" width="1380" height="953" size="67905">https://api.elsevier.com/content/object/eid/1-s2.0-S022352341930371X-gr40_lrg.jpg?httpAccept=%2A%2F%2A</object><object ref="gr10" category="high" type="IMAGE-HIGH-RES" multimediatype="JPEG image file" mimetype="image/jpeg" width="2464" height="957" size="157097">https://api.elsevier.com/content/object/eid/1-s2.0-S022352341930371X-gr10_lrg.jpg?httpAccept=%2A%2F%2A</object><object ref="gr44" category="high" type="IMAGE-HIGH-RES" multimediatype="JPEG image file" mimetype="image/jpeg" width="1380" height="645" size="53495">https://api.elsevier.com/content/object/eid/1-s2.0-S022352341930371X-gr44_lrg.jpg?httpAccept=%2A%2F%2A</object><object ref="gr36" category="high" type="IMAGE-HIGH-RES" multimediatype="JPEG image file" mimetype="image/jpeg" width="984" height="605" size="44281">https://api.elsevier.com/content/object/eid/1-s2.0-S022352341930371X-gr36_lrg.jpg?httpAccept=%2A%2F%2A</object><object ref="gr39" category="high" type="IMAGE-HIGH-RES" multimediatype="JPEG image file" mimetype="image/jpeg" width="789" height="1012" size="59185">https://api.elsevier.com/content/object/eid/1-s2.0-S022352341930371X-gr39_lrg.jpg?httpAccept=%2A%2F%2A</object><object ref="gr15" category="high" type="IMAGE-HIGH-RES" multimediatype="JPEG image file" mimetype="image/jpeg" width="2264" height="1389" size="192473">https://api.elsevier.com/content/object/eid/1-s2.0-S022352341930371X-gr15_lrg.jpg?httpAccept=%2A%2F%2A</object><object ref="gr34" category="high" type="IMAGE-HIGH-RES" multimediatype="JPEG image file" mimetype="image/jpeg" width="986" height="498" size="32973">https://api.elsevier.com/content/object/eid/1-s2.0-S022352341930371X-gr34_lrg.jpg?httpAccept=%2A%2F%2A</object><object ref="gr8" category="high" type="IMAGE-HIGH-RES" multimediatype="JPEG image file" mimetype="image/jpeg" width="1673" height="3290" size="910770">https://api.elsevier.com/content/object/eid/1-s2.0-S022352341930371X-gr8_lrg.jpg?httpAccept=%2A%2F%2A</object><object ref="gr17" category="high" type="IMAGE-HIGH-RES" multimediatype="JPEG image file" mimetype="image/jpeg" width="1675" height="820" size="103072">https://api.elsevier.com/content/object/eid/1-s2.0-S022352341930371X-gr17_lrg.jpg?httpAccept=%2A%2F%2A</object><object ref="gr22" category="high" type="IMAGE-HIGH-RES" multimediatype="JPEG image file" mimetype="image/jpeg" width="2265" height="839" size="133728">https://api.elsevier.com/content/object/eid/1-s2.0-S022352341930371X-gr22_lrg.jpg?httpAccept=%2A%2F%2A</object><object ref="gr23" category="high" type="IMAGE-HIGH-RES" multimediatype="JPEG image file" mimetype="image/jpeg" width="2264" height="751" size="150380">https://api.elsevier.com/content/object/eid/1-s2.0-S022352341930371X-gr23_lrg.jpg?httpAccept=%2A%2F%2A</object><object ref="gr11" category="high" type="IMAGE-HIGH-RES" multimediatype="JPEG image file" mimetype="image/jpeg" width="1677" height="900" size="109163">https://api.elsevier.com/content/object/eid/1-s2.0-S022352341930371X-gr11_lrg.jpg?httpAccept=%2A%2F%2A</object><object ref="gr24" category="high" type="IMAGE-HIGH-RES" multimediatype="JPEG image file" mimetype="image/jpeg" width="2264" height="1491" size="224337">https://api.elsevier.com/content/object/eid/1-s2.0-S022352341930371X-gr24_lrg.jpg?httpAccept=%2A%2F%2A</object><object ref="gr21" category="high" type="IMAGE-HIGH-RES" multimediatype="JPEG image file" mimetype="image/jpeg" width="2266" height="684" size="126792">https://api.elsevier.com/content/object/eid/1-s2.0-S022352341930371X-gr21_lrg.jpg?httpAccept=%2A%2F%2A</object><object ref="gr5" category="high" type="IMAGE-HIGH-RES" multimediatype="JPEG image file" mimetype="image/jpeg" width="2264" height="668" size="116403">https://api.elsevier.com/content/object/eid/1-s2.0-S022352341930371X-gr5_lrg.jpg?httpAccept=%2A%2F%2A</object><object ref="gr31" category="high" type="IMAGE-HIGH-RES" multimediatype="JPEG image file" mimetype="image/jpeg" width="1380" height="744" size="64386">https://api.elsevier.com/content/object/eid/1-s2.0-S022352341930371X-gr31_lrg.jpg?httpAccept=%2A%2F%2A</object><object ref="gr35" category="high" type="IMAGE-HIGH-RES" multimediatype="JPEG image file" mimetype="image/jpeg" width="2659" height="729" size="176287">https://api.elsevier.com/content/object/eid/1-s2.0-S022352341930371X-gr35_lrg.jpg?httpAccept=%2A%2F%2A</object><object ref="am" category="standard" type="AAM-PDF" multimediatype="Acrobat PDF file" mimetype="application/pdf" size="376922">https://api.elsevier.com/content/object/eid/1-s2.0-S022352341930371X-am.pdf?httpAccept=%2A%2F%2A</object></objects><scopus-id>85065255525</scopus-id><scopus-eid>2-s2.0-85065255525</scopus-eid><pubmed-id>31077998</pubmed-id><link href="https://api.elsevier.com/content/abstract/scopus_id/85065255525" rel="abstract"/></link><originalText><xocs:doc xsi:schemaLocation="http://www.elsevier.com/xml/xocs/dtd http://null/schema/dtds/document/fulltext/xcr/xocs-article.xsd"><xocs:meta xmlns:xoe="http://www.elsevier.com/xml/xoe/dtd">
      <xocs:content-family>serial</xocs:content-family>
      <xocs:content-type>JL</xocs:content-type>
      <xocs:cid>271932</xocs:cid>
      <xocs:ssids>
         <xocs:ssid type="alllist">291210</xocs:ssid>
         <xocs:ssid type="subj">291732</xocs:ssid>
         <xocs:ssid type="subj">291789</xocs:ssid>
         <xocs:ssid type="subj">291858</xocs:ssid>
         <xocs:ssid type="subj">291928</xocs:ssid>
         <xocs:ssid type="content">31</xocs:ssid>
      </xocs:ssids>
      <xocs:srctitle>European Journal of Medicinal Chemistry</xocs:srctitle>
      <xocs:normalized-srctitle>EUROPEANJOURNALMEDICINALCHEMISTRY</xocs:normalized-srctitle>
      <xocs:orig-load-date yyyymmdd="20190430">2019-04-30</xocs:orig-load-date>
      <xocs:available-online-date yyyymmdd="20190430">2019-04-30</xocs:available-online-date>
      <xocs:vor-load-date yyyymmdd="20190509">2019-05-09</xocs:vor-load-date>
      <xocs:vor-available-online-date yyyymmdd="20190509">2019-05-09</xocs:vor-available-online-date>
      <xocs:ew-transaction-id>2020-02-01T16:43:50</xocs:ew-transaction-id>
      <xocs:eid>1-s2.0-S022352341930371X</xocs:eid>
      <xocs:pii-formatted>S0223-5234(19)30371-X</xocs:pii-formatted>
      <xocs:pii-unformatted>S022352341930371X</xocs:pii-unformatted>
      <xocs:doi>10.1016/j.ejmech.2019.04.053</xocs:doi>
      <xocs:item-stage>S300</xocs:item-stage>
      <xocs:item-version-number>S300.2</xocs:item-version-number>
      <xocs:item-weight>FULL-TEXT</xocs:item-weight>
      <xocs:hub-eid>1-s2.0-S0223523419X00124</xocs:hub-eid>
      <xocs:timestamp yyyymmdd="20200206">2020-02-06T10:10:17.49216Z</xocs:timestamp>
      <xocs:dco>0</xocs:dco>
      <xocs:tomb>0</xocs:tomb>
      <xocs:date-search-begin>20190801</xocs:date-search-begin>
      <xocs:year-nav>2019</xocs:year-nav>
      <xocs:indexeddate epoch="1556637995">2019-04-30T15:26:35.107654Z</xocs:indexeddate>
      <xocs:articleinfo>absattachment articleinfo articletitlenorm authfirstinitialnorm authfirstsurnamenorm cid cids contenttype copyright crossmark dateloaded dateloadedtxt datesearch datesort dateupdated dco docsubtype doctype doi eid ewtransactionid hubeid indexeddate issn issnnorm itemstage itemtransactionid itemweight openaccess openarchive pg pgfirst pglast pii piinorm pubdatestart pubdatetxt pubyr sectiontitle sortorder srctitle srctitlenorm srctype ssids alllist content subj subheadings suppl tomb volfirst volissue volumelist webpdf webpdfpagecount yearnav figure table body acknowledge affil articletitle auth authfirstini authfull authkeywords authlast grantnumber grantsponsor grantsponsorid highlightsabst orcid primabst pubtype ref specialabst</xocs:articleinfo>
      <xocs:issns>
         <xocs:issn-primary-formatted>0223-5234</xocs:issn-primary-formatted>
         <xocs:issn-primary-unformatted>02235234</xocs:issn-primary-unformatted>
      </xocs:issns>
      <xocs:crossmark is-crossmark="1">true</xocs:crossmark>
      <xocs:vol-first>175</xocs:vol-first>
      <xocs:volume-list>
         <xocs:volume>175</xocs:volume>
      </xocs:volume-list>
      <xocs:suppl>C</xocs:suppl>
      <xocs:vol-iss-suppl-text>Volume 175</xocs:vol-iss-suppl-text>
      <xocs:sort-order>3</xocs:sort-order>
      <xocs:first-fp>129</xocs:first-fp>
      <xocs:last-lp>148</xocs:last-lp>
      <xocs:pages>
         <xocs:first-page>129</xocs:first-page>
         <xocs:last-page>148</xocs:last-page>
      </xocs:pages>
      <xocs:cover-date-orig>
         <xocs:start-date>20190801</xocs:start-date>
      </xocs:cover-date-orig>
      <xocs:cover-date-text>1 August 2019</xocs:cover-date-text>
      <xocs:cover-date-start>2019-08-01</xocs:cover-date-start>
      <xocs:cover-date-year>2019</xocs:cover-date-year>
      <xocs:hub-sec>
         <xocs:hub-sec-title>Review articles</xocs:hub-sec-title>
      </xocs:hub-sec>
      <xocs:document-type>article</xocs:document-type>
      <xocs:document-subtype>rev</xocs:document-subtype>
      <xocs:copyright-line>Â© 2019 Published by Elsevier Masson SAS.</xocs:copyright-line>
      <xocs:normalized-article-title>TARGETINGTROPOMYOSINRECEPTORKINASEFORCANCERTHERAPY</xocs:normalized-article-title>
      <xocs:normalized-first-auth-surname>MIAO</xocs:normalized-first-auth-surname>
      <xocs:normalized-first-auth-initial>Q</xocs:normalized-first-auth-initial>
      <xocs:item-toc>
         <xocs:item-toc-entry ref-elem="ce:sections">
            <xocs:item-toc-label>1</xocs:item-toc-label>
            <xocs:item-toc-section-title>Introduction</xocs:item-toc-section-title>
         </xocs:item-toc-entry>
         <xocs:item-toc-entry ref-elem="ce:sections">
            <xocs:item-toc-label>2</xocs:item-toc-label>
            <xocs:item-toc-section-title>Current reported compounds with Trk inhibitory potency</xocs:item-toc-section-title>
            <xocs:item-toc-entry ref-elem="ce:sections">
               <xocs:item-toc-label>2.1</xocs:item-toc-label>
               <xocs:item-toc-section-title>ATP-competitive inhibitors</xocs:item-toc-section-title>
            </xocs:item-toc-entry>
            <xocs:item-toc-entry ref-elem="ce:sections">
               <xocs:item-toc-label>2.2</xocs:item-toc-label>
               <xocs:item-toc-section-title>Non-ATP competitive inhibitors</xocs:item-toc-section-title>
               <xocs:item-toc-entry ref-elem="ce:sections">
                  <xocs:item-toc-label>2.2.1</xocs:item-toc-label>
                  <xocs:item-toc-section-title>Allosteric inhibitor</xocs:item-toc-section-title>
               </xocs:item-toc-entry>
               <xocs:item-toc-entry ref-elem="ce:sections">
                  <xocs:item-toc-label>2.2.2</xocs:item-toc-label>
                  <xocs:item-toc-section-title>Trk downstream pathway</xocs:item-toc-section-title>
               </xocs:item-toc-entry>
            </xocs:item-toc-entry>
            <xocs:item-toc-entry ref-elem="ce:sections">
               <xocs:item-toc-label>2.3</xocs:item-toc-label>
               <xocs:item-toc-section-title>Trk inhibitors with unknown mechanism</xocs:item-toc-section-title>
            </xocs:item-toc-entry>
         </xocs:item-toc-entry>
         <xocs:item-toc-entry ref-elem="ce:sections">
            <xocs:item-toc-label>3</xocs:item-toc-label>
            <xocs:item-toc-section-title>Concluding remarks</xocs:item-toc-section-title>
         </xocs:item-toc-entry>
         <xocs:item-toc-entry ref-elem="ce:sections">
            <xocs:item-toc-section-title>Abbreviations used</xocs:item-toc-section-title>
         </xocs:item-toc-entry>
         <xocs:item-toc-entry ref-elem="ce:sections">
            <xocs:item-toc-section-title>Author contributions</xocs:item-toc-section-title>
         </xocs:item-toc-entry>
         <xocs:item-toc-entry ref-elem="ce:acknowledgment">
            <xocs:item-toc-section-title>Acknowledgements</xocs:item-toc-section-title>
         </xocs:item-toc-entry>
         <xocs:item-toc-entry ref-elem="ce:bibliography">
            <xocs:item-toc-section-title>References</xocs:item-toc-section-title>
         </xocs:item-toc-entry>
      </xocs:item-toc>
      <xocs:references>
         <xocs:ref-info refid="sref1">
            <xocs:ref-normalized-surname>STEWART</xocs:ref-normalized-surname>
            <xocs:ref-pub-year>2014</xocs:ref-pub-year>
            <xocs:ref-normalized-initial>B</xocs:ref-normalized-initial>
            <xocs:ref-normalized-srctitle>WORLDCANCERREPORT2014</xocs:ref-normalized-srctitle>
         </xocs:ref-info>
         <xocs:ref-info refid="sref2">
            <xocs:ref-normalized-surname>FRIEDMAN</xocs:ref-normalized-surname>
            <xocs:ref-pub-year>2015</xocs:ref-pub-year>
            <xocs:ref-first-fp>747</xocs:ref-first-fp>
            <xocs:ref-last-lp>756</xocs:ref-last-lp>
            <xocs:ref-normalized-initial>A</xocs:ref-normalized-initial>
         </xocs:ref-info>
         <xocs:ref-info refid="sref3">
            <xocs:ref-normalized-surname>KHOURY</xocs:ref-normalized-surname>
            <xocs:ref-pub-year>2016</xocs:ref-pub-year>
            <xocs:ref-first-fp>398</xocs:ref-first-fp>
            <xocs:ref-last-lp>401</xocs:ref-last-lp>
            <xocs:ref-normalized-initial>M</xocs:ref-normalized-initial>
         </xocs:ref-info>
         <xocs:ref-info refid="sref4">
            <xocs:ref-normalized-surname>MARTINZANCA</xocs:ref-normalized-surname>
            <xocs:ref-pub-year>1986</xocs:ref-pub-year>
            <xocs:ref-first-fp>743</xocs:ref-first-fp>
            <xocs:ref-last-lp>748</xocs:ref-last-lp>
            <xocs:ref-normalized-initial>D</xocs:ref-normalized-initial>
         </xocs:ref-info>
         <xocs:ref-info refid="sref5">
            <xocs:ref-normalized-surname>BERTRAND</xocs:ref-normalized-surname>
            <xocs:ref-pub-year>2012</xocs:ref-pub-year>
            <xocs:ref-first-fp>439</xocs:ref-first-fp>
            <xocs:ref-last-lp>453</xocs:ref-last-lp>
            <xocs:ref-normalized-initial>T</xocs:ref-normalized-initial>
         </xocs:ref-info>
         <xocs:ref-info refid="sref6">
            <xocs:ref-normalized-surname>NAKAGAWARA</xocs:ref-normalized-surname>
            <xocs:ref-pub-year>2001</xocs:ref-pub-year>
            <xocs:ref-first-fp>107</xocs:ref-first-fp>
            <xocs:ref-last-lp>114</xocs:ref-last-lp>
            <xocs:ref-normalized-initial>A</xocs:ref-normalized-initial>
         </xocs:ref-info>
         <xocs:ref-info refid="sref7">
            <xocs:ref-normalized-surname>TEJEDA</xocs:ref-normalized-surname>
            <xocs:ref-pub-year>2017</xocs:ref-pub-year>
            <xocs:ref-first-fp>268</xocs:ref-first-fp>
            <xocs:ref-normalized-initial>G</xocs:ref-normalized-initial>
         </xocs:ref-info>
         <xocs:ref-info refid="sref8">
            <xocs:ref-normalized-surname>KHOTSKAYA</xocs:ref-normalized-surname>
            <xocs:ref-pub-year>2017</xocs:ref-pub-year>
            <xocs:ref-first-fp>58</xocs:ref-first-fp>
            <xocs:ref-last-lp>66</xocs:ref-last-lp>
            <xocs:ref-normalized-initial>Y</xocs:ref-normalized-initial>
         </xocs:ref-info>
         <xocs:ref-info refid="sref9">
            <xocs:ref-normalized-surname>MORRISON</xocs:ref-normalized-surname>
            <xocs:ref-pub-year>2002</xocs:ref-pub-year>
            <xocs:ref-first-fp>5684</xocs:ref-first-fp>
            <xocs:ref-last-lp>5695</xocs:ref-last-lp>
            <xocs:ref-normalized-initial>K</xocs:ref-normalized-initial>
         </xocs:ref-info>
         <xocs:ref-info refid="sref10">
            <xocs:ref-normalized-surname>EGUCHI</xocs:ref-normalized-surname>
            <xocs:ref-pub-year>2001</xocs:ref-pub-year>
            <xocs:ref-first-fp>417</xocs:ref-first-fp>
            <xocs:ref-normalized-initial>M</xocs:ref-normalized-initial>
         </xocs:ref-info>
         <xocs:ref-info refid="sref11">
            <xocs:ref-normalized-surname>BOURGEOIS</xocs:ref-normalized-surname>
            <xocs:ref-pub-year>2000</xocs:ref-pub-year>
            <xocs:ref-first-fp>937</xocs:ref-first-fp>
            <xocs:ref-last-lp>946</xocs:ref-last-lp>
            <xocs:ref-normalized-initial>J</xocs:ref-normalized-initial>
         </xocs:ref-info>
         <xocs:ref-info refid="sref12">
            <xocs:ref-normalized-surname>KRALIK</xocs:ref-normalized-surname>
            <xocs:ref-pub-year>2011</xocs:ref-pub-year>
            <xocs:ref-first-fp>19</xocs:ref-first-fp>
            <xocs:ref-normalized-initial>J</xocs:ref-normalized-initial>
         </xocs:ref-info>
         <xocs:ref-info refid="sref13">
            <xocs:ref-normalized-surname>LANGE</xocs:ref-normalized-surname>
            <xocs:ref-pub-year>2018</xocs:ref-pub-year>
            <xocs:ref-normalized-initial>A</xocs:ref-normalized-initial>
         </xocs:ref-info>
         <xocs:ref-info refid="sref14">
            <xocs:ref-normalized-surname>ZHENG</xocs:ref-normalized-surname>
            <xocs:ref-pub-year>2014</xocs:ref-pub-year>
            <xocs:ref-first-fp>1479</xocs:ref-first-fp>
            <xocs:ref-last-lp>1484</xocs:ref-last-lp>
            <xocs:ref-normalized-initial>Z</xocs:ref-normalized-initial>
         </xocs:ref-info>
         <xocs:ref-info refid="sref15">
            <xocs:ref-normalized-surname>KIM</xocs:ref-normalized-surname>
            <xocs:ref-pub-year>2014</xocs:ref-pub-year>
            <xocs:ref-article-number>e91940</xocs:ref-article-number>
            <xocs:ref-normalized-initial>J</xocs:ref-normalized-initial>
         </xocs:ref-info>
         <xocs:ref-info refid="sref16">
            <xocs:ref-normalized-surname>FRATTINI</xocs:ref-normalized-surname>
            <xocs:ref-pub-year>2013</xocs:ref-pub-year>
            <xocs:ref-first-fp>1141</xocs:ref-first-fp>
            <xocs:ref-last-lp>1149</xocs:ref-last-lp>
            <xocs:ref-normalized-initial>V</xocs:ref-normalized-initial>
         </xocs:ref-info>
         <xocs:ref-info refid="sref17">
            <xocs:ref-normalized-surname>VAISHNAVI</xocs:ref-normalized-surname>
            <xocs:ref-pub-year>2013</xocs:ref-pub-year>
            <xocs:ref-first-fp>1469</xocs:ref-first-fp>
            <xocs:ref-last-lp>1472</xocs:ref-last-lp>
            <xocs:ref-normalized-initial>A</xocs:ref-normalized-initial>
         </xocs:ref-info>
         <xocs:ref-info refid="sref18">
            <xocs:ref-normalized-surname>DOEBELE</xocs:ref-normalized-surname>
            <xocs:ref-pub-year>2015</xocs:ref-pub-year>
            <xocs:ref-first-fp>1049</xocs:ref-first-fp>
            <xocs:ref-last-lp>1057</xocs:ref-last-lp>
            <xocs:ref-normalized-initial>R</xocs:ref-normalized-initial>
         </xocs:ref-info>
         <xocs:ref-info refid="sref19">
            <xocs:ref-normalized-surname>AMATU</xocs:ref-normalized-surname>
            <xocs:ref-pub-year>2016</xocs:ref-pub-year>
            <xocs:ref-article-number>e000023</xocs:ref-article-number>
            <xocs:ref-normalized-initial>A</xocs:ref-normalized-initial>
         </xocs:ref-info>
         <xocs:ref-info refid="sref20">
            <xocs:ref-normalized-surname>WONG</xocs:ref-normalized-surname>
            <xocs:ref-pub-year>2016</xocs:ref-pub-year>
            <xocs:ref-normalized-initial>V</xocs:ref-normalized-initial>
         </xocs:ref-info>
         <xocs:ref-info refid="sref21">
            <xocs:ref-normalized-surname>WIESNER</xocs:ref-normalized-surname>
            <xocs:ref-pub-year>2015</xocs:ref-pub-year>
            <xocs:ref-first-fp>1357</xocs:ref-first-fp>
            <xocs:ref-last-lp>1362</xocs:ref-last-lp>
            <xocs:ref-normalized-initial>T</xocs:ref-normalized-initial>
         </xocs:ref-info>
         <xocs:ref-info refid="sref22">
            <xocs:ref-normalized-surname>ZHENG</xocs:ref-normalized-surname>
            <xocs:ref-pub-year>2014</xocs:ref-pub-year>
            <xocs:ref-first-fp>1479</xocs:ref-first-fp>
            <xocs:ref-normalized-initial>Z</xocs:ref-normalized-initial>
         </xocs:ref-info>
         <xocs:ref-info refid="sref23">
            <xocs:ref-normalized-surname>ROSS</xocs:ref-normalized-surname>
            <xocs:ref-pub-year>2014</xocs:ref-pub-year>
            <xocs:ref-first-fp>235</xocs:ref-first-fp>
            <xocs:ref-last-lp>242</xocs:ref-last-lp>
            <xocs:ref-normalized-initial>J</xocs:ref-normalized-initial>
         </xocs:ref-info>
         <xocs:ref-info refid="sref24">
            <xocs:ref-normalized-surname>FERNANDEZCUESTA</xocs:ref-normalized-surname>
            <xocs:ref-pub-year>2014</xocs:ref-pub-year>
            <xocs:ref-normalized-initial>L</xocs:ref-normalized-initial>
         </xocs:ref-info>
         <xocs:ref-info refid="sref25">
            <xocs:ref-normalized-surname>FARAGO</xocs:ref-normalized-surname>
            <xocs:ref-pub-year>2015</xocs:ref-pub-year>
            <xocs:ref-first-fp>1670</xocs:ref-first-fp>
            <xocs:ref-last-lp>1674</xocs:ref-last-lp>
            <xocs:ref-normalized-initial>A</xocs:ref-normalized-initial>
         </xocs:ref-info>
         <xocs:ref-info refid="sref26">
            <xocs:ref-normalized-surname>GRECO</xocs:ref-normalized-surname>
            <xocs:ref-pub-year>2010</xocs:ref-pub-year>
            <xocs:ref-first-fp>44</xocs:ref-first-fp>
            <xocs:ref-last-lp>49</xocs:ref-last-lp>
            <xocs:ref-normalized-initial>A</xocs:ref-normalized-initial>
         </xocs:ref-info>
         <xocs:ref-info refid="sref27">
            <xocs:ref-normalized-surname>CREANCIER</xocs:ref-normalized-surname>
            <xocs:ref-pub-year>2015</xocs:ref-pub-year>
            <xocs:ref-first-fp>107</xocs:ref-first-fp>
            <xocs:ref-last-lp>111</xocs:ref-last-lp>
            <xocs:ref-normalized-initial>L</xocs:ref-normalized-initial>
         </xocs:ref-info>
         <xocs:ref-info refid="sref28">
            <xocs:ref-normalized-surname>ARDINI</xocs:ref-normalized-surname>
            <xocs:ref-pub-year>2014</xocs:ref-pub-year>
            <xocs:ref-first-fp>1495</xocs:ref-first-fp>
            <xocs:ref-last-lp>1507</xocs:ref-last-lp>
            <xocs:ref-normalized-initial>E</xocs:ref-normalized-initial>
         </xocs:ref-info>
         <xocs:ref-info refid="sref29">
            <xocs:ref-normalized-surname>WU</xocs:ref-normalized-surname>
            <xocs:ref-pub-year>2014</xocs:ref-pub-year>
            <xocs:ref-first-fp>444</xocs:ref-first-fp>
            <xocs:ref-last-lp>450</xocs:ref-last-lp>
            <xocs:ref-normalized-initial>G</xocs:ref-normalized-initial>
         </xocs:ref-info>
         <xocs:ref-info refid="sref30">
            <xocs:ref-normalized-surname>BUTTI</xocs:ref-normalized-surname>
            <xocs:ref-pub-year>1995</xocs:ref-pub-year>
            <xocs:ref-first-fp>15</xocs:ref-first-fp>
            <xocs:ref-last-lp>24</xocs:ref-last-lp>
            <xocs:ref-normalized-initial>M</xocs:ref-normalized-initial>
         </xocs:ref-info>
         <xocs:ref-info refid="sref31">
            <xocs:ref-normalized-surname>CLAUDIA</xocs:ref-normalized-surname>
            <xocs:ref-pub-year>1999</xocs:ref-pub-year>
            <xocs:ref-first-fp>842</xocs:ref-first-fp>
            <xocs:ref-last-lp>847</xocs:ref-last-lp>
            <xocs:ref-normalized-initial>B</xocs:ref-normalized-initial>
         </xocs:ref-info>
         <xocs:ref-info refid="sref32">
            <xocs:ref-normalized-surname>GRECO</xocs:ref-normalized-surname>
            <xocs:ref-pub-year>1992</xocs:ref-pub-year>
            <xocs:ref-first-fp>237</xocs:ref-first-fp>
            <xocs:ref-last-lp>242</xocs:ref-last-lp>
            <xocs:ref-normalized-initial>A</xocs:ref-normalized-initial>
         </xocs:ref-info>
         <xocs:ref-info refid="sref33">
            <xocs:ref-normalized-surname>ANGELA</xocs:ref-normalized-surname>
            <xocs:ref-pub-year>1997</xocs:ref-pub-year>
            <xocs:ref-first-fp>112</xocs:ref-first-fp>
            <xocs:ref-last-lp>123</xocs:ref-last-lp>
            <xocs:ref-normalized-initial>G</xocs:ref-normalized-initial>
         </xocs:ref-info>
         <xocs:ref-info refid="sref34">
            <xocs:ref-normalized-surname>MILIONE</xocs:ref-normalized-surname>
            <xocs:ref-pub-year>2017</xocs:ref-pub-year>
            <xocs:ref-first-fp>55353</xocs:ref-first-fp>
            <xocs:ref-last-lp>55360</xocs:ref-last-lp>
            <xocs:ref-normalized-initial>M</xocs:ref-normalized-initial>
         </xocs:ref-info>
         <xocs:ref-info refid="sref35">
            <xocs:ref-normalized-surname>STRANSKY</xocs:ref-normalized-surname>
            <xocs:ref-pub-year>2014</xocs:ref-pub-year>
            <xocs:ref-first-fp>4846</xocs:ref-first-fp>
            <xocs:ref-normalized-initial>N</xocs:ref-normalized-initial>
         </xocs:ref-info>
         <xocs:ref-info refid="sref36">
            <xocs:ref-normalized-surname>JONES</xocs:ref-normalized-surname>
            <xocs:ref-pub-year>2013</xocs:ref-pub-year>
            <xocs:ref-first-fp>927</xocs:ref-first-fp>
            <xocs:ref-last-lp>932</xocs:ref-last-lp>
            <xocs:ref-normalized-initial>D</xocs:ref-normalized-initial>
         </xocs:ref-info>
         <xocs:ref-info refid="sref37">
            <xocs:ref-normalized-surname>KRALIK</xocs:ref-normalized-surname>
            <xocs:ref-pub-year>2011</xocs:ref-pub-year>
            <xocs:ref-first-fp>19</xocs:ref-first-fp>
            <xocs:ref-normalized-initial>J</xocs:ref-normalized-initial>
         </xocs:ref-info>
         <xocs:ref-info refid="sref38">
            <xocs:ref-normalized-surname>EGUCHI</xocs:ref-normalized-surname>
            <xocs:ref-pub-year>1999</xocs:ref-pub-year>
            <xocs:ref-first-fp>1355</xocs:ref-first-fp>
            <xocs:ref-last-lp>1363</xocs:ref-last-lp>
            <xocs:ref-normalized-initial>M</xocs:ref-normalized-initial>
         </xocs:ref-info>
         <xocs:ref-info refid="sref39">
            <xocs:ref-normalized-surname>KNEZEVICH</xocs:ref-normalized-surname>
            <xocs:ref-pub-year>1998</xocs:ref-pub-year>
            <xocs:ref-first-fp>5046</xocs:ref-first-fp>
            <xocs:ref-last-lp>5048</xocs:ref-last-lp>
            <xocs:ref-normalized-initial>S</xocs:ref-normalized-initial>
         </xocs:ref-info>
         <xocs:ref-info refid="sref40">
            <xocs:ref-normalized-surname>KNEZEVICH</xocs:ref-normalized-surname>
            <xocs:ref-pub-year>1998</xocs:ref-pub-year>
            <xocs:ref-first-fp>184</xocs:ref-first-fp>
            <xocs:ref-last-lp>187</xocs:ref-last-lp>
            <xocs:ref-normalized-initial>S</xocs:ref-normalized-initial>
         </xocs:ref-info>
         <xocs:ref-info refid="sref41">
            <xocs:ref-normalized-surname>RUBIN</xocs:ref-normalized-surname>
            <xocs:ref-pub-year>1998</xocs:ref-pub-year>
            <xocs:ref-first-fp>1451</xocs:ref-first-fp>
            <xocs:ref-last-lp>1458</xocs:ref-last-lp>
            <xocs:ref-normalized-initial>B</xocs:ref-normalized-initial>
         </xocs:ref-info>
         <xocs:ref-info refid="sref42">
            <xocs:ref-normalized-surname>WATANABE</xocs:ref-normalized-surname>
            <xocs:ref-pub-year>2002</xocs:ref-pub-year>
            <xocs:ref-first-fp>10</xocs:ref-first-fp>
            <xocs:ref-last-lp>16</xocs:ref-last-lp>
            <xocs:ref-normalized-initial>N</xocs:ref-normalized-initial>
         </xocs:ref-info>
         <xocs:ref-info refid="sref43">
            <xocs:ref-normalized-surname>HECHTMAN</xocs:ref-normalized-surname>
            <xocs:ref-pub-year>2016</xocs:ref-pub-year>
            <xocs:ref-first-fp>296</xocs:ref-first-fp>
            <xocs:ref-last-lp>301</xocs:ref-last-lp>
            <xocs:ref-normalized-initial>J</xocs:ref-normalized-initial>
         </xocs:ref-info>
         <xocs:ref-info refid="sref44">
            <xocs:ref-normalized-surname>MAKRETSOV</xocs:ref-normalized-surname>
            <xocs:ref-pub-year>2004</xocs:ref-pub-year>
            <xocs:ref-first-fp>152</xocs:ref-first-fp>
            <xocs:ref-last-lp>157</xocs:ref-last-lp>
            <xocs:ref-normalized-initial>N</xocs:ref-normalized-initial>
         </xocs:ref-info>
         <xocs:ref-info refid="sref45">
            <xocs:ref-normalized-surname>ARCE</xocs:ref-normalized-surname>
            <xocs:ref-pub-year>2005</xocs:ref-pub-year>
            <xocs:ref-first-fp>35</xocs:ref-first-fp>
            <xocs:ref-normalized-initial>C</xocs:ref-normalized-initial>
         </xocs:ref-info>
         <xocs:ref-info refid="sref46">
            <xocs:ref-normalized-surname>PINTO</xocs:ref-normalized-surname>
            <xocs:ref-pub-year>2014</xocs:ref-pub-year>
            <xocs:ref-first-fp>30</xocs:ref-first-fp>
            <xocs:ref-last-lp>37</xocs:ref-last-lp>
            <xocs:ref-normalized-initial>A</xocs:ref-normalized-initial>
         </xocs:ref-info>
         <xocs:ref-info refid="sref47">
            <xocs:ref-normalized-surname>MORERIO</xocs:ref-normalized-surname>
            <xocs:ref-pub-year>2004</xocs:ref-pub-year>
            <xocs:ref-first-fp>167</xocs:ref-first-fp>
            <xocs:ref-last-lp>168</xocs:ref-last-lp>
            <xocs:ref-normalized-initial>C</xocs:ref-normalized-initial>
         </xocs:ref-info>
         <xocs:ref-info refid="sref48">
            <xocs:ref-normalized-surname>PUNNETT</xocs:ref-normalized-surname>
            <xocs:ref-pub-year>2000</xocs:ref-pub-year>
            <xocs:ref-first-fp>137</xocs:ref-first-fp>
            <xocs:ref-last-lp>139</xocs:ref-last-lp>
            <xocs:ref-normalized-initial>H</xocs:ref-normalized-initial>
         </xocs:ref-info>
         <xocs:ref-info refid="sref49">
            <xocs:ref-normalized-surname>BRENCA</xocs:ref-normalized-surname>
            <xocs:ref-pub-year>2016</xocs:ref-pub-year>
            <xocs:ref-first-fp>543</xocs:ref-first-fp>
            <xocs:ref-last-lp>549</xocs:ref-last-lp>
            <xocs:ref-normalized-initial>M</xocs:ref-normalized-initial>
         </xocs:ref-info>
         <xocs:ref-info refid="sref50">
            <xocs:ref-normalized-surname>GRECO</xocs:ref-normalized-surname>
            <xocs:ref-pub-year>1993</xocs:ref-pub-year>
            <xocs:ref-first-fp>539</xocs:ref-first-fp>
            <xocs:ref-last-lp>546</xocs:ref-last-lp>
            <xocs:ref-normalized-initial>A</xocs:ref-normalized-initial>
         </xocs:ref-info>
         <xocs:ref-info refid="sref51">
            <xocs:ref-normalized-surname>SKALOVA</xocs:ref-normalized-surname>
            <xocs:ref-pub-year>2016</xocs:ref-pub-year>
            <xocs:ref-first-fp>3</xocs:ref-first-fp>
            <xocs:ref-last-lp>13</xocs:ref-last-lp>
            <xocs:ref-normalized-initial>A</xocs:ref-normalized-initial>
         </xocs:ref-info>
         <xocs:ref-info refid="sref52">
            <xocs:ref-normalized-surname>DELCASTILLO</xocs:ref-normalized-surname>
            <xocs:ref-pub-year>2015</xocs:ref-pub-year>
            <xocs:ref-first-fp>1458</xocs:ref-first-fp>
            <xocs:ref-last-lp>1467</xocs:ref-last-lp>
            <xocs:ref-normalized-initial>M</xocs:ref-normalized-initial>
         </xocs:ref-info>
         <xocs:ref-info refid="sref53">
            <xocs:ref-normalized-surname>LEEMANNEILL</xocs:ref-normalized-surname>
            <xocs:ref-pub-year>2014</xocs:ref-pub-year>
            <xocs:ref-first-fp>799</xocs:ref-first-fp>
            <xocs:ref-last-lp>807</xocs:ref-last-lp>
            <xocs:ref-normalized-initial>R</xocs:ref-normalized-initial>
         </xocs:ref-info>
         <xocs:ref-info refid="sref54">
            <xocs:ref-normalized-surname>LAGADEC</xocs:ref-normalized-surname>
            <xocs:ref-pub-year>2009</xocs:ref-pub-year>
            <xocs:ref-first-fp>1960</xocs:ref-first-fp>
            <xocs:ref-normalized-initial>C</xocs:ref-normalized-initial>
         </xocs:ref-info>
         <xocs:ref-info refid="sref55">
            <xocs:ref-normalized-surname>DRILON</xocs:ref-normalized-surname>
            <xocs:ref-pub-year>2017</xocs:ref-pub-year>
            <xocs:ref-first-fp>963</xocs:ref-first-fp>
            <xocs:ref-last-lp>972</xocs:ref-last-lp>
            <xocs:ref-normalized-initial>A</xocs:ref-normalized-initial>
         </xocs:ref-info>
         <xocs:ref-info refid="sref56">
            <xocs:ref-normalized-surname>CHEN</xocs:ref-normalized-surname>
            <xocs:ref-pub-year>2014</xocs:ref-pub-year>
            <xocs:ref-first-fp>1595</xocs:ref-first-fp>
            <xocs:ref-last-lp>1600</xocs:ref-last-lp>
            <xocs:ref-normalized-initial>Y</xocs:ref-normalized-initial>
         </xocs:ref-info>
         <xocs:ref-info refid="sref57">
            <xocs:ref-normalized-surname>NAKAGAWARA</xocs:ref-normalized-surname>
            <xocs:ref-pub-year>2001</xocs:ref-pub-year>
            <xocs:ref-first-fp>107</xocs:ref-first-fp>
            <xocs:ref-last-lp>114</xocs:ref-last-lp>
            <xocs:ref-normalized-initial>A</xocs:ref-normalized-initial>
         </xocs:ref-info>
         <xocs:ref-info refid="sref58">
            <xocs:ref-normalized-surname>YAN</xocs:ref-normalized-surname>
            <xocs:ref-pub-year>2019</xocs:ref-pub-year>
            <xocs:ref-first-fp>1731</xocs:ref-first-fp>
            <xocs:ref-last-lp>1760</xocs:ref-last-lp>
            <xocs:ref-normalized-initial>W</xocs:ref-normalized-initial>
         </xocs:ref-info>
         <xocs:ref-info refid="sref59">
            <xocs:ref-normalized-surname>NORMAN</xocs:ref-normalized-surname>
            <xocs:ref-pub-year>2017</xocs:ref-pub-year>
            <xocs:ref-first-fp>66</xocs:ref-first-fp>
            <xocs:ref-last-lp>88</xocs:ref-last-lp>
            <xocs:ref-normalized-initial>B</xocs:ref-normalized-initial>
         </xocs:ref-info>
         <xocs:ref-info refid="sref60">
            <xocs:ref-normalized-surname>BAILEY</xocs:ref-normalized-surname>
            <xocs:ref-pub-year>2017</xocs:ref-pub-year>
            <xocs:ref-first-fp>733</xocs:ref-first-fp>
            <xocs:ref-last-lp>751</xocs:ref-last-lp>
            <xocs:ref-normalized-initial>J</xocs:ref-normalized-initial>
         </xocs:ref-info>
         <xocs:ref-info refid="sref61">
            <xocs:ref-normalized-surname>BAILEY</xocs:ref-normalized-surname>
            <xocs:ref-pub-year>2017</xocs:ref-pub-year>
            <xocs:ref-first-fp>831</xocs:ref-first-fp>
            <xocs:ref-last-lp>849</xocs:ref-last-lp>
            <xocs:ref-normalized-initial>J</xocs:ref-normalized-initial>
         </xocs:ref-info>
         <xocs:ref-info refid="sref62">
            <xocs:ref-normalized-surname>HONG</xocs:ref-normalized-surname>
            <xocs:ref-pub-year>2012</xocs:ref-pub-year>
            <xocs:ref-first-fp>5337</xocs:ref-first-fp>
            <xocs:ref-last-lp>5349</xocs:ref-last-lp>
            <xocs:ref-normalized-initial>S</xocs:ref-normalized-initial>
         </xocs:ref-info>
         <xocs:ref-info refid="sref63">
            <xocs:ref-normalized-surname>SCOTT</xocs:ref-normalized-surname>
            <xocs:ref-pub-year>2019</xocs:ref-pub-year>
            <xocs:ref-first-fp>201</xocs:ref-first-fp>
            <xocs:ref-last-lp>206</xocs:ref-last-lp>
            <xocs:ref-normalized-initial>L</xocs:ref-normalized-initial>
         </xocs:ref-info>
         <xocs:ref-info refid="sref64">
            <xocs:ref-normalized-surname>DRILON</xocs:ref-normalized-surname>
            <xocs:ref-pub-year>2018</xocs:ref-pub-year>
            <xocs:ref-first-fp>731</xocs:ref-first-fp>
            <xocs:ref-last-lp>739</xocs:ref-last-lp>
            <xocs:ref-normalized-initial>A</xocs:ref-normalized-initial>
         </xocs:ref-info>
         <xocs:ref-info refid="sref65">
            <xocs:ref-normalized-surname>SASMAL</xocs:ref-normalized-surname>
            <xocs:ref-pub-year>2015</xocs:ref-pub-year>
            <xocs:ref-normalized-initial>P</xocs:ref-normalized-initial>
            <xocs:ref-normalized-srctitle>SUBSTITUTEDIMIDAZO12APYRIDINECOMPOUNDSTROPOMYOSINRECEPTORKINASEATRKAINHIBITORS</xocs:ref-normalized-srctitle>
         </xocs:ref-info>
         <xocs:ref-info refid="sref66">
            <xocs:ref-normalized-surname>ZHU</xocs:ref-normalized-surname>
            <xocs:ref-pub-year>2018</xocs:ref-pub-year>
            <xocs:ref-normalized-initial>L</xocs:ref-normalized-initial>
            <xocs:ref-normalized-srctitle>AMINOPYRAZOLOPYRIMIDINECOMPOUNDUSEDNEUROTROPHICFACTORTYROSINEKINASERECEPTORINHIBITOR</xocs:ref-normalized-srctitle>
         </xocs:ref-info>
         <xocs:ref-info refid="sref67">
            <xocs:ref-normalized-surname>CUI</xocs:ref-normalized-surname>
            <xocs:ref-pub-year>2018</xocs:ref-pub-year>
            <xocs:ref-normalized-initial>J</xocs:ref-normalized-initial>
            <xocs:ref-normalized-srctitle>MARCOCYCLEKINASEINHIBITORS</xocs:ref-normalized-srctitle>
         </xocs:ref-info>
         <xocs:ref-info refid="sref68">
            <xocs:ref-normalized-surname>CHOI</xocs:ref-normalized-surname>
            <xocs:ref-pub-year>2015</xocs:ref-pub-year>
            <xocs:ref-first-fp>562</xocs:ref-first-fp>
            <xocs:ref-last-lp>567</xocs:ref-last-lp>
            <xocs:ref-normalized-initial>H</xocs:ref-normalized-initial>
         </xocs:ref-info>
         <xocs:ref-info refid="sref69">
            <xocs:ref-normalized-surname>CHEN</xocs:ref-normalized-surname>
            <xocs:ref-pub-year>2007</xocs:ref-pub-year>
            <xocs:ref-normalized-initial>P</xocs:ref-normalized-initial>
            <xocs:ref-normalized-srctitle>PYRROLOTRIAZINEKINASEINHIBITORS</xocs:ref-normalized-srctitle>
         </xocs:ref-info>
         <xocs:ref-info refid="sref70">
            <xocs:ref-normalized-surname>COOKE</xocs:ref-normalized-surname>
            <xocs:ref-pub-year>2015</xocs:ref-pub-year>
            <xocs:ref-normalized-initial>A</xocs:ref-normalized-initial>
            <xocs:ref-normalized-srctitle>TRKAKINASEINHIBITORSCOMPOSITIONSMETHODS</xocs:ref-normalized-srctitle>
         </xocs:ref-info>
         <xocs:ref-info refid="sref71">
            <xocs:ref-normalized-surname>COOKEJ</xocs:ref-normalized-surname>
            <xocs:ref-pub-year>2015</xocs:ref-pub-year>
            <xocs:ref-normalized-initial>A</xocs:ref-normalized-initial>
            <xocs:ref-normalized-srctitle>TRKAKINASEINHIBITORSCOMPOSITIONSMETHODS</xocs:ref-normalized-srctitle>
         </xocs:ref-info>
         <xocs:ref-info refid="sref72">
            <xocs:ref-normalized-surname>MITCHELL</xocs:ref-normalized-surname>
            <xocs:ref-pub-year>2015</xocs:ref-pub-year>
            <xocs:ref-normalized-initial>H</xocs:ref-normalized-initial>
            <xocs:ref-normalized-srctitle>TRKAKINASEINHIBITORSCOMPOSITIONSMETHODS</xocs:ref-normalized-srctitle>
         </xocs:ref-info>
         <xocs:ref-info refid="sref73">
            <xocs:ref-normalized-surname>MITCHELL</xocs:ref-normalized-surname>
            <xocs:ref-pub-year>2015</xocs:ref-pub-year>
            <xocs:ref-normalized-initial>H</xocs:ref-normalized-initial>
            <xocs:ref-normalized-srctitle>TRKAKINASEINHIBITORSCOMPOSITIONSMETHODS</xocs:ref-normalized-srctitle>
         </xocs:ref-info>
         <xocs:ref-info refid="sref74">
            <xocs:ref-normalized-surname>COOKE</xocs:ref-normalized-surname>
            <xocs:ref-pub-year>2016</xocs:ref-pub-year>
            <xocs:ref-normalized-initial>A</xocs:ref-normalized-initial>
            <xocs:ref-normalized-srctitle>TRKAKINASEINHIBITORSCOMPOSITIONSMETHODS</xocs:ref-normalized-srctitle>
         </xocs:ref-info>
         <xocs:ref-info refid="sref75">
            <xocs:ref-normalized-surname>BAGAL</xocs:ref-normalized-surname>
            <xocs:ref-pub-year>2015</xocs:ref-pub-year>
            <xocs:ref-normalized-initial>S</xocs:ref-normalized-initial>
            <xocs:ref-normalized-srctitle>TROPOMYOSINRELATEDKINASEINHIBITORSCONTAININGBOTHA1HPYRAZOLEAPYRIMIDINEMOIETY</xocs:ref-normalized-srctitle>
         </xocs:ref-info>
         <xocs:ref-info refid="sref76">
            <xocs:ref-normalized-surname>BAGAL</xocs:ref-normalized-surname>
            <xocs:ref-pub-year>2015</xocs:ref-pub-year>
            <xocs:ref-normalized-initial>S</xocs:ref-normalized-initial>
            <xocs:ref-normalized-srctitle>TROPOMYOSINRELATEDKINASEINHIBITORS</xocs:ref-normalized-srctitle>
         </xocs:ref-info>
         <xocs:ref-info refid="sref77">
            <xocs:ref-normalized-surname>NAGASWAMY</xocs:ref-normalized-surname>
            <xocs:ref-pub-year>2016</xocs:ref-pub-year>
            <xocs:ref-normalized-initial>K</xocs:ref-normalized-initial>
            <xocs:ref-normalized-srctitle>INHIBITORSTRKAKINASE</xocs:ref-normalized-srctitle>
         </xocs:ref-info>
         <xocs:ref-info refid="sref78">
            <xocs:ref-normalized-surname>YUKIMASA</xocs:ref-normalized-surname>
            <xocs:ref-pub-year>2017</xocs:ref-pub-year>
            <xocs:ref-normalized-initial>A</xocs:ref-normalized-initial>
            <xocs:ref-normalized-srctitle>NITROGENCONTANINGHETEROCYCLETRKAINHIBITORYACTIVITYCARBOCYCLICDERIVATIVE</xocs:ref-normalized-srctitle>
         </xocs:ref-info>
         <xocs:ref-info refid="sref79">
            <xocs:ref-normalized-surname>KANO</xocs:ref-normalized-surname>
            <xocs:ref-pub-year>2018</xocs:ref-pub-year>
            <xocs:ref-normalized-initial>K</xocs:ref-normalized-initial>
            <xocs:ref-normalized-srctitle>NITROGENCONTAININGHETEROCYCLETRKAINHIBITORYACTIVITYCARBOCYCLICDERIVATIVE</xocs:ref-normalized-srctitle>
         </xocs:ref-info>
         <xocs:ref-info refid="sref80">
            <xocs:ref-normalized-surname>WENGLOWSKY</xocs:ref-normalized-surname>
            <xocs:ref-pub-year>2017</xocs:ref-pub-year>
            <xocs:ref-normalized-initial>S</xocs:ref-normalized-initial>
            <xocs:ref-normalized-srctitle>COMPOUNDSCOMPOSITIONSUSEFULFORTREATINGDISORDERSRELATEDNTRK</xocs:ref-normalized-srctitle>
         </xocs:ref-info>
         <xocs:ref-info refid="sref81">
            <xocs:ref-normalized-surname>WENGLOWSKY</xocs:ref-normalized-surname>
            <xocs:ref-pub-year>2017</xocs:ref-pub-year>
            <xocs:ref-normalized-initial>S</xocs:ref-normalized-initial>
            <xocs:ref-normalized-srctitle>COMPOUNDSCOMPOSITIONSUSEFULFORTREATINGDISORDERSRELATEDNTRK</xocs:ref-normalized-srctitle>
         </xocs:ref-info>
         <xocs:ref-info refid="sref82">
            <xocs:ref-normalized-surname>KIM</xocs:ref-normalized-surname>
            <xocs:ref-pub-year>2015</xocs:ref-pub-year>
            <xocs:ref-normalized-initial>M</xocs:ref-normalized-initial>
            <xocs:ref-normalized-srctitle>FUSEDRINGHETEROARYLCOMPOUNDSUSETRKINHIBITORS</xocs:ref-normalized-srctitle>
         </xocs:ref-info>
         <xocs:ref-info refid="sref83">
            <xocs:ref-normalized-surname>THRESS</xocs:ref-normalized-surname>
            <xocs:ref-pub-year>2009</xocs:ref-pub-year>
            <xocs:ref-first-fp>1818</xocs:ref-first-fp>
            <xocs:ref-last-lp>1827</xocs:ref-last-lp>
            <xocs:ref-normalized-initial>K</xocs:ref-normalized-initial>
         </xocs:ref-info>
         <xocs:ref-info refid="sref84">
            <xocs:ref-normalized-surname>WANG</xocs:ref-normalized-surname>
            <xocs:ref-pub-year>2012</xocs:ref-pub-year>
            <xocs:ref-first-fp>705</xocs:ref-first-fp>
            <xocs:ref-last-lp>709</xocs:ref-last-lp>
            <xocs:ref-normalized-initial>T</xocs:ref-normalized-initial>
         </xocs:ref-info>
         <xocs:ref-info refid="sref85">
            <xocs:ref-normalized-surname>LYNE</xocs:ref-normalized-surname>
            <xocs:ref-pub-year>2005</xocs:ref-pub-year>
            <xocs:ref-normalized-initial>P</xocs:ref-normalized-initial>
            <xocs:ref-normalized-srctitle>CHEMICALCOMPOUNDS</xocs:ref-normalized-srctitle>
         </xocs:ref-info>
         <xocs:ref-info refid="sref86">
            <xocs:ref-normalized-surname>BLOCK</xocs:ref-normalized-surname>
            <xocs:ref-pub-year>2005</xocs:ref-pub-year>
            <xocs:ref-normalized-initial>M</xocs:ref-normalized-initial>
            <xocs:ref-normalized-srctitle>PYRAZOLEDERIVATIVESINHIBITORSRECEPTORTYROSYNEKINASES</xocs:ref-normalized-srctitle>
         </xocs:ref-info>
         <xocs:ref-info refid="sref87">
            <xocs:ref-normalized-surname>DAVIES</xocs:ref-normalized-surname>
            <xocs:ref-pub-year>2006</xocs:ref-pub-year>
            <xocs:ref-normalized-initial>A</xocs:ref-normalized-initial>
            <xocs:ref-normalized-srctitle>PYRAZOLYLAMINOPYRIDINEDERIVATIVESUSEFULKINASEINHIBITORS</xocs:ref-normalized-srctitle>
         </xocs:ref-info>
         <xocs:ref-info refid="sref88">
            <xocs:ref-normalized-surname>WANG</xocs:ref-normalized-surname>
            <xocs:ref-pub-year>2006</xocs:ref-pub-year>
            <xocs:ref-normalized-initial>B</xocs:ref-normalized-initial>
            <xocs:ref-normalized-srctitle>CHEMICALCOMPOUNDS</xocs:ref-normalized-srctitle>
         </xocs:ref-info>
         <xocs:ref-info refid="sref89">
            <xocs:ref-normalized-surname>FENG</xocs:ref-normalized-surname>
            <xocs:ref-pub-year>2007</xocs:ref-pub-year>
            <xocs:ref-normalized-initial>X</xocs:ref-normalized-initial>
            <xocs:ref-normalized-srctitle>43AMINOPYRAZOLEPYRIMIDINEDERIVATIVESFORUSETYROSINEKINASEINHIBITORSINTREATMENTCANCER</xocs:ref-normalized-srctitle>
         </xocs:ref-info>
         <xocs:ref-info refid="sref90">
            <xocs:ref-normalized-surname>ALMEIDA</xocs:ref-normalized-surname>
            <xocs:ref-pub-year>2008</xocs:ref-pub-year>
            <xocs:ref-normalized-initial>L</xocs:ref-normalized-initial>
            <xocs:ref-normalized-srctitle>PYRAZOLYLAMINOSUBSTITUTEDPYRAZINESUSEFORTREATMENTCANCER</xocs:ref-normalized-srctitle>
         </xocs:ref-info>
         <xocs:ref-info refid="sref91">
            <xocs:ref-normalized-surname>TATEMATSU</xocs:ref-normalized-surname>
            <xocs:ref-pub-year>2014</xocs:ref-pub-year>
            <xocs:ref-first-fp>725</xocs:ref-first-fp>
            <xocs:ref-last-lp>730</xocs:ref-last-lp>
            <xocs:ref-normalized-initial>T</xocs:ref-normalized-initial>
         </xocs:ref-info>
         <xocs:ref-info refid="sref92">
            <xocs:ref-normalized-surname>ALAM</xocs:ref-normalized-surname>
            <xocs:ref-pub-year>2017</xocs:ref-pub-year>
            <xocs:ref-first-fp>389</xocs:ref-first-fp>
            <xocs:ref-last-lp>396</xocs:ref-last-lp>
            <xocs:ref-normalized-initial>M</xocs:ref-normalized-initial>
         </xocs:ref-info>
         <xocs:ref-info refid="sref93">
            <xocs:ref-normalized-surname>LECHT</xocs:ref-normalized-surname>
            <xocs:ref-pub-year>2010</xocs:ref-pub-year>
            <xocs:ref-first-fp>201</xocs:ref-first-fp>
            <xocs:ref-last-lp>213</xocs:ref-last-lp>
            <xocs:ref-normalized-initial>S</xocs:ref-normalized-initial>
         </xocs:ref-info>
         <xocs:ref-info refid="sref94">
            <xocs:ref-normalized-surname>AKINAGA</xocs:ref-normalized-surname>
            <xocs:ref-pub-year>1992</xocs:ref-pub-year>
            <xocs:ref-first-fp>266</xocs:ref-first-fp>
            <xocs:ref-last-lp>272</xocs:ref-last-lp>
            <xocs:ref-normalized-initial>S</xocs:ref-normalized-initial>
         </xocs:ref-info>
         <xocs:ref-info refid="sref95">
            <xocs:ref-normalized-surname>CAMORATTO</xocs:ref-normalized-surname>
            <xocs:ref-pub-year>1997</xocs:ref-pub-year>
            <xocs:ref-first-fp>673</xocs:ref-first-fp>
            <xocs:ref-last-lp>679</xocs:ref-last-lp>
            <xocs:ref-normalized-initial>A</xocs:ref-normalized-initial>
         </xocs:ref-info>
         <xocs:ref-info refid="sref96">
            <xocs:ref-normalized-surname>DIONNE</xocs:ref-normalized-surname>
            <xocs:ref-pub-year>1998</xocs:ref-pub-year>
            <xocs:ref-first-fp>1887</xocs:ref-first-fp>
            <xocs:ref-last-lp>1898</xocs:ref-last-lp>
            <xocs:ref-normalized-initial>C</xocs:ref-normalized-initial>
         </xocs:ref-info>
         <xocs:ref-info refid="sref97">
            <xocs:ref-normalized-surname>MIKNYOCZKI</xocs:ref-normalized-surname>
            <xocs:ref-pub-year>1999</xocs:ref-pub-year>
            <xocs:ref-first-fp>2205</xocs:ref-first-fp>
            <xocs:ref-last-lp>2212</xocs:ref-last-lp>
            <xocs:ref-normalized-initial>S</xocs:ref-normalized-initial>
         </xocs:ref-info>
         <xocs:ref-info refid="sref98">
            <xocs:ref-normalized-surname>GEORGE</xocs:ref-normalized-surname>
            <xocs:ref-pub-year>1999</xocs:ref-pub-year>
            <xocs:ref-first-fp>2395</xocs:ref-first-fp>
            <xocs:ref-last-lp>2401</xocs:ref-last-lp>
            <xocs:ref-normalized-initial>D</xocs:ref-normalized-initial>
         </xocs:ref-info>
         <xocs:ref-info refid="sref99">
            <xocs:ref-normalized-surname>UNDEVIA</xocs:ref-normalized-surname>
            <xocs:ref-pub-year>2004</xocs:ref-pub-year>
            <xocs:ref-first-fp>449</xocs:ref-first-fp>
            <xocs:ref-last-lp>458</xocs:ref-last-lp>
            <xocs:ref-normalized-initial>S</xocs:ref-normalized-initial>
         </xocs:ref-info>
         <xocs:ref-info refid="sref100">
            <xocs:ref-normalized-surname>COLLINS</xocs:ref-normalized-surname>
            <xocs:ref-pub-year>2007</xocs:ref-pub-year>
            <xocs:ref-first-fp>1360</xocs:ref-first-fp>
            <xocs:ref-last-lp>1367</xocs:ref-last-lp>
            <xocs:ref-normalized-initial>C</xocs:ref-normalized-initial>
         </xocs:ref-info>
         <xocs:ref-info refid="sref101">
            <xocs:ref-normalized-surname>ARDINI</xocs:ref-normalized-surname>
            <xocs:ref-pub-year>2016</xocs:ref-pub-year>
            <xocs:ref-first-fp>628</xocs:ref-first-fp>
            <xocs:ref-last-lp>639</xocs:ref-last-lp>
            <xocs:ref-normalized-initial>E</xocs:ref-normalized-initial>
         </xocs:ref-info>
         <xocs:ref-info refid="sref102">
            <xocs:ref-normalized-surname>IYER</xocs:ref-normalized-surname>
            <xocs:ref-pub-year>2016</xocs:ref-pub-year>
            <xocs:ref-first-fp>179</xocs:ref-first-fp>
            <xocs:ref-last-lp>186</xocs:ref-last-lp>
            <xocs:ref-normalized-initial>R</xocs:ref-normalized-initial>
         </xocs:ref-info>
         <xocs:ref-info refid="sref103">
            <xocs:ref-normalized-surname>DRILON</xocs:ref-normalized-surname>
            <xocs:ref-pub-year>2017</xocs:ref-pub-year>
            <xocs:ref-first-fp>400</xocs:ref-first-fp>
            <xocs:ref-last-lp>409</xocs:ref-last-lp>
            <xocs:ref-normalized-initial>A</xocs:ref-normalized-initial>
         </xocs:ref-info>
         <xocs:ref-info refid="sref104">
            <xocs:ref-normalized-surname>BRASCA</xocs:ref-normalized-surname>
            <xocs:ref-pub-year>2009</xocs:ref-pub-year>
            <xocs:ref-first-fp>5152</xocs:ref-first-fp>
            <xocs:ref-last-lp>5163</xocs:ref-last-lp>
            <xocs:ref-normalized-initial>M</xocs:ref-normalized-initial>
         </xocs:ref-info>
         <xocs:ref-info refid="sref105">
            <xocs:ref-normalized-surname>ALBANESE</xocs:ref-normalized-surname>
            <xocs:ref-pub-year>2010</xocs:ref-pub-year>
            <xocs:ref-first-fp>2243</xocs:ref-first-fp>
            <xocs:ref-last-lp>2254</xocs:ref-last-lp>
            <xocs:ref-normalized-initial>C</xocs:ref-normalized-initial>
         </xocs:ref-info>
         <xocs:ref-info refid="sref106">
            <xocs:ref-normalized-surname>NARAYANAN</xocs:ref-normalized-surname>
            <xocs:ref-pub-year>2013</xocs:ref-pub-year>
            <xocs:ref-first-fp>14</xocs:ref-first-fp>
            <xocs:ref-normalized-initial>R</xocs:ref-normalized-initial>
         </xocs:ref-info>
         <xocs:ref-info refid="sref107">
            <xocs:ref-normalized-surname>ELDAMASY</xocs:ref-normalized-surname>
            <xocs:ref-pub-year>2016</xocs:ref-pub-year>
            <xocs:ref-first-fp>1587</xocs:ref-first-fp>
            <xocs:ref-last-lp>1595</xocs:ref-last-lp>
            <xocs:ref-normalized-initial>A</xocs:ref-normalized-initial>
         </xocs:ref-info>
         <xocs:ref-info refid="sref108">
            <xocs:ref-normalized-surname>ALBAUGH</xocs:ref-normalized-surname>
            <xocs:ref-pub-year>2012</xocs:ref-pub-year>
            <xocs:ref-first-fp>140</xocs:ref-first-fp>
            <xocs:ref-last-lp>145</xocs:ref-last-lp>
            <xocs:ref-normalized-initial>P</xocs:ref-normalized-initial>
         </xocs:ref-info>
         <xocs:ref-info refid="sref109">
            <xocs:ref-normalized-surname>WAN</xocs:ref-normalized-surname>
            <xocs:ref-pub-year>2006</xocs:ref-pub-year>
            <xocs:ref-normalized-initial>Y</xocs:ref-normalized-initial>
            <xocs:ref-normalized-srctitle>COMPOUNDSCOMPOSITIONSPROTEINKINASEINHIBITORS</xocs:ref-normalized-srctitle>
         </xocs:ref-info>
         <xocs:ref-info refid="sref110">
            <xocs:ref-normalized-surname>FANG</xocs:ref-normalized-surname>
            <xocs:ref-pub-year>2018</xocs:ref-pub-year>
            <xocs:ref-first-fp>25</xocs:ref-first-fp>
            <xocs:ref-last-lp>36</xocs:ref-last-lp>
            <xocs:ref-normalized-initial>Z</xocs:ref-normalized-initial>
         </xocs:ref-info>
         <xocs:ref-info refid="sref111">
            <xocs:ref-normalized-surname>STABILE</xocs:ref-normalized-surname>
            <xocs:ref-pub-year>2013</xocs:ref-pub-year>
            <xocs:ref-first-fp>74</xocs:ref-first-fp>
            <xocs:ref-last-lp>83</xocs:ref-last-lp>
            <xocs:ref-normalized-initial>A</xocs:ref-normalized-initial>
         </xocs:ref-info>
         <xocs:ref-info refid="sref112">
            <xocs:ref-normalized-surname>SEO</xocs:ref-normalized-surname>
            <xocs:ref-pub-year>2013</xocs:ref-pub-year>
            <xocs:ref-first-fp>271</xocs:ref-first-fp>
            <xocs:ref-last-lp>281</xocs:ref-last-lp>
            <xocs:ref-normalized-initial>J</xocs:ref-normalized-initial>
         </xocs:ref-info>
         <xocs:ref-info refid="sref113">
            <xocs:ref-normalized-surname>KAFSHDOUZIAMIN</xocs:ref-normalized-surname>
            <xocs:ref-pub-year>2016</xocs:ref-pub-year>
            <xocs:ref-first-fp>289</xocs:ref-first-fp>
            <xocs:ref-last-lp>299</xocs:ref-last-lp>
            <xocs:ref-normalized-initial>M</xocs:ref-normalized-initial>
         </xocs:ref-info>
         <xocs:ref-info refid="sref114">
            <xocs:ref-normalized-surname>CROUCHER</xocs:ref-normalized-surname>
            <xocs:ref-pub-year>2015</xocs:ref-pub-year>
            <xocs:ref-first-fp>131</xocs:ref-first-fp>
            <xocs:ref-last-lp>141</xocs:ref-last-lp>
            <xocs:ref-normalized-initial>J</xocs:ref-normalized-initial>
         </xocs:ref-info>
         <xocs:ref-info refid="sref115">
            <xocs:ref-normalized-surname>KAWAMOTO</xocs:ref-normalized-surname>
            <xocs:ref-pub-year>2018</xocs:ref-pub-year>
            <xocs:ref-first-fp>1979</xocs:ref-first-fp>
            <xocs:ref-last-lp>1986</xocs:ref-last-lp>
            <xocs:ref-normalized-initial>M</xocs:ref-normalized-initial>
         </xocs:ref-info>
      </xocs:references>
      <xocs:refkeys>
         <xocs:refkey3>MIAOX2019X129</xocs:refkey3>
         <xocs:refkey4lp>MIAOX2019X129X148</xocs:refkey4lp>
         <xocs:refkey4ai>MIAOX2019X129XQ</xocs:refkey4ai>
         <xocs:refkey5>MIAOX2019X129X148XQ</xocs:refkey5>
      </xocs:refkeys>
      <xocs:open-access>
         <xocs:oa-article-status is-open-access="0" is-open-archive="0"/></xocs:oa-article-status>
      </xocs:open-access>
      <xocs:open-research>
         <xocs:or-embargo-opening-date>2021-05-09T00:00:00.000Z</xocs:or-embargo-opening-date>
      </xocs:open-research>
      <xocs:self-archiving>
         <xocs:sa-start-date>2021-05-09T00:00:00.000Z</xocs:sa-start-date>
      </xocs:self-archiving>
      <xocs:copyright-info>
         <xocs:cp-notices>
            <xocs:cp-notice lang="en">Â© 2019 Published by Elsevier Masson SAS.</xocs:cp-notice>
         </xocs:cp-notices>
      </xocs:copyright-info>
      <xocs:funding-list has-funding-info="1">
         <xocs:funding-addon-generated-timestamp>2019-05-11T21:35:53.827Z</xocs:funding-addon-generated-timestamp>
         <xocs:funding-addon-type>http://vtw.elsevier.com/data/voc/AddOnTypes/50.7/nlp</xocs:funding-addon-type>
         <xocs:funding-source-document source-document-type="pii">S022352341930371X</xocs:funding-source-document>
         <xocs:funding>
            <xocs:funding-agency-matched-string>Chinese Pharmaceutical Association-Yiling Biopharmaceutical Innovation Foundation</xocs:funding-agency-matched-string>
         </xocs:funding>
         <xocs:funding>
            <xocs:funding-agency-matched-string>National Natural Science Foundation of China</xocs:funding-agency-matched-string>
            <xocs:funding-id>21807114</xocs:funding-id>
            <xocs:funding-id>21472191</xocs:funding-id>
            <xocs:funding-id>81773559</xocs:funding-id>
            <xocs:funding-agency>National Natural Science Foundation of China</xocs:funding-agency>
            <xocs:funding-agency-id>http://data.elsevier.com/vocabulary/SciValFunders/501100001809</xocs:funding-agency-id>
            <xocs:funding-agency-country>http://sws.geonames.org/1814991/</xocs:funding-agency-country>
         </xocs:funding>
         <xocs:funding>
            <xocs:funding-agency-matched-string>National Major Scientific and Technological Program for Drug Discovery</xocs:funding-agency-matched-string>
            <xocs:funding-id>2018ZX09301045002</xocs:funding-id>
         </xocs:funding>
         <xocs:funding>
            <xocs:funding-agency-matched-string>Double First-Class University Project</xocs:funding-agency-matched-string>
            <xocs:funding-id>CPU2018GY03</xocs:funding-id>
         </xocs:funding>
         <xocs:funding>
            <xocs:funding-agency-matched-string>Project of State Key Laboratory of Natural Medicines , China Pharmaceutical University</xocs:funding-agency-matched-string>
            <xocs:funding-id>SKLNMZZRC201810</xocs:funding-id>
         </xocs:funding>
         <xocs:funding>
            <xocs:funding-agency-matched-string>International Cooperation Grant of Guangzhou</xocs:funding-agency-matched-string>
            <xocs:funding-id>201704030099</xocs:funding-id>
         </xocs:funding>
         <xocs:funding-text>This work was supported by the National Natural Science Foundation of China ( 81773559 , 21807114 , 21472191 ), the Double First-Class University Project ( CPU2018GY03 ), the National Major Scientific and Technological Program for Drug Discovery Grant ( 2018ZX09301045002 ), the International Cooperation Grant of Guangzhou ( 201704030099 ) of Guangzhou, the Project of State Key Laboratory of Natural Medicines , China Pharmaceutical University ( SKLNMZZRC201810 ), and Chinese Pharmaceutical Association-Yiling Biopharmaceutical Innovation Foundation .  </xocs:funding-text>
      </xocs:funding-list>
      <xocs:attachment-metadata-doc>
         <xocs:attachment-set-type>item</xocs:attachment-set-type>
         <xocs:pii-formatted>S0223-5234(19)30371-X</xocs:pii-formatted>
         <xocs:pii-unformatted>S022352341930371X</xocs:pii-unformatted>
         <xocs:eid>1-s2.0-S022352341930371X</xocs:eid>
         <xocs:doi>10.1016/j.ejmech.2019.04.053</xocs:doi>
         <xocs:cid>271932</xocs:cid>
         <xocs:timestamp>2020-02-06T10:10:17.49216Z</xocs:timestamp>
         <xocs:cover-date-start>2019-08-01</xocs:cover-date-start>
         <xocs:attachments>
            <xocs:web-pdf>
               <xocs:attachment-eid>1-s2.0-S022352341930371X-main.pdf</xocs:attachment-eid>
               <xocs:ucs-locator>https://s3-eu-west-1.amazonaws.com/prod-ucs-content-store-eu-west/content/pii:S022352341930371X/MAIN/application/pdf/8abd17af57fabfb7846e5b0d40da26de/main.pdf</xocs:ucs-locator>
               <xocs:filename>main.pdf</xocs:filename>
               <xocs:extension>pdf</xocs:extension>
               <xocs:pdf-optimized>true</xocs:pdf-optimized>
               <xocs:filesize>4392332</xocs:filesize>
               <xocs:web-pdf-purpose>MAIN</xocs:web-pdf-purpose>
               <xocs:web-pdf-page-count>20</xocs:web-pdf-page-count>
               <xocs:web-pdf-images>
                  <xocs:web-pdf-image>
                     <xocs:attachment-eid>1-s2.0-S022352341930371X-main_1.png</xocs:attachment-eid>
                     <xocs:ucs-locator>https://s3-eu-west-1.amazonaws.com/prod-ucs-content-store-eu-west/content/pii:S022352341930371X/PREVIEW/image/png/7cde7f7a4ff0765e55efadcd3361a8ee/main_1.png</xocs:ucs-locator>
                     <xocs:filename>main_1.png</xocs:filename>
                     <xocs:extension>png</xocs:extension>
                     <xocs:filesize>41697</xocs:filesize>
                     <xocs:pixel-height>849</xocs:pixel-height>
                     <xocs:pixel-width>656</xocs:pixel-width>
                     <xocs:attachment-type>IMAGE-WEB-PDF</xocs:attachment-type>
                     <xocs:pdf-page-num>1</xocs:pdf-page-num>
                  </xocs:web-pdf-image>
               </xocs:web-pdf-images>
            </xocs:web-pdf>
            <xocs:attachment>
               <xocs:attachment-eid>1-s2.0-S022352341930371X-gr6.jpg</xocs:attachment-eid>
               <xocs:ucs-locator>https://s3-eu-west-1.amazonaws.com/prod-ucs-content-store-eu-west/content/pii:S022352341930371X/gr6/DOWNSAMPLED/image/jpeg/136cdfbf12a085193510c24f84446cd3/gr6.jpg</xocs:ucs-locator>
               <xocs:file-basename>gr6</xocs:file-basename>
               <xocs:filename>gr6.jpg</xocs:filename>
               <xocs:extension>jpg</xocs:extension>
               <xocs:filesize>11553</xocs:filesize>
               <xocs:pixel-height>139</xocs:pixel-height>
               <xocs:pixel-width>378</xocs:pixel-width>
               <xocs:attachment-type>IMAGE-DOWNSAMPLED</xocs:attachment-type>
            </xocs:attachment>
            <xocs:attachment>
               <xocs:attachment-eid>1-s2.0-S022352341930371X-gr33.jpg</xocs:attachment-eid>
               <xocs:ucs-locator>https://s3-eu-west-1.amazonaws.com/prod-ucs-content-store-eu-west/content/pii:S022352341930371X/gr33/DOWNSAMPLED/image/jpeg/49549ec440db2e8751038c91c52e7ff4/gr33.jpg</xocs:ucs-locator>
               <xocs:file-basename>gr33</xocs:file-basename>
               <xocs:filename>gr33.jpg</xocs:filename>
               <xocs:extension>jpg</xocs:extension>
               <xocs:filesize>4859</xocs:filesize>
               <xocs:pixel-height>121</xocs:pixel-height>
               <xocs:pixel-width>222</xocs:pixel-width>
               <xocs:attachment-type>IMAGE-DOWNSAMPLED</xocs:attachment-type>
            </xocs:attachment>
            <xocs:attachment>
               <xocs:attachment-eid>1-s2.0-S022352341930371X-gr45.jpg</xocs:attachment-eid>
               <xocs:ucs-locator>https://s3-eu-west-1.amazonaws.com/prod-ucs-content-store-eu-west/content/pii:S022352341930371X/gr45/DOWNSAMPLED/image/jpeg/c934c2aa4b684240d35942e3bec8ff1f/gr45.jpg</xocs:ucs-locator>
               <xocs:file-basename>gr45</xocs:file-basename>
               <xocs:filename>gr45.jpg</xocs:filename>
               <xocs:extension>jpg</xocs:extension>
               <xocs:filesize>6529</xocs:filesize>
               <xocs:pixel-height>221</xocs:pixel-height>
               <xocs:pixel-width>178</xocs:pixel-width>
               <xocs:attachment-type>IMAGE-DOWNSAMPLED</xocs:attachment-type>
            </xocs:attachment>
            <xocs:attachment>
               <xocs:attachment-eid>1-s2.0-S022352341930371X-gr30.jpg</xocs:attachment-eid>
               <xocs:ucs-locator>https://s3-eu-west-1.amazonaws.com/prod-ucs-content-store-eu-west/content/pii:S022352341930371X/gr30/DOWNSAMPLED/image/jpeg/e772ac0115e6cf570ecec543eca88e27/gr30.jpg</xocs:ucs-locator>
               <xocs:file-basename>gr30</xocs:file-basename>
               <xocs:filename>gr30.jpg</xocs:filename>
               <xocs:extension>jpg</xocs:extension>
               <xocs:filesize>15494</xocs:filesize>
               <xocs:pixel-height>108</xocs:pixel-height>
               <xocs:pixel-width>623</xocs:pixel-width>
               <xocs:attachment-type>IMAGE-DOWNSAMPLED</xocs:attachment-type>
            </xocs:attachment>
            <xocs:attachment>
               <xocs:attachment-eid>1-s2.0-S022352341930371X-gr9.jpg</xocs:attachment-eid>
               <xocs:ucs-locator>https://s3-eu-west-1.amazonaws.com/prod-ucs-content-store-eu-west/content/pii:S022352341930371X/gr9/DOWNSAMPLED/image/jpeg/dc8ead06f4fb63fdce45ab49106e3193/gr9.jpg</xocs:ucs-locator>
               <xocs:file-basename>gr9</xocs:file-basename>
               <xocs:filename>gr9.jpg</xocs:filename>
               <xocs:extension>jpg</xocs:extension>
               <xocs:filesize>35011</xocs:filesize>
               <xocs:pixel-height>309</xocs:pixel-height>
               <xocs:pixel-width>600</xocs:pixel-width>
               <xocs:attachment-type>IMAGE-DOWNSAMPLED</xocs:attachment-type>
            </xocs:attachment>
            <xocs:attachment>
               <xocs:attachment-eid>1-s2.0-S022352341930371X-gr2.jpg</xocs:attachment-eid>
               <xocs:ucs-locator>https://s3-eu-west-1.amazonaws.com/prod-ucs-content-store-eu-west/content/pii:S022352341930371X/gr2/DOWNSAMPLED/image/jpeg/2887169b86c877beb851f71863043b6e/gr2.jpg</xocs:ucs-locator>
               <xocs:file-basename>gr2</xocs:file-basename>
               <xocs:filename>gr2.jpg</xocs:filename>
               <xocs:extension>jpg</xocs:extension>
               <xocs:filesize>13273</xocs:filesize>
               <xocs:pixel-height>187</xocs:pixel-height>
               <xocs:pixel-width>512</xocs:pixel-width>
               <xocs:attachment-type>IMAGE-DOWNSAMPLED</xocs:attachment-type>
            </xocs:attachment>
            <xocs:attachment>
               <xocs:attachment-eid>1-s2.0-S022352341930371X-gr29.jpg</xocs:attachment-eid>
               <xocs:ucs-locator>https://s3-eu-west-1.amazonaws.com/prod-ucs-content-store-eu-west/content/pii:S022352341930371X/gr29/DOWNSAMPLED/image/jpeg/b5a19d174177b3ef2e8af345e13dee56/gr29.jpg</xocs:ucs-locator>
               <xocs:file-basename>gr29</xocs:file-basename>
               <xocs:filename>gr29.jpg</xocs:filename>
               <xocs:extension>jpg</xocs:extension>
               <xocs:filesize>14592</xocs:filesize>
               <xocs:pixel-height>206</xocs:pixel-height>
               <xocs:pixel-width>511</xocs:pixel-width>
               <xocs:attachment-type>IMAGE-DOWNSAMPLED</xocs:attachment-type>
            </xocs:attachment>
            <xocs:attachment>
               <xocs:attachment-eid>1-s2.0-S022352341930371X-gr46.jpg</xocs:attachment-eid>
               <xocs:ucs-locator>https://s3-eu-west-1.amazonaws.com/prod-ucs-content-store-eu-west/content/pii:S022352341930371X/gr46/DOWNSAMPLED/image/jpeg/2a2cf3d41d631e65754a0229ef942bdf/gr46.jpg</xocs:ucs-locator>
               <xocs:file-basename>gr46</xocs:file-basename>
               <xocs:filename>gr46.jpg</xocs:filename>
               <xocs:extension>jpg</xocs:extension>
               <xocs:filesize>5232</xocs:filesize>
               <xocs:pixel-height>160</xocs:pixel-height>
               <xocs:pixel-width>178</xocs:pixel-width>
               <xocs:attachment-type>IMAGE-DOWNSAMPLED</xocs:attachment-type>
            </xocs:attachment>
            <xocs:attachment>
               <xocs:attachment-eid>1-s2.0-S022352341930371X-gr13.jpg</xocs:attachment-eid>
               <xocs:ucs-locator>https://s3-eu-west-1.amazonaws.com/prod-ucs-content-store-eu-west/content/pii:S022352341930371X/gr13/DOWNSAMPLED/image/jpeg/bb529dc95d7a593e302be7564fd77440/gr13.jpg</xocs:ucs-locator>
               <xocs:file-basename>gr13</xocs:file-basename>
               <xocs:filename>gr13.jpg</xocs:filename>
               <xocs:extension>jpg</xocs:extension>
               <xocs:filesize>20751</xocs:filesize>
               <xocs:pixel-height>176</xocs:pixel-height>
               <xocs:pixel-width>511</xocs:pixel-width>
               <xocs:attachment-type>IMAGE-DOWNSAMPLED</xocs:attachment-type>
            </xocs:attachment>
            <xocs:attachment>
               <xocs:attachment-eid>1-s2.0-S022352341930371X-gr19.jpg</xocs:attachment-eid>
               <xocs:ucs-locator>https://s3-eu-west-1.amazonaws.com/prod-ucs-content-store-eu-west/content/pii:S022352341930371X/gr19/DOWNSAMPLED/image/jpeg/580d33a4988c82176f3665420334420c/gr19.jpg</xocs:ucs-locator>
               <xocs:file-basename>gr19</xocs:file-basename>
               <xocs:filename>gr19.jpg</xocs:filename>
               <xocs:extension>jpg</xocs:extension>
               <xocs:filesize>17712</xocs:filesize>
               <xocs:pixel-height>234</xocs:pixel-height>
               <xocs:pixel-width>512</xocs:pixel-width>
               <xocs:attachment-type>IMAGE-DOWNSAMPLED</xocs:attachment-type>
            </xocs:attachment>
            <xocs:attachment>
               <xocs:attachment-eid>1-s2.0-S022352341930371X-gr37.jpg</xocs:attachment-eid>
               <xocs:ucs-locator>https://s3-eu-west-1.amazonaws.com/prod-ucs-content-store-eu-west/content/pii:S022352341930371X/gr37/DOWNSAMPLED/image/jpeg/8552063d2ad21ce0c699fb7ff3a3595a/gr37.jpg</xocs:ucs-locator>
               <xocs:file-basename>gr37</xocs:file-basename>
               <xocs:filename>gr37.jpg</xocs:filename>
               <xocs:extension>jpg</xocs:extension>
               <xocs:filesize>51504</xocs:filesize>
               <xocs:pixel-height>394</xocs:pixel-height>
               <xocs:pixel-width>513</xocs:pixel-width>
               <xocs:attachment-type>IMAGE-DOWNSAMPLED</xocs:attachment-type>
            </xocs:attachment>
            <xocs:attachment>
               <xocs:attachment-eid>1-s2.0-S022352341930371X-gr1.jpg</xocs:attachment-eid>
               <xocs:ucs-locator>https://s3-eu-west-1.amazonaws.com/prod-ucs-content-store-eu-west/content/pii:S022352341930371X/gr1/DOWNSAMPLED/image/jpeg/20cbab08f94b0d0e04e12ea86333c8ee/gr1.jpg</xocs:ucs-locator>
               <xocs:file-basename>gr1</xocs:file-basename>
               <xocs:filename>gr1.jpg</xocs:filename>
               <xocs:extension>jpg</xocs:extension>
               <xocs:filesize>75676</xocs:filesize>
               <xocs:pixel-height>574</xocs:pixel-height>
               <xocs:pixel-width>513</xocs:pixel-width>
               <xocs:attachment-type>IMAGE-DOWNSAMPLED</xocs:attachment-type>
            </xocs:attachment>
            <xocs:attachment>
               <xocs:attachment-eid>1-s2.0-S022352341930371X-gr14.jpg</xocs:attachment-eid>
               <xocs:ucs-locator>https://s3-eu-west-1.amazonaws.com/prod-ucs-content-store-eu-west/content/pii:S022352341930371X/gr14/DOWNSAMPLED/image/jpeg/3100e76b73bdf85d6657fb77a6a04f65/gr14.jpg</xocs:ucs-locator>
               <xocs:file-basename>gr14</xocs:file-basename>
               <xocs:filename>gr14.jpg</xocs:filename>
               <xocs:extension>jpg</xocs:extension>
               <xocs:filesize>22913</xocs:filesize>
               <xocs:pixel-height>214</xocs:pixel-height>
               <xocs:pixel-width>511</xocs:pixel-width>
               <xocs:attachment-type>IMAGE-DOWNSAMPLED</xocs:attachment-type>
            </xocs:attachment>
            <xocs:attachment>
               <xocs:attachment-eid>1-s2.0-S022352341930371X-gr43.jpg</xocs:attachment-eid>
               <xocs:ucs-locator>https://s3-eu-west-1.amazonaws.com/prod-ucs-content-store-eu-west/content/pii:S022352341930371X/gr43/DOWNSAMPLED/image/jpeg/0aaadb309112a1f884fb53d862e0e5ed/gr43.jpg</xocs:ucs-locator>
               <xocs:file-basename>gr43</xocs:file-basename>
               <xocs:filename>gr43.jpg</xocs:filename>
               <xocs:extension>jpg</xocs:extension>
               <xocs:filesize>7444</xocs:filesize>
               <xocs:pixel-height>175</xocs:pixel-height>
               <xocs:pixel-width>312</xocs:pixel-width>
               <xocs:attachment-type>IMAGE-DOWNSAMPLED</xocs:attachment-type>
            </xocs:attachment>
            <xocs:attachment>
               <xocs:attachment-eid>1-s2.0-S022352341930371X-gr20.jpg</xocs:attachment-eid>
               <xocs:ucs-locator>https://s3-eu-west-1.amazonaws.com/prod-ucs-content-store-eu-west/content/pii:S022352341930371X/gr20/DOWNSAMPLED/image/jpeg/2e9c909fb193dc84445b5bd3c7bab209/gr20.jpg</xocs:ucs-locator>
               <xocs:file-basename>gr20</xocs:file-basename>
               <xocs:filename>gr20.jpg</xocs:filename>
               <xocs:extension>jpg</xocs:extension>
               <xocs:filesize>16697</xocs:filesize>
               <xocs:pixel-height>169</xocs:pixel-height>
               <xocs:pixel-width>512</xocs:pixel-width>
               <xocs:attachment-type>IMAGE-DOWNSAMPLED</xocs:attachment-type>
            </xocs:attachment>
            <xocs:attachment>
               <xocs:attachment-eid>1-s2.0-S022352341930371X-gr32.jpg</xocs:attachment-eid>
               <xocs:ucs-locator>https://s3-eu-west-1.amazonaws.com/prod-ucs-content-store-eu-west/content/pii:S022352341930371X/gr32/DOWNSAMPLED/image/jpeg/ccdda8d32f99a0fb5ed6fdb4d74e2889/gr32.jpg</xocs:ucs-locator>
               <xocs:file-basename>gr32</xocs:file-basename>
               <xocs:filename>gr32.jpg</xocs:filename>
               <xocs:extension>jpg</xocs:extension>
               <xocs:filesize>16303</xocs:filesize>
               <xocs:pixel-height>275</xocs:pixel-height>
               <xocs:pixel-width>378</xocs:pixel-width>
               <xocs:attachment-type>IMAGE-DOWNSAMPLED</xocs:attachment-type>
            </xocs:attachment>
            <xocs:attachment>
               <xocs:attachment-eid>1-s2.0-S022352341930371X-gr38.jpg</xocs:attachment-eid>
               <xocs:ucs-locator>https://s3-eu-west-1.amazonaws.com/prod-ucs-content-store-eu-west/content/pii:S022352341930371X/gr38/DOWNSAMPLED/image/jpeg/0503d9702d5bcc58117eb8e8e6641294/gr38.jpg</xocs:ucs-locator>
               <xocs:file-basename>gr38</xocs:file-basename>
               <xocs:filename>gr38.jpg</xocs:filename>
               <xocs:extension>jpg</xocs:extension>
               <xocs:filesize>5474</xocs:filesize>
               <xocs:pixel-height>109</xocs:pixel-height>
               <xocs:pixel-width>222</xocs:pixel-width>
               <xocs:attachment-type>IMAGE-DOWNSAMPLED</xocs:attachment-type>
            </xocs:attachment>
            <xocs:attachment>
               <xocs:attachment-eid>1-s2.0-S022352341930371X-gr25.jpg</xocs:attachment-eid>
               <xocs:ucs-locator>https://s3-eu-west-1.amazonaws.com/prod-ucs-content-store-eu-west/content/pii:S022352341930371X/gr25/DOWNSAMPLED/image/jpeg/22c542b7741565e4c1c181255535f3d3/gr25.jpg</xocs:ucs-locator>
               <xocs:file-basename>gr25</xocs:file-basename>
               <xocs:filename>gr25.jpg</xocs:filename>
               <xocs:extension>jpg</xocs:extension>
               <xocs:filesize>51283</xocs:filesize>
               <xocs:pixel-height>369</xocs:pixel-height>
               <xocs:pixel-width>557</xocs:pixel-width>
               <xocs:attachment-type>IMAGE-DOWNSAMPLED</xocs:attachment-type>
            </xocs:attachment>
            <xocs:attachment>
               <xocs:attachment-eid>1-s2.0-S022352341930371X-gr26.jpg</xocs:attachment-eid>
               <xocs:ucs-locator>https://s3-eu-west-1.amazonaws.com/prod-ucs-content-store-eu-west/content/pii:S022352341930371X/gr26/DOWNSAMPLED/image/jpeg/4b424e00af424627ecbec0a5b82e42f5/gr26.jpg</xocs:ucs-locator>
               <xocs:file-basename>gr26</xocs:file-basename>
               <xocs:filename>gr26.jpg</xocs:filename>
               <xocs:extension>jpg</xocs:extension>
               <xocs:filesize>49462</xocs:filesize>
               <xocs:pixel-height>511</xocs:pixel-height>
               <xocs:pixel-width>556</xocs:pixel-width>
               <xocs:attachment-type>IMAGE-DOWNSAMPLED</xocs:attachment-type>
            </xocs:attachment>
            <xocs:attachment>
               <xocs:attachment-eid>1-s2.0-S022352341930371X-gr41.jpg</xocs:attachment-eid>
               <xocs:ucs-locator>https://s3-eu-west-1.amazonaws.com/prod-ucs-content-store-eu-west/content/pii:S022352341930371X/gr41/DOWNSAMPLED/image/jpeg/d44dcf28dde91a98696d3abf852fdee8/gr41.jpg</xocs:ucs-locator>
               <xocs:file-basename>gr41</xocs:file-basename>
               <xocs:filename>gr41.jpg</xocs:filename>
               <xocs:extension>jpg</xocs:extension>
               <xocs:filesize>8035</xocs:filesize>
               <xocs:pixel-height>173</xocs:pixel-height>
               <xocs:pixel-width>311</xocs:pixel-width>
               <xocs:attachment-type>IMAGE-DOWNSAMPLED</xocs:attachment-type>
            </xocs:attachment>
            <xocs:attachment>
               <xocs:attachment-eid>1-s2.0-S022352341930371X-gr42.jpg</xocs:attachment-eid>
               <xocs:ucs-locator>https://s3-eu-west-1.amazonaws.com/prod-ucs-content-store-eu-west/content/pii:S022352341930371X/gr42/DOWNSAMPLED/image/jpeg/b7fdeacc04f73c60892ef9b4a2088f99/gr42.jpg</xocs:ucs-locator>
               <xocs:file-basename>gr42</xocs:file-basename>
               <xocs:filename>gr42.jpg</xocs:filename>
               <xocs:extension>jpg</xocs:extension>
               <xocs:filesize>48295</xocs:filesize>
               <xocs:pixel-height>338</xocs:pixel-height>
               <xocs:pixel-width>513</xocs:pixel-width>
               <xocs:attachment-type>IMAGE-DOWNSAMPLED</xocs:attachment-type>
            </xocs:attachment>
            <xocs:attachment>
               <xocs:attachment-eid>1-s2.0-S022352341930371X-gr47.jpg</xocs:attachment-eid>
               <xocs:ucs-locator>https://s3-eu-west-1.amazonaws.com/prod-ucs-content-store-eu-west/content/pii:S022352341930371X/gr47/DOWNSAMPLED/image/jpeg/37a2e63d6df85eacbef5ceb174f35b52/gr47.jpg</xocs:ucs-locator>
               <xocs:file-basename>gr47</xocs:file-basename>
               <xocs:filename>gr47.jpg</xocs:filename>
               <xocs:extension>jpg</xocs:extension>
               <xocs:filesize>4759</xocs:filesize>
               <xocs:pixel-height>69</xocs:pixel-height>
               <xocs:pixel-width>177</xocs:pixel-width>
               <xocs:attachment-type>IMAGE-DOWNSAMPLED</xocs:attachment-type>
            </xocs:attachment>
            <xocs:attachment>
               <xocs:attachment-eid>1-s2.0-S022352341930371X-gr27.jpg</xocs:attachment-eid>
               <xocs:ucs-locator>https://s3-eu-west-1.amazonaws.com/prod-ucs-content-store-eu-west/content/pii:S022352341930371X/gr27/DOWNSAMPLED/image/jpeg/1f7670635368e4825c87787324c34954/gr27.jpg</xocs:ucs-locator>
               <xocs:file-basename>gr27</xocs:file-basename>
               <xocs:filename>gr27.jpg</xocs:filename>
               <xocs:extension>jpg</xocs:extension>
               <xocs:filesize>15218</xocs:filesize>
               <xocs:pixel-height>172</xocs:pixel-height>
               <xocs:pixel-width>512</xocs:pixel-width>
               <xocs:attachment-type>IMAGE-DOWNSAMPLED</xocs:attachment-type>
            </xocs:attachment>
            <xocs:attachment>
               <xocs:attachment-eid>1-s2.0-S022352341930371X-fx1.jpg</xocs:attachment-eid>
               <xocs:ucs-locator>https://s3-eu-west-1.amazonaws.com/prod-ucs-content-store-eu-west/content/pii:S022352341930371X/fx1/DOWNSAMPLED/image/jpeg/9c45319bdd0962ba3688f2517d5cab56/fx1.jpg</xocs:ucs-locator>
               <xocs:file-basename>fx1</xocs:file-basename>
               <xocs:abstract-attachment>true</xocs:abstract-attachment>
               <xocs:filename>fx1.jpg</xocs:filename>
               <xocs:extension>jpg</xocs:extension>
               <xocs:filesize>22779</xocs:filesize>
               <xocs:pixel-height>200</xocs:pixel-height>
               <xocs:pixel-width>459</xocs:pixel-width>
               <xocs:attachment-type>IMAGE-DOWNSAMPLED</xocs:attachment-type>
            </xocs:attachment>
            <xocs:attachment>
               <xocs:attachment-eid>1-s2.0-S022352341930371X-gr7.jpg</xocs:attachment-eid>
               <xocs:ucs-locator>https://s3-eu-west-1.amazonaws.com/prod-ucs-content-store-eu-west/content/pii:S022352341930371X/gr7/DOWNSAMPLED/image/jpeg/378d78a2190c3716f4c1657c6148d994/gr7.jpg</xocs:ucs-locator>
               <xocs:file-basename>gr7</xocs:file-basename>
               <xocs:filename>gr7.jpg</xocs:filename>
               <xocs:extension>jpg</xocs:extension>
               <xocs:filesize>20923</xocs:filesize>
               <xocs:pixel-height>405</xocs:pixel-height>
               <xocs:pixel-width>511</xocs:pixel-width>
               <xocs:attachment-type>IMAGE-DOWNSAMPLED</xocs:attachment-type>
            </xocs:attachment>
            <xocs:attachment>
               <xocs:attachment-eid>1-s2.0-S022352341930371X-gr16.jpg</xocs:attachment-eid>
               <xocs:ucs-locator>https://s3-eu-west-1.amazonaws.com/prod-ucs-content-store-eu-west/content/pii:S022352341930371X/gr16/DOWNSAMPLED/image/jpeg/f1315e5c03e0235eecab204ad1a4c88b/gr16.jpg</xocs:ucs-locator>
               <xocs:file-basename>gr16</xocs:file-basename>
               <xocs:filename>gr16.jpg</xocs:filename>
               <xocs:extension>jpg</xocs:extension>
               <xocs:filesize>17768</xocs:filesize>
               <xocs:pixel-height>155</xocs:pixel-height>
               <xocs:pixel-width>556</xocs:pixel-width>
               <xocs:attachment-type>IMAGE-DOWNSAMPLED</xocs:attachment-type>
            </xocs:attachment>
            <xocs:attachment>
               <xocs:attachment-eid>1-s2.0-S022352341930371X-gr3.jpg</xocs:attachment-eid>
               <xocs:ucs-locator>https://s3-eu-west-1.amazonaws.com/prod-ucs-content-store-eu-west/content/pii:S022352341930371X/gr3/DOWNSAMPLED/image/jpeg/6fcfd5ad92514cf0dc65ba5ba7a0436f/gr3.jpg</xocs:ucs-locator>
               <xocs:file-basename>gr3</xocs:file-basename>
               <xocs:filename>gr3.jpg</xocs:filename>
               <xocs:extension>jpg</xocs:extension>
               <xocs:filesize>15610</xocs:filesize>
               <xocs:pixel-height>167</xocs:pixel-height>
               <xocs:pixel-width>511</xocs:pixel-width>
               <xocs:attachment-type>IMAGE-DOWNSAMPLED</xocs:attachment-type>
            </xocs:attachment>
            <xocs:attachment>
               <xocs:attachment-eid>1-s2.0-S022352341930371X-gr12.jpg</xocs:attachment-eid>
               <xocs:ucs-locator>https://s3-eu-west-1.amazonaws.com/prod-ucs-content-store-eu-west/content/pii:S022352341930371X/gr12/DOWNSAMPLED/image/jpeg/7810ac52a8b41862b9e7db6d1e18fed5/gr12.jpg</xocs:ucs-locator>
               <xocs:file-basename>gr12</xocs:file-basename>
               <xocs:filename>gr12.jpg</xocs:filename>
               <xocs:extension>jpg</xocs:extension>
               <xocs:filesize>21555</xocs:filesize>
               <xocs:pixel-height>177</xocs:pixel-height>
               <xocs:pixel-width>511</xocs:pixel-width>
               <xocs:attachment-type>IMAGE-DOWNSAMPLED</xocs:attachment-type>
            </xocs:attachment>
            <xocs:attachment>
               <xocs:attachment-eid>1-s2.0-S022352341930371X-gr28.jpg</xocs:attachment-eid>
               <xocs:ucs-locator>https://s3-eu-west-1.amazonaws.com/prod-ucs-content-store-eu-west/content/pii:S022352341930371X/gr28/DOWNSAMPLED/image/jpeg/b44ef8e82db5a1b2dd63fb5fdd2ec9f4/gr28.jpg</xocs:ucs-locator>
               <xocs:file-basename>gr28</xocs:file-basename>
               <xocs:filename>gr28.jpg</xocs:filename>
               <xocs:extension>jpg</xocs:extension>
               <xocs:filesize>14841</xocs:filesize>
               <xocs:pixel-height>139</xocs:pixel-height>
               <xocs:pixel-width>511</xocs:pixel-width>
               <xocs:attachment-type>IMAGE-DOWNSAMPLED</xocs:attachment-type>
            </xocs:attachment>
            <xocs:attachment>
               <xocs:attachment-eid>1-s2.0-S022352341930371X-gr4.jpg</xocs:attachment-eid>
               <xocs:ucs-locator>https://s3-eu-west-1.amazonaws.com/prod-ucs-content-store-eu-west/content/pii:S022352341930371X/gr4/DOWNSAMPLED/image/jpeg/430e91b2f471c245d07daa9682909565/gr4.jpg</xocs:ucs-locator>
               <xocs:file-basename>gr4</xocs:file-basename>
               <xocs:filename>gr4.jpg</xocs:filename>
               <xocs:extension>jpg</xocs:extension>
               <xocs:filesize>14001</xocs:filesize>
               <xocs:pixel-height>118</xocs:pixel-height>
               <xocs:pixel-width>556</xocs:pixel-width>
               <xocs:attachment-type>IMAGE-DOWNSAMPLED</xocs:attachment-type>
            </xocs:attachment>
            <xocs:attachment>
               <xocs:attachment-eid>1-s2.0-S022352341930371X-gr18.jpg</xocs:attachment-eid>
               <xocs:ucs-locator>https://s3-eu-west-1.amazonaws.com/prod-ucs-content-store-eu-west/content/pii:S022352341930371X/gr18/DOWNSAMPLED/image/jpeg/4f6c361bb3aa17b34cb6af546d260f45/gr18.jpg</xocs:ucs-locator>
               <xocs:file-basename>gr18</xocs:file-basename>
               <xocs:filename>gr18.jpg</xocs:filename>
               <xocs:extension>jpg</xocs:extension>
               <xocs:filesize>19229</xocs:filesize>
               <xocs:pixel-height>199</xocs:pixel-height>
               <xocs:pixel-width>556</xocs:pixel-width>
               <xocs:attachment-type>IMAGE-DOWNSAMPLED</xocs:attachment-type>
            </xocs:attachment>
            <xocs:attachment>
               <xocs:attachment-eid>1-s2.0-S022352341930371X-gr40.jpg</xocs:attachment-eid>
               <xocs:ucs-locator>https://s3-eu-west-1.amazonaws.com/prod-ucs-content-store-eu-west/content/pii:S022352341930371X/gr40/DOWNSAMPLED/image/jpeg/477f3e5a0a830b0d3f7c76539f7f0c28/gr40.jpg</xocs:ucs-locator>
               <xocs:file-basename>gr40</xocs:file-basename>
               <xocs:filename>gr40.jpg</xocs:filename>
               <xocs:extension>jpg</xocs:extension>
               <xocs:filesize>8078</xocs:filesize>
               <xocs:pixel-height>215</xocs:pixel-height>
               <xocs:pixel-width>311</xocs:pixel-width>
               <xocs:attachment-type>IMAGE-DOWNSAMPLED</xocs:attachment-type>
            </xocs:attachment>
            <xocs:attachment>
               <xocs:attachment-eid>1-s2.0-S022352341930371X-gr10.jpg</xocs:attachment-eid>
               <xocs:ucs-locator>https://s3-eu-west-1.amazonaws.com/prod-ucs-content-store-eu-west/content/pii:S022352341930371X/gr10/DOWNSAMPLED/image/jpeg/aca6d952d37c8569081bb14522cc7179/gr10.jpg</xocs:ucs-locator>
               <xocs:file-basename>gr10</xocs:file-basename>
               <xocs:filename>gr10.jpg</xocs:filename>
               <xocs:extension>jpg</xocs:extension>
               <xocs:filesize>20195</xocs:filesize>
               <xocs:pixel-height>216</xocs:pixel-height>
               <xocs:pixel-width>556</xocs:pixel-width>
               <xocs:attachment-type>IMAGE-DOWNSAMPLED</xocs:attachment-type>
            </xocs:attachment>
            <xocs:attachment>
               <xocs:attachment-eid>1-s2.0-S022352341930371X-gr44.jpg</xocs:attachment-eid>
               <xocs:ucs-locator>https://s3-eu-west-1.amazonaws.com/prod-ucs-content-store-eu-west/content/pii:S022352341930371X/gr44/DOWNSAMPLED/image/jpeg/38467383fc9bcd2301a4ffdd8c9448fa/gr44.jpg</xocs:ucs-locator>
               <xocs:file-basename>gr44</xocs:file-basename>
               <xocs:filename>gr44.jpg</xocs:filename>
               <xocs:extension>jpg</xocs:extension>
               <xocs:filesize>6683</xocs:filesize>
               <xocs:pixel-height>145</xocs:pixel-height>
               <xocs:pixel-width>311</xocs:pixel-width>
               <xocs:attachment-type>IMAGE-DOWNSAMPLED</xocs:attachment-type>
            </xocs:attachment>
            <xocs:attachment>
               <xocs:attachment-eid>1-s2.0-S022352341930371X-gr36.jpg</xocs:attachment-eid>
               <xocs:ucs-locator>https://s3-eu-west-1.amazonaws.com/prod-ucs-content-store-eu-west/content/pii:S022352341930371X/gr36/DOWNSAMPLED/image/jpeg/8f1ae723b9082bc3af7931fb43eae207/gr36.jpg</xocs:ucs-locator>
               <xocs:file-basename>gr36</xocs:file-basename>
               <xocs:filename>gr36.jpg</xocs:filename>
               <xocs:extension>jpg</xocs:extension>
               <xocs:filesize>5551</xocs:filesize>
               <xocs:pixel-height>136</xocs:pixel-height>
               <xocs:pixel-width>222</xocs:pixel-width>
               <xocs:attachment-type>IMAGE-DOWNSAMPLED</xocs:attachment-type>
            </xocs:attachment>
            <xocs:attachment>
               <xocs:attachment-eid>1-s2.0-S022352341930371X-gr39.jpg</xocs:attachment-eid>
               <xocs:ucs-locator>https://s3-eu-west-1.amazonaws.com/prod-ucs-content-store-eu-west/content/pii:S022352341930371X/gr39/DOWNSAMPLED/image/jpeg/5ba659641a9354f14d10eae064edce1e/gr39.jpg</xocs:ucs-locator>
               <xocs:file-basename>gr39</xocs:file-basename>
               <xocs:filename>gr39.jpg</xocs:filename>
               <xocs:extension>jpg</xocs:extension>
               <xocs:filesize>7457</xocs:filesize>
               <xocs:pixel-height>228</xocs:pixel-height>
               <xocs:pixel-width>178</xocs:pixel-width>
               <xocs:attachment-type>IMAGE-DOWNSAMPLED</xocs:attachment-type>
            </xocs:attachment>
            <xocs:attachment>
               <xocs:attachment-eid>1-s2.0-S022352341930371X-gr15.jpg</xocs:attachment-eid>
               <xocs:ucs-locator>https://s3-eu-west-1.amazonaws.com/prod-ucs-content-store-eu-west/content/pii:S022352341930371X/gr15/DOWNSAMPLED/image/jpeg/81f8c61450411b7bb86ccbba96729633/gr15.jpg</xocs:ucs-locator>
               <xocs:file-basename>gr15</xocs:file-basename>
               <xocs:filename>gr15.jpg</xocs:filename>
               <xocs:extension>jpg</xocs:extension>
               <xocs:filesize>24190</xocs:filesize>
               <xocs:pixel-height>314</xocs:pixel-height>
               <xocs:pixel-width>511</xocs:pixel-width>
               <xocs:attachment-type>IMAGE-DOWNSAMPLED</xocs:attachment-type>
            </xocs:attachment>
            <xocs:attachment>
               <xocs:attachment-eid>1-s2.0-S022352341930371X-gr34.jpg</xocs:attachment-eid>
               <xocs:ucs-locator>https://s3-eu-west-1.amazonaws.com/prod-ucs-content-store-eu-west/content/pii:S022352341930371X/gr34/DOWNSAMPLED/image/jpeg/5beeff96e8971b8b967eaada6eedaf35/gr34.jpg</xocs:ucs-locator>
               <xocs:file-basename>gr34</xocs:file-basename>
               <xocs:filename>gr34.jpg</xocs:filename>
               <xocs:extension>jpg</xocs:extension>
               <xocs:filesize>4304</xocs:filesize>
               <xocs:pixel-height>112</xocs:pixel-height>
               <xocs:pixel-width>222</xocs:pixel-width>
               <xocs:attachment-type>IMAGE-DOWNSAMPLED</xocs:attachment-type>
            </xocs:attachment>
            <xocs:attachment>
               <xocs:attachment-eid>1-s2.0-S022352341930371X-gr8.jpg</xocs:attachment-eid>
               <xocs:ucs-locator>https://s3-eu-west-1.amazonaws.com/prod-ucs-content-store-eu-west/content/pii:S022352341930371X/gr8/DOWNSAMPLED/image/jpeg/31165cdc2d19249a93958be938832b6d/gr8.jpg</xocs:ucs-locator>
               <xocs:file-basename>gr8</xocs:file-basename>
               <xocs:filename>gr8.jpg</xocs:filename>
               <xocs:extension>jpg</xocs:extension>
               <xocs:filesize>92030</xocs:filesize>
               <xocs:pixel-height>743</xocs:pixel-height>
               <xocs:pixel-width>378</xocs:pixel-width>
               <xocs:attachment-type>IMAGE-DOWNSAMPLED</xocs:attachment-type>
            </xocs:attachment>
            <xocs:attachment>
               <xocs:attachment-eid>1-s2.0-S022352341930371X-gr17.jpg</xocs:attachment-eid>
               <xocs:ucs-locator>https://s3-eu-west-1.amazonaws.com/prod-ucs-content-store-eu-west/content/pii:S022352341930371X/gr17/DOWNSAMPLED/image/jpeg/2ae172c124c48e23885e1ce9427e1595/gr17.jpg</xocs:ucs-locator>
               <xocs:file-basename>gr17</xocs:file-basename>
               <xocs:filename>gr17.jpg</xocs:filename>
               <xocs:extension>jpg</xocs:extension>
               <xocs:filesize>12933</xocs:filesize>
               <xocs:pixel-height>185</xocs:pixel-height>
               <xocs:pixel-width>378</xocs:pixel-width>
               <xocs:attachment-type>IMAGE-DOWNSAMPLED</xocs:attachment-type>
            </xocs:attachment>
            <xocs:attachment>
               <xocs:attachment-eid>1-s2.0-S022352341930371X-gr22.jpg</xocs:attachment-eid>
               <xocs:ucs-locator>https://s3-eu-west-1.amazonaws.com/prod-ucs-content-store-eu-west/content/pii:S022352341930371X/gr22/DOWNSAMPLED/image/jpeg/3f6725ec73627c53749b9efc85d7442d/gr22.jpg</xocs:ucs-locator>
               <xocs:file-basename>gr22</xocs:file-basename>
               <xocs:filename>gr22.jpg</xocs:filename>
               <xocs:extension>jpg</xocs:extension>
               <xocs:filesize>17461</xocs:filesize>
               <xocs:pixel-height>189</xocs:pixel-height>
               <xocs:pixel-width>511</xocs:pixel-width>
               <xocs:attachment-type>IMAGE-DOWNSAMPLED</xocs:attachment-type>
            </xocs:attachment>
            <xocs:attachment>
               <xocs:attachment-eid>1-s2.0-S022352341930371X-gr23.jpg</xocs:attachment-eid>
               <xocs:ucs-locator>https://s3-eu-west-1.amazonaws.com/prod-ucs-content-store-eu-west/content/pii:S022352341930371X/gr23/DOWNSAMPLED/image/jpeg/0f435dcdc7058482f9b7f889c900389e/gr23.jpg</xocs:ucs-locator>
               <xocs:file-basename>gr23</xocs:file-basename>
               <xocs:filename>gr23.jpg</xocs:filename>
               <xocs:extension>jpg</xocs:extension>
               <xocs:filesize>20469</xocs:filesize>
               <xocs:pixel-height>170</xocs:pixel-height>
               <xocs:pixel-width>511</xocs:pixel-width>
               <xocs:attachment-type>IMAGE-DOWNSAMPLED</xocs:attachment-type>
            </xocs:attachment>
            <xocs:attachment>
               <xocs:attachment-eid>1-s2.0-S022352341930371X-gr11.jpg</xocs:attachment-eid>
               <xocs:ucs-locator>https://s3-eu-west-1.amazonaws.com/prod-ucs-content-store-eu-west/content/pii:S022352341930371X/gr11/DOWNSAMPLED/image/jpeg/b5ff6a1e8e67ef4a24c66aeeaca6fefc/gr11.jpg</xocs:ucs-locator>
               <xocs:file-basename>gr11</xocs:file-basename>
               <xocs:filename>gr11.jpg</xocs:filename>
               <xocs:extension>jpg</xocs:extension>
               <xocs:filesize>13800</xocs:filesize>
               <xocs:pixel-height>203</xocs:pixel-height>
               <xocs:pixel-width>379</xocs:pixel-width>
               <xocs:attachment-type>IMAGE-DOWNSAMPLED</xocs:attachment-type>
            </xocs:attachment>
            <xocs:attachment>
               <xocs:attachment-eid>1-s2.0-S022352341930371X-gr24.jpg</xocs:attachment-eid>
               <xocs:ucs-locator>https://s3-eu-west-1.amazonaws.com/prod-ucs-content-store-eu-west/content/pii:S022352341930371X/gr24/DOWNSAMPLED/image/jpeg/e9201c66be8ade06207e541fc8b8ed8b/gr24.jpg</xocs:ucs-locator>
               <xocs:file-basename>gr24</xocs:file-basename>
               <xocs:filename>gr24.jpg</xocs:filename>
               <xocs:extension>jpg</xocs:extension>
               <xocs:filesize>29301</xocs:filesize>
               <xocs:pixel-height>337</xocs:pixel-height>
               <xocs:pixel-width>511</xocs:pixel-width>
               <xocs:attachment-type>IMAGE-DOWNSAMPLED</xocs:attachment-type>
            </xocs:attachment>
            <xocs:attachment>
               <xocs:attachment-eid>1-s2.0-S022352341930371X-gr21.jpg</xocs:attachment-eid>
               <xocs:ucs-locator>https://s3-eu-west-1.amazonaws.com/prod-ucs-content-store-eu-west/content/pii:S022352341930371X/gr21/DOWNSAMPLED/image/jpeg/e259d767e524e877192b10c4361e269e/gr21.jpg</xocs:ucs-locator>
               <xocs:file-basename>gr21</xocs:file-basename>
               <xocs:filename>gr21.jpg</xocs:filename>
               <xocs:extension>jpg</xocs:extension>
               <xocs:filesize>17194</xocs:filesize>
               <xocs:pixel-height>155</xocs:pixel-height>
               <xocs:pixel-width>512</xocs:pixel-width>
               <xocs:attachment-type>IMAGE-DOWNSAMPLED</xocs:attachment-type>
            </xocs:attachment>
            <xocs:attachment>
               <xocs:attachment-eid>1-s2.0-S022352341930371X-gr5.jpg</xocs:attachment-eid>
               <xocs:ucs-locator>https://s3-eu-west-1.amazonaws.com/prod-ucs-content-store-eu-west/content/pii:S022352341930371X/gr5/DOWNSAMPLED/image/jpeg/fac3233afc3ffa0f68828b13cdcaf72c/gr5.jpg</xocs:ucs-locator>
               <xocs:file-basename>gr5</xocs:file-basename>
               <xocs:filename>gr5.jpg</xocs:filename>
               <xocs:extension>jpg</xocs:extension>
               <xocs:filesize>16457</xocs:filesize>
               <xocs:pixel-height>151</xocs:pixel-height>
               <xocs:pixel-width>511</xocs:pixel-width>
               <xocs:attachment-type>IMAGE-DOWNSAMPLED</xocs:attachment-type>
            </xocs:attachment>
            <xocs:attachment>
               <xocs:attachment-eid>1-s2.0-S022352341930371X-gr31.jpg</xocs:attachment-eid>
               <xocs:ucs-locator>https://s3-eu-west-1.amazonaws.com/prod-ucs-content-store-eu-west/content/pii:S022352341930371X/gr31/DOWNSAMPLED/image/jpeg/333f96d37edf8a2d92ed66f4d46aa2e7/gr31.jpg</xocs:ucs-locator>
               <xocs:file-basename>gr31</xocs:file-basename>
               <xocs:filename>gr31.jpg</xocs:filename>
               <xocs:extension>jpg</xocs:extension>
               <xocs:filesize>8959</xocs:filesize>
               <xocs:pixel-height>168</xocs:pixel-height>
               <xocs:pixel-width>311</xocs:pixel-width>
               <xocs:attachment-type>IMAGE-DOWNSAMPLED</xocs:attachment-type>
            </xocs:attachment>
            <xocs:attachment>
               <xocs:attachment-eid>1-s2.0-S022352341930371X-gr35.jpg</xocs:attachment-eid>
               <xocs:ucs-locator>https://s3-eu-west-1.amazonaws.com/prod-ucs-content-store-eu-west/content/pii:S022352341930371X/gr35/DOWNSAMPLED/image/jpeg/b24eff51d0f4b30a36e15c969b6aa30f/gr35.jpg</xocs:ucs-locator>
               <xocs:file-basename>gr35</xocs:file-basename>
               <xocs:filename>gr35.jpg</xocs:filename>
               <xocs:extension>jpg</xocs:extension>
               <xocs:filesize>22523</xocs:filesize>
               <xocs:pixel-height>164</xocs:pixel-height>
               <xocs:pixel-width>600</xocs:pixel-width>
               <xocs:attachment-type>IMAGE-DOWNSAMPLED</xocs:attachment-type>
            </xocs:attachment>
            <xocs:attachment>
               <xocs:attachment-eid>1-s2.0-S022352341930371X-gr6.sml</xocs:attachment-eid>
               <xocs:ucs-locator>https://s3-eu-west-1.amazonaws.com/prod-ucs-content-store-eu-west/content/pii:S022352341930371X/gr6/THUMBNAIL/image/gif/edd6f773e2a42e46a7802d379aee28eb/gr6.sml</xocs:ucs-locator>
               <xocs:file-basename>gr6</xocs:file-basename>
               <xocs:filename>gr6.sml</xocs:filename>
               <xocs:extension>sml</xocs:extension>
               <xocs:filesize>2701</xocs:filesize>
               <xocs:pixel-height>81</xocs:pixel-height>
               <xocs:pixel-width>219</xocs:pixel-width>
               <xocs:attachment-type>IMAGE-THUMBNAIL</xocs:attachment-type>
            </xocs:attachment>
            <xocs:attachment>
               <xocs:attachment-eid>1-s2.0-S022352341930371X-gr33.sml</xocs:attachment-eid>
               <xocs:ucs-locator>https://s3-eu-west-1.amazonaws.com/prod-ucs-content-store-eu-west/content/pii:S022352341930371X/gr33/THUMBNAIL/image/gif/bab127daa4041eecf6496917ccbd80bf/gr33.sml</xocs:ucs-locator>
               <xocs:file-basename>gr33</xocs:file-basename>
               <xocs:filename>gr33.sml</xocs:filename>
               <xocs:extension>sml</xocs:extension>
               <xocs:filesize>2532</xocs:filesize>
               <xocs:pixel-height>119</xocs:pixel-height>
               <xocs:pixel-width>219</xocs:pixel-width>
               <xocs:attachment-type>IMAGE-THUMBNAIL</xocs:attachment-type>
            </xocs:attachment>
            <xocs:attachment>
               <xocs:attachment-eid>1-s2.0-S022352341930371X-gr45.sml</xocs:attachment-eid>
               <xocs:ucs-locator>https://s3-eu-west-1.amazonaws.com/prod-ucs-content-store-eu-west/content/pii:S022352341930371X/gr45/THUMBNAIL/image/gif/585d25ce56c377b8a2146733232cc252/gr45.sml</xocs:ucs-locator>
               <xocs:file-basename>gr45</xocs:file-basename>
               <xocs:filename>gr45.sml</xocs:filename>
               <xocs:extension>sml</xocs:extension>
               <xocs:filesize>2204</xocs:filesize>
               <xocs:pixel-height>164</xocs:pixel-height>
               <xocs:pixel-width>132</xocs:pixel-width>
               <xocs:attachment-type>IMAGE-THUMBNAIL</xocs:attachment-type>
            </xocs:attachment>
            <xocs:attachment>
               <xocs:attachment-eid>1-s2.0-S022352341930371X-gr30.sml</xocs:attachment-eid>
               <xocs:ucs-locator>https://s3-eu-west-1.amazonaws.com/prod-ucs-content-store-eu-west/content/pii:S022352341930371X/gr30/THUMBNAIL/image/gif/115c8eea7099a8079bb815e1e2607e05/gr30.sml</xocs:ucs-locator>
               <xocs:file-basename>gr30</xocs:file-basename>
               <xocs:filename>gr30.sml</xocs:filename>
               <xocs:extension>sml</xocs:extension>
               <xocs:filesize>2626</xocs:filesize>
               <xocs:pixel-height>38</xocs:pixel-height>
               <xocs:pixel-width>219</xocs:pixel-width>
               <xocs:attachment-type>IMAGE-THUMBNAIL</xocs:attachment-type>
            </xocs:attachment>
            <xocs:attachment>
               <xocs:attachment-eid>1-s2.0-S022352341930371X-gr9.sml</xocs:attachment-eid>
               <xocs:ucs-locator>https://s3-eu-west-1.amazonaws.com/prod-ucs-content-store-eu-west/content/pii:S022352341930371X/gr9/THUMBNAIL/image/gif/5c48fd4120b7b15a575e9a88be9b04f7/gr9.sml</xocs:ucs-locator>
               <xocs:file-basename>gr9</xocs:file-basename>
               <xocs:filename>gr9.sml</xocs:filename>
               <xocs:extension>sml</xocs:extension>
               <xocs:filesize>3805</xocs:filesize>
               <xocs:pixel-height>113</xocs:pixel-height>
               <xocs:pixel-width>219</xocs:pixel-width>
               <xocs:attachment-type>IMAGE-THUMBNAIL</xocs:attachment-type>
            </xocs:attachment>
            <xocs:attachment>
               <xocs:attachment-eid>1-s2.0-S022352341930371X-gr2.sml</xocs:attachment-eid>
               <xocs:ucs-locator>https://s3-eu-west-1.amazonaws.com/prod-ucs-content-store-eu-west/content/pii:S022352341930371X/gr2/THUMBNAIL/image/gif/89f2509cef52e0667cf72ab52a4713f0/gr2.sml</xocs:ucs-locator>
               <xocs:file-basename>gr2</xocs:file-basename>
               <xocs:filename>gr2.sml</xocs:filename>
               <xocs:extension>sml</xocs:extension>
               <xocs:filesize>2953</xocs:filesize>
               <xocs:pixel-height>80</xocs:pixel-height>
               <xocs:pixel-width>219</xocs:pixel-width>
               <xocs:attachment-type>IMAGE-THUMBNAIL</xocs:attachment-type>
            </xocs:attachment>
            <xocs:attachment>
               <xocs:attachment-eid>1-s2.0-S022352341930371X-gr29.sml</xocs:attachment-eid>
               <xocs:ucs-locator>https://s3-eu-west-1.amazonaws.com/prod-ucs-content-store-eu-west/content/pii:S022352341930371X/gr29/THUMBNAIL/image/gif/2fea6cb16d8d24016d1f021e6e8750f3/gr29.sml</xocs:ucs-locator>
               <xocs:file-basename>gr29</xocs:file-basename>
               <xocs:filename>gr29.sml</xocs:filename>
               <xocs:extension>sml</xocs:extension>
               <xocs:filesize>3115</xocs:filesize>
               <xocs:pixel-height>88</xocs:pixel-height>
               <xocs:pixel-width>219</xocs:pixel-width>
               <xocs:attachment-type>IMAGE-THUMBNAIL</xocs:attachment-type>
            </xocs:attachment>
            <xocs:attachment>
               <xocs:attachment-eid>1-s2.0-S022352341930371X-gr46.sml</xocs:attachment-eid>
               <xocs:ucs-locator>https://s3-eu-west-1.amazonaws.com/prod-ucs-content-store-eu-west/content/pii:S022352341930371X/gr46/THUMBNAIL/image/gif/dd51150551ded626d373d92cf524e219/gr46.sml</xocs:ucs-locator>
               <xocs:file-basename>gr46</xocs:file-basename>
               <xocs:filename>gr46.sml</xocs:filename>
               <xocs:extension>sml</xocs:extension>
               <xocs:filesize>2895</xocs:filesize>
               <xocs:pixel-height>164</xocs:pixel-height>
               <xocs:pixel-width>183</xocs:pixel-width>
               <xocs:attachment-type>IMAGE-THUMBNAIL</xocs:attachment-type>
            </xocs:attachment>
            <xocs:attachment>
               <xocs:attachment-eid>1-s2.0-S022352341930371X-gr13.sml</xocs:attachment-eid>
               <xocs:ucs-locator>https://s3-eu-west-1.amazonaws.com/prod-ucs-content-store-eu-west/content/pii:S022352341930371X/gr13/THUMBNAIL/image/gif/fe82d1d169465d6cfa09b85e656eda05/gr13.sml</xocs:ucs-locator>
               <xocs:file-basename>gr13</xocs:file-basename>
               <xocs:filename>gr13.sml</xocs:filename>
               <xocs:extension>sml</xocs:extension>
               <xocs:filesize>3088</xocs:filesize>
               <xocs:pixel-height>75</xocs:pixel-height>
               <xocs:pixel-width>219</xocs:pixel-width>
               <xocs:attachment-type>IMAGE-THUMBNAIL</xocs:attachment-type>
            </xocs:attachment>
            <xocs:attachment>
               <xocs:attachment-eid>1-s2.0-S022352341930371X-gr19.sml</xocs:attachment-eid>
               <xocs:ucs-locator>https://s3-eu-west-1.amazonaws.com/prod-ucs-content-store-eu-west/content/pii:S022352341930371X/gr19/THUMBNAIL/image/gif/6ff9caa425f8fe026fbcf0cff16c92e8/gr19.sml</xocs:ucs-locator>
               <xocs:file-basename>gr19</xocs:file-basename>
               <xocs:filename>gr19.sml</xocs:filename>
               <xocs:extension>sml</xocs:extension>
               <xocs:filesize>2603</xocs:filesize>
               <xocs:pixel-height>100</xocs:pixel-height>
               <xocs:pixel-width>219</xocs:pixel-width>
               <xocs:attachment-type>IMAGE-THUMBNAIL</xocs:attachment-type>
            </xocs:attachment>
            <xocs:attachment>
               <xocs:attachment-eid>1-s2.0-S022352341930371X-gr37.sml</xocs:attachment-eid>
               <xocs:ucs-locator>https://s3-eu-west-1.amazonaws.com/prod-ucs-content-store-eu-west/content/pii:S022352341930371X/gr37/THUMBNAIL/image/gif/3b06befb47b797ac79e8a15e6f15bc25/gr37.sml</xocs:ucs-locator>
               <xocs:file-basename>gr37</xocs:file-basename>
               <xocs:filename>gr37.sml</xocs:filename>
               <xocs:extension>sml</xocs:extension>
               <xocs:filesize>14550</xocs:filesize>
               <xocs:pixel-height>164</xocs:pixel-height>
               <xocs:pixel-width>214</xocs:pixel-width>
               <xocs:attachment-type>IMAGE-THUMBNAIL</xocs:attachment-type>
            </xocs:attachment>
            <xocs:attachment>
               <xocs:attachment-eid>1-s2.0-S022352341930371X-gr1.sml</xocs:attachment-eid>
               <xocs:ucs-locator>https://s3-eu-west-1.amazonaws.com/prod-ucs-content-store-eu-west/content/pii:S022352341930371X/gr1/THUMBNAIL/image/gif/5d46cda692137cedae012fd2d4358479/gr1.sml</xocs:ucs-locator>
               <xocs:file-basename>gr1</xocs:file-basename>
               <xocs:filename>gr1.sml</xocs:filename>
               <xocs:extension>sml</xocs:extension>
               <xocs:filesize>8989</xocs:filesize>
               <xocs:pixel-height>163</xocs:pixel-height>
               <xocs:pixel-width>146</xocs:pixel-width>
               <xocs:attachment-type>IMAGE-THUMBNAIL</xocs:attachment-type>
            </xocs:attachment>
            <xocs:attachment>
               <xocs:attachment-eid>1-s2.0-S022352341930371X-gr14.sml</xocs:attachment-eid>
               <xocs:ucs-locator>https://s3-eu-west-1.amazonaws.com/prod-ucs-content-store-eu-west/content/pii:S022352341930371X/gr14/THUMBNAIL/image/gif/8edaaefff4f67ccb6996e3e9eb8f84b7/gr14.sml</xocs:ucs-locator>
               <xocs:file-basename>gr14</xocs:file-basename>
               <xocs:filename>gr14.sml</xocs:filename>
               <xocs:extension>sml</xocs:extension>
               <xocs:filesize>3208</xocs:filesize>
               <xocs:pixel-height>92</xocs:pixel-height>
               <xocs:pixel-width>219</xocs:pixel-width>
               <xocs:attachment-type>IMAGE-THUMBNAIL</xocs:attachment-type>
            </xocs:attachment>
            <xocs:attachment>
               <xocs:attachment-eid>1-s2.0-S022352341930371X-gr43.sml</xocs:attachment-eid>
               <xocs:ucs-locator>https://s3-eu-west-1.amazonaws.com/prod-ucs-content-store-eu-west/content/pii:S022352341930371X/gr43/THUMBNAIL/image/gif/a6e59e2fd1dcc34f57997f8029597395/gr43.sml</xocs:ucs-locator>
               <xocs:file-basename>gr43</xocs:file-basename>
               <xocs:filename>gr43.sml</xocs:filename>
               <xocs:extension>sml</xocs:extension>
               <xocs:filesize>2349</xocs:filesize>
               <xocs:pixel-height>123</xocs:pixel-height>
               <xocs:pixel-width>219</xocs:pixel-width>
               <xocs:attachment-type>IMAGE-THUMBNAIL</xocs:attachment-type>
            </xocs:attachment>
            <xocs:attachment>
               <xocs:attachment-eid>1-s2.0-S022352341930371X-gr20.sml</xocs:attachment-eid>
               <xocs:ucs-locator>https://s3-eu-west-1.amazonaws.com/prod-ucs-content-store-eu-west/content/pii:S022352341930371X/gr20/THUMBNAIL/image/gif/326e777766dabe8603cdfcd21d3c84e1/gr20.sml</xocs:ucs-locator>
               <xocs:file-basename>gr20</xocs:file-basename>
               <xocs:filename>gr20.sml</xocs:filename>
               <xocs:extension>sml</xocs:extension>
               <xocs:filesize>2350</xocs:filesize>
               <xocs:pixel-height>72</xocs:pixel-height>
               <xocs:pixel-width>219</xocs:pixel-width>
               <xocs:attachment-type>IMAGE-THUMBNAIL</xocs:attachment-type>
            </xocs:attachment>
            <xocs:attachment>
               <xocs:attachment-eid>1-s2.0-S022352341930371X-gr32.sml</xocs:attachment-eid>
               <xocs:ucs-locator>https://s3-eu-west-1.amazonaws.com/prod-ucs-content-store-eu-west/content/pii:S022352341930371X/gr32/THUMBNAIL/image/gif/1ad6c913933eb97781bdc04ede20167c/gr32.sml</xocs:ucs-locator>
               <xocs:file-basename>gr32</xocs:file-basename>
               <xocs:filename>gr32.sml</xocs:filename>
               <xocs:extension>sml</xocs:extension>
               <xocs:filesize>4025</xocs:filesize>
               <xocs:pixel-height>159</xocs:pixel-height>
               <xocs:pixel-width>219</xocs:pixel-width>
               <xocs:attachment-type>IMAGE-THUMBNAIL</xocs:attachment-type>
            </xocs:attachment>
            <xocs:attachment>
               <xocs:attachment-eid>1-s2.0-S022352341930371X-gr38.sml</xocs:attachment-eid>
               <xocs:ucs-locator>https://s3-eu-west-1.amazonaws.com/prod-ucs-content-store-eu-west/content/pii:S022352341930371X/gr38/THUMBNAIL/image/gif/d829600c9228bd0fe0fde64412ffdb3b/gr38.sml</xocs:ucs-locator>
               <xocs:file-basename>gr38</xocs:file-basename>
               <xocs:filename>gr38.sml</xocs:filename>
               <xocs:extension>sml</xocs:extension>
               <xocs:filesize>2756</xocs:filesize>
               <xocs:pixel-height>107</xocs:pixel-height>
               <xocs:pixel-width>219</xocs:pixel-width>
               <xocs:attachment-type>IMAGE-THUMBNAIL</xocs:attachment-type>
            </xocs:attachment>
            <xocs:attachment>
               <xocs:attachment-eid>1-s2.0-S022352341930371X-gr25.sml</xocs:attachment-eid>
               <xocs:ucs-locator>https://s3-eu-west-1.amazonaws.com/prod-ucs-content-store-eu-west/content/pii:S022352341930371X/gr25/THUMBNAIL/image/gif/2a4cf680247f7f727bc0124cd16547d3/gr25.sml</xocs:ucs-locator>
               <xocs:file-basename>gr25</xocs:file-basename>
               <xocs:filename>gr25.sml</xocs:filename>
               <xocs:extension>sml</xocs:extension>
               <xocs:filesize>15320</xocs:filesize>
               <xocs:pixel-height>145</xocs:pixel-height>
               <xocs:pixel-width>219</xocs:pixel-width>
               <xocs:attachment-type>IMAGE-THUMBNAIL</xocs:attachment-type>
            </xocs:attachment>
            <xocs:attachment>
               <xocs:attachment-eid>1-s2.0-S022352341930371X-gr26.sml</xocs:attachment-eid>
               <xocs:ucs-locator>https://s3-eu-west-1.amazonaws.com/prod-ucs-content-store-eu-west/content/pii:S022352341930371X/gr26/THUMBNAIL/image/gif/88a52dd927dd3c1f694965fb09e2e569/gr26.sml</xocs:ucs-locator>
               <xocs:file-basename>gr26</xocs:file-basename>
               <xocs:filename>gr26.sml</xocs:filename>
               <xocs:extension>sml</xocs:extension>
               <xocs:filesize>4515</xocs:filesize>
               <xocs:pixel-height>163</xocs:pixel-height>
               <xocs:pixel-width>178</xocs:pixel-width>
               <xocs:attachment-type>IMAGE-THUMBNAIL</xocs:attachment-type>
            </xocs:attachment>
            <xocs:attachment>
               <xocs:attachment-eid>1-s2.0-S022352341930371X-gr41.sml</xocs:attachment-eid>
               <xocs:ucs-locator>https://s3-eu-west-1.amazonaws.com/prod-ucs-content-store-eu-west/content/pii:S022352341930371X/gr41/THUMBNAIL/image/gif/33faf3c721c7d7c9f23a2f7dc2163f1b/gr41.sml</xocs:ucs-locator>
               <xocs:file-basename>gr41</xocs:file-basename>
               <xocs:filename>gr41.sml</xocs:filename>
               <xocs:extension>sml</xocs:extension>
               <xocs:filesize>2589</xocs:filesize>
               <xocs:pixel-height>122</xocs:pixel-height>
               <xocs:pixel-width>219</xocs:pixel-width>
               <xocs:attachment-type>IMAGE-THUMBNAIL</xocs:attachment-type>
            </xocs:attachment>
            <xocs:attachment>
               <xocs:attachment-eid>1-s2.0-S022352341930371X-gr42.sml</xocs:attachment-eid>
               <xocs:ucs-locator>https://s3-eu-west-1.amazonaws.com/prod-ucs-content-store-eu-west/content/pii:S022352341930371X/gr42/THUMBNAIL/image/gif/225c17952d2e15996a44381c73cef029/gr42.sml</xocs:ucs-locator>
               <xocs:file-basename>gr42</xocs:file-basename>
               <xocs:filename>gr42.sml</xocs:filename>
               <xocs:extension>sml</xocs:extension>
               <xocs:filesize>14297</xocs:filesize>
               <xocs:pixel-height>144</xocs:pixel-height>
               <xocs:pixel-width>219</xocs:pixel-width>
               <xocs:attachment-type>IMAGE-THUMBNAIL</xocs:attachment-type>
            </xocs:attachment>
            <xocs:attachment>
               <xocs:attachment-eid>1-s2.0-S022352341930371X-gr47.sml</xocs:attachment-eid>
               <xocs:ucs-locator>https://s3-eu-west-1.amazonaws.com/prod-ucs-content-store-eu-west/content/pii:S022352341930371X/gr47/THUMBNAIL/image/gif/285d5f40a445d8f246dcfc06b01ee140/gr47.sml</xocs:ucs-locator>
               <xocs:file-basename>gr47</xocs:file-basename>
               <xocs:filename>gr47.sml</xocs:filename>
               <xocs:extension>sml</xocs:extension>
               <xocs:filesize>3200</xocs:filesize>
               <xocs:pixel-height>86</xocs:pixel-height>
               <xocs:pixel-width>219</xocs:pixel-width>
               <xocs:attachment-type>IMAGE-THUMBNAIL</xocs:attachment-type>
            </xocs:attachment>
            <xocs:attachment>
               <xocs:attachment-eid>1-s2.0-S022352341930371X-gr27.sml</xocs:attachment-eid>
               <xocs:ucs-locator>https://s3-eu-west-1.amazonaws.com/prod-ucs-content-store-eu-west/content/pii:S022352341930371X/gr27/THUMBNAIL/image/gif/2167365b0ece9b67728c3ec7f354f355/gr27.sml</xocs:ucs-locator>
               <xocs:file-basename>gr27</xocs:file-basename>
               <xocs:filename>gr27.sml</xocs:filename>
               <xocs:extension>sml</xocs:extension>
               <xocs:filesize>2259</xocs:filesize>
               <xocs:pixel-height>74</xocs:pixel-height>
               <xocs:pixel-width>219</xocs:pixel-width>
               <xocs:attachment-type>IMAGE-THUMBNAIL</xocs:attachment-type>
            </xocs:attachment>
            <xocs:attachment>
               <xocs:attachment-eid>1-s2.0-S022352341930371X-fx1.sml</xocs:attachment-eid>
               <xocs:ucs-locator>https://s3-eu-west-1.amazonaws.com/prod-ucs-content-store-eu-west/content/pii:S022352341930371X/fx1/THUMBNAIL/image/gif/676b65194f8d1e04a953231a9bb79b44/fx1.sml</xocs:ucs-locator>
               <xocs:file-basename>fx1</xocs:file-basename>
               <xocs:abstract-attachment>true</xocs:abstract-attachment>
               <xocs:filename>fx1.sml</xocs:filename>
               <xocs:extension>sml</xocs:extension>
               <xocs:filesize>5834</xocs:filesize>
               <xocs:pixel-height>95</xocs:pixel-height>
               <xocs:pixel-width>219</xocs:pixel-width>
               <xocs:attachment-type>IMAGE-THUMBNAIL</xocs:attachment-type>
            </xocs:attachment>
            <xocs:attachment>
               <xocs:attachment-eid>1-s2.0-S022352341930371X-gr7.sml</xocs:attachment-eid>
               <xocs:ucs-locator>https://s3-eu-west-1.amazonaws.com/prod-ucs-content-store-eu-west/content/pii:S022352341930371X/gr7/THUMBNAIL/image/gif/031a14baba0fca322a8c2de524977402/gr7.sml</xocs:ucs-locator>
               <xocs:file-basename>gr7</xocs:file-basename>
               <xocs:filename>gr7.sml</xocs:filename>
               <xocs:extension>sml</xocs:extension>
               <xocs:filesize>3772</xocs:filesize>
               <xocs:pixel-height>164</xocs:pixel-height>
               <xocs:pixel-width>207</xocs:pixel-width>
               <xocs:attachment-type>IMAGE-THUMBNAIL</xocs:attachment-type>
            </xocs:attachment>
            <xocs:attachment>
               <xocs:attachment-eid>1-s2.0-S022352341930371X-gr16.sml</xocs:attachment-eid>
               <xocs:ucs-locator>https://s3-eu-west-1.amazonaws.com/prod-ucs-content-store-eu-west/content/pii:S022352341930371X/gr16/THUMBNAIL/image/gif/97dbc1a8b5b3426c4812f4f21a1255ed/gr16.sml</xocs:ucs-locator>
               <xocs:file-basename>gr16</xocs:file-basename>
               <xocs:filename>gr16.sml</xocs:filename>
               <xocs:extension>sml</xocs:extension>
               <xocs:filesize>2264</xocs:filesize>
               <xocs:pixel-height>61</xocs:pixel-height>
               <xocs:pixel-width>219</xocs:pixel-width>
               <xocs:attachment-type>IMAGE-THUMBNAIL</xocs:attachment-type>
            </xocs:attachment>
            <xocs:attachment>
               <xocs:attachment-eid>1-s2.0-S022352341930371X-gr3.sml</xocs:attachment-eid>
               <xocs:ucs-locator>https://s3-eu-west-1.amazonaws.com/prod-ucs-content-store-eu-west/content/pii:S022352341930371X/gr3/THUMBNAIL/image/gif/9a5824062fd9360d77d19406c689ea5e/gr3.sml</xocs:ucs-locator>
               <xocs:file-basename>gr3</xocs:file-basename>
               <xocs:filename>gr3.sml</xocs:filename>
               <xocs:extension>sml</xocs:extension>
               <xocs:filesize>2478</xocs:filesize>
               <xocs:pixel-height>72</xocs:pixel-height>
               <xocs:pixel-width>219</xocs:pixel-width>
               <xocs:attachment-type>IMAGE-THUMBNAIL</xocs:attachment-type>
            </xocs:attachment>
            <xocs:attachment>
               <xocs:attachment-eid>1-s2.0-S022352341930371X-gr12.sml</xocs:attachment-eid>
               <xocs:ucs-locator>https://s3-eu-west-1.amazonaws.com/prod-ucs-content-store-eu-west/content/pii:S022352341930371X/gr12/THUMBNAIL/image/gif/dcfed66d44e7f41b57e31967f32bdcb0/gr12.sml</xocs:ucs-locator>
               <xocs:file-basename>gr12</xocs:file-basename>
               <xocs:filename>gr12.sml</xocs:filename>
               <xocs:extension>sml</xocs:extension>
               <xocs:filesize>3131</xocs:filesize>
               <xocs:pixel-height>76</xocs:pixel-height>
               <xocs:pixel-width>219</xocs:pixel-width>
               <xocs:attachment-type>IMAGE-THUMBNAIL</xocs:attachment-type>
            </xocs:attachment>
            <xocs:attachment>
               <xocs:attachment-eid>1-s2.0-S022352341930371X-gr28.sml</xocs:attachment-eid>
               <xocs:ucs-locator>https://s3-eu-west-1.amazonaws.com/prod-ucs-content-store-eu-west/content/pii:S022352341930371X/gr28/THUMBNAIL/image/gif/b414f87e04a32070cb2168c5fe3d5f50/gr28.sml</xocs:ucs-locator>
               <xocs:file-basename>gr28</xocs:file-basename>
               <xocs:filename>gr28.sml</xocs:filename>
               <xocs:extension>sml</xocs:extension>
               <xocs:filesize>2194</xocs:filesize>
               <xocs:pixel-height>60</xocs:pixel-height>
               <xocs:pixel-width>219</xocs:pixel-width>
               <xocs:attachment-type>IMAGE-THUMBNAIL</xocs:attachment-type>
            </xocs:attachment>
            <xocs:attachment>
               <xocs:attachment-eid>1-s2.0-S022352341930371X-gr4.sml</xocs:attachment-eid>
               <xocs:ucs-locator>https://s3-eu-west-1.amazonaws.com/prod-ucs-content-store-eu-west/content/pii:S022352341930371X/gr4/THUMBNAIL/image/gif/b79ae69388ad42e050235299dfa4454c/gr4.sml</xocs:ucs-locator>
               <xocs:file-basename>gr4</xocs:file-basename>
               <xocs:filename>gr4.sml</xocs:filename>
               <xocs:extension>sml</xocs:extension>
               <xocs:filesize>2735</xocs:filesize>
               <xocs:pixel-height>47</xocs:pixel-height>
               <xocs:pixel-width>219</xocs:pixel-width>
               <xocs:attachment-type>IMAGE-THUMBNAIL</xocs:attachment-type>
            </xocs:attachment>
            <xocs:attachment>
               <xocs:attachment-eid>1-s2.0-S022352341930371X-gr18.sml</xocs:attachment-eid>
               <xocs:ucs-locator>https://s3-eu-west-1.amazonaws.com/prod-ucs-content-store-eu-west/content/pii:S022352341930371X/gr18/THUMBNAIL/image/gif/db3c3572f1235b83631461af6b51b400/gr18.sml</xocs:ucs-locator>
               <xocs:file-basename>gr18</xocs:file-basename>
               <xocs:filename>gr18.sml</xocs:filename>
               <xocs:extension>sml</xocs:extension>
               <xocs:filesize>2335</xocs:filesize>
               <xocs:pixel-height>78</xocs:pixel-height>
               <xocs:pixel-width>219</xocs:pixel-width>
               <xocs:attachment-type>IMAGE-THUMBNAIL</xocs:attachment-type>
            </xocs:attachment>
            <xocs:attachment>
               <xocs:attachment-eid>1-s2.0-S022352341930371X-gr40.sml</xocs:attachment-eid>
               <xocs:ucs-locator>https://s3-eu-west-1.amazonaws.com/prod-ucs-content-store-eu-west/content/pii:S022352341930371X/gr40/THUMBNAIL/image/gif/b094dcde0bfaf0dba920625af3098cbf/gr40.sml</xocs:ucs-locator>
               <xocs:file-basename>gr40</xocs:file-basename>
               <xocs:filename>gr40.sml</xocs:filename>
               <xocs:extension>sml</xocs:extension>
               <xocs:filesize>2570</xocs:filesize>
               <xocs:pixel-height>151</xocs:pixel-height>
               <xocs:pixel-width>219</xocs:pixel-width>
               <xocs:attachment-type>IMAGE-THUMBNAIL</xocs:attachment-type>
            </xocs:attachment>
            <xocs:attachment>
               <xocs:attachment-eid>1-s2.0-S022352341930371X-gr10.sml</xocs:attachment-eid>
               <xocs:ucs-locator>https://s3-eu-west-1.amazonaws.com/prod-ucs-content-store-eu-west/content/pii:S022352341930371X/gr10/THUMBNAIL/image/gif/1477ec3d2b29bf519051a54ef57b7eef/gr10.sml</xocs:ucs-locator>
               <xocs:file-basename>gr10</xocs:file-basename>
               <xocs:filename>gr10.sml</xocs:filename>
               <xocs:extension>sml</xocs:extension>
               <xocs:filesize>2659</xocs:filesize>
               <xocs:pixel-height>85</xocs:pixel-height>
               <xocs:pixel-width>219</xocs:pixel-width>
               <xocs:attachment-type>IMAGE-THUMBNAIL</xocs:attachment-type>
            </xocs:attachment>
            <xocs:attachment>
               <xocs:attachment-eid>1-s2.0-S022352341930371X-gr44.sml</xocs:attachment-eid>
               <xocs:ucs-locator>https://s3-eu-west-1.amazonaws.com/prod-ucs-content-store-eu-west/content/pii:S022352341930371X/gr44/THUMBNAIL/image/gif/296a99ce8df88e770ec2f3d0e72ba9ef/gr44.sml</xocs:ucs-locator>
               <xocs:file-basename>gr44</xocs:file-basename>
               <xocs:filename>gr44.sml</xocs:filename>
               <xocs:extension>sml</xocs:extension>
               <xocs:filesize>2090</xocs:filesize>
               <xocs:pixel-height>102</xocs:pixel-height>
               <xocs:pixel-width>219</xocs:pixel-width>
               <xocs:attachment-type>IMAGE-THUMBNAIL</xocs:attachment-type>
            </xocs:attachment>
            <xocs:attachment>
               <xocs:attachment-eid>1-s2.0-S022352341930371X-gr36.sml</xocs:attachment-eid>
               <xocs:ucs-locator>https://s3-eu-west-1.amazonaws.com/prod-ucs-content-store-eu-west/content/pii:S022352341930371X/gr36/THUMBNAIL/image/gif/5da458dd6977fbcacec243a78e264edd/gr36.sml</xocs:ucs-locator>
               <xocs:file-basename>gr36</xocs:file-basename>
               <xocs:filename>gr36.sml</xocs:filename>
               <xocs:extension>sml</xocs:extension>
               <xocs:filesize>2800</xocs:filesize>
               <xocs:pixel-height>135</xocs:pixel-height>
               <xocs:pixel-width>219</xocs:pixel-width>
               <xocs:attachment-type>IMAGE-THUMBNAIL</xocs:attachment-type>
            </xocs:attachment>
            <xocs:attachment>
               <xocs:attachment-eid>1-s2.0-S022352341930371X-gr39.sml</xocs:attachment-eid>
               <xocs:ucs-locator>https://s3-eu-west-1.amazonaws.com/prod-ucs-content-store-eu-west/content/pii:S022352341930371X/gr39/THUMBNAIL/image/gif/0a691cb4b172157a8ceb648902dfc837/gr39.sml</xocs:ucs-locator>
               <xocs:file-basename>gr39</xocs:file-basename>
               <xocs:filename>gr39.sml</xocs:filename>
               <xocs:extension>sml</xocs:extension>
               <xocs:filesize>2509</xocs:filesize>
               <xocs:pixel-height>164</xocs:pixel-height>
               <xocs:pixel-width>128</xocs:pixel-width>
               <xocs:attachment-type>IMAGE-THUMBNAIL</xocs:attachment-type>
            </xocs:attachment>
            <xocs:attachment>
               <xocs:attachment-eid>1-s2.0-S022352341930371X-gr15.sml</xocs:attachment-eid>
               <xocs:ucs-locator>https://s3-eu-west-1.amazonaws.com/prod-ucs-content-store-eu-west/content/pii:S022352341930371X/gr15/THUMBNAIL/image/gif/fc4adb104247229feb9881b192f20f4b/gr15.sml</xocs:ucs-locator>
               <xocs:file-basename>gr15</xocs:file-basename>
               <xocs:filename>gr15.sml</xocs:filename>
               <xocs:extension>sml</xocs:extension>
               <xocs:filesize>3548</xocs:filesize>
               <xocs:pixel-height>134</xocs:pixel-height>
               <xocs:pixel-width>219</xocs:pixel-width>
               <xocs:attachment-type>IMAGE-THUMBNAIL</xocs:attachment-type>
            </xocs:attachment>
            <xocs:attachment>
               <xocs:attachment-eid>1-s2.0-S022352341930371X-gr34.sml</xocs:attachment-eid>
               <xocs:ucs-locator>https://s3-eu-west-1.amazonaws.com/prod-ucs-content-store-eu-west/content/pii:S022352341930371X/gr34/THUMBNAIL/image/gif/13c3f9873669191b62cf84288ace3f13/gr34.sml</xocs:ucs-locator>
               <xocs:file-basename>gr34</xocs:file-basename>
               <xocs:filename>gr34.sml</xocs:filename>
               <xocs:extension>sml</xocs:extension>
               <xocs:filesize>2278</xocs:filesize>
               <xocs:pixel-height>111</xocs:pixel-height>
               <xocs:pixel-width>219</xocs:pixel-width>
               <xocs:attachment-type>IMAGE-THUMBNAIL</xocs:attachment-type>
            </xocs:attachment>
            <xocs:attachment>
               <xocs:attachment-eid>1-s2.0-S022352341930371X-gr8.sml</xocs:attachment-eid>
               <xocs:ucs-locator>https://s3-eu-west-1.amazonaws.com/prod-ucs-content-store-eu-west/content/pii:S022352341930371X/gr8/THUMBNAIL/image/gif/e1c835f50e358b3927b3178cd699c611/gr8.sml</xocs:ucs-locator>
               <xocs:file-basename>gr8</xocs:file-basename>
               <xocs:filename>gr8.sml</xocs:filename>
               <xocs:extension>sml</xocs:extension>
               <xocs:filesize>9245</xocs:filesize>
               <xocs:pixel-height>163</xocs:pixel-height>
               <xocs:pixel-width>83</xocs:pixel-width>
               <xocs:attachment-type>IMAGE-THUMBNAIL</xocs:attachment-type>
            </xocs:attachment>
            <xocs:attachment>
               <xocs:attachment-eid>1-s2.0-S022352341930371X-gr17.sml</xocs:attachment-eid>
               <xocs:ucs-locator>https://s3-eu-west-1.amazonaws.com/prod-ucs-content-store-eu-west/content/pii:S022352341930371X/gr17/THUMBNAIL/image/gif/c3908f5566e1bd179289c2470f5be433/gr17.sml</xocs:ucs-locator>
               <xocs:file-basename>gr17</xocs:file-basename>
               <xocs:filename>gr17.sml</xocs:filename>
               <xocs:extension>sml</xocs:extension>
               <xocs:filesize>2859</xocs:filesize>
               <xocs:pixel-height>107</xocs:pixel-height>
               <xocs:pixel-width>219</xocs:pixel-width>
               <xocs:attachment-type>IMAGE-THUMBNAIL</xocs:attachment-type>
            </xocs:attachment>
            <xocs:attachment>
               <xocs:attachment-eid>1-s2.0-S022352341930371X-gr22.sml</xocs:attachment-eid>
               <xocs:ucs-locator>https://s3-eu-west-1.amazonaws.com/prod-ucs-content-store-eu-west/content/pii:S022352341930371X/gr22/THUMBNAIL/image/gif/709378093666f1c45d414e24ef7f8f10/gr22.sml</xocs:ucs-locator>
               <xocs:file-basename>gr22</xocs:file-basename>
               <xocs:filename>gr22.sml</xocs:filename>
               <xocs:extension>sml</xocs:extension>
               <xocs:filesize>2551</xocs:filesize>
               <xocs:pixel-height>81</xocs:pixel-height>
               <xocs:pixel-width>219</xocs:pixel-width>
               <xocs:attachment-type>IMAGE-THUMBNAIL</xocs:attachment-type>
            </xocs:attachment>
            <xocs:attachment>
               <xocs:attachment-eid>1-s2.0-S022352341930371X-gr23.sml</xocs:attachment-eid>
               <xocs:ucs-locator>https://s3-eu-west-1.amazonaws.com/prod-ucs-content-store-eu-west/content/pii:S022352341930371X/gr23/THUMBNAIL/image/gif/9533de0932ce95ee10d89d5fea8e73c0/gr23.sml</xocs:ucs-locator>
               <xocs:file-basename>gr23</xocs:file-basename>
               <xocs:filename>gr23.sml</xocs:filename>
               <xocs:extension>sml</xocs:extension>
               <xocs:filesize>3010</xocs:filesize>
               <xocs:pixel-height>73</xocs:pixel-height>
               <xocs:pixel-width>219</xocs:pixel-width>
               <xocs:attachment-type>IMAGE-THUMBNAIL</xocs:attachment-type>
            </xocs:attachment>
            <xocs:attachment>
               <xocs:attachment-eid>1-s2.0-S022352341930371X-gr11.sml</xocs:attachment-eid>
               <xocs:ucs-locator>https://s3-eu-west-1.amazonaws.com/prod-ucs-content-store-eu-west/content/pii:S022352341930371X/gr11/THUMBNAIL/image/gif/e3dfd4ba59109fec8c3072d7a4bc5fa7/gr11.sml</xocs:ucs-locator>
               <xocs:file-basename>gr11</xocs:file-basename>
               <xocs:filename>gr11.sml</xocs:filename>
               <xocs:extension>sml</xocs:extension>
               <xocs:filesize>3371</xocs:filesize>
               <xocs:pixel-height>118</xocs:pixel-height>
               <xocs:pixel-width>219</xocs:pixel-width>
               <xocs:attachment-type>IMAGE-THUMBNAIL</xocs:attachment-type>
            </xocs:attachment>
            <xocs:attachment>
               <xocs:attachment-eid>1-s2.0-S022352341930371X-gr24.sml</xocs:attachment-eid>
               <xocs:ucs-locator>https://s3-eu-west-1.amazonaws.com/prod-ucs-content-store-eu-west/content/pii:S022352341930371X/gr24/THUMBNAIL/image/gif/14402f76632a6c92200ddc1f2fc94238/gr24.sml</xocs:ucs-locator>
               <xocs:file-basename>gr24</xocs:file-basename>
               <xocs:filename>gr24.sml</xocs:filename>
               <xocs:extension>sml</xocs:extension>
               <xocs:filesize>3862</xocs:filesize>
               <xocs:pixel-height>144</xocs:pixel-height>
               <xocs:pixel-width>219</xocs:pixel-width>
               <xocs:attachment-type>IMAGE-THUMBNAIL</xocs:attachment-type>
            </xocs:attachment>
            <xocs:attachment>
               <xocs:attachment-eid>1-s2.0-S022352341930371X-gr21.sml</xocs:attachment-eid>
               <xocs:ucs-locator>https://s3-eu-west-1.amazonaws.com/prod-ucs-content-store-eu-west/content/pii:S022352341930371X/gr21/THUMBNAIL/image/gif/1661ca7133a24f68a58106e84920e541/gr21.sml</xocs:ucs-locator>
               <xocs:file-basename>gr21</xocs:file-basename>
               <xocs:filename>gr21.sml</xocs:filename>
               <xocs:extension>sml</xocs:extension>
               <xocs:filesize>2631</xocs:filesize>
               <xocs:pixel-height>66</xocs:pixel-height>
               <xocs:pixel-width>219</xocs:pixel-width>
               <xocs:attachment-type>IMAGE-THUMBNAIL</xocs:attachment-type>
            </xocs:attachment>
            <xocs:attachment>
               <xocs:attachment-eid>1-s2.0-S022352341930371X-gr5.sml</xocs:attachment-eid>
               <xocs:ucs-locator>https://s3-eu-west-1.amazonaws.com/prod-ucs-content-store-eu-west/content/pii:S022352341930371X/gr5/THUMBNAIL/image/gif/8739e1fe403bebb2e1b2946abbe505bf/gr5.sml</xocs:ucs-locator>
               <xocs:file-basename>gr5</xocs:file-basename>
               <xocs:filename>gr5.sml</xocs:filename>
               <xocs:extension>sml</xocs:extension>
               <xocs:filesize>2710</xocs:filesize>
               <xocs:pixel-height>65</xocs:pixel-height>
               <xocs:pixel-width>219</xocs:pixel-width>
               <xocs:attachment-type>IMAGE-THUMBNAIL</xocs:attachment-type>
            </xocs:attachment>
            <xocs:attachment>
               <xocs:attachment-eid>1-s2.0-S022352341930371X-gr31.sml</xocs:attachment-eid>
               <xocs:ucs-locator>https://s3-eu-west-1.amazonaws.com/prod-ucs-content-store-eu-west/content/pii:S022352341930371X/gr31/THUMBNAIL/image/gif/9537f60c96e6c8b3a55bfb821133026c/gr31.sml</xocs:ucs-locator>
               <xocs:file-basename>gr31</xocs:file-basename>
               <xocs:filename>gr31.sml</xocs:filename>
               <xocs:extension>sml</xocs:extension>
               <xocs:filesize>2797</xocs:filesize>
               <xocs:pixel-height>118</xocs:pixel-height>
               <xocs:pixel-width>219</xocs:pixel-width>
               <xocs:attachment-type>IMAGE-THUMBNAIL</xocs:attachment-type>
            </xocs:attachment>
            <xocs:attachment>
               <xocs:attachment-eid>1-s2.0-S022352341930371X-gr35.sml</xocs:attachment-eid>
               <xocs:ucs-locator>https://s3-eu-west-1.amazonaws.com/prod-ucs-content-store-eu-west/content/pii:S022352341930371X/gr35/THUMBNAIL/image/gif/789330f03778b0c706e5cdc37571232b/gr35.sml</xocs:ucs-locator>
               <xocs:file-basename>gr35</xocs:file-basename>
               <xocs:filename>gr35.sml</xocs:filename>
               <xocs:extension>sml</xocs:extension>
               <xocs:filesize>2476</xocs:filesize>
               <xocs:pixel-height>60</xocs:pixel-height>
               <xocs:pixel-width>219</xocs:pixel-width>
               <xocs:attachment-type>IMAGE-THUMBNAIL</xocs:attachment-type>
            </xocs:attachment>
            <xocs:attachment>
               <xocs:attachment-eid>1-s2.0-S022352341930371X-gr6_lrg.jpg</xocs:attachment-eid>
               <xocs:ucs-locator>https://s3-eu-west-1.amazonaws.com/prod-ucs-content-store-eu-west/content/pii:S022352341930371X/gr6/HIGHRES/image/jpeg/8464522f78e18816b3e4c46cd66e28f3/gr6_lrg.jpg</xocs:ucs-locator>
               <xocs:file-basename>gr6</xocs:file-basename>
               <xocs:filename>gr6_lrg.jpg</xocs:filename>
               <xocs:extension>jpg</xocs:extension>
               <xocs:filesize>83857</xocs:filesize>
               <xocs:pixel-height>615</xocs:pixel-height>
               <xocs:pixel-width>1673</xocs:pixel-width>
               <xocs:attachment-type>IMAGE-HIGH-RES</xocs:attachment-type>
            </xocs:attachment>
            <xocs:attachment>
               <xocs:attachment-eid>1-s2.0-S022352341930371X-gr33_lrg.jpg</xocs:attachment-eid>
               <xocs:ucs-locator>https://s3-eu-west-1.amazonaws.com/prod-ucs-content-store-eu-west/content/pii:S022352341930371X/gr33/HIGHRES/image/jpeg/06ee0da88343636d23dff166a921c726/gr33_lrg.jpg</xocs:ucs-locator>
               <xocs:file-basename>gr33</xocs:file-basename>
               <xocs:filename>gr33_lrg.jpg</xocs:filename>
               <xocs:extension>jpg</xocs:extension>
               <xocs:filesize>37621</xocs:filesize>
               <xocs:pixel-height>537</xocs:pixel-height>
               <xocs:pixel-width>986</xocs:pixel-width>
               <xocs:attachment-type>IMAGE-HIGH-RES</xocs:attachment-type>
            </xocs:attachment>
            <xocs:attachment>
               <xocs:attachment-eid>1-s2.0-S022352341930371X-gr45_lrg.jpg</xocs:attachment-eid>
               <xocs:ucs-locator>https://s3-eu-west-1.amazonaws.com/prod-ucs-content-store-eu-west/content/pii:S022352341930371X/gr45/HIGHRES/image/jpeg/120443c9b3ce48a8efda1709281a5612/gr45_lrg.jpg</xocs:ucs-locator>
               <xocs:file-basename>gr45</xocs:file-basename>
               <xocs:filename>gr45_lrg.jpg</xocs:filename>
               <xocs:extension>jpg</xocs:extension>
               <xocs:filesize>51057</xocs:filesize>
               <xocs:pixel-height>984</xocs:pixel-height>
               <xocs:pixel-width>792</xocs:pixel-width>
               <xocs:attachment-type>IMAGE-HIGH-RES</xocs:attachment-type>
            </xocs:attachment>
            <xocs:attachment>
               <xocs:attachment-eid>1-s2.0-S022352341930371X-gr30_lrg.jpg</xocs:attachment-eid>
               <xocs:ucs-locator>https://s3-eu-west-1.amazonaws.com/prod-ucs-content-store-eu-west/content/pii:S022352341930371X/gr30/HIGHRES/image/jpeg/88ec732b389405d3a297f6b3cdc75127/gr30_lrg.jpg</xocs:ucs-locator>
               <xocs:file-basename>gr30</xocs:file-basename>
               <xocs:filename>gr30_lrg.jpg</xocs:filename>
               <xocs:extension>jpg</xocs:extension>
               <xocs:filesize>114436</xocs:filesize>
               <xocs:pixel-height>480</xocs:pixel-height>
               <xocs:pixel-width>2757</xocs:pixel-width>
               <xocs:attachment-type>IMAGE-HIGH-RES</xocs:attachment-type>
            </xocs:attachment>
            <xocs:attachment>
               <xocs:attachment-eid>1-s2.0-S022352341930371X-gr9_lrg.jpg</xocs:attachment-eid>
               <xocs:ucs-locator>https://s3-eu-west-1.amazonaws.com/prod-ucs-content-store-eu-west/content/pii:S022352341930371X/gr9/HIGHRES/image/jpeg/4ec798e7770770ca1d03f82a0e8ec6a8/gr9_lrg.jpg</xocs:ucs-locator>
               <xocs:file-basename>gr9</xocs:file-basename>
               <xocs:filename>gr9_lrg.jpg</xocs:filename>
               <xocs:extension>jpg</xocs:extension>
               <xocs:filesize>282177</xocs:filesize>
               <xocs:pixel-height>1369</xocs:pixel-height>
               <xocs:pixel-width>2657</xocs:pixel-width>
               <xocs:attachment-type>IMAGE-HIGH-RES</xocs:attachment-type>
            </xocs:attachment>
            <xocs:attachment>
               <xocs:attachment-eid>1-s2.0-S022352341930371X-gr2_lrg.jpg</xocs:attachment-eid>
               <xocs:ucs-locator>https://s3-eu-west-1.amazonaws.com/prod-ucs-content-store-eu-west/content/pii:S022352341930371X/gr2/HIGHRES/image/jpeg/394e97974689e254a1403f4808e7ab43/gr2_lrg.jpg</xocs:ucs-locator>
               <xocs:file-basename>gr2</xocs:file-basename>
               <xocs:filename>gr2_lrg.jpg</xocs:filename>
               <xocs:extension>jpg</xocs:extension>
               <xocs:filesize>103184</xocs:filesize>
               <xocs:pixel-height>827</xocs:pixel-height>
               <xocs:pixel-width>2267</xocs:pixel-width>
               <xocs:attachment-type>IMAGE-HIGH-RES</xocs:attachment-type>
            </xocs:attachment>
            <xocs:attachment>
               <xocs:attachment-eid>1-s2.0-S022352341930371X-gr29_lrg.jpg</xocs:attachment-eid>
               <xocs:ucs-locator>https://s3-eu-west-1.amazonaws.com/prod-ucs-content-store-eu-west/content/pii:S022352341930371X/gr29/HIGHRES/image/jpeg/d9551495ce09e2a935225b9aff1afe53/gr29_lrg.jpg</xocs:ucs-locator>
               <xocs:file-basename>gr29</xocs:file-basename>
               <xocs:filename>gr29_lrg.jpg</xocs:filename>
               <xocs:extension>jpg</xocs:extension>
               <xocs:filesize>118310</xocs:filesize>
               <xocs:pixel-height>914</xocs:pixel-height>
               <xocs:pixel-width>2265</xocs:pixel-width>
               <xocs:attachment-type>IMAGE-HIGH-RES</xocs:attachment-type>
            </xocs:attachment>
            <xocs:attachment>
               <xocs:attachment-eid>1-s2.0-S022352341930371X-gr46_lrg.jpg</xocs:attachment-eid>
               <xocs:ucs-locator>https://s3-eu-west-1.amazonaws.com/prod-ucs-content-store-eu-west/content/pii:S022352341930371X/gr46/HIGHRES/image/jpeg/cb4ef4355898ed9406610fffecc67dd8/gr46_lrg.jpg</xocs:ucs-locator>
               <xocs:file-basename>gr46</xocs:file-basename>
               <xocs:filename>gr46_lrg.jpg</xocs:filename>
               <xocs:extension>jpg</xocs:extension>
               <xocs:filesize>42709</xocs:filesize>
               <xocs:pixel-height>708</xocs:pixel-height>
               <xocs:pixel-width>789</xocs:pixel-width>
               <xocs:attachment-type>IMAGE-HIGH-RES</xocs:attachment-type>
            </xocs:attachment>
            <xocs:attachment>
               <xocs:attachment-eid>1-s2.0-S022352341930371X-gr13_lrg.jpg</xocs:attachment-eid>
               <xocs:ucs-locator>https://s3-eu-west-1.amazonaws.com/prod-ucs-content-store-eu-west/content/pii:S022352341930371X/gr13/HIGHRES/image/jpeg/8c96f9c88f5ff91c60080706558b9bf3/gr13_lrg.jpg</xocs:ucs-locator>
               <xocs:file-basename>gr13</xocs:file-basename>
               <xocs:filename>gr13_lrg.jpg</xocs:filename>
               <xocs:extension>jpg</xocs:extension>
               <xocs:filesize>159043</xocs:filesize>
               <xocs:pixel-height>779</xocs:pixel-height>
               <xocs:pixel-width>2264</xocs:pixel-width>
               <xocs:attachment-type>IMAGE-HIGH-RES</xocs:attachment-type>
            </xocs:attachment>
            <xocs:attachment>
               <xocs:attachment-eid>1-s2.0-S022352341930371X-gr19_lrg.jpg</xocs:attachment-eid>
               <xocs:ucs-locator>https://s3-eu-west-1.amazonaws.com/prod-ucs-content-store-eu-west/content/pii:S022352341930371X/gr19/HIGHRES/image/jpeg/ae92bfbe378dc0e6a52d6864e0caa35d/gr19_lrg.jpg</xocs:ucs-locator>
               <xocs:file-basename>gr19</xocs:file-basename>
               <xocs:filename>gr19_lrg.jpg</xocs:filename>
               <xocs:extension>jpg</xocs:extension>
               <xocs:filesize>135023</xocs:filesize>
               <xocs:pixel-height>1034</xocs:pixel-height>
               <xocs:pixel-width>2266</xocs:pixel-width>
               <xocs:attachment-type>IMAGE-HIGH-RES</xocs:attachment-type>
            </xocs:attachment>
            <xocs:attachment>
               <xocs:attachment-eid>1-s2.0-S022352341930371X-gr37_lrg.jpg</xocs:attachment-eid>
               <xocs:ucs-locator>https://s3-eu-west-1.amazonaws.com/prod-ucs-content-store-eu-west/content/pii:S022352341930371X/gr37/HIGHRES/image/jpeg/151272b08e1a894b3e00326d93b46e4c/gr37_lrg.jpg</xocs:ucs-locator>
               <xocs:file-basename>gr37</xocs:file-basename>
               <xocs:filename>gr37_lrg.jpg</xocs:filename>
               <xocs:extension>jpg</xocs:extension>
               <xocs:filesize>481839</xocs:filesize>
               <xocs:pixel-height>1743</xocs:pixel-height>
               <xocs:pixel-width>2272</xocs:pixel-width>
               <xocs:attachment-type>IMAGE-HIGH-RES</xocs:attachment-type>
            </xocs:attachment>
            <xocs:attachment>
               <xocs:attachment-eid>1-s2.0-S022352341930371X-gr1_lrg.jpg</xocs:attachment-eid>
               <xocs:ucs-locator>https://s3-eu-west-1.amazonaws.com/prod-ucs-content-store-eu-west/content/pii:S022352341930371X/gr1/HIGHRES/image/jpeg/ff5a8b18f2e0e342e4efd608d93a1404/gr1_lrg.jpg</xocs:ucs-locator>
               <xocs:file-basename>gr1</xocs:file-basename>
               <xocs:filename>gr1_lrg.jpg</xocs:filename>
               <xocs:extension>jpg</xocs:extension>
               <xocs:filesize>656724</xocs:filesize>
               <xocs:pixel-height>2544</xocs:pixel-height>
               <xocs:pixel-width>2272</xocs:pixel-width>
               <xocs:attachment-type>IMAGE-HIGH-RES</xocs:attachment-type>
            </xocs:attachment>
            <xocs:attachment>
               <xocs:attachment-eid>1-s2.0-S022352341930371X-gr14_lrg.jpg</xocs:attachment-eid>
               <xocs:ucs-locator>https://s3-eu-west-1.amazonaws.com/prod-ucs-content-store-eu-west/content/pii:S022352341930371X/gr14/HIGHRES/image/jpeg/1ec9739b68e37b07c157407f10c44f4e/gr14_lrg.jpg</xocs:ucs-locator>
               <xocs:file-basename>gr14</xocs:file-basename>
               <xocs:filename>gr14_lrg.jpg</xocs:filename>
               <xocs:extension>jpg</xocs:extension>
               <xocs:filesize>175368</xocs:filesize>
               <xocs:pixel-height>946</xocs:pixel-height>
               <xocs:pixel-width>2264</xocs:pixel-width>
               <xocs:attachment-type>IMAGE-HIGH-RES</xocs:attachment-type>
            </xocs:attachment>
            <xocs:attachment>
               <xocs:attachment-eid>1-s2.0-S022352341930371X-gr43_lrg.jpg</xocs:attachment-eid>
               <xocs:ucs-locator>https://s3-eu-west-1.amazonaws.com/prod-ucs-content-store-eu-west/content/pii:S022352341930371X/gr43/HIGHRES/image/jpeg/9feb48375a51171e11e49138a32b44ef/gr43_lrg.jpg</xocs:ucs-locator>
               <xocs:file-basename>gr43</xocs:file-basename>
               <xocs:filename>gr43_lrg.jpg</xocs:filename>
               <xocs:extension>jpg</xocs:extension>
               <xocs:filesize>59649</xocs:filesize>
               <xocs:pixel-height>774</xocs:pixel-height>
               <xocs:pixel-width>1381</xocs:pixel-width>
               <xocs:attachment-type>IMAGE-HIGH-RES</xocs:attachment-type>
            </xocs:attachment>
            <xocs:attachment>
               <xocs:attachment-eid>1-s2.0-S022352341930371X-gr20_lrg.jpg</xocs:attachment-eid>
               <xocs:ucs-locator>https://s3-eu-west-1.amazonaws.com/prod-ucs-content-store-eu-west/content/pii:S022352341930371X/gr20/HIGHRES/image/jpeg/dfd3353f430642557d3cab12fb875cc6/gr20_lrg.jpg</xocs:ucs-locator>
               <xocs:file-basename>gr20</xocs:file-basename>
               <xocs:filename>gr20_lrg.jpg</xocs:filename>
               <xocs:extension>jpg</xocs:extension>
               <xocs:filesize>132203</xocs:filesize>
               <xocs:pixel-height>747</xocs:pixel-height>
               <xocs:pixel-width>2266</xocs:pixel-width>
               <xocs:attachment-type>IMAGE-HIGH-RES</xocs:attachment-type>
            </xocs:attachment>
            <xocs:attachment>
               <xocs:attachment-eid>1-s2.0-S022352341930371X-gr32_lrg.jpg</xocs:attachment-eid>
               <xocs:ucs-locator>https://s3-eu-west-1.amazonaws.com/prod-ucs-content-store-eu-west/content/pii:S022352341930371X/gr32/HIGHRES/image/jpeg/e7c0ff9549ea0c38463e39149ff008e6/gr32_lrg.jpg</xocs:ucs-locator>
               <xocs:file-basename>gr32</xocs:file-basename>
               <xocs:filename>gr32_lrg.jpg</xocs:filename>
               <xocs:extension>jpg</xocs:extension>
               <xocs:filesize>124617</xocs:filesize>
               <xocs:pixel-height>1216</xocs:pixel-height>
               <xocs:pixel-width>1673</xocs:pixel-width>
               <xocs:attachment-type>IMAGE-HIGH-RES</xocs:attachment-type>
            </xocs:attachment>
            <xocs:attachment>
               <xocs:attachment-eid>1-s2.0-S022352341930371X-gr38_lrg.jpg</xocs:attachment-eid>
               <xocs:ucs-locator>https://s3-eu-west-1.amazonaws.com/prod-ucs-content-store-eu-west/content/pii:S022352341930371X/gr38/HIGHRES/image/jpeg/158f5b0abad56af587b40d537ae183a1/gr38_lrg.jpg</xocs:ucs-locator>
               <xocs:file-basename>gr38</xocs:file-basename>
               <xocs:filename>gr38_lrg.jpg</xocs:filename>
               <xocs:extension>jpg</xocs:extension>
               <xocs:filesize>43162</xocs:filesize>
               <xocs:pixel-height>483</xocs:pixel-height>
               <xocs:pixel-width>986</xocs:pixel-width>
               <xocs:attachment-type>IMAGE-HIGH-RES</xocs:attachment-type>
            </xocs:attachment>
            <xocs:attachment>
               <xocs:attachment-eid>1-s2.0-S022352341930371X-gr25_lrg.jpg</xocs:attachment-eid>
               <xocs:ucs-locator>https://s3-eu-west-1.amazonaws.com/prod-ucs-content-store-eu-west/content/pii:S022352341930371X/gr25/HIGHRES/image/jpeg/87757b3099de490493e72a1d30d93f8a/gr25_lrg.jpg</xocs:ucs-locator>
               <xocs:file-basename>gr25</xocs:file-basename>
               <xocs:filename>gr25_lrg.jpg</xocs:filename>
               <xocs:extension>jpg</xocs:extension>
               <xocs:filesize>495497</xocs:filesize>
               <xocs:pixel-height>1636</xocs:pixel-height>
               <xocs:pixel-width>2469</xocs:pixel-width>
               <xocs:attachment-type>IMAGE-HIGH-RES</xocs:attachment-type>
            </xocs:attachment>
            <xocs:attachment>
               <xocs:attachment-eid>1-s2.0-S022352341930371X-gr26_lrg.jpg</xocs:attachment-eid>
               <xocs:ucs-locator>https://s3-eu-west-1.amazonaws.com/prod-ucs-content-store-eu-west/content/pii:S022352341930371X/gr26/HIGHRES/image/jpeg/baa9e5a1d89f39d821acc7c875704417/gr26_lrg.jpg</xocs:ucs-locator>
               <xocs:file-basename>gr26</xocs:file-basename>
               <xocs:filename>gr26_lrg.jpg</xocs:filename>
               <xocs:extension>jpg</xocs:extension>
               <xocs:filesize>386309</xocs:filesize>
               <xocs:pixel-height>2260</xocs:pixel-height>
               <xocs:pixel-width>2461</xocs:pixel-width>
               <xocs:attachment-type>IMAGE-HIGH-RES</xocs:attachment-type>
            </xocs:attachment>
            <xocs:attachment>
               <xocs:attachment-eid>1-s2.0-S022352341930371X-gr41_lrg.jpg</xocs:attachment-eid>
               <xocs:ucs-locator>https://s3-eu-west-1.amazonaws.com/prod-ucs-content-store-eu-west/content/pii:S022352341930371X/gr41/HIGHRES/image/jpeg/cbd776dea40230a70aa65d4bb5e5ab41/gr41_lrg.jpg</xocs:ucs-locator>
               <xocs:file-basename>gr41</xocs:file-basename>
               <xocs:filename>gr41_lrg.jpg</xocs:filename>
               <xocs:extension>jpg</xocs:extension>
               <xocs:filesize>63408</xocs:filesize>
               <xocs:pixel-height>768</xocs:pixel-height>
               <xocs:pixel-width>1378</xocs:pixel-width>
               <xocs:attachment-type>IMAGE-HIGH-RES</xocs:attachment-type>
            </xocs:attachment>
            <xocs:attachment>
               <xocs:attachment-eid>1-s2.0-S022352341930371X-gr42_lrg.jpg</xocs:attachment-eid>
               <xocs:ucs-locator>https://s3-eu-west-1.amazonaws.com/prod-ucs-content-store-eu-west/content/pii:S022352341930371X/gr42/HIGHRES/image/jpeg/36e02e450e697ae05159e2942da429a5/gr42_lrg.jpg</xocs:ucs-locator>
               <xocs:file-basename>gr42</xocs:file-basename>
               <xocs:filename>gr42_lrg.jpg</xocs:filename>
               <xocs:extension>jpg</xocs:extension>
               <xocs:filesize>466813</xocs:filesize>
               <xocs:pixel-height>1497</xocs:pixel-height>
               <xocs:pixel-width>2272</xocs:pixel-width>
               <xocs:attachment-type>IMAGE-HIGH-RES</xocs:attachment-type>
            </xocs:attachment>
            <xocs:attachment>
               <xocs:attachment-eid>1-s2.0-S022352341930371X-gr47_lrg.jpg</xocs:attachment-eid>
               <xocs:ucs-locator>https://s3-eu-west-1.amazonaws.com/prod-ucs-content-store-eu-west/content/pii:S022352341930371X/gr47/HIGHRES/image/jpeg/16dad26d276886e3b18a821e1a93c5e9/gr47_lrg.jpg</xocs:ucs-locator>
               <xocs:file-basename>gr47</xocs:file-basename>
               <xocs:filename>gr47_lrg.jpg</xocs:filename>
               <xocs:extension>jpg</xocs:extension>
               <xocs:filesize>31252</xocs:filesize>
               <xocs:pixel-height>308</xocs:pixel-height>
               <xocs:pixel-width>787</xocs:pixel-width>
               <xocs:attachment-type>IMAGE-HIGH-RES</xocs:attachment-type>
            </xocs:attachment>
            <xocs:attachment>
               <xocs:attachment-eid>1-s2.0-S022352341930371X-gr27_lrg.jpg</xocs:attachment-eid>
               <xocs:ucs-locator>https://s3-eu-west-1.amazonaws.com/prod-ucs-content-store-eu-west/content/pii:S022352341930371X/gr27/HIGHRES/image/jpeg/9b7bc7584f93e6030c5f9ec7f0c0261e/gr27_lrg.jpg</xocs:ucs-locator>
               <xocs:file-basename>gr27</xocs:file-basename>
               <xocs:filename>gr27_lrg.jpg</xocs:filename>
               <xocs:extension>jpg</xocs:extension>
               <xocs:filesize>122348</xocs:filesize>
               <xocs:pixel-height>763</xocs:pixel-height>
               <xocs:pixel-width>2267</xocs:pixel-width>
               <xocs:attachment-type>IMAGE-HIGH-RES</xocs:attachment-type>
            </xocs:attachment>
            <xocs:attachment>
               <xocs:attachment-eid>1-s2.0-S022352341930371X-fx1_lrg.jpg</xocs:attachment-eid>
               <xocs:ucs-locator>https://s3-eu-west-1.amazonaws.com/prod-ucs-content-store-eu-west/content/pii:S022352341930371X/fx1/HIGHRES/image/jpeg/799a38fa2033389318e6d2ded211b14c/fx1_lrg.jpg</xocs:ucs-locator>
               <xocs:file-basename>fx1</xocs:file-basename>
               <xocs:abstract-attachment>true</xocs:abstract-attachment>
               <xocs:filename>fx1_lrg.jpg</xocs:filename>
               <xocs:extension>jpg</xocs:extension>
               <xocs:filesize>151517</xocs:filesize>
               <xocs:pixel-height>886</xocs:pixel-height>
               <xocs:pixel-width>2032</xocs:pixel-width>
               <xocs:attachment-type>IMAGE-HIGH-RES</xocs:attachment-type>
            </xocs:attachment>
            <xocs:attachment>
               <xocs:attachment-eid>1-s2.0-S022352341930371X-gr7_lrg.jpg</xocs:attachment-eid>
               <xocs:ucs-locator>https://s3-eu-west-1.amazonaws.com/prod-ucs-content-store-eu-west/content/pii:S022352341930371X/gr7/HIGHRES/image/jpeg/7e8e4fad7051ff18d54a3c8275230b10/gr7_lrg.jpg</xocs:ucs-locator>
               <xocs:file-basename>gr7</xocs:file-basename>
               <xocs:filename>gr7_lrg.jpg</xocs:filename>
               <xocs:extension>jpg</xocs:extension>
               <xocs:filesize>175823</xocs:filesize>
               <xocs:pixel-height>1797</xocs:pixel-height>
               <xocs:pixel-width>2265</xocs:pixel-width>
               <xocs:attachment-type>IMAGE-HIGH-RES</xocs:attachment-type>
            </xocs:attachment>
            <xocs:attachment>
               <xocs:attachment-eid>1-s2.0-S022352341930371X-gr16_lrg.jpg</xocs:attachment-eid>
               <xocs:ucs-locator>https://s3-eu-west-1.amazonaws.com/prod-ucs-content-store-eu-west/content/pii:S022352341930371X/gr16/HIGHRES/image/jpeg/079c0062512cdcc505e0b5dbed7189dc/gr16_lrg.jpg</xocs:ucs-locator>
               <xocs:file-basename>gr16</xocs:file-basename>
               <xocs:filename>gr16_lrg.jpg</xocs:filename>
               <xocs:extension>jpg</xocs:extension>
               <xocs:filesize>138717</xocs:filesize>
               <xocs:pixel-height>684</xocs:pixel-height>
               <xocs:pixel-width>2461</xocs:pixel-width>
               <xocs:attachment-type>IMAGE-HIGH-RES</xocs:attachment-type>
            </xocs:attachment>
            <xocs:attachment>
               <xocs:attachment-eid>1-s2.0-S022352341930371X-gr3_lrg.jpg</xocs:attachment-eid>
               <xocs:ucs-locator>https://s3-eu-west-1.amazonaws.com/prod-ucs-content-store-eu-west/content/pii:S022352341930371X/gr3/HIGHRES/image/jpeg/312a33bf62f2e74f7e4e1a8c8143b4bb/gr3_lrg.jpg</xocs:ucs-locator>
               <xocs:file-basename>gr3</xocs:file-basename>
               <xocs:filename>gr3_lrg.jpg</xocs:filename>
               <xocs:extension>jpg</xocs:extension>
               <xocs:filesize>121918</xocs:filesize>
               <xocs:pixel-height>741</xocs:pixel-height>
               <xocs:pixel-width>2264</xocs:pixel-width>
               <xocs:attachment-type>IMAGE-HIGH-RES</xocs:attachment-type>
            </xocs:attachment>
            <xocs:attachment>
               <xocs:attachment-eid>1-s2.0-S022352341930371X-gr12_lrg.jpg</xocs:attachment-eid>
               <xocs:ucs-locator>https://s3-eu-west-1.amazonaws.com/prod-ucs-content-store-eu-west/content/pii:S022352341930371X/gr12/HIGHRES/image/jpeg/d7af3f4d07331006a3d8a37c9f3fe614/gr12_lrg.jpg</xocs:ucs-locator>
               <xocs:file-basename>gr12</xocs:file-basename>
               <xocs:filename>gr12_lrg.jpg</xocs:filename>
               <xocs:extension>jpg</xocs:extension>
               <xocs:filesize>163522</xocs:filesize>
               <xocs:pixel-height>785</xocs:pixel-height>
               <xocs:pixel-width>2264</xocs:pixel-width>
               <xocs:attachment-type>IMAGE-HIGH-RES</xocs:attachment-type>
            </xocs:attachment>
            <xocs:attachment>
               <xocs:attachment-eid>1-s2.0-S022352341930371X-gr28_lrg.jpg</xocs:attachment-eid>
               <xocs:ucs-locator>https://s3-eu-west-1.amazonaws.com/prod-ucs-content-store-eu-west/content/pii:S022352341930371X/gr28/HIGHRES/image/jpeg/da2d35b6a6629c14b8259ee53902f735/gr28_lrg.jpg</xocs:ucs-locator>
               <xocs:file-basename>gr28</xocs:file-basename>
               <xocs:filename>gr28_lrg.jpg</xocs:filename>
               <xocs:extension>jpg</xocs:extension>
               <xocs:filesize>116787</xocs:filesize>
               <xocs:pixel-height>618</xocs:pixel-height>
               <xocs:pixel-width>2265</xocs:pixel-width>
               <xocs:attachment-type>IMAGE-HIGH-RES</xocs:attachment-type>
            </xocs:attachment>
            <xocs:attachment>
               <xocs:attachment-eid>1-s2.0-S022352341930371X-gr4_lrg.jpg</xocs:attachment-eid>
               <xocs:ucs-locator>https://s3-eu-west-1.amazonaws.com/prod-ucs-content-store-eu-west/content/pii:S022352341930371X/gr4/HIGHRES/image/jpeg/4047c9aa10f0e97dc019dda4ad7feefc/gr4_lrg.jpg</xocs:ucs-locator>
               <xocs:file-basename>gr4</xocs:file-basename>
               <xocs:filename>gr4_lrg.jpg</xocs:filename>
               <xocs:extension>jpg</xocs:extension>
               <xocs:filesize>106716</xocs:filesize>
               <xocs:pixel-height>523</xocs:pixel-height>
               <xocs:pixel-width>2461</xocs:pixel-width>
               <xocs:attachment-type>IMAGE-HIGH-RES</xocs:attachment-type>
            </xocs:attachment>
            <xocs:attachment>
               <xocs:attachment-eid>1-s2.0-S022352341930371X-gr18_lrg.jpg</xocs:attachment-eid>
               <xocs:ucs-locator>https://s3-eu-west-1.amazonaws.com/prod-ucs-content-store-eu-west/content/pii:S022352341930371X/gr18/HIGHRES/image/jpeg/435a44d92c502d046363b33327be085d/gr18_lrg.jpg</xocs:ucs-locator>
               <xocs:file-basename>gr18</xocs:file-basename>
               <xocs:filename>gr18_lrg.jpg</xocs:filename>
               <xocs:extension>jpg</xocs:extension>
               <xocs:filesize>152509</xocs:filesize>
               <xocs:pixel-height>883</xocs:pixel-height>
               <xocs:pixel-width>2464</xocs:pixel-width>
               <xocs:attachment-type>IMAGE-HIGH-RES</xocs:attachment-type>
            </xocs:attachment>
            <xocs:attachment>
               <xocs:attachment-eid>1-s2.0-S022352341930371X-gr40_lrg.jpg</xocs:attachment-eid>
               <xocs:ucs-locator>https://s3-eu-west-1.amazonaws.com/prod-ucs-content-store-eu-west/content/pii:S022352341930371X/gr40/HIGHRES/image/jpeg/7f5d2948d08d427fda4745583c0c50a6/gr40_lrg.jpg</xocs:ucs-locator>
               <xocs:file-basename>gr40</xocs:file-basename>
               <xocs:filename>gr40_lrg.jpg</xocs:filename>
               <xocs:extension>jpg</xocs:extension>
               <xocs:filesize>67905</xocs:filesize>
               <xocs:pixel-height>953</xocs:pixel-height>
               <xocs:pixel-width>1380</xocs:pixel-width>
               <xocs:attachment-type>IMAGE-HIGH-RES</xocs:attachment-type>
            </xocs:attachment>
            <xocs:attachment>
               <xocs:attachment-eid>1-s2.0-S022352341930371X-gr10_lrg.jpg</xocs:attachment-eid>
               <xocs:ucs-locator>https://s3-eu-west-1.amazonaws.com/prod-ucs-content-store-eu-west/content/pii:S022352341930371X/gr10/HIGHRES/image/jpeg/60d9c33ab797b6343444511cfa5cb1a4/gr10_lrg.jpg</xocs:ucs-locator>
               <xocs:file-basename>gr10</xocs:file-basename>
               <xocs:filename>gr10_lrg.jpg</xocs:filename>
               <xocs:extension>jpg</xocs:extension>
               <xocs:filesize>157097</xocs:filesize>
               <xocs:pixel-height>957</xocs:pixel-height>
               <xocs:pixel-width>2464</xocs:pixel-width>
               <xocs:attachment-type>IMAGE-HIGH-RES</xocs:attachment-type>
            </xocs:attachment>
            <xocs:attachment>
               <xocs:attachment-eid>1-s2.0-S022352341930371X-gr44_lrg.jpg</xocs:attachment-eid>
               <xocs:ucs-locator>https://s3-eu-west-1.amazonaws.com/prod-ucs-content-store-eu-west/content/pii:S022352341930371X/gr44/HIGHRES/image/jpeg/aeacb9a390c5b30d31a17a7bcf8a8e83/gr44_lrg.jpg</xocs:ucs-locator>
               <xocs:file-basename>gr44</xocs:file-basename>
               <xocs:filename>gr44_lrg.jpg</xocs:filename>
               <xocs:extension>jpg</xocs:extension>
               <xocs:filesize>53495</xocs:filesize>
               <xocs:pixel-height>645</xocs:pixel-height>
               <xocs:pixel-width>1380</xocs:pixel-width>
               <xocs:attachment-type>IMAGE-HIGH-RES</xocs:attachment-type>
            </xocs:attachment>
            <xocs:attachment>
               <xocs:attachment-eid>1-s2.0-S022352341930371X-gr36_lrg.jpg</xocs:attachment-eid>
               <xocs:ucs-locator>https://s3-eu-west-1.amazonaws.com/prod-ucs-content-store-eu-west/content/pii:S022352341930371X/gr36/HIGHRES/image/jpeg/8ad3460138e4c676aef6d0fe2d351a28/gr36_lrg.jpg</xocs:ucs-locator>
               <xocs:file-basename>gr36</xocs:file-basename>
               <xocs:filename>gr36_lrg.jpg</xocs:filename>
               <xocs:extension>jpg</xocs:extension>
               <xocs:filesize>44281</xocs:filesize>
               <xocs:pixel-height>605</xocs:pixel-height>
               <xocs:pixel-width>984</xocs:pixel-width>
               <xocs:attachment-type>IMAGE-HIGH-RES</xocs:attachment-type>
            </xocs:attachment>
            <xocs:attachment>
               <xocs:attachment-eid>1-s2.0-S022352341930371X-gr39_lrg.jpg</xocs:attachment-eid>
               <xocs:ucs-locator>https://s3-eu-west-1.amazonaws.com/prod-ucs-content-store-eu-west/content/pii:S022352341930371X/gr39/HIGHRES/image/jpeg/79db11225bbd9297374d0f58feb6e278/gr39_lrg.jpg</xocs:ucs-locator>
               <xocs:file-basename>gr39</xocs:file-basename>
               <xocs:filename>gr39_lrg.jpg</xocs:filename>
               <xocs:extension>jpg</xocs:extension>
               <xocs:filesize>59185</xocs:filesize>
               <xocs:pixel-height>1012</xocs:pixel-height>
               <xocs:pixel-width>789</xocs:pixel-width>
               <xocs:attachment-type>IMAGE-HIGH-RES</xocs:attachment-type>
            </xocs:attachment>
            <xocs:attachment>
               <xocs:attachment-eid>1-s2.0-S022352341930371X-gr15_lrg.jpg</xocs:attachment-eid>
               <xocs:ucs-locator>https://s3-eu-west-1.amazonaws.com/prod-ucs-content-store-eu-west/content/pii:S022352341930371X/gr15/HIGHRES/image/jpeg/052c9579f358e77366ce2ad609caa205/gr15_lrg.jpg</xocs:ucs-locator>
               <xocs:file-basename>gr15</xocs:file-basename>
               <xocs:filename>gr15_lrg.jpg</xocs:filename>
               <xocs:extension>jpg</xocs:extension>
               <xocs:filesize>192473</xocs:filesize>
               <xocs:pixel-height>1389</xocs:pixel-height>
               <xocs:pixel-width>2264</xocs:pixel-width>
               <xocs:attachment-type>IMAGE-HIGH-RES</xocs:attachment-type>
            </xocs:attachment>
            <xocs:attachment>
               <xocs:attachment-eid>1-s2.0-S022352341930371X-gr34_lrg.jpg</xocs:attachment-eid>
               <xocs:ucs-locator>https://s3-eu-west-1.amazonaws.com/prod-ucs-content-store-eu-west/content/pii:S022352341930371X/gr34/HIGHRES/image/jpeg/3ac061b55402ca748e2a095f4615e8dd/gr34_lrg.jpg</xocs:ucs-locator>
               <xocs:file-basename>gr34</xocs:file-basename>
               <xocs:filename>gr34_lrg.jpg</xocs:filename>
               <xocs:extension>jpg</xocs:extension>
               <xocs:filesize>32973</xocs:filesize>
               <xocs:pixel-height>498</xocs:pixel-height>
               <xocs:pixel-width>986</xocs:pixel-width>
               <xocs:attachment-type>IMAGE-HIGH-RES</xocs:attachment-type>
            </xocs:attachment>
            <xocs:attachment>
               <xocs:attachment-eid>1-s2.0-S022352341930371X-gr8_lrg.jpg</xocs:attachment-eid>
               <xocs:ucs-locator>https://s3-eu-west-1.amazonaws.com/prod-ucs-content-store-eu-west/content/pii:S022352341930371X/gr8/HIGHRES/image/jpeg/4c2eb57543b1afccd2e42da287f72e1d/gr8_lrg.jpg</xocs:ucs-locator>
               <xocs:file-basename>gr8</xocs:file-basename>
               <xocs:filename>gr8_lrg.jpg</xocs:filename>
               <xocs:extension>jpg</xocs:extension>
               <xocs:filesize>910770</xocs:filesize>
               <xocs:pixel-height>3290</xocs:pixel-height>
               <xocs:pixel-width>1673</xocs:pixel-width>
               <xocs:attachment-type>IMAGE-HIGH-RES</xocs:attachment-type>
            </xocs:attachment>
            <xocs:attachment>
               <xocs:attachment-eid>1-s2.0-S022352341930371X-gr17_lrg.jpg</xocs:attachment-eid>
               <xocs:ucs-locator>https://s3-eu-west-1.amazonaws.com/prod-ucs-content-store-eu-west/content/pii:S022352341930371X/gr17/HIGHRES/image/jpeg/35889f3bb6dc8dcd0abf0757946fabd3/gr17_lrg.jpg</xocs:ucs-locator>
               <xocs:file-basename>gr17</xocs:file-basename>
               <xocs:filename>gr17_lrg.jpg</xocs:filename>
               <xocs:extension>jpg</xocs:extension>
               <xocs:filesize>103072</xocs:filesize>
               <xocs:pixel-height>820</xocs:pixel-height>
               <xocs:pixel-width>1675</xocs:pixel-width>
               <xocs:attachment-type>IMAGE-HIGH-RES</xocs:attachment-type>
            </xocs:attachment>
            <xocs:attachment>
               <xocs:attachment-eid>1-s2.0-S022352341930371X-gr22_lrg.jpg</xocs:attachment-eid>
               <xocs:ucs-locator>https://s3-eu-west-1.amazonaws.com/prod-ucs-content-store-eu-west/content/pii:S022352341930371X/gr22/HIGHRES/image/jpeg/64bd6d822a4dad210cb405fa661caef8/gr22_lrg.jpg</xocs:ucs-locator>
               <xocs:file-basename>gr22</xocs:file-basename>
               <xocs:filename>gr22_lrg.jpg</xocs:filename>
               <xocs:extension>jpg</xocs:extension>
               <xocs:filesize>133728</xocs:filesize>
               <xocs:pixel-height>839</xocs:pixel-height>
               <xocs:pixel-width>2265</xocs:pixel-width>
               <xocs:attachment-type>IMAGE-HIGH-RES</xocs:attachment-type>
            </xocs:attachment>
            <xocs:attachment>
               <xocs:attachment-eid>1-s2.0-S022352341930371X-gr23_lrg.jpg</xocs:attachment-eid>
               <xocs:ucs-locator>https://s3-eu-west-1.amazonaws.com/prod-ucs-content-store-eu-west/content/pii:S022352341930371X/gr23/HIGHRES/image/jpeg/fcc4a919367ab3c5e139e9ad7a13fb54/gr23_lrg.jpg</xocs:ucs-locator>
               <xocs:file-basename>gr23</xocs:file-basename>
               <xocs:filename>gr23_lrg.jpg</xocs:filename>
               <xocs:extension>jpg</xocs:extension>
               <xocs:filesize>150380</xocs:filesize>
               <xocs:pixel-height>751</xocs:pixel-height>
               <xocs:pixel-width>2264</xocs:pixel-width>
               <xocs:attachment-type>IMAGE-HIGH-RES</xocs:attachment-type>
            </xocs:attachment>
            <xocs:attachment>
               <xocs:attachment-eid>1-s2.0-S022352341930371X-gr11_lrg.jpg</xocs:attachment-eid>
               <xocs:ucs-locator>https://s3-eu-west-1.amazonaws.com/prod-ucs-content-store-eu-west/content/pii:S022352341930371X/gr11/HIGHRES/image/jpeg/a7bab7529980ac130078d7ec4a01ca0e/gr11_lrg.jpg</xocs:ucs-locator>
               <xocs:file-basename>gr11</xocs:file-basename>
               <xocs:filename>gr11_lrg.jpg</xocs:filename>
               <xocs:extension>jpg</xocs:extension>
               <xocs:filesize>109163</xocs:filesize>
               <xocs:pixel-height>900</xocs:pixel-height>
               <xocs:pixel-width>1677</xocs:pixel-width>
               <xocs:attachment-type>IMAGE-HIGH-RES</xocs:attachment-type>
            </xocs:attachment>
            <xocs:attachment>
               <xocs:attachment-eid>1-s2.0-S022352341930371X-gr24_lrg.jpg</xocs:attachment-eid>
               <xocs:ucs-locator>https://s3-eu-west-1.amazonaws.com/prod-ucs-content-store-eu-west/content/pii:S022352341930371X/gr24/HIGHRES/image/jpeg/40b14d14f2bff3275d0eca255cf54e4d/gr24_lrg.jpg</xocs:ucs-locator>
               <xocs:file-basename>gr24</xocs:file-basename>
               <xocs:filename>gr24_lrg.jpg</xocs:filename>
               <xocs:extension>jpg</xocs:extension>
               <xocs:filesize>224337</xocs:filesize>
               <xocs:pixel-height>1491</xocs:pixel-height>
               <xocs:pixel-width>2264</xocs:pixel-width>
               <xocs:attachment-type>IMAGE-HIGH-RES</xocs:attachment-type>
            </xocs:attachment>
            <xocs:attachment>
               <xocs:attachment-eid>1-s2.0-S022352341930371X-gr21_lrg.jpg</xocs:attachment-eid>
               <xocs:ucs-locator>https://s3-eu-west-1.amazonaws.com/prod-ucs-content-store-eu-west/content/pii:S022352341930371X/gr21/HIGHRES/image/jpeg/772553fed9e537d91bf915bf605f4bf7/gr21_lrg.jpg</xocs:ucs-locator>
               <xocs:file-basename>gr21</xocs:file-basename>
               <xocs:filename>gr21_lrg.jpg</xocs:filename>
               <xocs:extension>jpg</xocs:extension>
               <xocs:filesize>126792</xocs:filesize>
               <xocs:pixel-height>684</xocs:pixel-height>
               <xocs:pixel-width>2266</xocs:pixel-width>
               <xocs:attachment-type>IMAGE-HIGH-RES</xocs:attachment-type>
            </xocs:attachment>
            <xocs:attachment>
               <xocs:attachment-eid>1-s2.0-S022352341930371X-gr5_lrg.jpg</xocs:attachment-eid>
               <xocs:ucs-locator>https://s3-eu-west-1.amazonaws.com/prod-ucs-content-store-eu-west/content/pii:S022352341930371X/gr5/HIGHRES/image/jpeg/697673459df6fa7e489d22cf2841def5/gr5_lrg.jpg</xocs:ucs-locator>
               <xocs:file-basename>gr5</xocs:file-basename>
               <xocs:filename>gr5_lrg.jpg</xocs:filename>
               <xocs:extension>jpg</xocs:extension>
               <xocs:filesize>116403</xocs:filesize>
               <xocs:pixel-height>668</xocs:pixel-height>
               <xocs:pixel-width>2264</xocs:pixel-width>
               <xocs:attachment-type>IMAGE-HIGH-RES</xocs:attachment-type>
            </xocs:attachment>
            <xocs:attachment>
               <xocs:attachment-eid>1-s2.0-S022352341930371X-gr31_lrg.jpg</xocs:attachment-eid>
               <xocs:ucs-locator>https://s3-eu-west-1.amazonaws.com/prod-ucs-content-store-eu-west/content/pii:S022352341930371X/gr31/HIGHRES/image/jpeg/580783db91f6b1fd7eac11375730311a/gr31_lrg.jpg</xocs:ucs-locator>
               <xocs:file-basename>gr31</xocs:file-basename>
               <xocs:filename>gr31_lrg.jpg</xocs:filename>
               <xocs:extension>jpg</xocs:extension>
               <xocs:filesize>64386</xocs:filesize>
               <xocs:pixel-height>744</xocs:pixel-height>
               <xocs:pixel-width>1380</xocs:pixel-width>
               <xocs:attachment-type>IMAGE-HIGH-RES</xocs:attachment-type>
            </xocs:attachment>
            <xocs:attachment>
               <xocs:attachment-eid>1-s2.0-S022352341930371X-gr35_lrg.jpg</xocs:attachment-eid>
               <xocs:ucs-locator>https://s3-eu-west-1.amazonaws.com/prod-ucs-content-store-eu-west/content/pii:S022352341930371X/gr35/HIGHRES/image/jpeg/05ccb686412949f2ebdcbae8f85150e3/gr35_lrg.jpg</xocs:ucs-locator>
               <xocs:file-basename>gr35</xocs:file-basename>
               <xocs:filename>gr35_lrg.jpg</xocs:filename>
               <xocs:extension>jpg</xocs:extension>
               <xocs:filesize>176287</xocs:filesize>
               <xocs:pixel-height>729</xocs:pixel-height>
               <xocs:pixel-width>2659</xocs:pixel-width>
               <xocs:attachment-type>IMAGE-HIGH-RES</xocs:attachment-type>
            </xocs:attachment>
            <xocs:attachment>
               <xocs:attachment-eid>1-s2.0-S022352341930371X-am.pdf</xocs:attachment-eid>
               <xocs:file-basename>am</xocs:file-basename>
               <xocs:filename>am.pdf</xocs:filename>
               <xocs:extension>pdf</xocs:extension>
               <xocs:filesize>376922</xocs:filesize>
               <xocs:attachment-type>AAM-PDF</xocs:attachment-type>
               <xocs:ucs-locator>https://s3-eu-west-1.amazonaws.com/prod-ucs-content-store-eu-west/content/egi:10303KKD6TL/MAIN/application/pdf/1b6e2cdc621c16e08b5623b67752ee08/am.pdf</xocs:ucs-locator>
            </xocs:attachment>
         </xocs:attachments>
      </xocs:attachment-metadata-doc>
   </xocs:meta><xocs:serial-item xmlns:xoe="http://www.elsevier.com/xml/xoe/dtd">
      <article xmlns="http://www.elsevier.com/xml/ja/dtd" docsubtype="rev" version="5.5" xml:lang="en">
         <item-info>
            <jid>EJMECH</jid>
            <aid>11288</aid>
            <ce:pii>S0223-5234(19)30371-X</ce:pii>
            <ce:doi>10.1016/j.ejmech.2019.04.053</ce:doi>
            <ce:copyright type="unknown" year="2019"/></ce:copyright>
         </item-info>
         <ce:floats>
            <ce:figure id="fig1">
               <ce:label>Fig.Â 1</ce:label>
               <ce:caption id="cap0010">
                  <ce:simple-para id="fspara0010" view="all">Trk pathway.</ce:simple-para>
               </ce:caption>
               <ce:alt-text role="short" id="alttext0015">Fig.Â 1</ce:alt-text>
               <ce:link locator="gr1" xlink:type="simple" xlink:role="http://data.elsevier.com/vocabulary/ElsevierContentTypes/23.4" xlink:href="pii:S022352341930371X/gr1"/></ce:link>
            </ce:figure>
            <ce:figure id="fig2">
               <ce:label>Fig.Â 2</ce:label>
               <ce:caption id="cap0015">
                  <ce:simple-para id="fspara0015" view="all">Chemical structure of lead compound <ce:bold>1</ce:bold> and modified compound <ce:bold>2</ce:bold>.</ce:simple-para>
               </ce:caption>
               <ce:alt-text role="short" id="alttext0020">Fig.Â 2</ce:alt-text>
               <ce:link locator="gr2" xlink:type="simple" xlink:role="http://data.elsevier.com/vocabulary/ElsevierContentTypes/23.4" xlink:href="pii:S022352341930371X/gr2"/></ce:link>
            </ce:figure>
            <ce:figure id="fig3">
               <ce:label>Fig.Â 3</ce:label>
               <ce:caption id="cap0020">
                  <ce:simple-para id="fspara0020" view="all">Chemical structures of LOXO-101 (<ce:bold>3</ce:bold>) and LOXO-195 (<ce:bold>4</ce:bold>).</ce:simple-para>
               </ce:caption>
               <ce:alt-text role="short" id="alttext0025">Fig.Â 3</ce:alt-text>
               <ce:link locator="gr3" xlink:type="simple" xlink:role="http://data.elsevier.com/vocabulary/ElsevierContentTypes/23.4" xlink:href="pii:S022352341930371X/gr3"/></ce:link>
            </ce:figure>
            <ce:figure id="fig4">
               <ce:label>Fig.Â 4</ce:label>
               <ce:caption id="cap0025">
                  <ce:simple-para id="fspara0025" view="all">Chemical structures claimed in patent US20150368238.</ce:simple-para>
               </ce:caption>
               <ce:alt-text role="short" id="alttext0030">Fig.Â 4</ce:alt-text>
               <ce:link locator="gr4" xlink:type="simple" xlink:role="http://data.elsevier.com/vocabulary/ElsevierContentTypes/23.4" xlink:href="pii:S022352341930371X/gr4"/></ce:link>
            </ce:figure>
            <ce:figure id="fig5">
               <ce:label>Fig.Â 5</ce:label>
               <ce:caption id="cap0030">
                  <ce:simple-para id="fspara0030" view="all">Chemical structures claimed in WO2018077246.</ce:simple-para>
               </ce:caption>
               <ce:alt-text role="short" id="alttext0035">Fig.Â 5</ce:alt-text>
               <ce:link locator="gr5" xlink:type="simple" xlink:role="http://data.elsevier.com/vocabulary/ElsevierContentTypes/23.4" xlink:href="pii:S022352341930371X/gr5"/></ce:link>
            </ce:figure>
            <ce:figure id="fig6">
               <ce:label>Fig.Â 6</ce:label>
               <ce:caption id="cap0035">
                  <ce:simple-para id="fspara0035" view="all">Chemical structures claimed in WO2018022911.</ce:simple-para>
               </ce:caption>
               <ce:alt-text role="short" id="alttext0040">Fig.Â 6</ce:alt-text>
               <ce:link locator="gr6" xlink:type="simple" xlink:role="http://data.elsevier.com/vocabulary/ElsevierContentTypes/23.4" xlink:href="pii:S022352341930371X/gr6"/></ce:link>
            </ce:figure>
            <ce:figure id="fig7">
               <ce:label>Fig.Â 7</ce:label>
               <ce:caption id="cap0040">
                  <ce:simple-para id="fspara0040" view="all">Chemical structure of <ce:bold>12</ce:bold>â<ce:bold>15</ce:bold> and its optimal compound GNF-8625 (<ce:bold>15</ce:bold>).</ce:simple-para>
               </ce:caption>
               <ce:alt-text role="short" id="alttext0045">Fig.Â 7</ce:alt-text>
               <ce:link locator="gr7" xlink:type="simple" xlink:role="http://data.elsevier.com/vocabulary/ElsevierContentTypes/23.4" xlink:href="pii:S022352341930371X/gr7"/></ce:link>
            </ce:figure>
            <ce:figure id="fig8">
               <ce:label>Fig.Â 8</ce:label>
               <ce:caption id="cap0045">
                  <ce:simple-para id="fspara0045" view="all">a) X-ray crystal structure of <ce:bold>12</ce:bold> bound to TrkC (PDB ID code 4YMJ); b) X-ray crystal structure of <ce:bold>13</ce:bold> bound to TrkB (PDB ID code 4YPS); c) X-ray crystal structure of <ce:bold>14</ce:bold> bound to TrkA (PDB ID code 4YNE).</ce:simple-para>
                  <ce:simple-para id="fspara0245" view="all">Backbones of protein are shown in grey. Carbons of ligands are shown in green. Nitrogens are shown in purple. Oxygens are shown in red. Sulfurs are shown in yellow. Fluorides are shown in bright blue. Hydrogen bonds are shown in green dashed line. Ï-charge interactions are shown in yellow dash lines. Ï-Ï interactions are shown in pink dashed lines. Hydrophobic contacts are shown in bright blue dashed line. Color coding are the same in the following figures.</ce:simple-para>
               </ce:caption>
               <ce:alt-text role="short" id="alttext0050">Fig.Â 8</ce:alt-text>
               <ce:link locator="gr8" xlink:type="simple" xlink:role="http://data.elsevier.com/vocabulary/ElsevierContentTypes/23.4" xlink:href="pii:S022352341930371X/gr8"/></ce:link>
            </ce:figure>
            <ce:figure id="fig9">
               <ce:label>Fig.Â 9</ce:label>
               <ce:caption id="cap0050">
                  <ce:simple-para id="fspara0050" view="all">Examples in WO2007061882 and their IC<ce:inf loc="post">50</ce:inf> values against TrkA/B.</ce:simple-para>
               </ce:caption>
               <ce:alt-text role="short" id="alttext0055">Fig.Â 9</ce:alt-text>
               <ce:link locator="gr9" xlink:type="simple" xlink:role="http://data.elsevier.com/vocabulary/ElsevierContentTypes/23.4" xlink:href="pii:S022352341930371X/gr9"/></ce:link>
            </ce:figure>
            <ce:figure id="fig10">
               <ce:label>Fig.Â 10</ce:label>
               <ce:caption id="cap0055">
                  <ce:simple-para id="fspara0055" view="all">Examples in WO2015175788.</ce:simple-para>
               </ce:caption>
               <ce:alt-text role="short" id="alttext0060">Fig.Â 10</ce:alt-text>
               <ce:link locator="gr10" xlink:type="simple" xlink:role="http://data.elsevier.com/vocabulary/ElsevierContentTypes/23.4" xlink:href="pii:S022352341930371X/gr10"/></ce:link>
            </ce:figure>
            <ce:figure id="fig11">
               <ce:label>Fig.Â 11</ce:label>
               <ce:caption id="cap0060">
                  <ce:simple-para id="fspara0060" view="all">Examples in WO2015042085 and their IC<ce:inf loc="post">50</ce:inf> values against TrkA.</ce:simple-para>
               </ce:caption>
               <ce:alt-text role="short" id="alttext0065">Fig.Â 11</ce:alt-text>
               <ce:link locator="gr11" xlink:type="simple" xlink:role="http://data.elsevier.com/vocabulary/ElsevierContentTypes/23.4" xlink:href="pii:S022352341930371X/gr11"/></ce:link>
            </ce:figure>
            <ce:figure id="fig12">
               <ce:label>Fig.Â 12</ce:label>
               <ce:caption id="cap0065">
                  <ce:simple-para id="fspara0065" view="all">Examples in WO2015042088 and their IC<ce:inf loc="post">50</ce:inf> values against TrkA.</ce:simple-para>
               </ce:caption>
               <ce:alt-text role="short" id="alttext0070">Fig.Â 12</ce:alt-text>
               <ce:link locator="gr12" xlink:type="simple" xlink:role="http://data.elsevier.com/vocabulary/ElsevierContentTypes/23.4" xlink:href="pii:S022352341930371X/gr12"/></ce:link>
            </ce:figure>
            <ce:figure id="fig13">
               <ce:label>Fig.Â 13</ce:label>
               <ce:caption id="cap0070">
                  <ce:simple-para id="fspara0070" view="all">Examples in WO2015143652 and their IC<ce:inf loc="post">50</ce:inf> values against TrkA.</ce:simple-para>
               </ce:caption>
               <ce:alt-text role="short" id="alttext0075">Fig.Â 13</ce:alt-text>
               <ce:link locator="gr13" xlink:type="simple" xlink:role="http://data.elsevier.com/vocabulary/ElsevierContentTypes/23.4" xlink:href="pii:S022352341930371X/gr13"/></ce:link>
            </ce:figure>
            <ce:figure id="fig14">
               <ce:label>Fig.Â 14</ce:label>
               <ce:caption id="cap0075">
                  <ce:simple-para id="fspara0075" view="all">Examples in WO2015143854 and their IC<ce:inf loc="post">50</ce:inf> values against TrkA.</ce:simple-para>
               </ce:caption>
               <ce:alt-text role="short" id="alttext0080">Fig.Â 14</ce:alt-text>
               <ce:link locator="gr14" xlink:type="simple" xlink:role="http://data.elsevier.com/vocabulary/ElsevierContentTypes/23.4" xlink:href="pii:S022352341930371X/gr14"/></ce:link>
            </ce:figure>
            <ce:figure id="fig15">
               <ce:label>Fig.Â 15</ce:label>
               <ce:caption id="cap0080">
                  <ce:simple-para id="fspara0080" view="all">Examples in WO2016054807 and their IC<ce:inf loc="post">50</ce:inf> values against TrkA.</ce:simple-para>
               </ce:caption>
               <ce:alt-text role="short" id="alttext0085">Fig.Â 15</ce:alt-text>
               <ce:link locator="gr15" xlink:type="simple" xlink:role="http://data.elsevier.com/vocabulary/ElsevierContentTypes/23.4" xlink:href="pii:S022352341930371X/gr15"/></ce:link>
            </ce:figure>
            <ce:figure id="fig16">
               <ce:label>Fig.Â 16</ce:label>
               <ce:caption id="cap0085">
                  <ce:simple-para id="fspara0085" view="all">Examples in WO2015159175 and their IC<ce:inf loc="post">50</ce:inf> values against TrkA.</ce:simple-para>
               </ce:caption>
               <ce:alt-text role="short" id="alttext0090">Fig.Â 16</ce:alt-text>
               <ce:link locator="gr16" xlink:type="simple" xlink:role="http://data.elsevier.com/vocabulary/ElsevierContentTypes/23.4" xlink:href="pii:S022352341930371X/gr16"/></ce:link>
            </ce:figure>
            <ce:figure id="fig17">
               <ce:label>Fig.Â 17</ce:label>
               <ce:caption id="cap0090">
                  <ce:simple-para id="fspara0090" view="all">Examples in WO2015170218 and their IC<ce:inf loc="post">50</ce:inf> values against TrkA.</ce:simple-para>
               </ce:caption>
               <ce:alt-text role="short" id="alttext0095">Fig.Â 17</ce:alt-text>
               <ce:link locator="gr17" xlink:type="simple" xlink:role="http://data.elsevier.com/vocabulary/ElsevierContentTypes/23.4" xlink:href="pii:S022352341930371X/gr17"/></ce:link>
            </ce:figure>
            <ce:figure id="fig18">
               <ce:label>Fig.Â 18</ce:label>
               <ce:caption id="cap0095">
                  <ce:simple-para id="fspara0095" view="all">Examples in WO2016116900 and their IC<ce:inf loc="post">50</ce:inf> values against TrkA.</ce:simple-para>
               </ce:caption>
               <ce:alt-text role="short" id="alttext0100">Fig.Â 18</ce:alt-text>
               <ce:link locator="gr18" xlink:type="simple" xlink:role="http://data.elsevier.com/vocabulary/ElsevierContentTypes/23.4" xlink:href="pii:S022352341930371X/gr18"/></ce:link>
            </ce:figure>
            <ce:figure id="fig19">
               <ce:label>Fig.Â 19</ce:label>
               <ce:caption id="cap0100">
                  <ce:simple-para id="fspara0100" view="all">Examples in WO2017135399 and their IC<ce:inf loc="post">50</ce:inf> values against TrkA.</ce:simple-para>
               </ce:caption>
               <ce:alt-text role="short" id="alttext0105">Fig.Â 19</ce:alt-text>
               <ce:link locator="gr19" xlink:type="simple" xlink:role="http://data.elsevier.com/vocabulary/ElsevierContentTypes/23.4" xlink:href="pii:S022352341930371X/gr19"/></ce:link>
            </ce:figure>
            <ce:figure id="fig20">
               <ce:label>Fig.Â 20</ce:label>
               <ce:caption id="cap0105">
                  <ce:simple-para id="fspara0105" view="all">Examples in WO2018079759 and their IC<ce:inf loc="post">50</ce:inf> values against TrkA.</ce:simple-para>
               </ce:caption>
               <ce:alt-text role="short" id="alttext0110">Fig.Â 20</ce:alt-text>
               <ce:link locator="gr20" xlink:type="simple" xlink:role="http://data.elsevier.com/vocabulary/ElsevierContentTypes/23.4" xlink:href="pii:S022352341930371X/gr20"/></ce:link>
            </ce:figure>
            <ce:figure id="fig21">
               <ce:label>Fig.Â 21</ce:label>
               <ce:caption id="cap0110">
                  <ce:simple-para id="fspara0110" view="all">Examples in WO2017087778.</ce:simple-para>
               </ce:caption>
               <ce:alt-text role="short" id="alttext0115">Fig.Â 21</ce:alt-text>
               <ce:link locator="gr21" xlink:type="simple" xlink:role="http://data.elsevier.com/vocabulary/ElsevierContentTypes/23.4" xlink:href="pii:S022352341930371X/gr21"/></ce:link>
            </ce:figure>
            <ce:figure id="fig22">
               <ce:label>Fig.Â 22</ce:label>
               <ce:caption id="cap0115">
                  <ce:simple-para id="fspara0115" view="all">Examples in US20160168156 and their IC<ce:inf loc="post">50</ce:inf> values against TrkA-C.</ce:simple-para>
               </ce:caption>
               <ce:alt-text role="short" id="alttext0120">Fig.Â 22</ce:alt-text>
               <ce:link locator="gr22" xlink:type="simple" xlink:role="http://data.elsevier.com/vocabulary/ElsevierContentTypes/23.4" xlink:href="pii:S022352341930371X/gr22"/></ce:link>
            </ce:figure>
            <ce:figure id="fig23">
               <ce:label>Fig.Â 23</ce:label>
               <ce:caption id="cap0120">
                  <ce:simple-para id="fspara0120" view="all">Examples in WO2017035354.</ce:simple-para>
               </ce:caption>
               <ce:alt-text role="short" id="alttext0125">Fig.Â 23</ce:alt-text>
               <ce:link locator="gr23" xlink:type="simple" xlink:role="http://data.elsevier.com/vocabulary/ElsevierContentTypes/23.4" xlink:href="pii:S022352341930371X/gr23"/></ce:link>
            </ce:figure>
            <ce:figure id="fig24">
               <ce:label>Fig.Â 24</ce:label>
               <ce:caption id="cap0125">
                  <ce:simple-para id="fspara0125" view="all">Chemical structures of AZ-23 (<ce:bold>60</ce:bold>) and its derivatives (<ce:bold>61, 62</ce:bold>).</ce:simple-para>
               </ce:caption>
               <ce:alt-text role="short" id="alttext0130">Fig.Â 24</ce:alt-text>
               <ce:link locator="gr24" xlink:type="simple" xlink:role="http://data.elsevier.com/vocabulary/ElsevierContentTypes/23.4" xlink:href="pii:S022352341930371X/gr24"/></ce:link>
            </ce:figure>
            <ce:figure id="fig25">
               <ce:label>Fig.Â 25</ce:label>
               <ce:caption id="cap0130">
                  <ce:simple-para id="fspara0130" view="all">X-ray crystal structure of AZ-23 bound to TrkA (PDB ID code 4AOJ).</ce:simple-para>
               </ce:caption>
               <ce:alt-text role="short" id="alttext0135">Fig.Â 25</ce:alt-text>
               <ce:link locator="gr25" xlink:type="simple" xlink:role="http://data.elsevier.com/vocabulary/ElsevierContentTypes/23.4" xlink:href="pii:S022352341930371X/gr25"/></ce:link>
            </ce:figure>
            <ce:figure id="fig26">
               <ce:label>Fig.Â 26</ce:label>
               <ce:caption id="cap0135">
                  <ce:simple-para id="fspara0135" view="all">Skeletons comprising of 1H-pyrazol-3-amine claimed by AstraZeneca in patents.</ce:simple-para>
               </ce:caption>
               <ce:alt-text role="short" id="alttext0140">Fig.Â 26</ce:alt-text>
               <ce:link locator="gr26" xlink:type="simple" xlink:role="http://data.elsevier.com/vocabulary/ElsevierContentTypes/23.4" xlink:href="pii:S022352341930371X/gr26"/></ce:link>
            </ce:figure>
            <ce:figure id="fig27">
               <ce:label>Fig.Â 27</ce:label>
               <ce:caption id="cap0140">
                  <ce:simple-para id="fspara0140" view="all">Examples of Trk inhibitors in WO2005049033 and their IC<ce:inf loc="post">50</ce:inf>s against Trk.</ce:simple-para>
               </ce:caption>
               <ce:alt-text role="short" id="alttext0145">Fig.Â 27</ce:alt-text>
               <ce:link locator="gr27" xlink:type="simple" xlink:role="http://data.elsevier.com/vocabulary/ElsevierContentTypes/23.4" xlink:href="pii:S022352341930371X/gr27"/></ce:link>
            </ce:figure>
            <ce:figure id="fig28">
               <ce:label>Fig.Â 28</ce:label>
               <ce:caption id="cap0145">
                  <ce:simple-para id="fspara0145" view="all">Examples of Trk inhibitors in WO2005103010 and their IC<ce:inf loc="post">50</ce:inf>s against Trk.</ce:simple-para>
               </ce:caption>
               <ce:alt-text role="short" id="alttext0150">Fig.Â 28</ce:alt-text>
               <ce:link locator="gr28" xlink:type="simple" xlink:role="http://data.elsevier.com/vocabulary/ElsevierContentTypes/23.4" xlink:href="pii:S022352341930371X/gr28"/></ce:link>
            </ce:figure>
            <ce:figure id="fig29">
               <ce:label>Fig.Â 29</ce:label>
               <ce:caption id="cap0150">
                  <ce:simple-para id="fspara0150" view="all">Examples of Trk inhibitors in WO2006082392 and their IC<ce:inf loc="post">50</ce:inf>s against Trk.</ce:simple-para>
               </ce:caption>
               <ce:alt-text role="short" id="alttext0155">Fig.Â 29</ce:alt-text>
               <ce:link locator="gr29" xlink:type="simple" xlink:role="http://data.elsevier.com/vocabulary/ElsevierContentTypes/23.4" xlink:href="pii:S022352341930371X/gr29"/></ce:link>
            </ce:figure>
            <ce:figure id="fig30">
               <ce:label>Fig.Â 30</ce:label>
               <ce:caption id="cap0155">
                  <ce:simple-para id="fspara0155" view="all">Examples of Trk inhibitors in WO2006123113 and their IC<ce:inf loc="post">50</ce:inf>s against Trk.</ce:simple-para>
               </ce:caption>
               <ce:alt-text role="short" id="alttext0160">Fig.Â 30</ce:alt-text>
               <ce:link locator="gr30" xlink:type="simple" xlink:role="http://data.elsevier.com/vocabulary/ElsevierContentTypes/23.4" xlink:href="pii:S022352341930371X/gr30"/></ce:link>
            </ce:figure>
            <ce:figure id="fig31">
               <ce:label>Fig.Â 31</ce:label>
               <ce:caption id="cap0160">
                  <ce:simple-para id="fspara0160" view="all">Example of Trk inhibitors in WO2007049041 and IC<ce:inf loc="post">50</ce:inf> against Trk.</ce:simple-para>
               </ce:caption>
               <ce:alt-text role="short" id="alttext0165">Fig.Â 31</ce:alt-text>
               <ce:link locator="gr31" xlink:type="simple" xlink:role="http://data.elsevier.com/vocabulary/ElsevierContentTypes/23.4" xlink:href="pii:S022352341930371X/gr31"/></ce:link>
            </ce:figure>
            <ce:figure id="fig32">
               <ce:label>Fig.Â 32</ce:label>
               <ce:caption id="cap0165">
                  <ce:simple-para id="fspara0165" view="all">Examples in WO2008117050 and their IC<ce:inf loc="post">50</ce:inf> values against JAK or Trk.</ce:simple-para>
               </ce:caption>
               <ce:alt-text role="short" id="alttext0170">Fig.Â 32</ce:alt-text>
               <ce:link locator="gr32" xlink:type="simple" xlink:role="http://data.elsevier.com/vocabulary/ElsevierContentTypes/23.4" xlink:href="pii:S022352341930371X/gr32"/></ce:link>
            </ce:figure>
            <ce:figure id="fig33">
               <ce:label>Fig.Â 33</ce:label>
               <ce:caption id="cap0170">
                  <ce:simple-para id="fspara0170" view="all">Chemical structure of AZD7451 (<ce:bold>78</ce:bold>).</ce:simple-para>
               </ce:caption>
               <ce:alt-text role="short" id="alttext0175">Fig.Â 33</ce:alt-text>
               <ce:link locator="gr33" xlink:type="simple" xlink:role="http://data.elsevier.com/vocabulary/ElsevierContentTypes/23.4" xlink:href="pii:S022352341930371X/gr33"/></ce:link>
            </ce:figure>
            <ce:figure id="fig34">
               <ce:label>Fig.Â 34</ce:label>
               <ce:caption id="cap0175">
                  <ce:simple-para id="fspara0175" view="all">Chemical structure of <ce:bold>79</ce:bold>.</ce:simple-para>
               </ce:caption>
               <ce:alt-text role="short" id="alttext0180">Fig.Â 34</ce:alt-text>
               <ce:link locator="gr34" xlink:type="simple" xlink:role="http://data.elsevier.com/vocabulary/ElsevierContentTypes/23.4" xlink:href="pii:S022352341930371X/gr34"/></ce:link>
            </ce:figure>
            <ce:figure id="fig35">
               <ce:label>Fig.Â 35</ce:label>
               <ce:caption id="cap0180">
                  <ce:simple-para id="fspara0180" view="all">Chemical structures of K-252a (<ce:bold>80</ce:bold>) and its derivatives <ce:bold>81</ce:bold>â<ce:bold>83</ce:bold>.</ce:simple-para>
               </ce:caption>
               <ce:alt-text role="short" id="alttext0185">Fig.Â 35</ce:alt-text>
               <ce:link locator="gr35" xlink:type="simple" xlink:role="http://data.elsevier.com/vocabulary/ElsevierContentTypes/23.4" xlink:href="pii:S022352341930371X/gr35"/></ce:link>
            </ce:figure>
            <ce:figure id="fig36">
               <ce:label>Fig.Â 36</ce:label>
               <ce:caption id="cap0185">
                  <ce:simple-para id="fspara0185" view="all">Chemical structure of Entrectinib (<ce:bold>84</ce:bold>).</ce:simple-para>
               </ce:caption>
               <ce:alt-text role="short" id="alttext0190">Fig.Â 36</ce:alt-text>
               <ce:link locator="gr36" xlink:type="simple" xlink:role="http://data.elsevier.com/vocabulary/ElsevierContentTypes/23.4" xlink:href="pii:S022352341930371X/gr36"/></ce:link>
            </ce:figure>
            <ce:figure id="fig37">
               <ce:label>Fig.Â 37</ce:label>
               <ce:caption id="cap0190">
                  <ce:simple-para id="fspara0190" view="all">X-ray crystal structure of entrectinib (<ce:bold>84</ce:bold>) bound to TrkA (PDB ID code 5KVT).</ce:simple-para>
               </ce:caption>
               <ce:alt-text role="short" id="alttext0195">Fig.Â 37</ce:alt-text>
               <ce:link locator="gr37" xlink:type="simple" xlink:role="http://data.elsevier.com/vocabulary/ElsevierContentTypes/23.4" xlink:href="pii:S022352341930371X/gr37"/></ce:link>
            </ce:figure>
            <ce:figure id="fig38">
               <ce:label>Fig.Â 38</ce:label>
               <ce:caption id="cap0195">
                  <ce:simple-para id="fspara0195" view="all">Chemical structure of milciclib (<ce:bold>85</ce:bold>).</ce:simple-para>
               </ce:caption>
               <ce:alt-text role="short" id="alttext0200">Fig.Â 38</ce:alt-text>
               <ce:link locator="gr38" xlink:type="simple" xlink:role="http://data.elsevier.com/vocabulary/ElsevierContentTypes/23.4" xlink:href="pii:S022352341930371X/gr38"/></ce:link>
            </ce:figure>
            <ce:figure id="fig39">
               <ce:label>Fig.Â 39</ce:label>
               <ce:caption id="cap0200">
                  <ce:simple-para id="fspara0200" view="all">Chemical structure of (dl)-crizotinib (<ce:bold>86</ce:bold>) and its (S)-isomer, GTx-186 (<ce:bold>87</ce:bold>).</ce:simple-para>
               </ce:caption>
               <ce:alt-text role="short" id="alttext0205">Fig.Â 39</ce:alt-text>
               <ce:link locator="gr39" xlink:type="simple" xlink:role="http://data.elsevier.com/vocabulary/ElsevierContentTypes/23.4" xlink:href="pii:S022352341930371X/gr39"/></ce:link>
            </ce:figure>
            <ce:figure id="fig40">
               <ce:label>Fig.Â 40</ce:label>
               <ce:caption id="cap0205">
                  <ce:simple-para id="fspara0205" view="all">Chemical structure of KST016366 (<ce:bold>88</ce:bold>).</ce:simple-para>
               </ce:caption>
               <ce:alt-text role="short" id="alttext0210">Fig.Â 40</ce:alt-text>
               <ce:link locator="gr40" xlink:type="simple" xlink:role="http://data.elsevier.com/vocabulary/ElsevierContentTypes/23.4" xlink:href="pii:S022352341930371X/gr40"/></ce:link>
            </ce:figure>
            <ce:figure id="fig41">
               <ce:label>Fig.Â 41</ce:label>
               <ce:caption id="cap0210">
                  <ce:simple-para id="fspara0210" view="all">Chemical structure of GNF-5837 (<ce:bold>89</ce:bold>).</ce:simple-para>
               </ce:caption>
               <ce:alt-text role="short" id="alttext0215">Fig.Â 41</ce:alt-text>
               <ce:link locator="gr41" xlink:type="simple" xlink:role="http://data.elsevier.com/vocabulary/ElsevierContentTypes/23.4" xlink:href="pii:S022352341930371X/gr41"/></ce:link>
            </ce:figure>
            <ce:figure id="fig42">
               <ce:label>Fig.Â 42</ce:label>
               <ce:caption id="cap0215">
                  <ce:simple-para id="fspara0215" view="all">X-ray crystal structure of GNF-5837 (<ce:bold>52</ce:bold>) bound to TrkC (PDB ID code 3V5Q).</ce:simple-para>
               </ce:caption>
               <ce:alt-text role="short" id="alttext0220">Fig.Â 42</ce:alt-text>
               <ce:link locator="gr42" xlink:type="simple" xlink:role="http://data.elsevier.com/vocabulary/ElsevierContentTypes/23.4" xlink:href="pii:S022352341930371X/gr42"/></ce:link>
            </ce:figure>
            <ce:figure id="fig43">
               <ce:label>Fig.Â 43</ce:label>
               <ce:caption id="cap0220">
                  <ce:simple-para id="fspara0220" view="all">Example <ce:bold>1</ce:bold> in WO2006052936.</ce:simple-para>
               </ce:caption>
               <ce:alt-text role="short" id="alttext0225">Fig.Â 43</ce:alt-text>
               <ce:link locator="gr43" xlink:type="simple" xlink:role="http://data.elsevier.com/vocabulary/ElsevierContentTypes/23.4" xlink:href="pii:S022352341930371X/gr43"/></ce:link>
            </ce:figure>
            <ce:figure id="fig44">
               <ce:label>Fig.Â 44</ce:label>
               <ce:caption id="cap0225">
                  <ce:simple-para id="fspara0225" view="all">Chemical structure of KK5101 (<ce:bold>91</ce:bold>).</ce:simple-para>
               </ce:caption>
               <ce:alt-text role="short" id="alttext0230">Fig.Â 44</ce:alt-text>
               <ce:link locator="gr44" xlink:type="simple" xlink:role="http://data.elsevier.com/vocabulary/ElsevierContentTypes/23.4" xlink:href="pii:S022352341930371X/gr44"/></ce:link>
            </ce:figure>
            <ce:figure id="fig45">
               <ce:label>Fig.Â 45</ce:label>
               <ce:caption id="cap0230">
                  <ce:simple-para id="fspara0230" view="all">Chemical structure of GW441756 (<ce:bold>92</ce:bold>).</ce:simple-para>
               </ce:caption>
               <ce:alt-text role="short" id="alttext0235">Fig.Â 45</ce:alt-text>
               <ce:link locator="gr45" xlink:type="simple" xlink:role="http://data.elsevier.com/vocabulary/ElsevierContentTypes/23.4" xlink:href="pii:S022352341930371X/gr45"/></ce:link>
            </ce:figure>
            <ce:figure id="fig46">
               <ce:label>Fig.Â 46</ce:label>
               <ce:caption id="cap0235">
                  <ce:simple-para id="fspara0235" view="all">Chemical structure of HS345 (<ce:bold>93</ce:bold>).</ce:simple-para>
               </ce:caption>
               <ce:alt-text role="short" id="alttext0240">Fig.Â 46</ce:alt-text>
               <ce:link locator="gr46" xlink:type="simple" xlink:role="http://data.elsevier.com/vocabulary/ElsevierContentTypes/23.4" xlink:href="pii:S022352341930371X/gr46"/></ce:link>
            </ce:figure>
            <ce:figure id="fig47">
               <ce:label>Fig.Â 47</ce:label>
               <ce:caption id="cap0240">
                  <ce:simple-para id="fspara0240" view="all">Chemical structures of <ce:bold>94</ce:bold> and <ce:bold>95</ce:bold>.</ce:simple-para>
               </ce:caption>
               <ce:alt-text role="short" id="alttext0245">Fig.Â 47</ce:alt-text>
               <ce:link locator="gr47" xlink:type="simple" xlink:role="http://data.elsevier.com/vocabulary/ElsevierContentTypes/23.4" xlink:href="pii:S022352341930371X/gr47"/></ce:link>
            </ce:figure>
            <ce:table xmlns="http://www.elsevier.com/xml/common/cals/dtd" id="tbl1" frame="topbot" colsep="0" rowsep="0">
               <ce:label>TableÂ 1</ce:label>
               <ce:caption id="cap0245">
                  <ce:simple-para id="tspara0010" view="all">Reported <ce:italic>NTRK</ce:italic> gene fusion cases concerning with neoplasm<ce:bold>s</ce:bold>.</ce:simple-para>
               </ce:caption>
               <ce:alt-text role="short" id="alttext0250">TableÂ 1</ce:alt-text>
               <tgroup cols="4">
                  <colspec colnum="1" colname="col1"/></colspec>
                  <colspec colnum="2" colname="col2"/></colspec>
                  <colspec colnum="3" colname="col3"/></colspec>
                  <colspec colnum="4" colname="col4"/></colspec>
                  <thead>
                     <row rowsep="1" valign="top">
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd">
                           <italic>NTRK</italic>
                        </entry>
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd">Fusion Protein Partner</entry>
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd">Cancer Type</entry>
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd">Frequency</entry>
                     </row>
                  </thead>
                  <tbody>
                     <row valign="top">
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd" morerows="27" align="left">
                           <italic>NTRK1</italic>
                        </entry>
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd" align="left">
                           <italic>ARHGEF2</italic>
                        </entry>
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd" align="left">Glioblastoma</entry>
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd" align="left">1/115 [<cross-ref refid="bib14" id="crosref0690">14</cross-ref>]</entry>
                     </row>
                     <row valign="top">
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd" morerows="1" align="left">
                           <italic>BCAN</italic>
                        </entry>
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd" morerows="1" align="left">Glioblastoma</entry>
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd" align="left">1/162 [<cross-ref refid="bib15" id="crosref0695">15</cross-ref>]</entry>
                     </row>
                     <row valign="top">
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd" align="left">1/185 [<cross-ref refid="bib16" id="crosref0700">16</cross-ref>]</entry>
                     </row>
                     <row valign="top">
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd" align="left">
                           <italic>CD74</italic>
                        </entry>
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd" align="left">Lung adenocarcinoma</entry>
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd" align="left">2/36 [<cross-ref refid="bib17" id="crosref0705">17</cross-ref>]</entry>
                     </row>
                     <row valign="top">
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd" align="left">
                           <italic>CHTOP</italic>
                        </entry>
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd" align="left">Glioblastoma</entry>
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd" align="left">2/115 [<cross-ref refid="bib14" id="crosref0710">14</cross-ref>]</entry>
                     </row>
                     <row valign="top">
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd" morerows="3" align="left">
                           <italic>LMNA</italic>
                        </entry>
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd" align="left">AYA sarcoma</entry>
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd" align="left">1 case report [<cross-ref refid="bib18" id="crosref0715">18</cross-ref>]</entry>
                     </row>
                     <row valign="top">
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd" align="left">Colorectal</entry>
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd" align="left">1 case report [<cross-ref refid="bib19" id="crosref0720">19</cross-ref>]</entry>
                     </row>
                     <row valign="top">
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd" align="left">Congenital infantile fibrosarcoma</entry>
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd" align="left">1 case report [<cross-ref refid="bib20" id="crosref0725">20</cross-ref>]</entry>
                     </row>
                     <row valign="top">
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd" align="left">Spitzoid neoplasms</entry>
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd" align="left">
                           <cross-ref refid="tbl1fna" id="crosref0730">
                              <sup loc="post">a</sup>
                           </cross-ref> [<cross-ref refid="bib21" id="crosref0735">21</cross-ref>]</entry>
                     </row>
                     <row valign="top">
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd" align="left">
                           <italic>MPRIP</italic>
                        </entry>
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd" align="left">Lung adenocarcinoma</entry>
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd" align="left">3/91 [<cross-ref refid="bib17" id="crosref0740">17</cross-ref>]</entry>
                     </row>
                     <row valign="top">
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd" morerows="1" align="left">
                           <italic>NFASC</italic>
                        </entry>
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd" morerows="1" align="left">Glioblastoma</entry>
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd" align="left">1/162 [<cross-ref refid="bib15" id="crosref0745">15</cross-ref>]</entry>
                     </row>
                     <row valign="top">
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd" align="left">4/162 [<cross-ref refid="bib16" id="crosref0750">16</cross-ref>]</entry>
                     </row>
                     <row valign="top">
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd" align="left">
                           <italic>PPL</italic>
                        </entry>
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd" align="left">Thyroid carcinoma</entry>
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd" align="left">1 case report [<cross-ref refid="bib22" id="crosref0755">22</cross-ref>]</entry>
                     </row>
                     <row valign="top">
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd" align="left">
                           <italic>RABGAP1L</italic>
                        </entry>
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd" align="left">Intrahepatic cholangiocellular carcinoma</entry>
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd" align="left">1/182 [<cross-ref refid="bib23" id="crosref0760">23</cross-ref>]</entry>
                     </row>
                     <row valign="top">
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd" align="left">
                           <italic>RFWD2</italic>
                        </entry>
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd" align="left">Large cell neuroendocrine tumor</entry>
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd" align="left">1 case report [<cross-ref refid="bib24" id="crosref0765">24</cross-ref>]</entry>
                     </row>
                     <row valign="top">
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd" align="left">
                           <italic>SQSTM1</italic>
                        </entry>
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd" align="left">Lung adenocarcinoma</entry>
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd" align="left">1/1378 [<cross-ref refid="bib25" id="crosref0770">25</cross-ref>]</entry>
                     </row>
                     <row valign="top">
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd" align="left">
                           <italic>TFG</italic>
                        </entry>
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd" align="left">Papillary thyroid carcinoma</entry>
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd" align="left">28/228 [<cross-ref refid="bib26" id="crosref0775">26</cross-ref>]</entry>
                     </row>
                     <row valign="top">
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd" align="left">
                           <italic>TP53</italic>
                        </entry>
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd" align="left">Spitzoid neoplasms</entry>
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd" align="left">
                           <cross-ref refid="tbl1fna" id="crosref0780">
                              <sup loc="post">a</sup>
                           </cross-ref> [<cross-ref refid="bib21" id="crosref0785">21</cross-ref>]</entry>
                     </row>
                     <row valign="top">
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd" morerows="5" align="left">
                           <italic>TPM3</italic>
                        </entry>
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd" align="left">NSCLC</entry>
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd" align="left">1/1378 [<cross-ref refid="bib25" id="crosref0790">25</cross-ref>]</entry>
                     </row>
                     <row valign="top">
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd" morerows="1" align="left">Colorectal cancer</entry>
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd" align="left">1/408 [<cross-ref refid="bib27" id="crosref0795">27</cross-ref>]</entry>
                     </row>
                     <row valign="top">
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd" align="left">1 case report [<cross-ref refid="bib28" id="crosref0800">28</cross-ref>]</entry>
                     </row>
                     <row valign="top">
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd" align="left">Glioblastoma</entry>
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd" align="left">2/185 [<cross-ref refid="bib29" id="crosref0805">29</cross-ref>]</entry>
                     </row>
                     <row valign="top">
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd" morerows="1" align="left">Papillary thyroid carcinoma</entry>
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd" align="left">2/52 [<cross-ref refid="bib30" id="crosref0810">30</cross-ref>]</entry>
                     </row>
                     <row valign="top">
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd" align="left">5/81 [<cross-ref refid="bib31" id="crosref0815">31</cross-ref>]</entry>
                     </row>
                     <row valign="top">
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd" morerows="2" align="left">
                           <italic>TPR</italic>
                        </entry>
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd" morerows="1" align="left">Papillary thyroid carcinoma</entry>
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd" align="left">2 case reports [<cross-ref refid="bib32" id="crosref0820">32</cross-ref>]</entry>
                     </row>
                     <row valign="top">
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd" align="left">1 case report [<cross-ref refid="bib33" id="crosref0825">33</cross-ref>]</entry>
                     </row>
                     <row valign="top">
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd" align="left">Colorectal cancer</entry>
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd" align="left">1/408 [<cross-ref refid="bib27" id="crosref0830">27</cross-ref>]</entry>
                     </row>
                     <row valign="top">
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd" align="left">
                           <italic>SCYL3</italic>
                        </entry>
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd" align="left">Colorectal cancer</entry>
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd" align="left">1 case report [<cross-ref refid="bib34" id="crosref0835">34</cross-ref>]</entry>
                     </row>
                     <row valign="top">
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd" morerows="9" align="left">
                           <italic>NTRK2</italic>
                        </entry>
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd" align="left">
                           <italic>AFAP1</italic>
                        </entry>
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd" align="left">Low-grade glioma</entry>
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd" align="left">2/461 [<cross-ref refid="bib35" id="crosref0840">35</cross-ref>]</entry>
                     </row>
                     <row valign="top">
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd" align="left">
                           <italic>AGBL4</italic>
                        </entry>
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd" align="left">Glioblastoma</entry>
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd" align="left">1 case report [<cross-ref refid="bib29" id="crosref0845">29</cross-ref>]</entry>
                     </row>
                     <row valign="top">
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd" align="left">
                           <italic>NACC2</italic>
                        </entry>
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd" align="left">Pilocytic astrocytoma</entry>
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd" align="left">1 case report [<cross-ref refid="bib36" id="crosref0850">36</cross-ref>]</entry>
                     </row>
                     <row valign="top">
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd" morerows="1" align="left">
                           <italic>PAN3</italic>
                        </entry>
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd" morerows="1" align="left">Head and neck squamous cell carcinoma</entry>
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd" align="left">1 case report [<cross-ref refid="bib29" id="crosref0855">29</cross-ref>]</entry>
                     </row>
                     <row valign="top">
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd" align="left">1/335 [<cross-ref refid="bib35" id="crosref0860">35</cross-ref>]</entry>
                     </row>
                     <row valign="top">
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd" align="left">
                           <italic>QKI</italic>
                        </entry>
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd" align="left">Pilocytic astrocytoma</entry>
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd" align="left">1 case report [<cross-ref refid="bib36" id="crosref0865">36</cross-ref>]</entry>
                     </row>
                     <row valign="top">
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd" morerows="1" align="left">
                           <italic>TRIM24</italic>
                        </entry>
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd" morerows="1" align="left">Lung adenocarcinomas</entry>
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd" align="left">1 case report [<cross-ref refid="bib29" id="crosref0870">29</cross-ref>]</entry>
                     </row>
                     <row valign="top">
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd" align="left">1/513 [<cross-ref refid="bib35" id="crosref0875">35</cross-ref>]</entry>
                     </row>
                     <row valign="top">
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd" align="left">
                           <italic>VCL</italic>
                        </entry>
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd" align="left">Glioblastoma</entry>
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd" align="left">1 case report [<cross-ref refid="bib29" id="crosref0880">29</cross-ref>]</entry>
                     </row>
                     <row valign="top">
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd" align="left">
                           <italic>BTBD1</italic>
                        </entry>
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd" align="left">Glioblastoma</entry>
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd" align="left">1 case report [<cross-ref refid="bib29" id="crosref0885">29</cross-ref>]</entry>
                     </row>
                     <row valign="top">
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd" morerows="19" align="left">
                           <italic>NTRK3</italic>
                        </entry>
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd" morerows="19" align="left">
                           <italic>ETV6</italic>
                        </entry>
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd" morerows="2" align="left">Acute myelogenous leukemia</entry>
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd" align="left">1 case report [<cross-ref refid="bib37" id="crosref0890">37</cross-ref>]</entry>
                     </row>
                     <row valign="top">
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd" align="left">1 case report [<cross-ref refid="bib38" id="crosref0895">38</cross-ref>]</entry>
                     </row>
                     <row valign="top">
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd" align="left">1 case report [<cross-ref refid="bib39" id="crosref0900">39</cross-ref>]</entry>
                     </row>
                     <row valign="top">
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd" morerows="1" align="left">Congenital fibrosarcoma</entry>
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd" align="left">1 case report [<cross-ref refid="bib40" id="crosref0905">40</cross-ref>]</entry>
                     </row>
                     <row valign="top">
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd" align="left">10/11 [<cross-ref refid="bib11" id="crosref0910">11</cross-ref>]</entry>
                     </row>
                     <row valign="top">
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd" morerows="2" align="left">Congenital mesoblastic nephroma</entry>
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd" align="left">1 case report [<cross-ref refid="bib39" id="crosref0915">39</cross-ref>]</entry>
                     </row>
                     <row valign="top">
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd" align="left">6/11 [<cross-ref refid="bib41" id="crosref0920">41</cross-ref>]</entry>
                     </row>
                     <row valign="top">
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd" align="left">3/6 [<cross-ref refid="bib42" id="crosref0925">42</cross-ref>]</entry>
                     </row>
                     <row valign="top">
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd" align="left">Colorectal cancer</entry>
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd" align="left">1/751 [<cross-ref refid="bib43" id="crosref0930">43</cross-ref>]</entry>
                     </row>
                     <row valign="top">
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd" morerows="2" align="left">Ductal carcinoma</entry>
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd" align="left">1/202 [<cross-ref refid="bib44" id="crosref0935">44</cross-ref>]</entry>
                     </row>
                     <row valign="top">
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd" align="left">1 case report [<cross-ref refid="bib45" id="crosref0940">45</cross-ref>]</entry>
                     </row>
                     <row valign="top">
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd" align="left">3/10 [<cross-ref refid="bib46" id="crosref0945">46</cross-ref>]</entry>
                     </row>
                     <row valign="top">
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd" morerows="1" align="left">Fibrosarcoma</entry>
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd" align="left">1 case report [<cross-ref refid="bib47" id="crosref0950">47</cross-ref>]</entry>
                     </row>
                     <row valign="top">
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd" align="left">1 case report [<cross-ref refid="bib48" id="crosref0955">48</cross-ref>]</entry>
                     </row>
                     <row valign="top">
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd" align="left">Gastrointestinal stromal carcinoma</entry>
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd" align="left">1/5 [<cross-ref refid="bib49" id="crosref0960">49</cross-ref>]</entry>
                     </row>
                     <row valign="top">
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd" align="left">Glioblastoma</entry>
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd" align="left">2/5 [<cross-ref refid="bib29" id="crosref0965">29</cross-ref>]</entry>
                     </row>
                     <row valign="top">
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd" morerows="2" align="left">Mammary analogue secretory carcinoma</entry>
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd" align="left">12/12 [<cross-ref refid="bib50" id="crosref0970">50</cross-ref>]</entry>
                     </row>
                     <row valign="top">
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd" align="left">25/121 [<cross-ref refid="bib51" id="crosref0975">51</cross-ref>]</entry>
                     </row>
                     <row valign="top">
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd" align="left">1/11 [<cross-ref refid="bib52" id="crosref0980">52</cross-ref>]</entry>
                     </row>
                     <row valign="top">
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd" align="left">Papillary thyroid carcinoma</entry>
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd" align="left">9/62 [<cross-ref refid="bib53" id="crosref0985">53</cross-ref>]</entry>
                     </row>
                  </tbody>
               </tgroup>
               <ce:table-footnote id="tbl1fna">
                  <ce:label>a</ce:label>
                  <ce:note-para id="ntpara0010" view="all">The total frequency of <ce:italic>NTRK1-LMNA</ce:italic> and <ce:italic>NTRK1-TP53</ce:italic> detected in spitzoid neoplasm patients is 23/140.</ce:note-para>
               </ce:table-footnote>
            </ce:table>
            <ce:table xmlns="http://www.elsevier.com/xml/common/cals/dtd" id="tbl2" frame="topbot" colsep="0" rowsep="0">
               <ce:label>TableÂ 2</ce:label>
               <ce:caption id="cap0250">
                  <ce:simple-para id="tspara0015" view="all">Pharmacokinetic data of larotrectinib.</ce:simple-para>
               </ce:caption>
               <ce:alt-text role="short" id="alttext0255">TableÂ 2</ce:alt-text>
               <tgroup cols="2">
                  <colspec colnum="1" colname="col1"/></colspec>
                  <colspec colnum="2" colname="col2"/></colspec>
                  <tbody>
                     <row valign="top">
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd" align="left">Recommended adult dosage</entry>
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd" align="left">100â¯mg twice daily</entry>
                     </row>
                     <row valign="top">
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd" align="left">C<inf loc="post">max</inf>
                           <cross-ref refid="tbl2fna" id="crosref0990">
                              <sup loc="post">a</sup>
                           </cross-ref>
                        </entry>
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd" align="left">788â¯ng/mL</entry>
                     </row>
                     <row valign="top">
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd" align="left">t<inf loc="post">max</inf>
                           <cross-ref refid="tbl2fna" id="crosref0995">
                              <sup loc="post">a</sup>
                           </cross-ref>
                        </entry>
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd" align="left">1â¯h</entry>
                     </row>
                     <row valign="top">
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd" align="left">AUC<inf loc="post">0â24hr</inf>
                           <cross-ref refid="tbl2fna" id="crosref1000">
                              <sup loc="post">a</sup>
                           </cross-ref>
                        </entry>
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd" align="left">4351Â ng*h/mL</entry>
                     </row>
                     <row valign="top">
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd" align="left">F<cross-ref refid="tbl2fnb" id="crosref1005">
                              <sup loc="post">b</sup>
                           </cross-ref>
                        </entry>
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd" align="left">32%â37%</entry>
                     </row>
                     <row valign="top">
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd" align="left">V<inf loc="post">ss</inf>
                           <cross-ref refid="tbl2fnb" id="crosref1010">
                              <sup loc="post">b</sup>
                           </cross-ref>
                        </entry>
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd" align="left">48â¯L</entry>
                     </row>
                     <row valign="top">
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd" align="left">CL/F<cross-ref refid="tbl2fnb" id="crosref1015">
                              <sup loc="post">b</sup>
                           </cross-ref>
                        </entry>
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd" align="left">98â¯L/h</entry>
                     </row>
                     <row valign="top">
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd" align="left">t<inf loc="post">1/2</inf>
                           <cross-ref refid="tbl2fnb" id="crosref1020">
                              <sup loc="post">b</sup>
                           </cross-ref>
                        </entry>
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd" align="left">2.9â¯h</entry>
                     </row>
                     <row valign="top">
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd" align="left">Main metabolism product</entry>
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd" align="left">O-linked glucuronide</entry>
                     </row>
                  </tbody>
               </tgroup>
               <ce:table-footnote id="tbl2fna">
                  <ce:label>a</ce:label>
                  <ce:note-para id="ntpara0015" view="all">Data were acquired from adult patients with a dosage of 100â¯mg twice daily.</ce:note-para>
               </ce:table-footnote>
               <ce:table-footnote id="tbl2fnb">
                  <ce:label>b</ce:label>
                  <ce:note-para id="ntpara0020" view="all">Data were acquired from healthy volunteers with a dosage of 100â¯mg twice daily.</ce:note-para>
               </ce:table-footnote>
            </ce:table>
            <ce:table xmlns="http://www.elsevier.com/xml/common/cals/dtd" id="tbl3" frame="topbot" colsep="0" rowsep="0">
               <ce:label>TableÂ 3</ce:label>
               <ce:caption id="cap0255">
                  <ce:simple-para id="tspara0020" view="all">IC<ce:inf loc="post">50</ce:inf> values of <ce:bold>8</ce:bold> and <ce:bold>9</ce:bold> against TrkA-C and JAK2.</ce:simple-para>
               </ce:caption>
               <ce:alt-text role="short" id="alttext0260">TableÂ 3</ce:alt-text>
               <tgroup cols="5">
                  <colspec colnum="1" colname="col1"/></colspec>
                  <colspec colnum="2" colname="col2"/></colspec>
                  <colspec colnum="3" colname="col3"/></colspec>
                  <colspec colnum="4" colname="col4"/></colspec>
                  <colspec colnum="5" colname="col5"/></colspec>
                  <thead>
                     <row rowsep="1" valign="top">
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd"/></entry>
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd">TrkA IC<inf loc="post">50</inf> (nM)</entry>
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd">TrkB IC<inf loc="post">50</inf> (nM)</entry>
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd">TrkC IC<inf loc="post">50</inf> (nM)</entry>
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd">JAK2 IC<inf loc="post">50</inf> (nM)</entry>
                     </row>
                  </thead>
                  <tbody>
                     <row valign="top">
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd" role="rowhead" align="left">
                           <bold>8</bold>
                        </entry>
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd" align="left"><1</entry>
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd" align="left"><10</entry>
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd" align="left"><10</entry>
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd" align="left">>2000</entry>
                     </row>
                     <row valign="top">
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd" role="rowhead" align="left">
                           <bold>9</bold>
                        </entry>
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd" align="left"><1</entry>
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd" align="left"><10</entry>
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd" align="left"><10</entry>
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd" align="left">>500</entry>
                     </row>
                  </tbody>
               </tgroup>
            </ce:table>
            <ce:table xmlns="http://www.elsevier.com/xml/common/cals/dtd" id="tbl4" frame="topbot" colsep="0" rowsep="0">
               <ce:label>TableÂ 4</ce:label>
               <ce:caption id="cap0260">
                  <ce:simple-para id="tspara0025" view="all">IC<ce:inf loc="post">50</ce:inf> values of <ce:bold>10</ce:bold> and <ce:bold>11</ce:bold> against TrkA, TrkB and BTK.</ce:simple-para>
               </ce:caption>
               <ce:alt-text role="short" id="alttext0265">TableÂ 4</ce:alt-text>
               <tgroup cols="4">
                  <colspec colnum="1" colname="col1"/></colspec>
                  <colspec colnum="2" colname="col2"/></colspec>
                  <colspec colnum="3" colname="col3"/></colspec>
                  <colspec colnum="4" colname="col4"/></colspec>
                  <thead>
                     <row rowsep="1" valign="top">
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd"/></entry>
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd">TrkA IC<inf loc="post">50</inf> (nM)</entry>
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd">TrkB IC<inf loc="post">50</inf> (nM)</entry>
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd">BTK IC<inf loc="post">50</inf> (nM)</entry>
                     </row>
                  </thead>
                  <tbody>
                     <row valign="top">
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd" role="rowhead" align="left">
                           <bold>10</bold>
                        </entry>
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd" align="left">0.2</entry>
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd" align="left">5000</entry>
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd" align="left">9.67</entry>
                     </row>
                     <row valign="top">
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd" role="rowhead" align="left">
                           <bold>11</bold>
                        </entry>
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd" align="left">0.2</entry>
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd" align="left">1500</entry>
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd" align="left">0.536</entry>
                     </row>
                  </tbody>
               </tgroup>
            </ce:table>
            <ce:table xmlns="http://www.elsevier.com/xml/common/cals/dtd" id="tbl5" frame="topbot" colsep="0" rowsep="0">
               <ce:label>TableÂ 5</ce:label>
               <ce:caption id="cap0265">
                  <ce:simple-para id="tspara0030" view="all">IC<ce:inf loc="post">50</ce:inf> values of <ce:bold>21</ce:bold>â<ce:bold>23</ce:bold> against TrkA.</ce:simple-para>
               </ce:caption>
               <ce:alt-text role="short" id="alttext0270">TableÂ 5</ce:alt-text>
               <tgroup cols="3">
                  <colspec colnum="1" colname="col1"/></colspec>
                  <colspec colnum="2" colname="col2"/></colspec>
                  <colspec colnum="3" colname="col3"/></colspec>
                  <thead>
                     <row rowsep="1" valign="top">
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd"/></entry>
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd">TrkA Enzyme IC<inf loc="post">50</inf> (nM)</entry>
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd">TrkA Cell IC<inf loc="post">50</inf> (nM)</entry>
                     </row>
                  </thead>
                  <tbody>
                     <row valign="top">
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd" role="rowhead" align="left">
                           <bold>21</bold>
                        </entry>
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd" align="left">1.1</entry>
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd" align="left">1.9</entry>
                     </row>
                     <row valign="top">
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd" role="rowhead" align="left">
                           <bold>22</bold>
                        </entry>
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd" align="left">1.5</entry>
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd" align="left">1.3</entry>
                     </row>
                     <row valign="top">
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd" role="rowhead" align="left">
                           <bold>23</bold>
                        </entry>
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd" align="left">1.7</entry>
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd" align="left">6.1</entry>
                     </row>
                  </tbody>
               </tgroup>
            </ce:table>
         </ce:floats>
         <head>
            <ce:dochead id="dhead0010">
               <ce:textfn>Review article</ce:textfn>
            </ce:dochead>
            <ce:title id="title0010">Targeting tropomyosin receptor kinase for cancer therapy</ce:title>
            <ce:author-group id="augrp0010">
               <ce:author id="au1" orcid="0000-0003-4250-2239" author-id="S022352341930371X-e1b191608b73a741a77fee33a13f6c03">
                  <ce:given-name>Qi</ce:given-name>
                  <ce:surname>Miao</ce:surname>
                  <ce:cross-ref refid="aff1" id="crosref0010">
                     <ce:sup loc="post">a</ce:sup>
                  </ce:cross-ref>
               </ce:author>
               <ce:author id="au2" author-id="S022352341930371X-275da54f311f8a5c1aad4656371daf5c">
                  <ce:given-name>Kun</ce:given-name>
                  <ce:surname>Ma</ce:surname>
                  <ce:cross-ref refid="aff2" id="crosref0015">
                     <ce:sup loc="post">b</ce:sup>
                  </ce:cross-ref>
               </ce:author>
               <ce:author id="au3" author-id="S022352341930371X-5c18ad9534b2e1ec4010107486d1886d">
                  <ce:given-name>Dong</ce:given-name>
                  <ce:surname>Chen</ce:surname>
                  <ce:cross-ref refid="aff1" id="crosref0020">
                     <ce:sup loc="post">a</ce:sup>
                  </ce:cross-ref>
               </ce:author>
               <ce:author id="au4" author-id="S022352341930371X-0486daf5865b5029469dee35fca6006c">
                  <ce:given-name>Xiaoxing</ce:given-name>
                  <ce:surname>Wu</ce:surname>
                  <ce:cross-ref refid="aff1" id="crosref0025">
                     <ce:sup loc="post">a</ce:sup>
                  </ce:cross-ref>
                  <ce:cross-ref refid="cor2" id="crosref0030">
                     <ce:sup loc="post">ââ</ce:sup>
                  </ce:cross-ref>
                  
               </ce:author>
               <ce:author id="au5" orcid="0000-0002-4550-5024" author-id="S022352341930371X-05cd02c178e208a8dfc3b16cc9e5b379">
                  <ce:given-name>Sheng</ce:given-name>
                  <ce:surname>Jiang</ce:surname>
                  <ce:cross-ref refid="aff1" id="crosref0035">
                     <ce:sup loc="post">a</ce:sup>
                  </ce:cross-ref>
                  <ce:cross-ref refid="cor1" id="crosref0040">
                     <ce:sup loc="post">â</ce:sup>
                  </ce:cross-ref>
                  
               </ce:author>
               <ce:affiliation id="aff1" affiliation-id="S022352341930371X-540356e28c0c3ff26ead6abf7863390d">
                  <ce:label>a</ce:label>
                  <ce:textfn>State Key Laboratory of Natural Medicines and Department of Medicinal Chemistry, School of Pharmacy, China Pharmaceutical University, Nanjing, 210009, China</ce:textfn>
                  <sa:affiliation>
                     <sa:organization>State Key Laboratory of Natural Medicines and Department of Medicinal Chemistry</sa:organization>
                     <sa:organization>School of Pharmacy</sa:organization>
                     <sa:organization>China Pharmaceutical University</sa:organization>
                     <sa:city>Nanjing</sa:city>
                     <sa:postal-code>210009</sa:postal-code>
                     <sa:country>China</sa:country>
                  </sa:affiliation>
               </ce:affiliation>
               <ce:affiliation id="aff2" affiliation-id="S022352341930371X-a181308a6624eec62dd14172f9f5b970">
                  <ce:label>b</ce:label>
                  <ce:textfn>Center for Drug Evaluation, China Food and Drug Administration, Beijing, 100038, China</ce:textfn>
                  <sa:affiliation>
                     <sa:organization>Center for Drug Evaluation</sa:organization>
                     <sa:organization>China Food and Drug Administration</sa:organization>
                     <sa:city>Beijing</sa:city>
                     <sa:postal-code>100038</sa:postal-code>
                     <sa:country>China</sa:country>
                  </sa:affiliation>
               </ce:affiliation>
               <ce:correspondence id="cor1">
                  <ce:label>â</ce:label>
                  <ce:text>Corresponding author. Department of Pharmacy, China Pharmaceutical University, 24 Tong Jia Xiang, Nanjing, 210009, China.</ce:text>
                  <sa:affiliation>
                     <sa:organization>Department of Pharmacy</sa:organization>
                     <sa:organization>China Pharmaceutical University</sa:organization>
                     <sa:address-line>24 Tong Jia Xiang</sa:address-line>
                     <sa:city>Nanjing</sa:city>
                     <sa:postal-code>210009</sa:postal-code>
                     <sa:country>China</sa:country>
                  </sa:affiliation>
               </ce:correspondence>
               <ce:correspondence id="cor2">
                  <ce:label>ââ</ce:label>
                  <ce:text>Corresponding author. Department of Pharmacy, China Pharmaceutical University, 24 Tong Jia Xiang, Nanjing, 210009, China.</ce:text>
                  <sa:affiliation>
                     <sa:organization>Department of Pharmacy</sa:organization>
                     <sa:organization>China Pharmaceutical University</sa:organization>
                     <sa:address-line>24 Tong Jia Xiang</sa:address-line>
                     <sa:city>Nanjing</sa:city>
                     <sa:postal-code>210009</sa:postal-code>
                     <sa:country>China</sa:country>
                  </sa:affiliation>
               </ce:correspondence>
            </ce:author-group>
            <ce:date-received day="11" month="2" year="2019"/></ce:date-received>
            <ce:date-revised day="17" month="4" year="2019"/></ce:date-revised>
            <ce:date-accepted day="18" month="4" year="2019"/></ce:date-accepted>
            <ce:abstract xml:lang="en" id="abs0010" view="all" class="author"><ce:abstract-sec id="abssec0010" view="all">
                  <ce:simple-para id="abspara0010" view="all">
                     <ce:italic>NTRK</ce:italic>s and their expression product tropomyosin receptor kinases (Trks) are widely distributed in mammals. While neural growth factor (NGF)-induced normal Trk activation plays a key role in nerve growth, <ce:italic>NTRK</ce:italic> alternations occurring in tumor cells were highly correlated to tumor progression and invasion. Recent clinical data from several pan-Trk inhibitors have demonstrated potential and broad applications in various cancers. This intrigues us to summarize the development of inhibitors targeting Trks with different mechanisms of action and their applications in cancer therapy. We believe that this perspective would be of great help in investigating novel anticancer drugs with better therapeutic index.</ce:simple-para>
               </ce:abstract-sec></ce:abstract>
            <ce:abstract class="graphical" id="abs0015" view="all">
               <ce:section-title id="sectitle0015">Graphical abstract</ce:section-title>
               <ce:abstract-sec id="abssec0015" view="all">
                  <ce:simple-para id="abspara0015" view="all">
                     <ce:display>
                        <ce:figure id="undfig1">
                           <ce:alt-text role="short" id="alttext0010">Image 1</ce:alt-text>
                           <ce:link locator="fx1" xlink:type="simple" xlink:role="http://data.elsevier.com/vocabulary/ElsevierContentTypes/23.4" xlink:href="pii:S022352341930371X/fx1"/></ce:link>
                        </ce:figure>
                     </ce:display>
                  </ce:simple-para>
               </ce:abstract-sec>
            </ce:abstract>
            
            <ce:keywords xml:lang="en" id="kwrds0010" view="all" class="keyword">
               <ce:section-title id="sectitle0025">Keywords</ce:section-title>
               <ce:keyword id="kwrd0010">
                  <ce:text>Tropomyosin receptor kinase</ce:text>
               </ce:keyword>
               <ce:keyword id="kwrd0015">
                  <ce:text>Neoplasm</ce:text>
               </ce:keyword>
               <ce:keyword id="kwrd0020">
                  <ce:text>Receptor kinase inhibitor</ce:text>
               </ce:keyword>
               <ce:keyword id="kwrd0025">
                  <ce:text>Gene alterations</ce:text>
               </ce:keyword>
            </ce:keywords>
         </head>
         <body view="all">
            <ce:sections>
               <ce:section id="sec1" role="introduction" view="all">
                  <ce:label>1</ce:label>
                  <ce:section-title id="sectitle0030">Introduction</ce:section-title>
                  <ce:para id="p0025" view="all">Cancer is the second leading cause of death worldwide according to the latest Cancer Report by WHO [<ce:cross-ref refid="bib1" id="crosref0045">1</ce:cross-ref>]. Considerable costs for the treatment of cancer have been witnessed and have brought heavy burden on society in the past few decades. Although substantial advances have been made in the development of anticancer drugs with novel mechanisms, drug effectiveness and resistance remain as a challenging task for pharmaceutical researchers. Owing to the development of human genome project and related gene sequencing tools, current cancer therapy has entered a new era â precision medicine [<ce:cross-ref refid="bib2" id="crosref0050">2</ce:cross-ref>,<ce:cross-ref refid="bib3" id="crosref0055">3</ce:cross-ref>]. It is important as well as reasonable for clinicians to prescribe medications for patients based on individual gene expression.</ce:para>
                  <ce:para id="p0030" view="all">In 1982, a high-molecular weight DNA was discovered from two colon carcinoma patients, leading to the identification of tropomyosin receptor kinase A (TrkA) [<ce:cross-ref refid="bib4" id="crosref0060">4</ce:cross-ref>]. Although Trk is initially identified in oncological transformation, this family is ubiquitously distributed in nervous systems and highly related to nerve development. Trk family includes TrkA, TrkB, and TrkC, which were encoded by <ce:italic>NTRK1</ce:italic>, <ce:italic>NTRK2</ce:italic>, and <ce:italic>NTRK3</ce:italic>, respectively. The kinase domains of TrkA-C share a sequence identity of more than 70%. Apo-TrkA-C displayed a similar pattern: phenylalanine in DFG motif occupies the ATP binding site and formed a T-stacking interaction with gatekeeper phenylalanine [<ce:cross-ref refid="bib5" id="crosref0065">5</ce:cross-ref>]. In normal cells, NGFs can firstly induce homo-dimerization of Trks which further bind and phosphorylate the tyrosine residues in NGFs, followed by autophosphorylation of each Trks monomer. Subsequently, the NPX<ce:underline>Y</ce:underline> motif in the juxtamembrane domain and the <ce:underline>Y</ce:underline>LDIG motif in the C-terminus are phosphorylated, creating attachment sites for downstream proteins [<ce:cross-ref refid="bib6" id="crosref0070">6</ce:cross-ref>]. The preferentially endogenous ligands for TrkA-C are slightly different. After binding with the preferred ligand NGF or NT-3, TrkA activates the pathway of PI3k/Akt and RAS/RAF/MAPK to induce nerve cell proliferation. TrkB tends to bind with BDNF or NT-3/4 and phosphorylate at Tyr515 residue. When Src-homology 2-domain containing adaptor protein (Shc) is fused into TrkB, the neural cell could survive <ce:italic>via</ce:italic> activation of PI3K/Akt pathway which further regulates bioactivities of several proteins such as Bcl-2 antagonist of cell death (BAD) and glycogen synthase kinase 3Î² (GSK-3Î²) [<ce:cross-ref refid="bib7" id="crosref0075">7</ce:cross-ref>]. TrkC commonly binds with NT-3 and can activate PI3K/Akt pathway to promote neuronal differentiation and inhibit cell apoptosis.</ce:para>
                  <ce:para id="p0035" view="all">The aforementioned Trk activation and signaling transduction can also proceed in oncological cells when <ce:italic>NTRK</ce:italic> gene alterations occur in these cells. Generally speaking, there are three main types of gene alterations associated with <ce:italic>NTRK</ce:italic>. The most common one in cancer is <ce:italic>NTRK</ce:italic> gene fusion. Different from normal expression of <ce:italic>NTRK,</ce:italic> when 3â² portion of <ce:italic>NTRK</ce:italic> fuses the 5â portion of another gene, the corresponding expression products would lead to a ligand-independent kinase activation and subsequent oncogenic singling [<ce:cross-ref refid="bib8" id="crosref0080">8</ce:cross-ref>]. Generally, gene fusion products could activate same pathways compared with normal expression products with one exception so far. In <ce:italic>ETV6âNTRK3</ce:italic> fusion, due to the lack of Tyr485 in the fusion breakpoint, a critical binding site for SHC-transforming protein 1, the corresponding expression product would utilize an alternate homologous protein, Insulin receptor substrate 1 (IRS-1) to activate downstream pathways (<ce:cross-ref refid="fig1" id="crosref0085">Fig.Â 1</ce:cross-ref>
                     <ce:float-anchor refid="fig1"/></ce:float-anchor>) [<ce:cross-ref refid="bib9" id="crosref0090">9</ce:cross-ref>]. As shown in <ce:cross-ref refid="tbl1" id="crosref0095">TableÂ 1</ce:cross-ref>
                     <ce:float-anchor refid="tbl1"/></ce:float-anchor>, Trk fusion widely distributed in different cancer types. The most noticeable cases are mammary analogue secretory carcinoma [<ce:cross-ref refid="bib10" id="crosref0100">10</ce:cross-ref>] and congenital fibrosarcoma, with 100% <ce:italic>NTRK</ce:italic> fusion detected in the two cancer types [<ce:cross-ref refid="bib11" id="crosref0105">11</ce:cross-ref>]. Several investigations have showed that <ce:italic>NTRK</ce:italic> gene fusions are the driving factors in certain acute myeloid leukemia (AML) cases [<ce:cross-ref refid="bib12" id="crosref0110">12</ce:cross-ref>]. Besides, <ce:italic>NTRK</ce:italic> fusion have also been reported in other cancers, such as lung adenocarcinoma and colorectal cancer, etc. [<ce:cross-ref refid="bib13" id="crosref0115">13</ce:cross-ref>].</ce:para>
                  <ce:para id="p0040" view="all">Apart from gene fusion, upregulation of <ce:italic>NTRK</ce:italic> copies in nerve cells would also lead to abnormal overexpression of Trk kinases. For example, Bourhis <ce:italic>etÂ al</ce:italic> reported that the level of TrkA and phospho-TrkA in MDA-MB-231â¯cells were distinctly higher than that in normal breast tissues. They further discovered that the overexpression of TrkA was highly related to cell proliferation and tumor metastasis [<ce:cross-ref refid="bib54" id="crosref0120">54</ce:cross-ref>]. Although single-point mutation occurring in Trks is rarely related to cancer development, but several reports proposed that mutation of single amino acid in Trk was highly correlated with drug resistance against Trk kinase inhibitors [<ce:cross-ref refid="bib55" id="crosref0125">55</ce:cross-ref>].</ce:para>
                  <ce:para id="p0045" view="all">Since most of the cancer-related <ce:italic>NTRK</ce:italic> gene alterations are associated with abnormal and uncontrolled kinase activation [<ce:cross-ref refid="bib56" id="crosref0130">56</ce:cross-ref>,<ce:cross-ref refid="bib57" id="crosref0135">57</ce:cross-ref>], Trk kinase inhibitors could function as anticancer agents for personalized drug therapy. There have been some successful examples in this field. The currently existed reviews mainly focused on Trk inhibitors in literature with anticancer [<ce:cross-ref refid="bib58" id="crosref0140">58</ce:cross-ref>] or analgesic [<ce:cross-ref refid="bib59" id="crosref0145">59</ce:cross-ref>] effects. While the most recent patent reviews summarized Trk inhibitors claimed before 2016 [<ce:cross-ref refid="bib60" id="crosref0150">60</ce:cross-ref>,<ce:cross-ref refid="bib61" id="crosref0155">61</ce:cross-ref>]. Herein, in this review, we mainly summarize recent literature and patents of Trk inhibitors for the treatment of cancer.</ce:para>
               </ce:section>
               <ce:section id="sec2" view="all">
                  <ce:label>2</ce:label>
                  <ce:section-title id="sectitle0035">Current reported compounds with Trk inhibitory potency</ce:section-title>
                  <ce:section id="sec2.1" view="all">
                     <ce:label>2.1</ce:label>
                     <ce:section-title id="sectitle0040">ATP-competitive inhibitors</ce:section-title>
                     <ce:para id="p0050" view="all">Soon-Sun Hong and Sungwoo Hong reported a series of 7-azaindole derivatives as novel Trk inhibitors by extensive kinase cross-screening (<ce:cross-ref refid="fig2" id="crosref0160">Fig.Â 2</ce:cross-ref>
                        <ce:float-anchor refid="fig2"/></ce:float-anchor>). Lead compound <ce:bold>1</ce:bold> was found to have a moderate inhibitory effect against TrkA but a potent inhibition against PI3KÎ±. By analyzing the structures of TrkA and PI3KÎ±, they found the substitution at 5 position of <ce:bold>1</ce:bold> may influence the selectivity between these two kinases. After several SAR optimizations, the final compound <ce:bold>2</ce:bold> can inhibit TrkA with an IC<ce:inf loc="post">50</ce:inf> value of 1.67â¯nM. The K<ce:inf loc="post">D</ce:inf> of <ce:bold>2</ce:bold> against TrkA was 16â¯nM and 2900â¯nM against PI3KÎ±, indicating a good selectivity. Antiproliferation investigations showed that <ce:bold>2</ce:bold> could inhibit cell growth with an IC<ce:inf loc="post">50</ce:inf> value of 4.2â¯Î¼M <ce:italic>via</ce:italic> inducing nuclei condenses and fragment in MCF-7â¯cell line. It was found later that <ce:bold>2</ce:bold> could effectively suppress the phosphorylation of TrkA and Akt and induce the apoptosis of MCF-7 by regulating the Trk and PI3k/Akt pathway. Additionally, <ce:bold>2</ce:bold> could induce the expression of cytochrome C and Bax, induce cleavage of caspase-3 and reduce expression of Bcl-2. It was also observed in MCF-7 that HIF-1Î± expression was increased and VEGF protein level was reduced. Hence, <ce:bold>2</ce:bold> was further tested in HUVEC cell and showed inhibitory effect against migration of by blocking VEGF-induced angiogenesis [<ce:cross-ref refid="bib62" id="crosref0165">62</ce:cross-ref>].</ce:para>
                     <ce:para id="p0055" view="all">JÃ¤nne and Doebele etÂ al. reported the discovery of larotrectinib (<ce:bold>3</ce:bold>), a pan-Trk inhibitor against with IC<ce:inf loc="post">50</ce:inf> value varying from 2 to 20â¯nM with good selectivity against other kinases (IC<ce:inf loc="post">50</ce:inf>â¯>â¯1â¯Î¼M) (<ce:cross-ref refid="fig3" id="crosref0170">Fig.Â 3</ce:cross-ref>
                        <ce:float-anchor refid="fig3"/></ce:float-anchor>). Larotrectinib could not prevent Ba/F3 cells from expressing other oncogene targets, such as EGFR, ALK and ROS1, but selectively inhibit autophosphorylation of <ce:italic>NTRK1</ce:italic> fusion cells. Meanwhile, MAPK and Akt pathways were also inhibited with the presence of <ce:bold>3</ce:bold>. In KM12â¯cell line, <ce:bold>3</ce:bold> could inhibit cell growth with IC<ce:inf loc="post">50</ce:inf> value of 1.9â¯nM. <ce:bold>3</ce:bold> could induce cell-cycle arrest in G1 and subsequent apoptosis of KM12â¯cell [<ce:cross-ref refid="bib22" id="crosref0175">22</ce:cross-ref>,<ce:cross-ref refid="bib23" id="crosref0180">23</ce:cross-ref>]. Pharmacokinetic data of larotrectinib were shown in <ce:cross-ref refid="tbl2" id="crosref0185">TableÂ 2</ce:cross-ref>
                        <ce:float-anchor refid="tbl2"/></ce:float-anchor>. In intent-to-treat analyses (nâ¯=â¯55) at primary data cut-off, the centrally-assessed overall response rate was 75%. Notably, Larotrectinib (<ce:bold>3</ce:bold>) was approved by FDA (Brand name: Vitrakvi) for the treatment of adult and pediatric patients with solid tumors that have a <ce:italic>NTRK</ce:italic> gene fusion, other than a specified cancer type [<ce:cross-ref refid="bib63" id="crosref0190">63</ce:cross-ref>,<ce:cross-ref refid="bib64" id="crosref0195">64</ce:cross-ref>].</ce:para>
                     <ce:para id="p0060" view="all">Despite the potent inhibitory effect of <ce:bold>3</ce:bold>, further investigations showed that duration of response eventually diminished by acquired resistance, due to the mutation of Trk. To overcome this limitation, Rothenberg and Hyman etÂ al. reported the discovery of LOXO-195 (<ce:bold>4</ce:bold>). First, TrkA-C inhibitory ability on LOXO-195 was tested, indicating similar inhibition and selectivity as <ce:bold>3</ce:bold>. Most importantly, the inhibitory effect of LOXO-101 on mutated TrkA was greatly reduced, while LOXO-195 still strongly inhibited this mutant with IC<ce:inf loc="post">50</ce:inf> values varying from 2 to 9â¯nM. Besides, LOXO-195 showed potent inhibition on cell proliferation in Trk fusion-containing KM12, CUTO-3, and MO-91â¯cell lines (IC<ce:inf loc="post">50</ce:inf>â¯â¤â¯5â¯nM). LOXO-195 suppressed tumor growth in Trk kinase-mutated tumor models, while LOXO-101 did not show good inhibitory ability [<ce:cross-ref refid="bib55" id="crosref0200">55</ce:cross-ref>].</ce:para>
                     <ce:para id="p0065" view="all">Dr. Reddy's Laboratories Ltd. claimed a series of imidazo [1,2-<ce:italic>a</ce:italic>]pyridine derivatives (<ce:bold>5</ce:bold>â<ce:bold>7</ce:bold>, <ce:cross-ref refid="fig4" id="crosref0205">Fig.Â 4</ce:cross-ref>
                        <ce:float-anchor refid="fig4"/></ce:float-anchor>), the inhibition rates of this series of compounds could reach the level of <50â¯nM [<ce:cross-ref refid="bib65" id="crosref0210">65</ce:cross-ref>].</ce:para>
                     <ce:para id="p0070" view="all">Chia Tai Tianqing pharmaceutical group co ltd also claimed a series of pyrazolo [1,5-<ce:italic>a</ce:italic>]pyrimidine derivatives (<ce:bold>8</ce:bold> and <ce:bold>9</ce:bold>, <ce:cross-ref refid="fig5" id="crosref0215">Fig.Â 5</ce:cross-ref>
                        <ce:float-anchor refid="fig5"/></ce:float-anchor>). In this series of compounds, urea group in LOXO-101 was replaced by amide group. Besides, a primary amine was substituted at 2-position. This series of compounds have a pan-Trk inhibitory ability with IC<ce:inf loc="post">50</ce:inf> values against TrkA-C could reach <10â¯nM, while JAK2 was not influenced (<ce:cross-ref refid="tbl3" id="crosref0220">TableÂ 3</ce:cross-ref>
                        <ce:float-anchor refid="tbl3"/></ce:float-anchor>) [<ce:cross-ref refid="bib66" id="crosref0225">66</ce:cross-ref>].</ce:para>
                     <ce:para id="p0075" view="all">TP therapeutics also claimed a series of macrocyclic compounds (<ce:bold>10</ce:bold> and <ce:bold>11</ce:bold>, <ce:cross-ref refid="fig6" id="crosref0230">Fig.Â 6</ce:cross-ref>
                        <ce:float-anchor refid="fig6"/></ce:float-anchor>). The biggest difference compared with LOXO-195 is that non-ring amine between aryl and pyrazolo [1,5-<ce:italic>a</ce:italic>]pyrimidine group and an oxygen atom was inserted. This series of compounds displayed potent inhibitory ability against TrkA (<ce:cross-ref refid="tbl4" id="crosref0235">TableÂ 4</ce:cross-ref>
                        <ce:float-anchor refid="tbl4"/></ce:float-anchor>) [<ce:cross-ref refid="bib67" id="crosref0240">67</ce:cross-ref>].</ce:para>
                     <ce:para id="p0085" view="all">Molteni reported (<ce:italic>R</ce:italic>)-2-phenylpyrrolidine substituted imidazopyridazines as potent and selective pan-Trk inhibitors (<ce:cross-ref refid="fig7" id="crosref0245">Fig.Â 7</ce:cross-ref>
                        <ce:float-anchor refid="fig7"/></ce:float-anchor>). Cellular Ba/F3 assay indicated lead compound <ce:bold>12</ce:bold> could inhibit TrkA-C with IC<ce:inf loc="post">50</ce:inf> values varying from 0.1 to 0.8â¯Î¼M. X-ray co-crystal structure of <ce:bold>12</ce:bold> with TrkC indicated that <ce:bold>12</ce:bold> bound to DFG-out kinase domain. A hydrogen-bond interaction was detected between N1 of <ce:bold>12</ce:bold> and Met620. Benzontrile motif could deeply bind to the pocket formed by Phe617, Phe698 and benzyl ring of <ce:bold>12</ce:bold> (<ce:cross-ref refid="fig8" id="crosref0250">Fig.Â 8</ce:cross-ref>
                        <ce:float-anchor refid="fig8"/></ce:float-anchor>a). Based on this co-crystal structure, they initially performed structural modifications on the benzylamino group. It was found that benzylamino group could be replaced by ring system, enhancing the interactions between ligand and protein. Hence, <ce:bold>13</ce:bold> was synthesized and co-crystalized with TrkB. This indicated that <ce:italic>R</ce:italic>-enantiomer preferentially induced protein conformation change (from DFG-out to the DFG-in state, <ce:cross-ref refid="fig8" id="crosref0255">Fig.Â 8</ce:cross-ref>b). Further, they attempted to change the <ce:glyph name="sbnd"/></ce:glyph>CN group and produced <ce:bold>14</ce:bold>. Interestingly, co-crystal structure of <ce:bold>14</ce:bold> and TrkA demonstrated that the conformation of <ce:bold>14</ce:bold> flipped around the imidazopyridazine core while maintaining key interaction with the hinge region. This structural flip was only observed in <ce:italic>R</ce:italic>-enantiomer in which fluorophenyl group inserted into hydrophobic pocket originally occupied by Phe669. Meanwhile, the 3-position of pyridine motif in <ce:bold>14</ce:bold> exposed to solvent, indicating that polar group could be introduced to the structure. In this series, GNF-8625 (<ce:bold>15</ce:bold>) was found to have excellent Trk inhibitory activity with IC<ce:inf loc="post">50</ce:inf> value varying from 2 to 4â¯nM (<ce:cross-ref refid="fig8" id="crosref0260">Fig.Â 8</ce:cross-ref>c). Ba/F3 cellular kinase panel displayed good selectivity of GNF-8625 over other kinases. GNF-8625 inhibited proliferation of Ba/F3 cell and KM12â¯cell lines with IC<ce:inf loc="post">50</ce:inf> value of 3â¯nM and 10â¯nM, respectively. Further, pharmacokinetics investigations of GNF-8625 were performed. High plasma clearance, moderate volume distribution and short half-life were observed for GNF-8625. In KM12 cell-derived xenograft model, GNF-8625 dose-dependently inhibited tumor growth when administered at ascending doses twice daily for 14 days in rats [<ce:cross-ref refid="bib68" id="crosref0265">68</ce:cross-ref>].</ce:para>
                     <ce:para id="p0090" view="all">Bristol-Myers Squibb disclosed a series of pyrrolo [2,1-f][1,2,4]triazine derivatives as TrkA/B inhibitor for the cancer treatment (<ce:bold>16</ce:bold>â<ce:bold>20</ce:bold>, <ce:cross-ref refid="fig9" id="crosref0270">Fig.Â 9</ce:cross-ref>
                        <ce:float-anchor refid="fig9"/></ce:float-anchor>). The IC<ce:inf loc="post">50</ce:inf> values of these compounds against TrkA/B could reach below 1â¯nM [<ce:cross-ref refid="bib69" id="crosref0275">69</ce:cross-ref>].</ce:para>
                     <ce:para id="p0095" view="all">Array Biopharma Inc. claimed a series of N, Nâ²-biarylurea derivatives with good inhibitory ability against TrkA as well as good selectivity among other kinases (<ce:cross-ref refid="fig10" id="crosref0280">Fig.Â 10</ce:cross-ref>
                        <ce:float-anchor refid="fig10"/></ce:float-anchor>, <ce:cross-ref refid="tbl5" id="crosref0285">TableÂ 5</ce:cross-ref>
                        <ce:float-anchor refid="tbl5"/></ce:float-anchor>).</ce:para>
                     <ce:para id="p0100" view="all">Merck sharp & dohme corp. claimed a series of N,Nâ²-biarylurea derivatives that possess strong inhibitory ability against TrkA. IC<ce:inf loc="post">50</ce:inf> values of examples claimed in WO2015042085 could reach the level of 50â¯nM (<ce:bold>24</ce:bold> and <ce:bold>25</ce:bold>, <ce:cross-ref refid="fig11" id="crosref0290">Fig.Â 11</ce:cross-ref>
                        <ce:float-anchor refid="fig11"/></ce:float-anchor>) [<ce:cross-ref refid="bib70" id="crosref0295">70</ce:cross-ref>]. In another patent, they fixed one aryl group with 9H-fluorenyl group. Inhibitory ability of the resulting compounds could be raised a bit with IC<ce:inf loc="post">50</ce:inf> values at about 30â¯nM (<ce:bold>26</ce:bold>â<ce:bold>28</ce:bold>, <ce:cross-ref refid="fig12" id="crosref0300">Fig.Â 12</ce:cross-ref>
                        <ce:float-anchor refid="fig12"/></ce:float-anchor>) [<ce:cross-ref refid="bib71" id="crosref0305">71</ce:cross-ref>]. Afterwards, in another patent claimed by Merck sharp & dohme corp., they deleted a nitrogen atom in urea hence formed an amide linker. Compounds in this series could inhibit TrkA at the level of 1â¯nM (<ce:bold>29</ce:bold>â<ce:bold>31</ce:bold>, <ce:cross-ref refid="fig13" id="crosref0310">Fig.Â 13</ce:cross-ref>
                        <ce:float-anchor refid="fig13"/></ce:float-anchor>) [<ce:cross-ref refid="bib72" id="crosref0315">72</ce:cross-ref>]. In the meantime, they explored another similar core skeleton, pyrazolo [4,3-<ce:italic>b</ce:italic>]pyridine. This series of compounds also displayed potent TrkA inhibitory ability (<ce:bold>32</ce:bold>â<ce:bold>34</ce:bold>, <ce:cross-ref refid="fig14" id="crosref0320">Fig.Â 14</ce:cross-ref>
                        <ce:float-anchor refid="fig14"/></ce:float-anchor>) [<ce:cross-ref refid="bib73" id="crosref0325">73</ce:cross-ref>].</ce:para>
                     <ce:para id="p0105" view="all">Apart from fusion of two rings, 4 fused rings could be seen in some patents. For example, Merck Sharp & Dohme Corp. claimed a series of 4-ring-fused amide derivatives which could inhibit TrkA with IC<ce:inf loc="post">50</ce:inf> value below 1â¯nM (<ce:bold>35</ce:bold>â<ce:bold>37</ce:bold>, <ce:cross-ref refid="fig15" id="crosref0330">Fig.Â 15</ce:cross-ref>
                        <ce:float-anchor refid="fig15"/></ce:float-anchor>) [<ce:cross-ref refid="bib74" id="crosref0335">74</ce:cross-ref>].</ce:para>
                     <ce:para id="p0110" view="all">Instead of fused rings, compounds claimed by Pfizer inc. chose the N-phenylpyrazolo ring as the core skeleton. Amide substitutions at 3- position are aliphatic chains. This series of compounds could reach the IC<ce:inf loc="post">50</ce:inf> value of 2â¯nM (<ce:bold>38</ce:bold>â<ce:bold>40</ce:bold>, <ce:cross-ref refid="fig16" id="crosref0340">Fig.Â 16</ce:cross-ref>
                        <ce:float-anchor refid="fig16"/></ce:float-anchor>) [<ce:cross-ref refid="bib75" id="crosref0345">75</ce:cross-ref>]. In the further study, they designed and synthesized a series of aryl-substituted 3-amidepyrazolo derivatives. This change of substitution could retain the inhibitory ability (<ce:bold>41</ce:bold> and <ce:bold>42</ce:bold>, <ce:cross-ref refid="fig17" id="crosref0350">Fig.Â 17</ce:cross-ref>
                        <ce:float-anchor refid="fig17"/></ce:float-anchor>) [<ce:cross-ref refid="bib76" id="crosref0355">76</ce:cross-ref>].</ce:para>
                     <ce:para id="p0115" view="all">GVK Biosciences claimed a series of urea derivatives, different from ureas derivatives mentioned above, one of the substitutions were replaced by tetrahydropyrrole group. This series of compounds also possess good inhibitory ability against TrkA (<ce:bold>43</ce:bold>â<ce:bold>45</ce:bold>, <ce:cross-ref refid="fig18" id="crosref0360">Fig.Â 18</ce:cross-ref>
                        <ce:float-anchor refid="fig18"/></ce:float-anchor>) [<ce:cross-ref refid="bib77" id="crosref0365">77</ce:cross-ref>].</ce:para>
                     <ce:para id="p0120" view="all">Shionogi & co., ltd. also claimed a series of tetrahydropyrrole-substituted urea derivatives, this series could also reach IC<ce:inf loc="post">50</ce:inf> valuesâ¯<â¯100â¯nM (<ce:bold>46</ce:bold> and <ce:bold>47</ce:bold>, <ce:cross-ref refid="fig19" id="crosref0370">Fig.Â 19</ce:cross-ref>
                        <ce:float-anchor refid="fig19"/></ce:float-anchor>) [<ce:cross-ref refid="bib78" id="crosref0375">78</ce:cross-ref>]. In 2018, they also claimed a series of 3-ring-fused urea derivatives. This series of compounds also possess good inhibitory ability (<ce:bold>48</ce:bold>â<ce:bold>50</ce:bold>, <ce:cross-ref refid="fig20" id="crosref0380">Fig.Â 20</ce:cross-ref>
                        <ce:float-anchor refid="fig20"/></ce:float-anchor>) [<ce:cross-ref refid="bib79" id="crosref0385">79</ce:cross-ref>].</ce:para>
                     <ce:para id="p0125" view="all">Blueprint medicines disclosed a series of pyrazolo [1,5-<ce:italic>a</ce:italic>]pyrimidine derivatives for the treatment of disorders related to <ce:italic>NTRK</ce:italic>. Examples shown in <ce:cross-ref refid="fig21" id="crosref0390">Fig.Â 21</ce:cross-ref>
                        <ce:float-anchor refid="fig21"/></ce:float-anchor> (<ce:bold>51â53</ce:bold>) were reported to have inhibitory potency against <ce:italic>NTRK1</ce:italic> and KM12â¯cell line with IC<ce:inf loc="post">50</ce:inf> values of lower than 10â¯nM. More importantly, compounds from these series demonstrated good inhibitory against G595R-KM12, a cell line that has drug resistance against Crizotinib [<ce:cross-ref refid="bib80" id="crosref0395">80</ce:cross-ref>]. In 2017, they claimed a series of pyrazolo [3,4-<ce:italic>d</ce:italic>]pyrimidine derivatives (<ce:bold>54</ce:bold>â<ce:bold>56</ce:bold>, <ce:cross-ref refid="fig22" id="crosref0400">Fig.Â 22</ce:cross-ref>
                        <ce:float-anchor refid="fig22"/></ce:float-anchor>). They also explored substitutions on the 2- and 4- position. These compounds could also reach the IC<ce:inf loc="post">50</ce:inf> value of below 10â¯nM [<ce:cross-ref refid="bib81" id="crosref0405">81</ce:cross-ref>].</ce:para>
                     <ce:para id="p0130" view="all">CMG Pharmaceutical & Handok also disclosed pyrazolo [1,5-<ce:italic>a</ce:italic>]pyrimidine derivatives as the Trk inhibitors (<ce:bold>57</ce:bold>â<ce:bold>59</ce:bold>, <ce:cross-ref refid="fig23" id="crosref0410">Fig.Â 23</ce:cross-ref>
                        <ce:float-anchor refid="fig23"/></ce:float-anchor>.). Different from Blueprint medicines, the chemical structures were incorporated with heterocycles in place of cyano group. This class of compounds possessed strong pan-Trk inhibitory effect, which can be potentially used for the treatment of cancer and pain, etc. [<ce:cross-ref refid="bib82" id="crosref0415">82</ce:cross-ref>].</ce:para>
                     <ce:para id="p0135" view="all">Thress etÂ al. reported a novel, potent, and selective Trk inhibitor AZ-23 (<ce:bold>60</ce:bold>, <ce:cross-refs refid="fig24 fig25" id="crosrefs0010">Figs.Â 24â25</ce:cross-refs>
                        <ce:float-anchor refid="fig24"/></ce:float-anchor>
                        <ce:float-anchor refid="fig25"/></ce:float-anchor>) [<ce:cross-ref refid="bib83" id="crosref0420">83</ce:cross-ref>]. AZ-23 showed strong inhibitory activity against human Trk on both enzymatic and cellular levels with IC<ce:inf loc="post">50</ce:inf> values of 2â¯nM and 8â¯nM, respectively. The inhibitory ability of AZ-23 was not attractive against Trk-independent cell line. Furtherly, anti-proliferation effect of AZ-23 was tested on 3T3-TrkA-Î allograft, an engineered subcutaneous model designed to be dependent on Trk signaling, and SK-N-SH cell line, a natural neuroblastoma model with endogenously expressing functional Trk receptors. Growth of both cells was strongly inhibited. Pharmacokinetic study indicated that the free concentration of AZ-23 in tumors is greatly higher than that needed for Trk inhibition, even two days after the administration [<ce:cross-ref refid="bib83" id="crosref0425">83</ce:cross-ref>]. In 2012, the same group reported two series of inhibitors structurally derived from AZ-23 (<ce:bold>61</ce:bold> and <ce:bold>62</ce:bold>). Both ring fusion patterns improved pharmacokinetic properties, while keeping the same inhibition against TrkA. These compounds showed high inhibitory ability against Trk-driven cell line (MCF10A-TrkA-Î) but less potency against MCF10A parental cells with more than 3800-fold selectivity [<ce:cross-ref refid="bib84" id="crosref0430">84</ce:cross-ref>].</ce:para>
                     <ce:para id="p0140" view="all">AstraZeneca has claimed a variety of patented structures shown in <ce:cross-ref refid="fig26" id="crosref0435">Fig.Â 26</ce:cross-ref>
                        <ce:float-anchor refid="fig26"/></ce:float-anchor> since 2005. The N-pyrimidine-1<ce:italic>H</ce:italic>-pyrazol-3-amines were first identified as Trk inhibitor for the treatment of cancer. (<ce:bold>63</ce:bold>â<ce:bold>65</ce:bold>, <ce:cross-ref refid="fig27" id="crosref0440">Fig.Â 27</ce:cross-ref>
                        <ce:float-anchor refid="fig27"/></ce:float-anchor>) [<ce:cross-ref refid="bib85" id="crosref0445">85</ce:cross-ref>]. However, the replacement of pyrimidine core to substituted phenyl ring decreased the inhibitory effect against Trks (<ce:bold>66</ce:bold>â<ce:bold>68</ce:bold>, <ce:cross-ref refid="fig28" id="crosref0450">Fig.Â 28</ce:cross-ref>
                        <ce:float-anchor refid="fig28"/></ce:float-anchor>) [<ce:cross-ref refid="bib86" id="crosref0455">86</ce:cross-ref>].</ce:para>
                     <ce:para id="p0145" view="all">In 2006, AstraZeneca attempted to replace the pyrimidine ring to pyridine ring in subsequent patent. The position of N in pyridine ring (In this markush structure, one of the X stood for N, the others were carbon with substitutions) was extensively studied, while only pyridines with 1,5-diamine retained the inhibitory potency (<ce:bold>69</ce:bold>â<ce:bold>71</ce:bold>, <ce:cross-ref refid="fig29" id="crosref0460">Fig.Â 29</ce:cross-ref>
                        <ce:float-anchor refid="fig29"/></ce:float-anchor>) [<ce:cross-ref refid="bib87" id="crosref0465">87</ce:cross-ref>]. Compared with previously reported, the structures in patent WO2006123113 were modified by deleting of substitution on amine (<ce:bold>72</ce:bold>â<ce:bold>74</ce:bold>, <ce:cross-ref refid="fig30" id="crosref0470">Fig.Â 30</ce:cross-ref>
                        <ce:float-anchor refid="fig30"/></ce:float-anchor>). Further introduction of 5-fuloropyridine-2-yl into these structures strongly enhance the inhibitory effect against Trks (<ce:cross-ref refid="fig31" id="crosref0475">Fig.Â 31</ce:cross-ref>
                        <ce:float-anchor refid="fig31"/></ce:float-anchor>) [<ce:cross-ref refid="bib88" id="crosref0480">88</ce:cross-ref>]. Similarly, in patent WO2007049041, the inhibitory activity of Example 7 (<ce:bold>75</ce:bold>) was 2-fold stronger than the original one. Further, this compound inhibited against JAK2 with an IC<ce:inf loc="post">50</ce:inf> value of 3.9â¯nM (<ce:cross-ref refid="fig31" id="crosref0485">Fig.Â 31</ce:cross-ref>) [<ce:cross-ref refid="bib89" id="crosref0490">89</ce:cross-ref>]. However, the change of pyrimidine ring into pyrazine led to increased JAK inhibition (<ce:bold>76</ce:bold> and <ce:bold>77</ce:bold>, <ce:cross-ref refid="fig32" id="crosref0495">Fig.Â 32</ce:cross-ref>
                        <ce:float-anchor refid="fig32"/></ce:float-anchor>) [<ce:cross-ref refid="bib90" id="crosref0500">90</ce:cross-ref>].</ce:para>
                     <ce:para id="p0150" view="all">Sasaki etÂ al. reported a pan-Trk inhibitor, AZD-7451 (<ce:bold>78</ce:bold>, <ce:cross-ref refid="fig33" id="crosref0505">Fig.Â 33</ce:cross-ref>
                        <ce:float-anchor refid="fig33"/></ce:float-anchor>), showing potent anticancer activity against non-small-cell lung cancer. The cell growth of KM12 bearing <ce:italic>NTRK-</ce:italic>fusion was greatly inhibited at a concentration of 2â¯nM. <ce:bold>78</ce:bold> also showed anti-proliferation on other <ce:italic>NTRK-</ce:italic>fusion cell lines such as KM12 and H460â¯cells. Interestingly, in H810â¯cell lines, AZD-7451 did not showed inhibitory effect against expression of wild-type <ce:italic>NTRK</ce:italic>1-3 [<ce:cross-ref refid="bib91" id="crosref0510">91</ce:cross-ref>].</ce:para>
                     <ce:para id="p0155" view="all">Lee designed and synthesized an array of salicyl-hydrazone analogues as TrkA inhibitors (<ce:cross-ref refid="fig34" id="crosref0515">Fig.Â 34</ce:cross-ref>
                        <ce:float-anchor refid="fig34"/></ce:float-anchor>). The most potent compound <ce:bold>79</ce:bold> could inhibit TrkA up to 98% at the concentration of 1â¯Î¼M. In the antiproliferation test, <ce:bold>79</ce:bold> also demonstrated good inhibitory activity against proliferation of HCT15, A549, SK-OV-3, SK-MEL-2 and MIA-PaCA-2 with IC<ce:inf loc="post">50</ce:inf> value of 0.89â¯Î¼M, 2.46â¯Î¼M, 1.43â¯Î¼M and 0.48â¯Î¼M, respectively [<ce:cross-ref refid="bib92" id="crosref0520">92</ce:cross-ref>].</ce:para>
                     <ce:para id="p0160" view="all">K-252a (<ce:bold>80</ce:bold>) was proven to be a potent inhibitor of Trk tyrosine receptor <ce:italic>inÂ vitro</ce:italic> and showed angiostatic effect in murine brain capillary endothelial cells [<ce:cross-ref refid="bib93" id="crosref0525">93</ce:cross-ref>]. However, no inhibitory effect of K-252a was found against P388 leukemia cell line [<ce:cross-ref refid="bib94" id="crosref0530">94</ce:cross-ref>]. Dionne etÂ al. reported that a K-252a derivative, CEP-751 (<ce:bold>82</ce:bold>), suppressed prostatic cancer growth in various animal models with good selectivity between cancerous and normal prostate cells. Biological evaluation proved that CEP-751 could inhibit Trk tyrosine receptor <ce:italic>via</ce:italic> inducing inhibition of tyrosine phosphorylation of Trk tyrosine receptor. Subsequent cellular assays indicated that CEP-751 inhibited growth of different prostatic cancer cell lines in a cycle-dependent manner, suggesting the potential combination of hormone-dependent and hormone-independent therapy against prostatic cancer [<ce:cross-refs refid="bib95 bib96 bib97" id="crosrefs0015">95â97</ce:cross-refs>]. Suppress of tumor growth on OVCAR-3 and SK-Mel-5 was efficiently detected when administration of <ce:bold>82</ce:bold> 
                        <ce:italic>s.c.</ce:italic> to adult rodents with 21â¯mg/kg BID for a period of 30 days. The hydroxyl form of CEP-751, commonly known as CEP-701 (<ce:bold>81</ce:bold>), can be orally administrated, exhibiting similar inhibitory activity on both enzyme and cell assays as CEP-751 [<ce:cross-ref refid="bib98" id="crosref0535">98</ce:cross-ref>]. To improve solubility, Vogelzang etÂ al. developed a lysinyl-Î²-alanyl ester of CEP-751, namely CEP-2563 (<ce:bold>83</ce:bold>). Preclinical studies and phase I clinical trial indicated that CEP-2563 showed antitumor activity in a variety of tumors and was reliably converted to CEP-751 <ce:italic>inÂ vivo</ce:italic> (<ce:cross-ref refid="fig35" id="crosref0540">Fig.Â 35</ce:cross-ref>
                        <ce:float-anchor refid="fig35"/></ce:float-anchor>) [<ce:cross-ref refid="bib99" id="crosref0545">99</ce:cross-ref>,<ce:cross-ref refid="bib100" id="crosref0550">100</ce:cross-ref>].</ce:para>
                     <ce:para id="p0165" view="all">Arfini etÂ al. has reported entrectinib targeting Trks, proto-oncogene tyrosine-protein kinase (ROS), and anaplastic lymphoma kinase (Alk) with inhibitory activities against multiple cancer indications (<ce:bold>84</ce:bold>, <ce:cross-refs refid="fig36 fig37" id="crosrefs0020">Figs.Â 36â37</ce:cross-refs>
                        <ce:float-anchor refid="fig36"/></ce:float-anchor>
                        <ce:float-anchor refid="fig37"/></ce:float-anchor>). Steady-state kinetic experiments proved entrectinib is a competitor for ATP binding, with <10â¯nM IC<ce:inf loc="post">50</ce:inf> against TrkA-C. In anti-proliferation test, entrectinib was found to exhibit inhibitory activity on three different kinds of cancer cell lines: TrkA-driven cell line (KM12, IC<ce:inf loc="post">50</ce:inf>â¯=â¯17â¯nM), Alk-dependent cell lines (SU-DHL-1, IC<ce:inf loc="post">50</ce:inf>â¯=â¯20â¯nM; Karpas-299, IC<ce:inf loc="post">50</ce:inf>â¯=â¯31â¯nM; SUP-M2, IC<ce:inf loc="post">50</ce:inf>â¯=â¯41â¯nM; SR786, IC<ce:inf loc="post">50</ce:inf>â¯=â¯81â¯nM and NCI-H2228, IC<ce:inf loc="post">50</ce:inf>â¯=â¯68â¯nM) and Flt3-dependent AML cell line (MV-4-11, IC<ce:inf loc="post">50</ce:inf>â¯=â¯81â¯nM). <ce:italic>InÂ vitro</ce:italic> assessment of entrectinib against KM12 showed accumulation of cells in the G1 phase and apoptosis. Further pharmacokinetic and efficacy studies in mouse demonstrated that entrectinib could be orally administrated and resulted in no weight loss at efficacious concentration. When dosed at 15â¯mg/kg, distinct decrease of tumor volume was observed [<ce:cross-ref refid="bib101" id="crosref0555">101</ce:cross-ref>]. Entrectinib could also inhibit growth of SY5Y-TrkB and NLF-TrkB both <ce:italic>inÂ vitro</ce:italic> and <ce:italic>inÂ vivo.</ce:italic> [<ce:cross-ref refid="bib102" id="crosref0560">102</ce:cross-ref>] Phase I trial indicated that entrectinib was safe and well-tolerated. Additionally, entrectinib could be beneficial to a broad range of solid tumors, such as non-small cell lung cancer (NSCLC), mammary analogue secretory carcinoma (MASC), melanoma, glioneuronal tumor, colorectal cancer and renal cell carcinoma. Especially entrectinib demonstrated excellent antitumor activity against neoplasm in central nervous system [<ce:cross-ref refid="bib103" id="crosref0565">103</ce:cross-ref>].</ce:para>
                     <ce:para id="p0170" view="all">Milciclib (<ce:bold>85,</ce:bold> 
                        <ce:cross-ref refid="fig38" id="crosref0570">Fig.Â 38</ce:cross-ref>
                        <ce:float-anchor refid="fig38"/></ce:float-anchor>) was first reported as a cyclin-dependent kinase (CDK) inhibitor with IC<ce:inf loc="post">50</ce:inf> value of 45â¯nM against CDK2/cyclin A complex kinase by Brasca <ce:italic>etÂ al</ce:italic>. [<ce:cross-ref refid="bib104" id="crosref0575">104</ce:cross-ref>] Albanese proved that milciclib could also function as a Trk inhibitor. Kinase profiling screen showed milciclib inhibited TrkA and TrkC with IC<ce:inf loc="post">50</ce:inf> values of 85â¯nM and 134â¯nM, respectively, while the inhibition against TrkB is slightly weaker (IC<ce:inf loc="post">50</ce:inf>â¯=â¯745â¯nM). Further, cellular assay indicated that proliferation of cancer cells were suppressed with less than 1â¯Î¼M IC<ce:inf loc="post">50</ce:inf> values against 96 kinds of cell lines. Moreover, the anti-proliferation of milciclib was not significantly influenced by P-gp over expression, DNA repair deficiency, and p53 activity [<ce:cross-ref refid="bib105" id="crosref0580">105</ce:cross-ref>]. To date, milicicib is in phase II trial for the treatment of patients with recurrent or metastatic hepatocellular carcinoma. Notably, milciclib have received orphan drug designation in the U.S. for the treatment of thymic epithelial tumors.</ce:para>
                     <ce:para id="p0175" view="all">Dalton reported small-molecule Trk and ROS1 tyrosine kinase inhibitors, crizotinib (<ce:bold>86</ce:bold>, <ce:cross-ref refid="fig39" id="crosref0585">Fig.Â 39</ce:cross-ref>
                        <ce:float-anchor refid="fig39"/></ce:float-anchor>), and its (S)-isomer, GTx-186 (<ce:bold>87</ce:bold>, <ce:cross-ref refid="fig39" id="crosref0590">Fig.Â 39</ce:cross-ref>). GTx-186 selectively inhibited TrkA, TrkB, TrkC, ROS1, ALK, and RET-mediated phosphorylation with IC<ce:inf loc="post">50</ce:inf> values in the picomolar to low nanomolar range. GTx-186 showed strong antiproliferative activity against IMR-32 with IC<ce:inf loc="post">50</ce:inf> value of about 100â¯nM and completely inhibited NGF-dependent migration of IMR-32â¯cells. Under the same circumstance, GTx-186 showed no inhibition against TrkA-null SH-SY5Y cells. Further, GTx-186 was found to function as a strong anti-inflammatory agent <ce:italic>via</ce:italic> PMA- and NGF-induced MMP-3 expression and effectively inhibit key inflammatory mediators such as cFos, IL-8, and IL-1b with ED<ce:inf loc="post">50</ce:inf> at nanomolar range [<ce:cross-ref refid="bib106" id="crosref0595">106</ce:cross-ref>].</ce:para>
                     <ce:para id="p0180" view="all">Gyochang Keum reported a series of urea derivatives as a multikinase inhibitor (<ce:cross-ref refid="fig40" id="crosref0600">Fig.Â 40</ce:cross-ref>
                        <ce:float-anchor refid="fig40"/></ce:float-anchor>). In this series, KST016366 (<ce:bold>88</ce:bold>) was found to have the most potent inhibitory activity against TrkA and TrkB with IC<ce:inf loc="post">50</ce:inf> values of 3.81â¯nM and 4.42â¯nM. It could also inhibit the proliferation of leukemia K-562 and colon carcinoma KM12â¯cell lines with GI<ce:inf loc="post">50</ce:inf> values of 51.4â¯nM and 19â¯nM. Docking study suggests that KST016366 could bind into the site that adjacent to ATP binding site. Additionally, the interaction of KST016366 and TrkA hinge region was observed, which revealed that KST016366 might function as a type II inhibitor [<ce:cross-ref refid="bib107" id="crosref0605">107</ce:cross-ref>].</ce:para>
                     <ce:para id="p0185" view="all">Molteni reported the discovery of GNF-5837 (<ce:bold>89</ce:bold>, <ce:cross-refs refid="fig41 fig42" id="crosrefs0025">Figs.Â 41â42</ce:cross-refs>
                        <ce:float-anchor refid="fig41"/></ce:float-anchor>
                        <ce:float-anchor refid="fig42"/></ce:float-anchor>), which is a potent, selective, and orally bioavailable pan-Trk inhibitor with <ce:italic>inÂ vitro</ce:italic> activities around 10â¯nM. Ba/F3 Cellular Kinase Panel indicated good selectivity of Trk kinases over other kinases. GNF-5837 showed strong antiproliferative activites in Ba/F3 and RIE (rat intestinal epithelial) cells with IC<ce:inf loc="post">50</ce:inf> values of 42â¯nM and 17â¯nM, respectively. X-ray crystallography showed that GNF-5837 could bind to the inactivated kinase, indicating that GNF-5837 functions as a type II kinase inhibitor. <ce:italic>InÂ vivo</ce:italic> efficacy evaluation in mice led to decreased tumor volume when administered at 50â¯mg/kg or more. However, pharmacokinetic study of GNF-5837 afforded moderate bioavailability (18% in BalB/C mice and 19% in Sqrague-Dawley rats) due to poor permeability and low solubility [<ce:cross-ref refid="bib108" id="crosref0610">108</ce:cross-ref>].</ce:para>
                     <ce:para id="p0190" view="all">IRM and LLC claimed a series of indolinone derivatives as Trk inhibitors. Example <ce:bold>1</ce:bold> (<ce:bold>90</ce:bold>, <ce:cross-ref refid="fig43" id="crosref0615">Fig.Â 43</ce:cross-ref>
                        <ce:float-anchor refid="fig43"/></ce:float-anchor>) was reported to have inhibitory activity against TrkB with IC<ce:inf loc="post">50</ce:inf> value of 14â¯nM. At the concentration of 10â¯Î¼M, 53 could inhibit TrkA-C with by more than 50%. Additionally, the IC<ce:inf loc="post">50</ce:inf> values of 53 to inhibit Aurora-A, C-RAF and cSRC were 15â¯nM, 116â¯nM and 53â¯nM, respectively [<ce:cross-ref refid="bib109" id="crosref0620">109</ce:cross-ref>].</ce:para>
                  </ce:section>
                  <ce:section id="sec2.2" view="all">
                     <ce:label>2.2</ce:label>
                     <ce:section-title id="sectitle0045">Non-ATP competitive inhibitors</ce:section-title>
                     <ce:section id="sec2.2.1" view="all">
                        <ce:label>2.2.1</ce:label>
                        <ce:section-title id="sectitle0050">Allosteric inhibitor</ce:section-title>
                        <ce:para id="p0195" view="all">Soon-Sun Hong and Gyochang Keum reported a novel TrkA inhibitor, KK5101 (<ce:bold>91</ce:bold>), for the treatment of pancreatic cancer (<ce:cross-ref refid="fig44" id="crosref0625">Fig.Â 44</ce:cross-ref>
                           <ce:float-anchor refid="fig44"/></ce:float-anchor>). KK5101 could strongly inhibit the cell growth of two kinds of pancreatic cancer cell line, MIAPaCa-2 and PANC-1, at the dose of 5â¯Î¼M. In mechanic investigation, it was found that KK5101 could inhibit the expressions of downstream signaling pathways <ce:italic>via</ce:italic> inhibition of TrkA phosphorylation. Besides, KK5101 could also exhibit strong anticancer activity in MIAPaCa-2 xenograft mouse models. With the administration of 5â¯mg/kg of KK5101 for 28 days, obvious decrease of tumor volume could be seen with no adverse effects and obvious loss of body weight. Docking analysis suggests that KK5101 bound to an allosteric site of TrkA but lack of interaction with the hinge region. Hence, KK5101 may function as a type III inhibitor of TrkA [<ce:cross-ref refid="bib110" id="crosref0630">110</ce:cross-ref>].</ce:para>
                     </ce:section>
                     <ce:section id="sec2.2.2" view="all">
                        <ce:label>2.2.2</ce:label>
                        <ce:section-title id="sectitle0055">Trk downstream pathway</ce:section-title>
                        <ce:para id="p0200" view="all">Rende first reported GW441756 (<ce:bold>92</ce:bold>) that exhibited strong antiproliferative and proapoptotic effects <ce:italic>via</ce:italic> Trk inhibition (<ce:cross-ref refid="fig45" id="crosref0635">Fig.Â 45</ce:cross-ref>
                           <ce:float-anchor refid="fig45"/></ce:float-anchor>). When 20â¯Î¼M were administrated, GW441756 completely inhibited proliferation and induced apoptosis against all the tested cancer cell lines including HTB-114, HTB-115, HTB-82, TE-671 and PC-3. In mechanism investigation, GW441756 was found to upregulate P75<ce:sup loc="post">NTR</ce:sup> and caspase-3, as well as shift the TrkA/P75<ce:sup loc="post">NTR</ce:sup> receptor balance to a more proapoptotic phenotype. Interestingly, GW441756 did not directly affect TrkA or AKT. The apoptosis was actually mediated by a functional downregulation of TrkA/AKT pathway [<ce:cross-ref refid="bib111" id="crosref0640">111</ce:cross-ref>].</ce:para>
                        <ce:para id="p0205" view="all">Hong etÂ al. reported HS-345 (<ce:bold>93</ce:bold>, <ce:cross-ref refid="fig46" id="crosref0645">Fig.Â 46</ce:cross-ref>
                           <ce:float-anchor refid="fig46"/></ce:float-anchor>), a novel TrkA inhibitor. KINOMEscan indicated that HS-345 displayed tight binding with 3 kinases: TrkA, TrkB and CDK11. HS345 inhibited cell growth in a dose-dependent manner. When administrated with 10â¯Î¼M, viability of MIA PaCa-2 and BxPC-3 decreased to <20% and viability of PANC-1 reduced to around 30%. Subsequent human phosphokinase array analysis indicated that HS-345 functioned as anticancer agent <ce:italic>via</ce:italic> the inhibition of TrkA/AKT signaling pathway. In addition, HS-345 induced apoptosis in PANC-1 and MIA PaCa-2â¯cells. Increased level of cleaved PARP, cleaved caspase-3, and Bax, and decreased expression of Bcl-2 were observed in both two cells. HS-345 both <ce:italic>inÂ vitro</ce:italic> and <ce:italic>inÂ vivo</ce:italic> inhibited angiogenesis of HUVECs and pancreatic cancer cells [<ce:cross-ref refid="bib112" id="crosref0650">112</ce:cross-ref>].</ce:para>
                        <ce:para id="p0210" view="all">Giving BDNF is the natural ligand of TrkB, Gheibi designed and synthesized a library of TrkB small peptides based on the region III of the BDNF containing the sequence of Nâ²-TKCNPMGYTKE-Câ. Five mostly stable peptides were docked with TrkB to find lowest energy value for <ce:bold>94</ce:bold> and <ce:bold>95</ce:bold>. These two peptides can reduce the cell variability of ov-car-3 and sk-ov-3 with the IC<ce:inf loc="post">50</ce:inf> level of 200â¯nM. Further, <ce:bold>94</ce:bold> and <ce:bold>95</ce:bold> can effectively decrease phosphorylation on TrkB, MAPK3 and eIF4E to further induce apoptosis in the treated cells (<ce:cross-ref refid="fig47" id="crosref0655">Fig.Â 47</ce:cross-ref>
                           <ce:float-anchor refid="fig47"/></ce:float-anchor>) [<ce:cross-ref refid="bib113" id="crosref0660">113</ce:cross-ref>].</ce:para>
                     </ce:section>
                  </ce:section>
                  <ce:section id="sec2.3" view="all">
                     <ce:label>2.3</ce:label>
                     <ce:section-title id="sectitle0060">Trk inhibitors with unknown mechanism</ce:section-title>
                     <ce:para id="p0215" view="all">Croucher, Iyer and Brodeur etÂ al. reported GNF-4256 as a novel pan-Trk inhibitor, that could inhibit the growth of neuroblastoma xenografts. GNF-4256 was shown to inhibit Ba/F3-Tel-TrkA, TrkB and TrkC with an IC<ce:inf loc="post">50</ce:inf> less than 20â¯nM, while there was no activity in the parental Ba/F3 cells grown in the presence of IL-3. Kinase profiling test indicated high selectivity of Trk over ROS (IC<ce:inf loc="post">50</ce:inf>â¯=â¯3.8â¯Î¼M). In the GNF-4256-treated samples, there was a dose-dependent inhibition of ligand-induced phosphorylation with IC<ce:inf loc="post">50</ce:inf> between 3 and 10â¯nM. GNF-4256 was tested on SY5Y Trk-null and SY5Y-TrkB cells to confirm its TrkB specificity. While GNF-4256 did not obviously inhibit the cell growth of SY5Y-Trk-null cells, proliferation of SY5Y-TrkB cell could be inhibited with IC<ce:inf loc="post">50</ce:inf> value of 100â¯nM. When BDNF was added, GNF-4256 could inhibit the cell growth of SY5Y-TrkB cell with the IC<ce:inf loc="post">50</ce:inf> value of 50â¯nM. Compared between above inhibitory concentrations, GNF-4256 could be recognized as a potent and selective inhibitor of TrkB-expression NB cells. While single use of GNF-4256 decreased the tumor volume, the combination use of GNF-4256 with Irino and TMZ greatly enhanced antineoplastic effect and thus were better than single use of GNF-4256, Irino or TMZ [<ce:cross-ref refid="bib114" id="crosref0665">114</ce:cross-ref>].</ce:para>
                     <ce:para id="p0220" view="all">Onishi reported a novel selective pan-Trk inhibitor ONO-7579 with potent antitumor activity (structure not yet disclosed). ONO-7579 inhibited BDNF-induced TrkB phosphorylation and downstream activation of AKT, ERK and HIF-1Î± in TYGBK-1 and NOZ cells. Besides, ONO-7579 also inhibited MEK phosphorylation in TYGBK-1â¯cells with wild-type <ce:italic>KRAS</ce:italic>. In NOZ cell, MEK phosphorylation was not observed after treatment with ONO-7579 because of <ce:italic>KRAS</ce:italic> mutation. In migration study, ONO-7579 was found to show inhibitory ability against both GBC cells, especially TYGBK-1â¯cell line with wild-type <ce:italic>KRAS.</ce:italic> [<ce:cross-ref refid="bib115" id="crosref0670">115</ce:cross-ref>].</ce:para>
                  </ce:section>
               </ce:section>
               <ce:section id="sec3" view="all">
                  <ce:label>3</ce:label>
                  <ce:section-title id="sectitle0065">Concluding remarks</ce:section-title>
                  <ce:para id="p0225" view="all">With the rapid development of precision medicine, more and more clinical drug use for cancer treatment depends on the personal gene test. Among these oncological gene expression-induced tumor progressions, <ce:italic>NTRK</ce:italic> alteration has gained much attention due to its high correlation with tumor metastasis that was considered as the major death factor in cancer treatment. Actually, <ce:italic>NTRK</ce:italic> genes and their expression proteins Trks function nearly the same between CNS cells and oncological cells. Trks broadly distributes in brain tissue and function as growth modulator in the central nervous system. However, in aberrant conditions, such as <ce:italic>NTRK</ce:italic> fusion-induced auto-activation or <ce:italic>NTRK</ce:italic> gene over-expression, Trks would activate oncological signaling pathway to accelerate the growth and transformation of preneoplastic cells towards neoplastic cells. Delightfully, the selectivity across TrkA-C seems not so be essential because all Trk members are involved in tumor development and evasion. To date, <ce:italic>NTRK</ce:italic> alteration has been detected in various cancer cells. For example, gene sequence has shown that approximately 15% of NSCLC correlates with <ce:italic>NTRK</ce:italic> fusion [<ce:cross-ref refid="bib17" id="crosref0680">17</ce:cross-ref>]. Giving the major treatment for NSCLCs is still chemotherapy; the development of Trk inhibitors will provide a novel cancer therapy with higher efficacy and lower toxicity. This will also find wide application in other cancers that are induced by abnormal Trk activation [<ce:cross-ref refid="bib91" id="crosref0685">91</ce:cross-ref>].</ce:para>
                  <ce:para id="p0230" view="all">Although it is of high value to carry forward the drug development of Trk inhibitor, there are still some unneglectable aspects associated with Trk inhibition as for cancer treatment. Firstly, normal <ce:italic>NTRK</ce:italic> is widely expressed in brain tissue, targeting Trks without affecting CNS Trks would be a tricky problem. Thus, Trk inhibitors for the treatment of peripheral tumor should have poor permeability towards blood-brain barrier. Secondly, drug resistance, the common failure for all RTKs, still remains a trouble. Although aforementioned LOXO-195 could inhibit acquired resistance induced by LOXO-101, reports with inhibitory activity against mutated Trks were rarely witnessed. Since acquired mutations are frequently observed in ATP-competitive kinase inhibitors, much effort should be paid on the development of non-ATP competitive inhibitors based on known co-crystal structures of Trks [<ce:cross-ref refid="bib5" id="crosref0675">5</ce:cross-ref>].</ce:para>
               </ce:section>
               <ce:section id="sec4" view="all">
                  <ce:section-title id="sectitle0070">Abbreviations used</ce:section-title>
                  <ce:para id="p0240" view="all">Trk: tropomyosin receptor kinase; WHO: world health organization; GAB1: GRB2-associated-binding protein 1: GRB2: Growth factor receptor-bound protein 2: SOS: <ce:italic>Son of Sevenless</ce:italic> expression product, a set of genes encoding guanine nucleotide exchange factors that act on the Ras subfamily of small GTPases; NGF: neural growth factor; NT: neurotrophins; PI3k/Akt pathway: phosphoinositide 3-kinase/protein kinase B pathway; MAPK/ERK pathway: mitogen-activated protein kinases pathway; BDNF: brain derived neurotrophic factor; Shc: Src-homology 2-domain containing adaptor protein; Bcl-2: B-cell lymphoma-2; BAD: Bcl-2 antagonist of cell death; GSK-3Î²: glycogen Synthase Kinase 3Î²; IRS-1: Insulin receptor substrate 1; Pi3K: phosphatidylinositol 3-kinase; K<ce:inf loc="post">D:</ce:inf> affinity constant; AML: acute myeloid leukemia; Bax: Bcl-2-associated X protein; HIF-1Î±: hypoxia-inducible factor 1Î±; VEGF: vascular endothelial growth factor; ALK: anaplastic lymphoma kinase; ROS: proto-oncogene tyrosine-protein kinase; C<ce:inf loc="post">max</ce:inf>: peak plasma concentration; t<ce:inf loc="post">max</ce:inf>: time that reach C<ce:inf loc="post">max</ce:inf>; AUC<ce:inf loc="post">0â24h</ce:inf>: area under curve (0â24â¯h); F: Bioavailability; V<ce:inf loc="post">ss</ce:inf>: volume of distribution; CL/F: clearance; t<ce:inf loc="post">1/2</ce:inf>: half-life; JAK: janus kinase; CDK: cyclin-deoendent kinase; P-gp: P-glycoprotein; RET: rearranged during transfection; c-Fos: expression product of human homolog of the retroviral oncogene v-fos; IL: Interleukin; eIF4E: eukaryotic initiation factor 4E</ce:para>
               </ce:section>
               <ce:section id="sec5" view="all">
                  <ce:section-title id="sectitle0075">Author contributions</ce:section-title>
                  <ce:para id="p0245" view="all">Qi Miao and Kun Ma contributed equally.</ce:para>
               </ce:section>
            </ce:sections>
            <ce:acknowledgment id="ack0010" view="all">
               <ce:section-title id="sectitle0080">Acknowledgements</ce:section-title>
               <ce:para id="p0250" view="all">This work was supported by the <ce:grant-sponsor id="gs1" sponsor-id="https://doi.org/10.13039/501100001809" xlink:type="simple" xlink:role="http://www.elsevier.com/xml/linking-roles/grant-sponsor">National Natural Science Foundation of China</ce:grant-sponsor> (<ce:grant-number refid="gs1">81773559</ce:grant-number>, <ce:grant-number refid="gs1">21807114</ce:grant-number>, <ce:grant-number refid="gs1">21472191</ce:grant-number>), the <ce:grant-sponsor id="gs2" xlink:type="simple" xlink:role="http://www.elsevier.com/xml/linking-roles/grant-sponsor">Double First-Class University Project</ce:grant-sponsor> (<ce:grant-number refid="gs2">CPU2018GY03</ce:grant-number>), the <ce:grant-sponsor id="gs3" xlink:type="simple" xlink:role="http://www.elsevier.com/xml/linking-roles/grant-sponsor">National Major Scientific and Technological Program for Drug Discovery</ce:grant-sponsor> Grant (<ce:grant-number refid="gs3">2018ZX09301045002</ce:grant-number>), the <ce:grant-sponsor id="gs4" sponsor-id="https://doi.org/10.13039/100011259" xlink:type="simple" xlink:role="http://www.elsevier.com/xml/linking-roles/grant-sponsor">International Cooperation</ce:grant-sponsor> Grant of Guangzhou (<ce:grant-number refid="gs4">201704030099</ce:grant-number>) of Guangzhou, the Project of <ce:grant-sponsor id="gs5" sponsor-id="https://doi.org/10.13039/501100011360" xlink:type="simple" xlink:role="http://www.elsevier.com/xml/linking-roles/grant-sponsor">State Key Laboratory of Natural Medicines</ce:grant-sponsor>, <ce:grant-sponsor id="gs6" sponsor-id="https://doi.org/10.13039/501100002857" xlink:type="simple" xlink:role="http://www.elsevier.com/xml/linking-roles/grant-sponsor">China Pharmaceutical University</ce:grant-sponsor> (<ce:grant-number refid="gs6">SKLNMZZRC201810</ce:grant-number>), and <ce:grant-sponsor id="gs7" xlink:type="simple" xlink:role="http://www.elsevier.com/xml/linking-roles/grant-sponsor">Chinese Pharmaceutical Association-Yiling Biopharmaceutical Innovation Foundation</ce:grant-sponsor>.</ce:para>
            </ce:acknowledgment>
         </body>
         <tail view="all">
            <ce:bibliography id="cebib0010" view="all">
               <ce:section-title id="sectitle0085">References</ce:section-title>
               <ce:bibliography-sec id="cebibsec0010" view="all">
                  <ce:bib-reference id="bib1">
                     <ce:label>[1]</ce:label>
                     <sb:reference id="sref1">
                        <sb:contribution langtype="en">
                           <sb:authors>
                              <sb:author>
                                 <ce:given-name>B.W.</ce:given-name>
                                 <ce:surname>Stewart</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>C.P.</ce:given-name>
                                 <ce:surname>Wild</ce:surname>
                              </sb:author>
                           </sb:authors>
                           <sb:title>
                              <sb:maintitle>World Cancer Report 2014</sb:maintitle>
                           </sb:title>
                        </sb:contribution>
                        <sb:host>
                           <sb:book class="report">
                              <sb:date>2014</sb:date>
                              <sb:publisher>
                                 <sb:name>International Agency for Research on Cancer</sb:name>
                                 <sb:location>Lyon</sb:location>
                              </sb:publisher>
                           </sb:book>
                        </sb:host>
                     </sb:reference>
                  </ce:bib-reference>
                  <ce:bib-reference id="bib2">
                     <ce:label>[2]</ce:label>
                     <sb:reference id="sref2">
                        <sb:contribution langtype="en">
                           <sb:authors>
                              <sb:author>
                                 <ce:given-name>A.A.</ce:given-name>
                                 <ce:surname>Friedman</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>A.</ce:given-name>
                                 <ce:surname>Letai</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>D.E.</ce:given-name>
                                 <ce:surname>Fisher</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>K.T.</ce:given-name>
                                 <ce:surname>Flaherty</ce:surname>
                              </sb:author>
                           </sb:authors>
                           <sb:title>
                              <sb:maintitle>Precision medicine for cancer with next-generation functional diagnostics</sb:maintitle>
                           </sb:title>
                        </sb:contribution>
                        <sb:host>
                           <sb:issue>
                              <sb:series>
                                 <sb:title>
                                    <sb:maintitle>Nat. Rev. Canc.</sb:maintitle>
                                 </sb:title>
                                 <sb:volume-nr>15</sb:volume-nr>
                              </sb:series>
                              <sb:date>2015</sb:date>
                           </sb:issue>
                           <sb:pages>
                              <sb:first-page>747</sb:first-page>
                              <sb:last-page>756</sb:last-page>
                           </sb:pages>
                        </sb:host>
                     </sb:reference>
                  </ce:bib-reference>
                  <ce:bib-reference id="bib3">
                     <ce:label>[3]</ce:label>
                     <sb:reference id="sref3">
                        <sb:contribution langtype="en">
                           <sb:authors>
                              <sb:author>
                                 <ce:given-name>M.J.</ce:given-name>
                                 <ce:surname>Khoury</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>M.F.</ce:given-name>
                                 <ce:surname>Iademarco</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>W.T.</ce:given-name>
                                 <ce:surname>Riley</ce:surname>
                              </sb:author>
                           </sb:authors>
                           <sb:title>
                              <sb:maintitle>Precision public health for the era of precision medicine</sb:maintitle>
                           </sb:title>
                        </sb:contribution>
                        <sb:host>
                           <sb:issue>
                              <sb:series>
                                 <sb:title>
                                    <sb:maintitle>Am. J. Prev. Med.</sb:maintitle>
                                 </sb:title>
                                 <sb:volume-nr>50</sb:volume-nr>
                              </sb:series>
                              <sb:date>2016</sb:date>
                           </sb:issue>
                           <sb:pages>
                              <sb:first-page>398</sb:first-page>
                              <sb:last-page>401</sb:last-page>
                           </sb:pages>
                        </sb:host>
                     </sb:reference>
                  </ce:bib-reference>
                  <ce:bib-reference id="bib4">
                     <ce:label>[4]</ce:label>
                     <sb:reference id="sref4">
                        <sb:contribution langtype="en">
                           <sb:authors>
                              <sb:author>
                                 <ce:given-name>D.</ce:given-name>
                                 <ce:surname>Martin-Zanca</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>S.H.</ce:given-name>
                                 <ce:surname>Hughes</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>M.</ce:given-name>
                                 <ce:surname>Barbacid</ce:surname>
                              </sb:author>
                           </sb:authors>
                           <sb:title>
                              <sb:maintitle>AÂ human oncogene formed by the fusion of truncated tropomyosin and protein tyrosine kinase sequences</sb:maintitle>
                           </sb:title>
                        </sb:contribution>
                        <sb:host>
                           <sb:issue>
                              <sb:series>
                                 <sb:title>
                                    <sb:maintitle>Nature</sb:maintitle>
                                 </sb:title>
                                 <sb:volume-nr>319</sb:volume-nr>
                              </sb:series>
                              <sb:date>1986</sb:date>
                           </sb:issue>
                           <sb:pages>
                              <sb:first-page>743</sb:first-page>
                              <sb:last-page>748</sb:last-page>
                           </sb:pages>
                        </sb:host>
                     </sb:reference>
                  </ce:bib-reference>
                  <ce:bib-reference id="bib5">
                     <ce:label>[5]</ce:label>
                     <sb:reference id="sref5">
                        <sb:contribution langtype="en">
                           <sb:authors>
                              <sb:author>
                                 <ce:given-name>T.</ce:given-name>
                                 <ce:surname>Bertrand</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>M.</ce:given-name>
                                 <ce:surname>Kothe</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>J.</ce:given-name>
                                 <ce:surname>Liu</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>A.</ce:given-name>
                                 <ce:surname>Dupuy</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>A.</ce:given-name>
                                 <ce:surname>Rak</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>P.F.</ce:given-name>
                                 <ce:surname>Berne</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>S.</ce:given-name>
                                 <ce:surname>Davis</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>T.</ce:given-name>
                                 <ce:surname>Gladysheva</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>C.</ce:given-name>
                                 <ce:surname>Valtre</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>J.Y.</ce:given-name>
                                 <ce:surname>Crenne</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>M.</ce:given-name>
                                 <ce:surname>Mathieu</ce:surname>
                              </sb:author>
                           </sb:authors>
                           <sb:title>
                              <sb:maintitle>The crystal structures of TrkA and TrkB suggest key regions for achieving selective inhibition</sb:maintitle>
                           </sb:title>
                        </sb:contribution>
                        <sb:host>
                           <sb:issue>
                              <sb:series>
                                 <sb:title>
                                    <sb:maintitle>J.Â Mol. Biol.</sb:maintitle>
                                 </sb:title>
                                 <sb:volume-nr>423</sb:volume-nr>
                              </sb:series>
                              <sb:date>2012</sb:date>
                           </sb:issue>
                           <sb:pages>
                              <sb:first-page>439</sb:first-page>
                              <sb:last-page>453</sb:last-page>
                           </sb:pages>
                        </sb:host>
                     </sb:reference>
                  </ce:bib-reference>
                  <ce:bib-reference id="bib6">
                     <ce:label>[6]</ce:label>
                     <sb:reference id="sref6">
                        <sb:contribution langtype="en">
                           <sb:authors>
                              <sb:author>
                                 <ce:given-name>A.</ce:given-name>
                                 <ce:surname>Nakagawara</ce:surname>
                              </sb:author>
                           </sb:authors>
                           <sb:title>
                              <sb:maintitle>Trk receptor tyrosine kinases: a bridge between cancer and neural development</sb:maintitle>
                           </sb:title>
                        </sb:contribution>
                        <sb:host>
                           <sb:issue>
                              <sb:series>
                                 <sb:title>
                                    <sb:maintitle>Cancer Lett.</sb:maintitle>
                                 </sb:title>
                                 <sb:volume-nr>169</sb:volume-nr>
                              </sb:series>
                              <sb:date>2001</sb:date>
                           </sb:issue>
                           <sb:pages>
                              <sb:first-page>107</sb:first-page>
                              <sb:last-page>114</sb:last-page>
                           </sb:pages>
                        </sb:host>
                     </sb:reference>
                  </ce:bib-reference>
                  <ce:bib-reference id="bib7">
                     <ce:label>[7]</ce:label>
                     <sb:reference id="sref7">
                        <sb:contribution langtype="en">
                           <sb:authors>
                              <sb:author>
                                 <ce:given-name>G.S.</ce:given-name>
                                 <ce:surname>Tejeda</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>M.</ce:given-name>
                                 <ce:surname>Diaz-Guerra</ce:surname>
                              </sb:author>
                           </sb:authors>
                           <sb:title>
                              <sb:maintitle>Integral characterization of defective BDNF/TrkB signalling in neurological and psychiatric disorders leads the way to new therapies</sb:maintitle>
                           </sb:title>
                        </sb:contribution>
                        <sb:host>
                           <sb:issue>
                              <sb:series>
                                 <sb:title>
                                    <sb:maintitle>Int. J. Mol. Sci.</sb:maintitle>
                                 </sb:title>
                                 <sb:volume-nr>18</sb:volume-nr>
                              </sb:series>
                              <sb:date>2017</sb:date>
                           </sb:issue>
                           <sb:pages>
                              <sb:first-page>268</sb:first-page>
                           </sb:pages>
                        </sb:host>
                     </sb:reference>
                  </ce:bib-reference>
                  <ce:bib-reference id="bib8">
                     <ce:label>[8]</ce:label>
                     <sb:reference id="sref8">
                        <sb:contribution langtype="en">
                           <sb:authors>
                              <sb:author>
                                 <ce:given-name>Y.B.</ce:given-name>
                                 <ce:surname>Khotskaya</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>V.R.</ce:given-name>
                                 <ce:surname>Holla</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>A.F.</ce:given-name>
                                 <ce:surname>Farago</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>K.R.M.</ce:given-name>
                                 <ce:surname>Shaw</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>F.</ce:given-name>
                                 <ce:surname>Meric-Bernstam</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>D.S.</ce:given-name>
                                 <ce:surname>Hong</ce:surname>
                              </sb:author>
                           </sb:authors>
                           <sb:title>
                              <sb:maintitle>Targeting TRK family proteins in cancer</sb:maintitle>
                           </sb:title>
                        </sb:contribution>
                        <sb:host>
                           <sb:issue>
                              <sb:series>
                                 <sb:title>
                                    <sb:maintitle>Pharmacol. Ther.</sb:maintitle>
                                 </sb:title>
                                 <sb:volume-nr>173</sb:volume-nr>
                              </sb:series>
                              <sb:date>2017</sb:date>
                           </sb:issue>
                           <sb:pages>
                              <sb:first-page>58</sb:first-page>
                              <sb:last-page>66</sb:last-page>
                           </sb:pages>
                        </sb:host>
                     </sb:reference>
                  </ce:bib-reference>
                  <ce:bib-reference id="bib9">
                     <ce:label>[9]</ce:label>
                     <sb:reference id="sref9">
                        <sb:contribution langtype="en">
                           <sb:authors>
                              <sb:author>
                                 <ce:given-name>K.B.</ce:given-name>
                                 <ce:surname>Morrison</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>C.E.</ce:given-name>
                                 <ce:surname>Tognon</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>M.J.</ce:given-name>
                                 <ce:surname>Garnett</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>C.</ce:given-name>
                                 <ce:surname>Deal</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>P.H.</ce:given-name>
                                 <ce:surname>Sorensen</ce:surname>
                              </sb:author>
                           </sb:authors>
                           <sb:title>
                              <sb:maintitle>ETV6-NTRK3 transformation requires insulin-like growth factor 1 receptor signaling and is associated with constitutive IRS-1 tyrosine phosphorylation</sb:maintitle>
                           </sb:title>
                        </sb:contribution>
                        <sb:host>
                           <sb:issue>
                              <sb:series>
                                 <sb:title>
                                    <sb:maintitle>Oncogene</sb:maintitle>
                                 </sb:title>
                                 <sb:volume-nr>21</sb:volume-nr>
                              </sb:series>
                              <sb:date>2002</sb:date>
                           </sb:issue>
                           <sb:pages>
                              <sb:first-page>5684</sb:first-page>
                              <sb:last-page>5695</sb:last-page>
                           </sb:pages>
                        </sb:host>
                     </sb:reference>
                  </ce:bib-reference>
                  <ce:bib-reference id="bib10">
                     <ce:label>[10]</ce:label>
                     <sb:reference id="sref10">
                        <sb:contribution langtype="en">
                           <sb:authors>
                              <sb:author>
                                 <ce:given-name>M.</ce:given-name>
                                 <ce:surname>Eguchi</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>M.</ce:given-name>
                                 <ce:surname>Eguchi-Ishimae</ce:surname>
                              </sb:author>
                           </sb:authors>
                           <sb:title>
                              <sb:maintitle>Absence of t(12;15) associated ETV6-NTRK3 fusion transcripts in pediatric acute leukemias</sb:maintitle>
                           </sb:title>
                        </sb:contribution>
                        <sb:host>
                           <sb:issue>
                              <sb:series>
                                 <sb:title>
                                    <sb:maintitle>Med. Pediatr. Oncol.</sb:maintitle>
                                 </sb:title>
                                 <sb:volume-nr>37</sb:volume-nr>
                              </sb:series>
                              <sb:date>2001</sb:date>
                           </sb:issue>
                           <sb:pages>
                              <sb:first-page>417</sb:first-page>
                           </sb:pages>
                        </sb:host>
                     </sb:reference>
                  </ce:bib-reference>
                  <ce:bib-reference id="bib11">
                     <ce:label>[11]</ce:label>
                     <sb:reference id="sref11">
                        <sb:contribution langtype="en">
                           <sb:authors>
                              <sb:author>
                                 <ce:given-name>J.M.</ce:given-name>
                                 <ce:surname>Bourgeois</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>S.R.</ce:given-name>
                                 <ce:surname>Knezevich</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>J.A.</ce:given-name>
                                 <ce:surname>Mathers</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>P.H.B.</ce:given-name>
                                 <ce:surname>Sorensen</ce:surname>
                              </sb:author>
                           </sb:authors>
                           <sb:title>
                              <sb:maintitle>Molecular detection of the ETV6-NTRK3 gene fusion differentiates congenital fibrosarcoma from other childhood spindle cell tumors</sb:maintitle>
                           </sb:title>
                        </sb:contribution>
                        <sb:host>
                           <sb:issue>
                              <sb:series>
                                 <sb:title>
                                    <sb:maintitle>Am. J. Surg. Pathol.</sb:maintitle>
                                 </sb:title>
                                 <sb:volume-nr>24</sb:volume-nr>
                              </sb:series>
                              <sb:date>2000</sb:date>
                           </sb:issue>
                           <sb:pages>
                              <sb:first-page>937</sb:first-page>
                              <sb:last-page>946</sb:last-page>
                           </sb:pages>
                        </sb:host>
                     </sb:reference>
                  </ce:bib-reference>
                  <ce:bib-reference id="bib12">
                     <ce:label>[12]</ce:label>
                     <sb:reference id="sref12">
                        <sb:contribution langtype="en">
                           <sb:authors>
                              <sb:author>
                                 <ce:given-name>J.M.</ce:given-name>
                                 <ce:surname>Kralik</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>W.</ce:given-name>
                                 <ce:surname>Kranewitter</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>H.</ce:given-name>
                                 <ce:surname>Boesmueller</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>R.</ce:given-name>
                                 <ce:surname>Marschon</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>G.</ce:given-name>
                                 <ce:surname>Tschurtschenthaler</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>H.</ce:given-name>
                                 <ce:surname>Rumpold</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>K.</ce:given-name>
                                 <ce:surname>Wiesinger</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>M.</ce:given-name>
                                 <ce:surname>Erdel</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>A.L.</ce:given-name>
                                 <ce:surname>Petzer</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>G.</ce:given-name>
                                 <ce:surname>Webersinke</ce:surname>
                              </sb:author>
                           </sb:authors>
                           <sb:title>
                              <sb:maintitle>Characterization of a newly identified ETV6-NTRK3 fusion transcript in acute myeloid leukemia</sb:maintitle>
                           </sb:title>
                        </sb:contribution>
                        <sb:host>
                           <sb:issue>
                              <sb:series>
                                 <sb:title>
                                    <sb:maintitle>Diagn. Pathol.</sb:maintitle>
                                 </sb:title>
                                 <sb:volume-nr>6</sb:volume-nr>
                              </sb:series>
                              <sb:date>2011</sb:date>
                           </sb:issue>
                           <sb:pages>
                              <sb:first-page>19</sb:first-page>
                           </sb:pages>
                        </sb:host>
                     </sb:reference>
                  </ce:bib-reference>
                  <ce:bib-reference id="bib13">
                     <ce:label>[13]</ce:label>
                     <sb:reference id="sref13">
                        <sb:contribution langtype="en">
                           <sb:authors>
                              <sb:author>
                                 <ce:given-name>A.M.</ce:given-name>
                                 <ce:surname>Lange</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>H.W.</ce:given-name>
                                 <ce:surname>Lo</ce:surname>
                              </sb:author>
                           </sb:authors>
                           <sb:title>
                              <sb:maintitle>Inhibiting TRK proteins in clinical cancer therapy</sb:maintitle>
                           </sb:title>
                        </sb:contribution>
                        <sb:host>
                           <sb:issue>
                              <sb:series>
                                 <sb:title>
                                    <sb:maintitle>Cancers (Basel)</sb:maintitle>
                                 </sb:title>
                                 <sb:volume-nr>10</sb:volume-nr>
                              </sb:series>
                              <sb:date>2018</sb:date>
                           </sb:issue>
                        </sb:host>
                     </sb:reference>
                  </ce:bib-reference>
                  <ce:bib-reference id="bib14">
                     <ce:label>[14]</ce:label>
                     <sb:reference id="sref14">
                        <sb:contribution langtype="en">
                           <sb:authors>
                              <sb:author>
                                 <ce:given-name>Z.</ce:given-name>
                                 <ce:surname>Zheng</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>M.</ce:given-name>
                                 <ce:surname>Liebers</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>B.</ce:given-name>
                                 <ce:surname>Zhelyazkova</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>Y.</ce:given-name>
                                 <ce:surname>Cao</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>D.</ce:given-name>
                                 <ce:surname>Panditi</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>K.D.</ce:given-name>
                                 <ce:surname>Lynch</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>J.</ce:given-name>
                                 <ce:surname>Chen</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>H.E.</ce:given-name>
                                 <ce:surname>Robinson</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>H.S.</ce:given-name>
                                 <ce:surname>Shim</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>J.</ce:given-name>
                                 <ce:surname>Chmielecki</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>W.</ce:given-name>
                                 <ce:surname>Pao</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>J.A.</ce:given-name>
                                 <ce:surname>Engelman</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>A.J.</ce:given-name>
                                 <ce:surname>Iafrate</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>L.P.</ce:given-name>
                                 <ce:surname>Le</ce:surname>
                              </sb:author>
                           </sb:authors>
                           <sb:title>
                              <sb:maintitle>Anchored multiplex PCR for targeted next-generation sequencing</sb:maintitle>
                           </sb:title>
                        </sb:contribution>
                        <sb:host>
                           <sb:issue>
                              <sb:series>
                                 <sb:title>
                                    <sb:maintitle>Nat. Med.</sb:maintitle>
                                 </sb:title>
                                 <sb:volume-nr>20</sb:volume-nr>
                              </sb:series>
                              <sb:date>2014</sb:date>
                           </sb:issue>
                           <sb:pages>
                              <sb:first-page>1479</sb:first-page>
                              <sb:last-page>1484</sb:last-page>
                           </sb:pages>
                        </sb:host>
                     </sb:reference>
                  </ce:bib-reference>
                  <ce:bib-reference id="bib15">
                     <ce:label>[15]</ce:label>
                     <sb:reference id="sref15">
                        <sb:contribution langtype="en">
                           <sb:authors>
                              <sb:author>
                                 <ce:given-name>J.</ce:given-name>
                                 <ce:surname>Kim</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>Y.</ce:given-name>
                                 <ce:surname>Lee</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>H.J.</ce:given-name>
                                 <ce:surname>Cho</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>Y.E.</ce:given-name>
                                 <ce:surname>Lee</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>J.</ce:given-name>
                                 <ce:surname>An</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>G.H.</ce:given-name>
                                 <ce:surname>Cho</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>Y.H.</ce:given-name>
                                 <ce:surname>Ko</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>K.M.</ce:given-name>
                                 <ce:surname>Joo</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>D.H.</ce:given-name>
                                 <ce:surname>Nam</ce:surname>
                              </sb:author>
                           </sb:authors>
                           <sb:title>
                              <sb:maintitle>NTRK1 fusion in glioblastoma multiforme</sb:maintitle>
                           </sb:title>
                        </sb:contribution>
                        <sb:host>
                           <sb:issue>
                              <sb:series>
                                 <sb:title>
                                    <sb:maintitle>PLoS One</sb:maintitle>
                                 </sb:title>
                                 <sb:volume-nr>9</sb:volume-nr>
                              </sb:series>
                              <sb:date>2014</sb:date>
                           </sb:issue>
                           <sb:article-number>e91940</sb:article-number>
                        </sb:host>
                     </sb:reference>
                  </ce:bib-reference>
                  <ce:bib-reference id="bib16">
                     <ce:label>[16]</ce:label>
                     <sb:reference id="sref16">
                        <sb:contribution langtype="en">
                           <sb:authors>
                              <sb:author>
                                 <ce:given-name>V.</ce:given-name>
                                 <ce:surname>Frattini</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>V.</ce:given-name>
                                 <ce:surname>Trifonov</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>J.M.</ce:given-name>
                                 <ce:surname>Chan</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>A.</ce:given-name>
                                 <ce:surname>Castano</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>M.</ce:given-name>
                                 <ce:surname>Lia</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>F.</ce:given-name>
                                 <ce:surname>Abate</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>S.T.</ce:given-name>
                                 <ce:surname>Keir</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>A.X.</ce:given-name>
                                 <ce:surname>Ji</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>P.</ce:given-name>
                                 <ce:surname>Zoppoli</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>F.</ce:given-name>
                                 <ce:surname>Niola</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>C.</ce:given-name>
                                 <ce:surname>Danussi</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>I.</ce:given-name>
                                 <ce:surname>Dolgalev</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>P.</ce:given-name>
                                 <ce:surname>Porrati</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>S.</ce:given-name>
                                 <ce:surname>Pellegatta</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>A.</ce:given-name>
                                 <ce:surname>Heguy</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>G.</ce:given-name>
                                 <ce:surname>Gupta</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>D.J.</ce:given-name>
                                 <ce:surname>Pisapia</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>P.</ce:given-name>
                                 <ce:surname>Canoll</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>J.N.</ce:given-name>
                                 <ce:surname>Bruce</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>R.E.</ce:given-name>
                                 <ce:surname>McLendon</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>H.</ce:given-name>
                                 <ce:surname>Yan</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>K.</ce:given-name>
                                 <ce:surname>Aldape</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>G.</ce:given-name>
                                 <ce:surname>Finocchiaro</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>T.</ce:given-name>
                                 <ce:surname>Mikkelsen</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>G.G.</ce:given-name>
                                 <ce:surname>Prive</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>D.D.</ce:given-name>
                                 <ce:surname>Bigner</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>A.</ce:given-name>
                                 <ce:surname>Lasorella</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>R.</ce:given-name>
                                 <ce:surname>Rabadan</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>A.</ce:given-name>
                                 <ce:surname>Iavarone</ce:surname>
                              </sb:author>
                           </sb:authors>
                           <sb:title>
                              <sb:maintitle>The integrated landscape of driver genomic alterations in glioblastoma</sb:maintitle>
                           </sb:title>
                        </sb:contribution>
                        <sb:host>
                           <sb:issue>
                              <sb:series>
                                 <sb:title>
                                    <sb:maintitle>Nat. Genet.</sb:maintitle>
                                 </sb:title>
                                 <sb:volume-nr>45</sb:volume-nr>
                              </sb:series>
                              <sb:date>2013</sb:date>
                           </sb:issue>
                           <sb:pages>
                              <sb:first-page>1141</sb:first-page>
                              <sb:last-page>1149</sb:last-page>
                           </sb:pages>
                        </sb:host>
                     </sb:reference>
                  </ce:bib-reference>
                  <ce:bib-reference id="bib17">
                     <ce:label>[17]</ce:label>
                     <sb:reference id="sref17">
                        <sb:contribution langtype="en">
                           <sb:authors>
                              <sb:author>
                                 <ce:given-name>A.</ce:given-name>
                                 <ce:surname>Vaishnavi</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>M.</ce:given-name>
                                 <ce:surname>Capelletti</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>A.T.</ce:given-name>
                                 <ce:surname>Le</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>S.</ce:given-name>
                                 <ce:surname>Kako</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>M.</ce:given-name>
                                 <ce:surname>Butaney</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>D.</ce:given-name>
                                 <ce:surname>Ercan</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>S.</ce:given-name>
                                 <ce:surname>Mahale</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>K.D.</ce:given-name>
                                 <ce:surname>Davies</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>D.L.</ce:given-name>
                                 <ce:surname>Aisner</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>A.B.</ce:given-name>
                                 <ce:surname>Pilling</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>E.M.</ce:given-name>
                                 <ce:surname>Berge</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>J.</ce:given-name>
                                 <ce:surname>Kim</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>H.</ce:given-name>
                                 <ce:surname>Sasaki</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>S.</ce:given-name>
                                 <ce:surname>Park</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>G.</ce:given-name>
                                 <ce:surname>Kryukov</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>L.A.</ce:given-name>
                                 <ce:surname>Garraway</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>P.S.</ce:given-name>
                                 <ce:surname>Hammerman</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>J.</ce:given-name>
                                 <ce:surname>Haas</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>S.W.</ce:given-name>
                                 <ce:surname>Andrews</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>D.</ce:given-name>
                                 <ce:surname>Lipson</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>P.J.</ce:given-name>
                                 <ce:surname>Stephens</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>V.A.</ce:given-name>
                                 <ce:surname>Miller</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>M.</ce:given-name>
                                 <ce:surname>Varella-Garcia</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>P.A.</ce:given-name>
                                 <ce:surname>Janne</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>R.C.</ce:given-name>
                                 <ce:surname>Doebele</ce:surname>
                              </sb:author>
                           </sb:authors>
                           <sb:title>
                              <sb:maintitle>Oncogenic and drug-sensitive NTRK1 rearrangements in lung cancer</sb:maintitle>
                           </sb:title>
                        </sb:contribution>
                        <sb:host>
                           <sb:issue>
                              <sb:series>
                                 <sb:title>
                                    <sb:maintitle>Nat. Med.</sb:maintitle>
                                 </sb:title>
                                 <sb:volume-nr>19</sb:volume-nr>
                              </sb:series>
                              <sb:date>2013</sb:date>
                           </sb:issue>
                           <sb:pages>
                              <sb:first-page>1469</sb:first-page>
                              <sb:last-page>1472</sb:last-page>
                           </sb:pages>
                        </sb:host>
                     </sb:reference>
                  </ce:bib-reference>
                  <ce:bib-reference id="bib18">
                     <ce:label>[18]</ce:label>
                     <sb:reference id="sref18">
                        <sb:contribution langtype="en">
                           <sb:authors>
                              <sb:author>
                                 <ce:given-name>R.C.</ce:given-name>
                                 <ce:surname>Doebele</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>L.E.</ce:given-name>
                                 <ce:surname>Davis</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>A.</ce:given-name>
                                 <ce:surname>Vaishnavi</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>A.T.</ce:given-name>
                                 <ce:surname>Le</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>A.</ce:given-name>
                                 <ce:surname>Estrada-Bernal</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>S.</ce:given-name>
                                 <ce:surname>Keysar</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>A.</ce:given-name>
                                 <ce:surname>Jimeno</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>M.</ce:given-name>
                                 <ce:surname>Varella-Garcia</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>D.L.</ce:given-name>
                                 <ce:surname>Aisner</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>Y.</ce:given-name>
                                 <ce:surname>Li</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>P.J.</ce:given-name>
                                 <ce:surname>Stephens</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>D.</ce:given-name>
                                 <ce:surname>Morosini</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>B.B.</ce:given-name>
                                 <ce:surname>Tuch</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>M.</ce:given-name>
                                 <ce:surname>Fernandes</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>N.</ce:given-name>
                                 <ce:surname>Nanda</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>J.A.</ce:given-name>
                                 <ce:surname>Low</ce:surname>
                              </sb:author>
                           </sb:authors>
                           <sb:title>
                              <sb:maintitle>An oncogenic NTRK fusion in a patient with soft-tissue sarcoma with response to the tropomyosin-related kinase inhibitor LOXO-101</sb:maintitle>
                           </sb:title>
                        </sb:contribution>
                        <sb:host>
                           <sb:issue>
                              <sb:series>
                                 <sb:title>
                                    <sb:maintitle>Cancer Discov.</sb:maintitle>
                                 </sb:title>
                                 <sb:volume-nr>5</sb:volume-nr>
                              </sb:series>
                              <sb:date>2015</sb:date>
                           </sb:issue>
                           <sb:pages>
                              <sb:first-page>1049</sb:first-page>
                              <sb:last-page>1057</sb:last-page>
                           </sb:pages>
                        </sb:host>
                     </sb:reference>
                  </ce:bib-reference>
                  <ce:bib-reference id="bib19">
                     <ce:label>[19]</ce:label>
                     <sb:reference id="sref19">
                        <sb:contribution langtype="en">
                           <sb:authors>
                              <sb:author>
                                 <ce:given-name>A.</ce:given-name>
                                 <ce:surname>Amatu</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>A.</ce:given-name>
                                 <ce:surname>Sartore-Bianchi</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>S.</ce:given-name>
                                 <ce:surname>Siena</ce:surname>
                              </sb:author>
                           </sb:authors>
                           <sb:title>
                              <sb:maintitle>NTRK gene fusions as novel targets of cancer therapy across multiple tumour types</sb:maintitle>
                           </sb:title>
                        </sb:contribution>
                        <sb:host>
                           <sb:issue>
                              <sb:series>
                                 <sb:title>
                                    <sb:maintitle>ESMO open</sb:maintitle>
                                 </sb:title>
                                 <sb:volume-nr>1</sb:volume-nr>
                              </sb:series>
                              <sb:date>2016</sb:date>
                           </sb:issue>
                           <sb:article-number>e000023</sb:article-number>
                        </sb:host>
                     </sb:reference>
                  </ce:bib-reference>
                  <ce:bib-reference id="bib20">
                     <ce:label>[20]</ce:label>
                     <sb:reference id="sref20">
                        <sb:contribution langtype="en">
                           <sb:authors>
                              <sb:author>
                                 <ce:given-name>V.</ce:given-name>
                                 <ce:surname>Wong</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>D.</ce:given-name>
                                 <ce:surname>Pavlick</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>T.</ce:given-name>
                                 <ce:surname>Brennan</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>R.</ce:given-name>
                                 <ce:surname>Yelensky</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>J.</ce:given-name>
                                 <ce:surname>Crawford</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>J.S.</ce:given-name>
                                 <ce:surname>Ross</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>V.A.</ce:given-name>
                                 <ce:surname>Miller</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>D.</ce:given-name>
                                 <ce:surname>Malicki</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>P.J.</ce:given-name>
                                 <ce:surname>Stephens</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>S.M.</ce:given-name>
                                 <ce:surname>Ali</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>H.</ce:given-name>
                                 <ce:surname>Ahn</ce:surname>
                              </sb:author>
                           </sb:authors>
                           <sb:title>
                              <sb:maintitle>Evaluation of a congenital infantile fibrosarcoma by comprehensive genomic profiling reveals an LMNA-NTRK1 gene fusion responsive to crizotinib</sb:maintitle>
                           </sb:title>
                        </sb:contribution>
                        <sb:host>
                           <sb:issue>
                              <sb:series>
                                 <sb:title>
                                    <sb:maintitle>J.Â Natl. Cancer Inst.</sb:maintitle>
                                 </sb:title>
                                 <sb:volume-nr>108</sb:volume-nr>
                              </sb:series>
                              <sb:date>2016</sb:date>
                           </sb:issue>
                        </sb:host>
                     </sb:reference>
                  </ce:bib-reference>
                  <ce:bib-reference id="bib21">
                     <ce:label>[21]</ce:label>
                     <sb:reference id="sref21">
                        <sb:contribution langtype="en">
                           <sb:authors>
                              <sb:author>
                                 <ce:given-name>T.</ce:given-name>
                                 <ce:surname>Wiesner</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>M.</ce:given-name>
                                 <ce:surname>Kiuru</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>S.N.</ce:given-name>
                                 <ce:surname>Scott</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>M.</ce:given-name>
                                 <ce:surname>Arcila</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>A.C.</ce:given-name>
                                 <ce:surname>Halpern</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>T.</ce:given-name>
                                 <ce:surname>Hollmann</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>M.F.</ce:given-name>
                                 <ce:surname>Berger</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>K.J.</ce:given-name>
                                 <ce:surname>Busam</ce:surname>
                              </sb:author>
                           </sb:authors>
                           <sb:title>
                              <sb:maintitle>NF1 mutations are common in desmoplastic melanoma</sb:maintitle>
                           </sb:title>
                        </sb:contribution>
                        <sb:host>
                           <sb:issue>
                              <sb:series>
                                 <sb:title>
                                    <sb:maintitle>Am. J. Surg. Pathol.</sb:maintitle>
                                 </sb:title>
                                 <sb:volume-nr>39</sb:volume-nr>
                              </sb:series>
                              <sb:date>2015</sb:date>
                           </sb:issue>
                           <sb:pages>
                              <sb:first-page>1357</sb:first-page>
                              <sb:last-page>1362</sb:last-page>
                           </sb:pages>
                        </sb:host>
                     </sb:reference>
                  </ce:bib-reference>
                  <ce:bib-reference id="bib22">
                     <ce:label>[22]</ce:label>
                     <sb:reference id="sref22">
                        <sb:contribution langtype="en">
                           <sb:authors>
                              <sb:author>
                                 <ce:given-name>Z.</ce:given-name>
                                 <ce:surname>Zheng</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>M.</ce:given-name>
                                 <ce:surname>Liebers</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>B.</ce:given-name>
                                 <ce:surname>Zhelyazkova</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>Y.</ce:given-name>
                                 <ce:surname>Cao</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>D.</ce:given-name>
                                 <ce:surname>Panditi</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>K.D.</ce:given-name>
                                 <ce:surname>Lynch</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>J.</ce:given-name>
                                 <ce:surname>Chen</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>H.E.</ce:given-name>
                                 <ce:surname>Robinson</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>H.S.</ce:given-name>
                                 <ce:surname>Shim</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>J.</ce:given-name>
                                 <ce:surname>Chmielecki</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>W.</ce:given-name>
                                 <ce:surname>Pao</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>J.A.</ce:given-name>
                                 <ce:surname>Engelman</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>A.J.</ce:given-name>
                                 <ce:surname>Iafrate</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>L.P.</ce:given-name>
                                 <ce:surname>Le</ce:surname>
                              </sb:author>
                           </sb:authors>
                           <sb:title>
                              <sb:maintitle>Anchored multiplex PCR for targeted next-generation sequencing</sb:maintitle>
                           </sb:title>
                        </sb:contribution>
                        <sb:host>
                           <sb:issue>
                              <sb:series>
                                 <sb:title>
                                    <sb:maintitle>Nat. Med.</sb:maintitle>
                                 </sb:title>
                                 <sb:volume-nr>20</sb:volume-nr>
                              </sb:series>
                              <sb:date>2014</sb:date>
                           </sb:issue>
                           <sb:pages>
                              <sb:first-page>1479</sb:first-page>
                           </sb:pages>
                        </sb:host>
                     </sb:reference>
                  </ce:bib-reference>
                  <ce:bib-reference id="bib23">
                     <ce:label>[23]</ce:label>
                     <sb:reference id="sref23">
                        <sb:contribution langtype="en">
                           <sb:authors>
                              <sb:author>
                                 <ce:given-name>J.S.</ce:given-name>
                                 <ce:surname>Ross</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>K.</ce:given-name>
                                 <ce:surname>Wang</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>L.</ce:given-name>
                                 <ce:surname>Gay</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>R.</ce:given-name>
                                 <ce:surname>Al-Rohil</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>J.V.</ce:given-name>
                                 <ce:surname>Rand</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>D.M.</ce:given-name>
                                 <ce:surname>Jones</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>H.J.</ce:given-name>
                                 <ce:surname>Lee</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>C.E.</ce:given-name>
                                 <ce:surname>Sheehan</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>G.A.</ce:given-name>
                                 <ce:surname>Otto</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>G.</ce:given-name>
                                 <ce:surname>Palmer</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>R.</ce:given-name>
                                 <ce:surname>Yelensky</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>D.</ce:given-name>
                                 <ce:surname>Lipson</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>D.</ce:given-name>
                                 <ce:surname>Morosini</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>M.</ce:given-name>
                                 <ce:surname>Hawryluk</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>D.V.</ce:given-name>
                                 <ce:surname>Catenacci</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>V.A.</ce:given-name>
                                 <ce:surname>Miller</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>C.</ce:given-name>
                                 <ce:surname>Churi</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>S.</ce:given-name>
                                 <ce:surname>Ali</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>P.J.</ce:given-name>
                                 <ce:surname>Stephens</ce:surname>
                              </sb:author>
                           </sb:authors>
                           <sb:title>
                              <sb:maintitle>New routes to targeted therapy of intrahepatic cholangiocarcinomas revealed by next-generation sequencing</sb:maintitle>
                           </sb:title>
                        </sb:contribution>
                        <sb:host>
                           <sb:issue>
                              <sb:series>
                                 <sb:title>
                                    <sb:maintitle>Oncol.</sb:maintitle>
                                 </sb:title>
                                 <sb:volume-nr>19</sb:volume-nr>
                              </sb:series>
                              <sb:date>2014</sb:date>
                           </sb:issue>
                           <sb:pages>
                              <sb:first-page>235</sb:first-page>
                              <sb:last-page>242</sb:last-page>
                           </sb:pages>
                        </sb:host>
                     </sb:reference>
                  </ce:bib-reference>
                  <ce:bib-reference id="bib24">
                     <ce:label>[24]</ce:label>
                     <sb:reference id="sref24">
                        <sb:contribution langtype="en">
                           <sb:authors>
                              <sb:author>
                                 <ce:given-name>L.</ce:given-name>
                                 <ce:surname>Fernandez-Cuesta</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>M.</ce:given-name>
                                 <ce:surname>Peifer</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>X.</ce:given-name>
                                 <ce:surname>Lu</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>D.</ce:given-name>
                                 <ce:surname>Seidel</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>T.</ce:given-name>
                                 <ce:surname>Zander</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>F.</ce:given-name>
                                 <ce:surname>Leenders</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>L.</ce:given-name>
                                 <ce:surname>OzretiÄ</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>O.-T.</ce:given-name>
                                 <ce:surname>Brustugun</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>J.K.</ce:given-name>
                                 <ce:surname>Field</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>G.</ce:given-name>
                                 <ce:surname>Wright</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>B.</ce:given-name>
                                 <ce:surname>Solomon</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>R.</ce:given-name>
                                 <ce:surname>Buettner</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>C.</ce:given-name>
                                 <ce:surname>Brambilla</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>E.</ce:given-name>
                                 <ce:surname>Brambilla</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>R.K.</ce:given-name>
                                 <ce:surname>Thomas</ce:surname>
                              </sb:author>
                           </sb:authors>
                           <sb:title>
                              <sb:maintitle>Abstract 1531: cross-entity mutation analysis of lung neuroendocrine tumors sheds light into their molecular origin and identifies new therapeutic targets</sb:maintitle>
                           </sb:title>
                        </sb:contribution>
                        <sb:host>
                           <sb:issue>
                              <sb:series>
                                 <sb:title>
                                    <sb:maintitle>Cancer Res.</sb:maintitle>
                                 </sb:title>
                                 <sb:volume-nr>74</sb:volume-nr>
                              </sb:series>
                              <sb:date>2014</sb:date>
                           </sb:issue>
                        </sb:host>
                        <sb:comment>1531-1531</sb:comment>
                     </sb:reference>
                  </ce:bib-reference>
                  <ce:bib-reference id="bib25">
                     <ce:label>[25]</ce:label>
                     <sb:reference id="sref25">
                        <sb:contribution langtype="en">
                           <sb:authors>
                              <sb:author>
                                 <ce:given-name>A.F.</ce:given-name>
                                 <ce:surname>Farago</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>L.P.</ce:given-name>
                                 <ce:surname>Le</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>Z.</ce:given-name>
                                 <ce:surname>Zheng</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>A.</ce:given-name>
                                 <ce:surname>Muzikansky</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>A.</ce:given-name>
                                 <ce:surname>Drilon</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>M.</ce:given-name>
                                 <ce:surname>Patel</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>T.M.</ce:given-name>
                                 <ce:surname>Bauer</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>S.V.</ce:given-name>
                                 <ce:surname>Liu</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>S.H.</ce:given-name>
                                 <ce:surname>Ou</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>D.</ce:given-name>
                                 <ce:surname>Jackman</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>D.B.</ce:given-name>
                                 <ce:surname>Costa</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>P.S.</ce:given-name>
                                 <ce:surname>Multani</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>G.G.</ce:given-name>
                                 <ce:surname>Li</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>Z.</ce:given-name>
                                 <ce:surname>Hornby</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>E.</ce:given-name>
                                 <ce:surname>Chow-Maneval</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>D.</ce:given-name>
                                 <ce:surname>Luo</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>J.E.</ce:given-name>
                                 <ce:surname>Lim</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>A.J.</ce:given-name>
                                 <ce:surname>Iafrate</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>A.T.</ce:given-name>
                                 <ce:surname>Shaw</ce:surname>
                              </sb:author>
                           </sb:authors>
                           <sb:title>
                              <sb:maintitle>Durable clinical response to entrectinib in NTRK1-rearranged non-small cell lung cancer</sb:maintitle>
                           </sb:title>
                        </sb:contribution>
                        <sb:host>
                           <sb:issue>
                              <sb:series>
                                 <sb:title>
                                    <sb:maintitle>J.Â Thorac. Oncol.</sb:maintitle>
                                 </sb:title>
                                 <sb:volume-nr>10</sb:volume-nr>
                              </sb:series>
                              <sb:date>2015</sb:date>
                           </sb:issue>
                           <sb:pages>
                              <sb:first-page>1670</sb:first-page>
                              <sb:last-page>1674</sb:last-page>
                           </sb:pages>
                        </sb:host>
                     </sb:reference>
                  </ce:bib-reference>
                  <ce:bib-reference id="bib26">
                     <ce:label>[26]</ce:label>
                     <sb:reference id="sref26">
                        <sb:contribution langtype="en">
                           <sb:authors>
                              <sb:author>
                                 <ce:given-name>A.</ce:given-name>
                                 <ce:surname>Greco</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>C.</ce:given-name>
                                 <ce:surname>Miranda</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>M.A.</ce:given-name>
                                 <ce:surname>Pierotti</ce:surname>
                              </sb:author>
                           </sb:authors>
                           <sb:title>
                              <sb:maintitle>Rearrangements of NTRK1 gene in papillary thyroid carcinoma</sb:maintitle>
                           </sb:title>
                        </sb:contribution>
                        <sb:host>
                           <sb:issue>
                              <sb:series>
                                 <sb:title>
                                    <sb:maintitle>Mol. Cell. Endocrinol.</sb:maintitle>
                                 </sb:title>
                                 <sb:volume-nr>321</sb:volume-nr>
                              </sb:series>
                              <sb:date>2010</sb:date>
                           </sb:issue>
                           <sb:pages>
                              <sb:first-page>44</sb:first-page>
                              <sb:last-page>49</sb:last-page>
                           </sb:pages>
                        </sb:host>
                     </sb:reference>
                  </ce:bib-reference>
                  <ce:bib-reference id="bib27">
                     <ce:label>[27]</ce:label>
                     <sb:reference id="sref27">
                        <sb:contribution langtype="en">
                           <sb:authors>
                              <sb:author>
                                 <ce:given-name>L.</ce:given-name>
                                 <ce:surname>Creancier</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>I.</ce:given-name>
                                 <ce:surname>Vandenberghe</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>B.</ce:given-name>
                                 <ce:surname>Gomes</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>C.</ce:given-name>
                                 <ce:surname>Dejean</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>J.C.</ce:given-name>
                                 <ce:surname>Blanchet</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>J.</ce:given-name>
                                 <ce:surname>Meilleroux</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>R.</ce:given-name>
                                 <ce:surname>Guimbaud</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>J.</ce:given-name>
                                 <ce:surname>Selves</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>A.</ce:given-name>
                                 <ce:surname>Kruczynski</ce:surname>
                              </sb:author>
                           </sb:authors>
                           <sb:title>
                              <sb:maintitle>Chromosomal rearrangements involving the NTRK1 gene in colorectal carcinoma</sb:maintitle>
                           </sb:title>
                        </sb:contribution>
                        <sb:host>
                           <sb:issue>
                              <sb:series>
                                 <sb:title>
                                    <sb:maintitle>Cancer Lett.</sb:maintitle>
                                 </sb:title>
                                 <sb:volume-nr>365</sb:volume-nr>
                              </sb:series>
                              <sb:date>2015</sb:date>
                           </sb:issue>
                           <sb:pages>
                              <sb:first-page>107</sb:first-page>
                              <sb:last-page>111</sb:last-page>
                           </sb:pages>
                        </sb:host>
                     </sb:reference>
                  </ce:bib-reference>
                  <ce:bib-reference id="bib28">
                     <ce:label>[28]</ce:label>
                     <sb:reference id="sref28">
                        <sb:contribution langtype="en">
                           <sb:authors>
                              <sb:author>
                                 <ce:given-name>E.</ce:given-name>
                                 <ce:surname>Ardini</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>R.</ce:given-name>
                                 <ce:surname>Bosotti</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>A.L.</ce:given-name>
                                 <ce:surname>Borgia</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>C.</ce:given-name>
                                 <ce:surname>De Ponti</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>A.</ce:given-name>
                                 <ce:surname>Somaschini</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>R.</ce:given-name>
                                 <ce:surname>Cammarota</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>N.</ce:given-name>
                                 <ce:surname>Amboldi</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>L.</ce:given-name>
                                 <ce:surname>Raddrizzani</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>A.</ce:given-name>
                                 <ce:surname>Milani</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>P.</ce:given-name>
                                 <ce:surname>Magnaghi</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>D.</ce:given-name>
                                 <ce:surname>Ballinari</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>D.</ce:given-name>
                                 <ce:surname>Casero</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>F.</ce:given-name>
                                 <ce:surname>Gasparri</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>P.</ce:given-name>
                                 <ce:surname>Banfi</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>N.</ce:given-name>
                                 <ce:surname>Avanzi</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>M.B.</ce:given-name>
                                 <ce:surname>Saccardo</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>R.</ce:given-name>
                                 <ce:surname>Alzani</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>T.</ce:given-name>
                                 <ce:surname>Bandiera</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>E.</ce:given-name>
                                 <ce:surname>Felder</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>D.</ce:given-name>
                                 <ce:surname>Donati</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>E.</ce:given-name>
                                 <ce:surname>Pesenti</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>A.</ce:given-name>
                                 <ce:surname>Sartore-Bianchi</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>M.</ce:given-name>
                                 <ce:surname>Gambacorta</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>M.A.</ce:given-name>
                                 <ce:surname>Pierotti</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>S.</ce:given-name>
                                 <ce:surname>Siena</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>S.</ce:given-name>
                                 <ce:surname>Veronese</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>A.</ce:given-name>
                                 <ce:surname>Galvani</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>A.</ce:given-name>
                                 <ce:surname>Isacchi</ce:surname>
                              </sb:author>
                           </sb:authors>
                           <sb:title>
                              <sb:maintitle>The TPM3-NTRK1 rearrangement is a recurring event in colorectal carcinoma and is associated with tumor sensitivity to TRKA kinase inhibition</sb:maintitle>
                           </sb:title>
                        </sb:contribution>
                        <sb:host>
                           <sb:issue>
                              <sb:series>
                                 <sb:title>
                                    <sb:maintitle>Mol. Oncol.</sb:maintitle>
                                 </sb:title>
                                 <sb:volume-nr>8</sb:volume-nr>
                              </sb:series>
                              <sb:date>2014</sb:date>
                           </sb:issue>
                           <sb:pages>
                              <sb:first-page>1495</sb:first-page>
                              <sb:last-page>1507</sb:last-page>
                           </sb:pages>
                        </sb:host>
                     </sb:reference>
                  </ce:bib-reference>
                  <ce:bib-reference id="bib29">
                     <ce:label>[29]</ce:label>
                     <sb:reference id="sref29">
                        <sb:contribution langtype="en">
                           <sb:authors>
                              <sb:author>
                                 <ce:given-name>G.</ce:given-name>
                                 <ce:surname>Wu</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>A.K.</ce:given-name>
                                 <ce:surname>Diaz</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>B.S.</ce:given-name>
                                 <ce:surname>Paugh</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>S.L.</ce:given-name>
                                 <ce:surname>Rankin</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>B.</ce:given-name>
                                 <ce:surname>Ju</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>Y.</ce:given-name>
                                 <ce:surname>Li</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>X.</ce:given-name>
                                 <ce:surname>Zhu</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>C.</ce:given-name>
                                 <ce:surname>Qu</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>X.</ce:given-name>
                                 <ce:surname>Chen</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>J.</ce:given-name>
                                 <ce:surname>Zhang</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>J.</ce:given-name>
                                 <ce:surname>Easton</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>M.</ce:given-name>
                                 <ce:surname>Edmonson</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>X.</ce:given-name>
                                 <ce:surname>Ma</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>C.</ce:given-name>
                                 <ce:surname>Lu</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>P.</ce:given-name>
                                 <ce:surname>Nagahawatte</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>E.</ce:given-name>
                                 <ce:surname>Hedlund</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>M.</ce:given-name>
                                 <ce:surname>Rusch</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>S.</ce:given-name>
                                 <ce:surname>Pounds</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>T.</ce:given-name>
                                 <ce:surname>Lin</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>A.</ce:given-name>
                                 <ce:surname>Onar-Thomas</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>R.</ce:given-name>
                                 <ce:surname>Huether</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>R.</ce:given-name>
                                 <ce:surname>Kriwacki</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>M.</ce:given-name>
                                 <ce:surname>Parker</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>P.</ce:given-name>
                                 <ce:surname>Gupta</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>J.</ce:given-name>
                                 <ce:surname>Becksfort</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>L.</ce:given-name>
                                 <ce:surname>Wei</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>H.L.</ce:given-name>
                                 <ce:surname>Mulder</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>K.</ce:given-name>
                                 <ce:surname>Boggs</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>B.</ce:given-name>
                                 <ce:surname>Vadodaria</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>D.</ce:given-name>
                                 <ce:surname>Yergeau</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>J.C.</ce:given-name>
                                 <ce:surname>Russell</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>K.</ce:given-name>
                                 <ce:surname>Ochoa</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>R.S.</ce:given-name>
                                 <ce:surname>Fulton</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>L.L.</ce:given-name>
                                 <ce:surname>Fulton</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>C.</ce:given-name>
                                 <ce:surname>Jones</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>F.A.</ce:given-name>
                                 <ce:surname>Boop</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>A.</ce:given-name>
                                 <ce:surname>Broniscer</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>C.</ce:given-name>
                                 <ce:surname>Wetmore</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>A.</ce:given-name>
                                 <ce:surname>Gajjar</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>L.</ce:given-name>
                                 <ce:surname>Ding</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>E.R.</ce:given-name>
                                 <ce:surname>Mardis</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>R.K.</ce:given-name>
                                 <ce:surname>Wilson</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>M.R.</ce:given-name>
                                 <ce:surname>Taylor</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>J.R.</ce:given-name>
                                 <ce:surname>Downing</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>D.W.</ce:given-name>
                                 <ce:surname>Ellison</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>J.</ce:given-name>
                                 <ce:surname>Zhang</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>S.J.</ce:given-name>
                                 <ce:surname>Baker</ce:surname>
                              </sb:author>
                           </sb:authors>
                           <sb:title>
                              <sb:maintitle>The genomic landscape of diffuse intrinsic pontine glioma and pediatric non-brainstem high-grade glioma</sb:maintitle>
                           </sb:title>
                        </sb:contribution>
                        <sb:host>
                           <sb:issue>
                              <sb:series>
                                 <sb:title>
                                    <sb:maintitle>Nat. Genet.</sb:maintitle>
                                 </sb:title>
                                 <sb:volume-nr>46</sb:volume-nr>
                              </sb:series>
                              <sb:date>2014</sb:date>
                           </sb:issue>
                           <sb:pages>
                              <sb:first-page>444</sb:first-page>
                              <sb:last-page>450</sb:last-page>
                           </sb:pages>
                        </sb:host>
                     </sb:reference>
                  </ce:bib-reference>
                  <ce:bib-reference id="bib30">
                     <ce:label>[30]</ce:label>
                     <sb:reference id="sref30">
                        <sb:contribution langtype="en">
                           <sb:authors>
                              <sb:author>
                                 <ce:given-name>M.G.</ce:given-name>
                                 <ce:surname>Butti</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>I.</ce:given-name>
                                 <ce:surname>Bongarzone</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>G.</ce:given-name>
                                 <ce:surname>Ferraresi</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>P.</ce:given-name>
                                 <ce:surname>Mondellini</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>M.G.</ce:given-name>
                                 <ce:surname>Borrello</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>M.A.</ce:given-name>
                                 <ce:surname>Pierotti</ce:surname>
                              </sb:author>
                           </sb:authors>
                           <sb:title>
                              <sb:maintitle>AÂ sequence analysis of the genomic regions involved in the rearrangements between TPM3 and NTRK1 genes producing TRK oncogenes in papillary thyroid carcinomas</sb:maintitle>
                           </sb:title>
                        </sb:contribution>
                        <sb:host>
                           <sb:issue>
                              <sb:series>
                                 <sb:title>
                                    <sb:maintitle>Genomics</sb:maintitle>
                                 </sb:title>
                                 <sb:volume-nr>28</sb:volume-nr>
                              </sb:series>
                              <sb:date>1995</sb:date>
                           </sb:issue>
                           <sb:pages>
                              <sb:first-page>15</sb:first-page>
                              <sb:last-page>24</sb:last-page>
                           </sb:pages>
                        </sb:host>
                     </sb:reference>
                  </ce:bib-reference>
                  <ce:bib-reference id="bib31">
                     <ce:label>[31]</ce:label>
                     <sb:reference id="sref31">
                        <sb:contribution langtype="en">
                           <sb:authors>
                              <sb:author>
                                 <ce:given-name>B.</ce:given-name>
                                 <ce:surname>Claudia</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>K.</ce:given-name>
                                 <ce:surname>Sabine</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>P.</ce:given-name>
                                 <ce:surname>D.E.</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>L.</ce:given-name>
                                 <ce:surname>Edmund</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>R.H.</ce:given-name>
                                 <ce:surname>M</ce:surname>
                              </sb:author>
                           </sb:authors>
                           <sb:title>
                              <sb:maintitle>NTRK1 re-arrangement in papillary thyroid carcinomas of children after the Chernobyl reactor accident</sb:maintitle>
                           </sb:title>
                        </sb:contribution>
                        <sb:host>
                           <sb:issue>
                              <sb:series>
                                 <sb:title>
                                    <sb:maintitle>Int. J. Cancer</sb:maintitle>
                                 </sb:title>
                                 <sb:volume-nr>80</sb:volume-nr>
                              </sb:series>
                              <sb:date>1999</sb:date>
                           </sb:issue>
                           <sb:pages>
                              <sb:first-page>842</sb:first-page>
                              <sb:last-page>847</sb:last-page>
                           </sb:pages>
                        </sb:host>
                     </sb:reference>
                  </ce:bib-reference>
                  <ce:bib-reference id="bib32">
                     <ce:label>[32]</ce:label>
                     <sb:reference id="sref32">
                        <sb:contribution langtype="en">
                           <sb:authors>
                              <sb:author>
                                 <ce:given-name>A.</ce:given-name>
                                 <ce:surname>Greco</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>M.A.</ce:given-name>
                                 <ce:surname>Pierotti</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>I.</ce:given-name>
                                 <ce:surname>Bongarzone</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>S.</ce:given-name>
                                 <ce:surname>Pagliardini</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>C.</ce:given-name>
                                 <ce:surname>Lanzi</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>G.</ce:given-name>
                                 <ce:surname>Della Porta</ce:surname>
                              </sb:author>
                           </sb:authors>
                           <sb:title>
                              <sb:maintitle>TRK-T1 is a novel oncogene formed by the fusion of TPR and TRK genes in human papillary thyroid carcinomas</sb:maintitle>
                           </sb:title>
                        </sb:contribution>
                        <sb:host>
                           <sb:issue>
                              <sb:series>
                                 <sb:title>
                                    <sb:maintitle>Oncogene</sb:maintitle>
                                 </sb:title>
                                 <sb:volume-nr>7</sb:volume-nr>
                              </sb:series>
                              <sb:date>1992</sb:date>
                           </sb:issue>
                           <sb:pages>
                              <sb:first-page>237</sb:first-page>
                              <sb:last-page>242</sb:last-page>
                           </sb:pages>
                        </sb:host>
                     </sb:reference>
                  </ce:bib-reference>
                  <ce:bib-reference id="bib33">
                     <ce:label>[33]</ce:label>
                     <sb:reference id="sref33">
                        <sb:contribution langtype="en">
                           <sb:authors>
                              <sb:author>
                                 <ce:given-name>G.</ce:given-name>
                                 <ce:surname>Angela</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>M.</ce:given-name>
                                 <ce:surname>Claudia</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>P.</ce:given-name>
                                 <ce:surname>Sonia</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>F.</ce:given-name>
                                 <ce:surname>Lisa</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>B.</ce:given-name>
                                 <ce:surname>Italia</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>P.M.</ce:given-name>
                                 <ce:surname>A</ce:surname>
                              </sb:author>
                           </sb:authors>
                           <sb:title>
                              <sb:maintitle>Chromosome I rearrangements involving the genes TPR and NTRK1 produce structurally different thyroid-specific TRK oncogenes</sb:maintitle>
                           </sb:title>
                        </sb:contribution>
                        <sb:host>
                           <sb:issue>
                              <sb:series>
                                 <sb:title>
                                    <sb:maintitle>Genes Chromosomes Cancer</sb:maintitle>
                                 </sb:title>
                                 <sb:volume-nr>19</sb:volume-nr>
                              </sb:series>
                              <sb:date>1997</sb:date>
                           </sb:issue>
                           <sb:pages>
                              <sb:first-page>112</sb:first-page>
                              <sb:last-page>123</sb:last-page>
                           </sb:pages>
                        </sb:host>
                     </sb:reference>
                  </ce:bib-reference>
                  <ce:bib-reference id="bib34">
                     <ce:label>[34]</ce:label>
                     <sb:reference id="sref34">
                        <sb:contribution langtype="en">
                           <sb:authors>
                              <sb:author>
                                 <ce:given-name>M.</ce:given-name>
                                 <ce:surname>Milione</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>E.</ce:given-name>
                                 <ce:surname>Ardini</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>J.</ce:given-name>
                                 <ce:surname>Christiansen</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>E.</ce:given-name>
                                 <ce:surname>Valtorta</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>S.</ce:given-name>
                                 <ce:surname>Veronese</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>R.</ce:given-name>
                                 <ce:surname>Bosotti</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>A.</ce:given-name>
                                 <ce:surname>Pellegrinelli</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>A.</ce:given-name>
                                 <ce:surname>Testi</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>F.</ce:given-name>
                                 <ce:surname>Pietrantonio</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>G.</ce:given-name>
                                 <ce:surname>Fuca</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>G.</ce:given-name>
                                 <ce:surname>Wei</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>D.</ce:given-name>
                                 <ce:surname>Murphy</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>S.</ce:given-name>
                                 <ce:surname>Siena</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>A.</ce:given-name>
                                 <ce:surname>Isacchi</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>F.</ce:given-name>
                                 <ce:surname>De Braud</ce:surname>
                              </sb:author>
                           </sb:authors>
                           <sb:title>
                              <sb:maintitle>Identification and characterization of a novel SCYL3-NTRK1 rearrangement in a colorectal cancer patient</sb:maintitle>
                           </sb:title>
                        </sb:contribution>
                        <sb:host>
                           <sb:issue>
                              <sb:series>
                                 <sb:title>
                                    <sb:maintitle>Oncotarget</sb:maintitle>
                                 </sb:title>
                                 <sb:volume-nr>8</sb:volume-nr>
                              </sb:series>
                              <sb:date>2017</sb:date>
                           </sb:issue>
                           <sb:pages>
                              <sb:first-page>55353</sb:first-page>
                              <sb:last-page>55360</sb:last-page>
                           </sb:pages>
                        </sb:host>
                     </sb:reference>
                  </ce:bib-reference>
                  <ce:bib-reference id="bib35">
                     <ce:label>[35]</ce:label>
                     <sb:reference id="sref35">
                        <sb:contribution langtype="en">
                           <sb:authors>
                              <sb:author>
                                 <ce:given-name>N.</ce:given-name>
                                 <ce:surname>Stransky</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>E.</ce:given-name>
                                 <ce:surname>Cerami</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>S.</ce:given-name>
                                 <ce:surname>Schalm</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>J.L.</ce:given-name>
                                 <ce:surname>Kim</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>C.</ce:given-name>
                                 <ce:surname>Lengauer</ce:surname>
                              </sb:author>
                           </sb:authors>
                           <sb:title>
                              <sb:maintitle>The landscape of kinase fusions in cancer</sb:maintitle>
                           </sb:title>
                        </sb:contribution>
                        <sb:host>
                           <sb:issue>
                              <sb:series>
                                 <sb:title>
                                    <sb:maintitle>Nat. Commun.</sb:maintitle>
                                 </sb:title>
                                 <sb:volume-nr>5</sb:volume-nr>
                              </sb:series>
                              <sb:date>2014</sb:date>
                           </sb:issue>
                           <sb:pages>
                              <sb:first-page>4846</sb:first-page>
                           </sb:pages>
                        </sb:host>
                     </sb:reference>
                  </ce:bib-reference>
                  <ce:bib-reference id="bib36">
                     <ce:label>[36]</ce:label>
                     <sb:reference id="sref36">
                        <sb:contribution langtype="en">
                           <sb:authors>
                              <sb:author>
                                 <ce:given-name>D.T.</ce:given-name>
                                 <ce:surname>Jones</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>B.</ce:given-name>
                                 <ce:surname>Hutter</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>N.</ce:given-name>
                                 <ce:surname>Jager</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>A.</ce:given-name>
                                 <ce:surname>Korshunov</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>M.</ce:given-name>
                                 <ce:surname>Kool</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>H.J.</ce:given-name>
                                 <ce:surname>Warnatz</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>T.</ce:given-name>
                                 <ce:surname>Zichner</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>S.R.</ce:given-name>
                                 <ce:surname>Lambert</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>M.</ce:given-name>
                                 <ce:surname>Ryzhova</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>D.A.</ce:given-name>
                                 <ce:surname>Quang</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>A.M.</ce:given-name>
                                 <ce:surname>Fontebasso</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>A.M.</ce:given-name>
                                 <ce:surname>Stutz</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>S.</ce:given-name>
                                 <ce:surname>Hutter</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>M.</ce:given-name>
                                 <ce:surname>Zuckermann</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>D.</ce:given-name>
                                 <ce:surname>Sturm</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>J.</ce:given-name>
                                 <ce:surname>Gronych</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>B.</ce:given-name>
                                 <ce:surname>Lasitschka</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>S.</ce:given-name>
                                 <ce:surname>Schmidt</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>H.</ce:given-name>
                                 <ce:surname>Seker-Cin</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>H.</ce:given-name>
                                 <ce:surname>Witt</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>M.</ce:given-name>
                                 <ce:surname>Sultan</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>M.</ce:given-name>
                                 <ce:surname>Ralser</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>P.A.</ce:given-name>
                                 <ce:surname>Northcott</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>V.</ce:given-name>
                                 <ce:surname>Hovestadt</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>S.</ce:given-name>
                                 <ce:surname>Bender</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>E.</ce:given-name>
                                 <ce:surname>Pfaff</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>S.</ce:given-name>
                                 <ce:surname>Stark</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>D.</ce:given-name>
                                 <ce:surname>Faury</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>J.</ce:given-name>
                                 <ce:surname>Schwartzentruber</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>J.</ce:given-name>
                                 <ce:surname>Majewski</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>U.D.</ce:given-name>
                                 <ce:surname>Weber</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>M.</ce:given-name>
                                 <ce:surname>Zapatka</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>B.</ce:given-name>
                                 <ce:surname>Raeder</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>M.</ce:given-name>
                                 <ce:surname>Schlesner</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>C.L.</ce:given-name>
                                 <ce:surname>Worth</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>C.C.</ce:given-name>
                                 <ce:surname>Bartholomae</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>C.</ce:given-name>
                                 <ce:surname>von Kalle</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>C.D.</ce:given-name>
                                 <ce:surname>Imbusch</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>S.</ce:given-name>
                                 <ce:surname>Radomski</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>C.</ce:given-name>
                                 <ce:surname>Lawerenz</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>P.</ce:given-name>
                                 <ce:surname>van Sluis</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>J.</ce:given-name>
                                 <ce:surname>Koster</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>R.</ce:given-name>
                                 <ce:surname>Volckmann</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>R.</ce:given-name>
                                 <ce:surname>Versteeg</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>H.</ce:given-name>
                                 <ce:surname>Lehrach</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>C.</ce:given-name>
                                 <ce:surname>Monoranu</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>B.</ce:given-name>
                                 <ce:surname>Winkler</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>A.</ce:given-name>
                                 <ce:surname>Unterberg</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>C.</ce:given-name>
                                 <ce:surname>Herold-Mende</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>T.</ce:given-name>
                                 <ce:surname>Milde</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>A.E.</ce:given-name>
                                 <ce:surname>Kulozik</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>M.</ce:given-name>
                                 <ce:surname>Ebinger</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>M.U.</ce:given-name>
                                 <ce:surname>Schuhmann</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>Y.J.</ce:given-name>
                                 <ce:surname>Cho</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>S.L.</ce:given-name>
                                 <ce:surname>Pomeroy</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>A.</ce:given-name>
                                 <ce:surname>von Deimling</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>O.</ce:given-name>
                                 <ce:surname>Witt</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>M.D.</ce:given-name>
                                 <ce:surname>Taylor</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>S.</ce:given-name>
                                 <ce:surname>Wolf</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>M.A.</ce:given-name>
                                 <ce:surname>Karajannis</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>C.G.</ce:given-name>
                                 <ce:surname>Eberhart</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>W.</ce:given-name>
                                 <ce:surname>Scheurlen</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>M.</ce:given-name>
                                 <ce:surname>Hasselblatt</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>K.L.</ce:given-name>
                                 <ce:surname>Ligon</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>M.W.</ce:given-name>
                                 <ce:surname>Kieran</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>J.O.</ce:given-name>
                                 <ce:surname>Korbel</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>M.L.</ce:given-name>
                                 <ce:surname>Yaspo</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>B.</ce:given-name>
                                 <ce:surname>Brors</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>J.</ce:given-name>
                                 <ce:surname>Felsberg</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>G.</ce:given-name>
                                 <ce:surname>Reifenberger</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>V.P.</ce:given-name>
                                 <ce:surname>Collins</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>N.</ce:given-name>
                                 <ce:surname>Jabado</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>R.</ce:given-name>
                                 <ce:surname>Eils</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>P.</ce:given-name>
                                 <ce:surname>Lichter</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>S.M.</ce:given-name>
                                 <ce:surname>Pfister</ce:surname>
                              </sb:author>
                           </sb:authors>
                           <sb:title>
                              <sb:maintitle>Recurrent somatic alterations of FGFR1 and NTRK2 in pilocytic astrocytoma</sb:maintitle>
                           </sb:title>
                        </sb:contribution>
                        <sb:host>
                           <sb:issue>
                              <sb:series>
                                 <sb:title>
                                    <sb:maintitle>Nat. Genet.</sb:maintitle>
                                 </sb:title>
                                 <sb:volume-nr>45</sb:volume-nr>
                              </sb:series>
                              <sb:date>2013</sb:date>
                           </sb:issue>
                           <sb:pages>
                              <sb:first-page>927</sb:first-page>
                              <sb:last-page>932</sb:last-page>
                           </sb:pages>
                        </sb:host>
                     </sb:reference>
                  </ce:bib-reference>
                  <ce:bib-reference id="bib37">
                     <ce:label>[37]</ce:label>
                     <sb:reference id="sref37">
                        <sb:contribution langtype="en">
                           <sb:authors>
                              <sb:author>
                                 <ce:given-name>J.M.</ce:given-name>
                                 <ce:surname>Kralik</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>W.</ce:given-name>
                                 <ce:surname>Kranewitter</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>H.</ce:given-name>
                                 <ce:surname>Boesmueller</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>R.</ce:given-name>
                                 <ce:surname>Marschon</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>G.</ce:given-name>
                                 <ce:surname>Tschurtschenthaler</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>H.</ce:given-name>
                                 <ce:surname>Rumpold</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>K.</ce:given-name>
                                 <ce:surname>Wiesinger</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>M.</ce:given-name>
                                 <ce:surname>Erdel</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>A.L.</ce:given-name>
                                 <ce:surname>Petzer</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>G.</ce:given-name>
                                 <ce:surname>Webersinke</ce:surname>
                              </sb:author>
                           </sb:authors>
                           <sb:title>
                              <sb:maintitle>Characterization of a newly identified ETV6-NTRK3 fusion transcript in acute myeloid leukemia</sb:maintitle>
                           </sb:title>
                        </sb:contribution>
                        <sb:host>
                           <sb:issue>
                              <sb:series>
                                 <sb:title>
                                    <sb:maintitle>Diagn. Pathol.</sb:maintitle>
                                 </sb:title>
                                 <sb:volume-nr>6</sb:volume-nr>
                              </sb:series>
                              <sb:date>2011</sb:date>
                           </sb:issue>
                           <sb:pages>
                              <sb:first-page>19</sb:first-page>
                           </sb:pages>
                        </sb:host>
                     </sb:reference>
                  </ce:bib-reference>
                  <ce:bib-reference id="bib38">
                     <ce:label>[38]</ce:label>
                     <sb:reference id="sref38">
                        <sb:contribution langtype="en">
                           <sb:authors>
                              <sb:author>
                                 <ce:given-name>M.</ce:given-name>
                                 <ce:surname>Eguchi</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>M.</ce:given-name>
                                 <ce:surname>Eguchi-Ishimae</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>A.</ce:given-name>
                                 <ce:surname>Tojo</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>K.</ce:given-name>
                                 <ce:surname>Morishita</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>K.</ce:given-name>
                                 <ce:surname>Suzuki</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>Y.</ce:given-name>
                                 <ce:surname>Sato</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>S.</ce:given-name>
                                 <ce:surname>Kudoh</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>K.</ce:given-name>
                                 <ce:surname>Tanaka</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>M.</ce:given-name>
                                 <ce:surname>Setoyama</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>F.</ce:given-name>
                                 <ce:surname>Nagamura</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>S.</ce:given-name>
                                 <ce:surname>Asano</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>N.</ce:given-name>
                                 <ce:surname>Kamada</ce:surname>
                              </sb:author>
                           </sb:authors>
                           <sb:title>
                              <sb:maintitle>Fusion of ETV6 to neurotrophin-3 receptor TRKC in acute myeloid leukemia with t(12;15)(p13;q25)</sb:maintitle>
                           </sb:title>
                        </sb:contribution>
                        <sb:host>
                           <sb:issue>
                              <sb:series>
                                 <sb:title>
                                    <sb:maintitle>Blood</sb:maintitle>
                                 </sb:title>
                                 <sb:volume-nr>93</sb:volume-nr>
                              </sb:series>
                              <sb:date>1999</sb:date>
                           </sb:issue>
                           <sb:pages>
                              <sb:first-page>1355</sb:first-page>
                              <sb:last-page>1363</sb:last-page>
                           </sb:pages>
                        </sb:host>
                     </sb:reference>
                  </ce:bib-reference>
                  <ce:bib-reference id="bib39">
                     <ce:label>[39]</ce:label>
                     <sb:reference id="sref39">
                        <sb:contribution langtype="en">
                           <sb:authors>
                              <sb:author>
                                 <ce:given-name>S.R.</ce:given-name>
                                 <ce:surname>Knezevich</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>M.J.</ce:given-name>
                                 <ce:surname>Garnett</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>T.J.</ce:given-name>
                                 <ce:surname>Pysher</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>J.B.</ce:given-name>
                                 <ce:surname>Beckwith</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>P.E.</ce:given-name>
                                 <ce:surname>Grundy</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>P.H.</ce:given-name>
                                 <ce:surname>Sorensen</ce:surname>
                              </sb:author>
                           </sb:authors>
                           <sb:title>
                              <sb:maintitle>ETV6-NTRK3 gene fusions and trisomy 11 establish a histogenetic link between mesoblastic nephroma and congenital fibrosarcoma</sb:maintitle>
                           </sb:title>
                        </sb:contribution>
                        <sb:host>
                           <sb:issue>
                              <sb:series>
                                 <sb:title>
                                    <sb:maintitle>Cancer Res.</sb:maintitle>
                                 </sb:title>
                                 <sb:volume-nr>58</sb:volume-nr>
                              </sb:series>
                              <sb:date>1998</sb:date>
                           </sb:issue>
                           <sb:pages>
                              <sb:first-page>5046</sb:first-page>
                              <sb:last-page>5048</sb:last-page>
                           </sb:pages>
                        </sb:host>
                     </sb:reference>
                  </ce:bib-reference>
                  <ce:bib-reference id="bib40">
                     <ce:label>[40]</ce:label>
                     <sb:reference id="sref40">
                        <sb:contribution langtype="en">
                           <sb:authors>
                              <sb:author>
                                 <ce:given-name>S.R.</ce:given-name>
                                 <ce:surname>Knezevich</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>D.E.</ce:given-name>
                                 <ce:surname>McFadden</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>W.</ce:given-name>
                                 <ce:surname>Tao</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>J.F.</ce:given-name>
                                 <ce:surname>Lim</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>P.H.</ce:given-name>
                                 <ce:surname>Sorensen</ce:surname>
                              </sb:author>
                           </sb:authors>
                           <sb:title>
                              <sb:maintitle>AÂ novel ETV6-NTRK3 gene fusion in congenital fibrosarcoma</sb:maintitle>
                           </sb:title>
                        </sb:contribution>
                        <sb:host>
                           <sb:issue>
                              <sb:series>
                                 <sb:title>
                                    <sb:maintitle>Nat. Genet.</sb:maintitle>
                                 </sb:title>
                                 <sb:volume-nr>18</sb:volume-nr>
                              </sb:series>
                              <sb:date>1998</sb:date>
                           </sb:issue>
                           <sb:pages>
                              <sb:first-page>184</sb:first-page>
                              <sb:last-page>187</sb:last-page>
                           </sb:pages>
                        </sb:host>
                     </sb:reference>
                  </ce:bib-reference>
                  <ce:bib-reference id="bib41">
                     <ce:label>[41]</ce:label>
                     <sb:reference id="sref41">
                        <sb:contribution langtype="en">
                           <sb:authors>
                              <sb:author>
                                 <ce:given-name>B.P.</ce:given-name>
                                 <ce:surname>Rubin</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>C.-J.</ce:given-name>
                                 <ce:surname>Chen</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>T.W.</ce:given-name>
                                 <ce:surname>Morgan</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>S.</ce:given-name>
                                 <ce:surname>Xiao</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>H.E.</ce:given-name>
                                 <ce:surname>Grier</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>H.P.</ce:given-name>
                                 <ce:surname>Kozakewich</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>A.R.</ce:given-name>
                                 <ce:surname>Perez-Atayde</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>J.A.</ce:given-name>
                                 <ce:surname>Fletcher</ce:surname>
                              </sb:author>
                           </sb:authors>
                           <sb:title>
                              <sb:maintitle>Congenital mesoblastic nephroma t(12;15) is associated withETV6-NTRK3 gene fusion: cytogenetic and molecular relationship to congenital (infantile) fibrosarcoma</sb:maintitle>
                           </sb:title>
                        </sb:contribution>
                        <sb:host>
                           <sb:issue>
                              <sb:series>
                                 <sb:title>
                                    <sb:maintitle>Am. J. Pathol.</sb:maintitle>
                                 </sb:title>
                                 <sb:volume-nr>153</sb:volume-nr>
                              </sb:series>
                              <sb:date>1998</sb:date>
                           </sb:issue>
                           <sb:pages>
                              <sb:first-page>1451</sb:first-page>
                              <sb:last-page>1458</sb:last-page>
                           </sb:pages>
                        </sb:host>
                     </sb:reference>
                  </ce:bib-reference>
                  <ce:bib-reference id="bib42">
                     <ce:label>[42]</ce:label>
                     <sb:reference id="sref42">
                        <sb:contribution langtype="en">
                           <sb:authors>
                              <sb:author>
                                 <ce:given-name>N.</ce:given-name>
                                 <ce:surname>Watanabe</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>H.</ce:given-name>
                                 <ce:surname>Kobayashi</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>T.</ce:given-name>
                                 <ce:surname>Hirama</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>A.</ce:given-name>
                                 <ce:surname>Kikuta</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>S.</ce:given-name>
                                 <ce:surname>Koizumi</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>T.</ce:given-name>
                                 <ce:surname>Tsuru</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>Y.</ce:given-name>
                                 <ce:surname>Kaneko</ce:surname>
                              </sb:author>
                           </sb:authors>
                           <sb:title>
                              <sb:maintitle>Cryptic t(12;15)(p13;q26) producing the ETV6-NTRK3 fusion gene and no loss of IGF2 imprinting in congenital mesoblastic nephroma with trisomy 11: fluorescence in situ hybridization and IGF2 allelic expression analysis</sb:maintitle>
                           </sb:title>
                        </sb:contribution>
                        <sb:host>
                           <sb:issue>
                              <sb:series>
                                 <sb:title>
                                    <sb:maintitle>Cancer Genet. Cytogenet.</sb:maintitle>
                                 </sb:title>
                                 <sb:volume-nr>136</sb:volume-nr>
                              </sb:series>
                              <sb:date>2002</sb:date>
                           </sb:issue>
                           <sb:pages>
                              <sb:first-page>10</sb:first-page>
                              <sb:last-page>16</sb:last-page>
                           </sb:pages>
                        </sb:host>
                     </sb:reference>
                  </ce:bib-reference>
                  <ce:bib-reference id="bib43">
                     <ce:label>[43]</ce:label>
                     <sb:reference id="sref43">
                        <sb:contribution langtype="en">
                           <sb:authors>
                              <sb:author>
                                 <ce:given-name>J.F.</ce:given-name>
                                 <ce:surname>Hechtman</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>A.</ce:given-name>
                                 <ce:surname>Zehir</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>R.</ce:given-name>
                                 <ce:surname>Yaeger</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>L.</ce:given-name>
                                 <ce:surname>Wang</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>S.</ce:given-name>
                                 <ce:surname>Middha</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>T.</ce:given-name>
                                 <ce:surname>Zheng</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>D.M.</ce:given-name>
                                 <ce:surname>Hyman</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>D.</ce:given-name>
                                 <ce:surname>Solit</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>M.E.</ce:given-name>
                                 <ce:surname>Arcila</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>L.</ce:given-name>
                                 <ce:surname>Borsu</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>J.</ce:given-name>
                                 <ce:surname>Shia</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>E.</ce:given-name>
                                 <ce:surname>Vakiani</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>L.</ce:given-name>
                                 <ce:surname>Saltz</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>M.</ce:given-name>
                                 <ce:surname>Ladanyi</ce:surname>
                              </sb:author>
                           </sb:authors>
                           <sb:title>
                              <sb:maintitle>Identification of targetable kinase alterations in patients with colorectal carcinoma that are preferentially associated with wild-type RAS/RAF</sb:maintitle>
                           </sb:title>
                        </sb:contribution>
                        <sb:host>
                           <sb:issue>
                              <sb:series>
                                 <sb:title>
                                    <sb:maintitle>Mol. Canc. Res.</sb:maintitle>
                                 </sb:title>
                                 <sb:volume-nr>14</sb:volume-nr>
                              </sb:series>
                              <sb:date>2016</sb:date>
                           </sb:issue>
                           <sb:pages>
                              <sb:first-page>296</sb:first-page>
                              <sb:last-page>301</sb:last-page>
                           </sb:pages>
                        </sb:host>
                     </sb:reference>
                  </ce:bib-reference>
                  <ce:bib-reference id="bib44">
                     <ce:label>[44]</ce:label>
                     <sb:reference id="sref44">
                        <sb:contribution langtype="en">
                           <sb:authors>
                              <sb:author>
                                 <ce:given-name>N.</ce:given-name>
                                 <ce:surname>Makretsov</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>M.</ce:given-name>
                                 <ce:surname>He</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>M.</ce:given-name>
                                 <ce:surname>Hayes</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>S.</ce:given-name>
                                 <ce:surname>Chia</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>D.E.</ce:given-name>
                                 <ce:surname>Horsman</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>P.H.</ce:given-name>
                                 <ce:surname>Sorensen</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>D.G.</ce:given-name>
                                 <ce:surname>Huntsman</ce:surname>
                              </sb:author>
                           </sb:authors>
                           <sb:title>
                              <sb:maintitle>AÂ fluorescence in situ hybridization study of ETV6-NTRK3 fusion gene in secretory breast carcinoma</sb:maintitle>
                           </sb:title>
                        </sb:contribution>
                        <sb:host>
                           <sb:issue>
                              <sb:series>
                                 <sb:title>
                                    <sb:maintitle>Genes Chromosomes Cancer</sb:maintitle>
                                 </sb:title>
                                 <sb:volume-nr>40</sb:volume-nr>
                              </sb:series>
                              <sb:date>2004</sb:date>
                           </sb:issue>
                           <sb:pages>
                              <sb:first-page>152</sb:first-page>
                              <sb:last-page>157</sb:last-page>
                           </sb:pages>
                        </sb:host>
                     </sb:reference>
                  </ce:bib-reference>
                  <ce:bib-reference id="bib45">
                     <ce:label>[45]</ce:label>
                     <sb:reference id="sref45">
                        <sb:contribution langtype="en">
                           <sb:authors>
                              <sb:author>
                                 <ce:given-name>C.</ce:given-name>
                                 <ce:surname>Arce</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>D.</ce:given-name>
                                 <ce:surname>Cortes-Padilla</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>D.G.</ce:given-name>
                                 <ce:surname>Huntsman</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>M.A.</ce:given-name>
                                 <ce:surname>Miller</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>A.</ce:given-name>
                                 <ce:surname>Duennas-Gonzalez</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>A.</ce:given-name>
                                 <ce:surname>Alvarado</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>V.</ce:given-name>
                                 <ce:surname>Perez</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>D.</ce:given-name>
                                 <ce:surname>Gallardo-Rincon</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>F.</ce:given-name>
                                 <ce:surname>Lara-Medina</ce:surname>
                              </sb:author>
                           </sb:authors>
                           <sb:title>
                              <sb:maintitle>Secretory carcinoma of the breast containing the ETV6-NTRK3 fusion gene in a male: case report and review of the literature</sb:maintitle>
                           </sb:title>
                        </sb:contribution>
                        <sb:host>
                           <sb:issue>
                              <sb:series>
                                 <sb:title>
                                    <sb:maintitle>World J. Surg. Oncol.</sb:maintitle>
                                 </sb:title>
                                 <sb:volume-nr>3</sb:volume-nr>
                              </sb:series>
                              <sb:date>2005</sb:date>
                           </sb:issue>
                           <sb:pages>
                              <sb:first-page>35</sb:first-page>
                           </sb:pages>
                        </sb:host>
                     </sb:reference>
                  </ce:bib-reference>
                  <ce:bib-reference id="bib46">
                     <ce:label>[46]</ce:label>
                     <sb:reference id="sref46">
                        <sb:contribution langtype="en">
                           <sb:authors>
                              <sb:author>
                                 <ce:given-name>A.</ce:given-name>
                                 <ce:surname>Pinto</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>V.</ce:given-name>
                                 <ce:surname>Nose</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>C.</ce:given-name>
                                 <ce:surname>Rojas</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>Y.S.</ce:given-name>
                                 <ce:surname>Fan</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>C.</ce:given-name>
                                 <ce:surname>Gomez-Fernandez</ce:surname>
                              </sb:author>
                           </sb:authors>
                           <sb:title>
                              <sb:maintitle>Searching for mammary analogue [corrected] secretory carcinoma of salivary gland among its mimics</sb:maintitle>
                           </sb:title>
                        </sb:contribution>
                        <sb:host>
                           <sb:issue>
                              <sb:series>
                                 <sb:title>
                                    <sb:maintitle>Mod. Pathol.</sb:maintitle>
                                 </sb:title>
                                 <sb:volume-nr>27</sb:volume-nr>
                              </sb:series>
                              <sb:date>2014</sb:date>
                           </sb:issue>
                           <sb:pages>
                              <sb:first-page>30</sb:first-page>
                              <sb:last-page>37</sb:last-page>
                           </sb:pages>
                        </sb:host>
                     </sb:reference>
                  </ce:bib-reference>
                  <ce:bib-reference id="bib47">
                     <ce:label>[47]</ce:label>
                     <sb:reference id="sref47">
                        <sb:contribution langtype="en">
                           <sb:authors>
                              <sb:author>
                                 <ce:given-name>C.</ce:given-name>
                                 <ce:surname>Morerio</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>A.</ce:given-name>
                                 <ce:surname>Rapella</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>C.</ce:given-name>
                                 <ce:surname>Rosanda</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>E.</ce:given-name>
                                 <ce:surname>Tassano</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>M.</ce:given-name>
                                 <ce:surname>Conte</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>C.</ce:given-name>
                                 <ce:surname>Gambini</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>C.</ce:given-name>
                                 <ce:surname>Panarello</ce:surname>
                              </sb:author>
                           </sb:authors>
                           <sb:title>
                              <sb:maintitle>Differential diagnosis of congenital fibrosarcoma</sb:maintitle>
                           </sb:title>
                        </sb:contribution>
                        <sb:host>
                           <sb:issue>
                              <sb:series>
                                 <sb:title>
                                    <sb:maintitle>Cancer Genet. Cytogenet.</sb:maintitle>
                                 </sb:title>
                                 <sb:volume-nr>152</sb:volume-nr>
                              </sb:series>
                              <sb:date>2004</sb:date>
                           </sb:issue>
                           <sb:pages>
                              <sb:first-page>167</sb:first-page>
                              <sb:last-page>168</sb:last-page>
                           </sb:pages>
                        </sb:host>
                     </sb:reference>
                  </ce:bib-reference>
                  <ce:bib-reference id="bib48">
                     <ce:label>[48]</ce:label>
                     <sb:reference id="sref48">
                        <sb:contribution langtype="en">
                           <sb:authors>
                              <sb:author>
                                 <ce:given-name>H.H.</ce:given-name>
                                 <ce:surname>Punnett</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>E.Z.</ce:given-name>
                                 <ce:surname>Tomczak</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>B.R.</ce:given-name>
                                 <ce:surname>Pawel</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>J.P.</ce:given-name>
                                 <ce:surname>de Chadarevian</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>P.H.</ce:given-name>
                                 <ce:surname>Sorensen</ce:surname>
                              </sb:author>
                           </sb:authors>
                           <sb:title>
                              <sb:maintitle>ETV6-NTRK3 gene fusion in metastasizing congenital fibrosarcoma</sb:maintitle>
                           </sb:title>
                        </sb:contribution>
                        <sb:host>
                           <sb:issue>
                              <sb:series>
                                 <sb:title>
                                    <sb:maintitle>Med. Pediatr. Oncol.</sb:maintitle>
                                 </sb:title>
                                 <sb:volume-nr>35</sb:volume-nr>
                              </sb:series>
                              <sb:date>2000</sb:date>
                           </sb:issue>
                           <sb:pages>
                              <sb:first-page>137</sb:first-page>
                              <sb:last-page>139</sb:last-page>
                           </sb:pages>
                        </sb:host>
                     </sb:reference>
                  </ce:bib-reference>
                  <ce:bib-reference id="bib49">
                     <ce:label>[49]</ce:label>
                     <sb:reference id="sref49">
                        <sb:contribution langtype="en">
                           <sb:authors>
                              <sb:author>
                                 <ce:given-name>M.</ce:given-name>
                                 <ce:surname>Brenca</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>S.</ce:given-name>
                                 <ce:surname>Rossi</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>M.</ce:given-name>
                                 <ce:surname>Polano</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>D.</ce:given-name>
                                 <ce:surname>Gasparotto</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>L.</ce:given-name>
                                 <ce:surname>Zanatta</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>D.</ce:given-name>
                                 <ce:surname>Racanelli</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>L.</ce:given-name>
                                 <ce:surname>Valori</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>S.</ce:given-name>
                                 <ce:surname>Lamon</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>A.P.</ce:given-name>
                                 <ce:surname>Dei Tos</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>R.</ce:given-name>
                                 <ce:surname>Maestro</ce:surname>
                              </sb:author>
                           </sb:authors>
                           <sb:title>
                              <sb:maintitle>Transcriptome sequencing identifies ETV6-NTRK3 as a gene fusion involved in GIST</sb:maintitle>
                           </sb:title>
                        </sb:contribution>
                        <sb:host>
                           <sb:issue>
                              <sb:series>
                                 <sb:title>
                                    <sb:maintitle>J.Â Pathol.</sb:maintitle>
                                 </sb:title>
                                 <sb:volume-nr>238</sb:volume-nr>
                              </sb:series>
                              <sb:date>2016</sb:date>
                           </sb:issue>
                           <sb:pages>
                              <sb:first-page>543</sb:first-page>
                              <sb:last-page>549</sb:last-page>
                           </sb:pages>
                        </sb:host>
                     </sb:reference>
                  </ce:bib-reference>
                  <ce:bib-reference id="bib50">
                     <ce:label>[50]</ce:label>
                     <sb:reference id="sref50">
                        <sb:contribution langtype="en">
                           <sb:authors>
                              <sb:author>
                                 <ce:given-name>A.</ce:given-name>
                                 <ce:surname>Greco</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>R.</ce:given-name>
                                 <ce:surname>Orlandi</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>C.</ce:given-name>
                                 <ce:surname>Mariani</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>C.</ce:given-name>
                                 <ce:surname>Miranda</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>M.</ce:given-name>
                                 <ce:surname>Borrello</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>A.</ce:given-name>
                                 <ce:surname>Cattaneo</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>S.</ce:given-name>
                                 <ce:surname>Pagliardini</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>M.</ce:given-name>
                                 <ce:surname>Pierotti</ce:surname>
                              </sb:author>
                           </sb:authors>
                           <sb:title>
                              <sb:maintitle>Expression of TRK-T1 oncogene induces differentiation of PC12 cells</sb:maintitle>
                           </sb:title>
                        </sb:contribution>
                        <sb:host>
                           <sb:issue>
                              <sb:series>
                                 <sb:title>
                                    <sb:maintitle>Cell Growth Differ.</sb:maintitle>
                                 </sb:title>
                                 <sb:volume-nr>4</sb:volume-nr>
                              </sb:series>
                              <sb:date>1993</sb:date>
                           </sb:issue>
                           <sb:pages>
                              <sb:first-page>539</sb:first-page>
                              <sb:last-page>546</sb:last-page>
                           </sb:pages>
                        </sb:host>
                     </sb:reference>
                  </ce:bib-reference>
                  <ce:bib-reference id="bib51">
                     <ce:label>[51]</ce:label>
                     <sb:reference id="sref51">
                        <sb:contribution langtype="en">
                           <sb:authors>
                              <sb:author>
                                 <ce:given-name>A.</ce:given-name>
                                 <ce:surname>Skalova</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>T.</ce:given-name>
                                 <ce:surname>Vanecek</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>R.H.</ce:given-name>
                                 <ce:surname>Simpson</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>J.</ce:given-name>
                                 <ce:surname>Laco</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>H.</ce:given-name>
                                 <ce:surname>Majewska</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>M.</ce:given-name>
                                 <ce:surname>Baneckova</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>P.</ce:given-name>
                                 <ce:surname>Steiner</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>M.</ce:given-name>
                                 <ce:surname>Michal</ce:surname>
                              </sb:author>
                           </sb:authors>
                           <sb:title>
                              <sb:maintitle>Mammary analogue secretory carcinoma of salivary glands: molecular analysis of 25 ETV6 gene rearranged tumors with lack of detection of classical ETV6-NTRK3 fusion transcript by standard RT-PCR: report of 4 cases harboring ETV6-X gene fusion</sb:maintitle>
                           </sb:title>
                        </sb:contribution>
                        <sb:host>
                           <sb:issue>
                              <sb:series>
                                 <sb:title>
                                    <sb:maintitle>Am. J. Surg. Pathol.</sb:maintitle>
                                 </sb:title>
                                 <sb:volume-nr>40</sb:volume-nr>
                              </sb:series>
                              <sb:date>2016</sb:date>
                           </sb:issue>
                           <sb:pages>
                              <sb:first-page>3</sb:first-page>
                              <sb:last-page>13</sb:last-page>
                           </sb:pages>
                        </sb:host>
                     </sb:reference>
                  </ce:bib-reference>
                  <ce:bib-reference id="bib52">
                     <ce:label>[52]</ce:label>
                     <sb:reference id="sref52">
                        <sb:contribution langtype="en">
                           <sb:authors>
                              <sb:author>
                                 <ce:given-name>M.</ce:given-name>
                                 <ce:surname>Del Castillo</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>F.</ce:given-name>
                                 <ce:surname>Chibon</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>L.</ce:given-name>
                                 <ce:surname>Arnould</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>S.</ce:given-name>
                                 <ce:surname>Croce</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>A.</ce:given-name>
                                 <ce:surname>Ribeiro</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>G.</ce:given-name>
                                 <ce:surname>Perot</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>I.</ce:given-name>
                                 <ce:surname>Hostein</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>S.</ce:given-name>
                                 <ce:surname>Geha</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>C.</ce:given-name>
                                 <ce:surname>Bozon</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>A.</ce:given-name>
                                 <ce:surname>Garnier</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>M.</ce:given-name>
                                 <ce:surname>Lae</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>A.</ce:given-name>
                                 <ce:surname>Vincent-Salomon</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>G.</ce:given-name>
                                 <ce:surname>MacGrogan</ce:surname>
                              </sb:author>
                           </sb:authors>
                           <sb:title>
                              <sb:maintitle>Secretory breast carcinoma: a histopathologic and genomic spectrum characterized by a joint specific ETV6-NTRK3 gene fusion</sb:maintitle>
                           </sb:title>
                        </sb:contribution>
                        <sb:host>
                           <sb:issue>
                              <sb:series>
                                 <sb:title>
                                    <sb:maintitle>Am. J. Surg. Pathol.</sb:maintitle>
                                 </sb:title>
                                 <sb:volume-nr>39</sb:volume-nr>
                              </sb:series>
                              <sb:date>2015</sb:date>
                           </sb:issue>
                           <sb:pages>
                              <sb:first-page>1458</sb:first-page>
                              <sb:last-page>1467</sb:last-page>
                           </sb:pages>
                        </sb:host>
                     </sb:reference>
                  </ce:bib-reference>
                  <ce:bib-reference id="bib53">
                     <ce:label>[53]</ce:label>
                     <sb:reference id="sref53">
                        <sb:contribution langtype="en">
                           <sb:authors>
                              <sb:author>
                                 <ce:given-name>R.J.</ce:given-name>
                                 <ce:surname>Leeman-Neill</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>L.M.</ce:given-name>
                                 <ce:surname>Kelly</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>P.</ce:given-name>
                                 <ce:surname>Liu</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>A.V.</ce:given-name>
                                 <ce:surname>Brenner</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>M.P.</ce:given-name>
                                 <ce:surname>Little</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>T.I.</ce:given-name>
                                 <ce:surname>Bogdanova</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>V.N.</ce:given-name>
                                 <ce:surname>Evdokimova</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>M.</ce:given-name>
                                 <ce:surname>Hatch</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>L.Y.</ce:given-name>
                                 <ce:surname>Zurnadzy</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>M.N.</ce:given-name>
                                 <ce:surname>Nikiforova</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>N.J.</ce:given-name>
                                 <ce:surname>Yue</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>M.</ce:given-name>
                                 <ce:surname>Zhang</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>K.</ce:given-name>
                                 <ce:surname>Mabuchi</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>M.D.</ce:given-name>
                                 <ce:surname>Tronko</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>Y.E.</ce:given-name>
                                 <ce:surname>Nikiforov</ce:surname>
                              </sb:author>
                           </sb:authors>
                           <sb:title>
                              <sb:maintitle>ETV6-NTRK3 is a common chromosomal rearrangement in radiation-associated thyroid cancer</sb:maintitle>
                           </sb:title>
                        </sb:contribution>
                        <sb:host>
                           <sb:issue>
                              <sb:series>
                                 <sb:title>
                                    <sb:maintitle>Cancer</sb:maintitle>
                                 </sb:title>
                                 <sb:volume-nr>120</sb:volume-nr>
                              </sb:series>
                              <sb:date>2014</sb:date>
                           </sb:issue>
                           <sb:pages>
                              <sb:first-page>799</sb:first-page>
                              <sb:last-page>807</sb:last-page>
                           </sb:pages>
                        </sb:host>
                     </sb:reference>
                  </ce:bib-reference>
                  <ce:bib-reference id="bib54">
                     <ce:label>[54]</ce:label>
                     <sb:reference id="sref54">
                        <sb:contribution langtype="en">
                           <sb:authors>
                              <sb:author>
                                 <ce:given-name>C.</ce:given-name>
                                 <ce:surname>Lagadec</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>S.</ce:given-name>
                                 <ce:surname>Meignan</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>E.</ce:given-name>
                                 <ce:surname>Adriaenssens</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>B.</ce:given-name>
                                 <ce:surname>Foveau</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>E.</ce:given-name>
                                 <ce:surname>Vanhecke</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>R.</ce:given-name>
                                 <ce:surname>Romon</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>R.A.</ce:given-name>
                                 <ce:surname>Toillon</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>B.</ce:given-name>
                                 <ce:surname>Oxombre</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>H.</ce:given-name>
                                 <ce:surname>Hondermarck</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>X.</ce:given-name>
                                 <ce:surname>Le Bourhis</ce:surname>
                              </sb:author>
                           </sb:authors>
                           <sb:title>
                              <sb:maintitle>TrkA overexpression enhances growth and metastasis of breast cancer cells</sb:maintitle>
                           </sb:title>
                        </sb:contribution>
                        <sb:host>
                           <sb:issue>
                              <sb:series>
                                 <sb:title>
                                    <sb:maintitle>Oncogene</sb:maintitle>
                                 </sb:title>
                                 <sb:volume-nr>28</sb:volume-nr>
                              </sb:series>
                              <sb:date>2009</sb:date>
                           </sb:issue>
                           <sb:pages>
                              <sb:first-page>1960</sb:first-page>
                           </sb:pages>
                        </sb:host>
                     </sb:reference>
                  </ce:bib-reference>
                  <ce:bib-reference id="bib55">
                     <ce:label>[55]</ce:label>
                     <sb:reference id="sref55">
                        <sb:contribution langtype="en">
                           <sb:authors>
                              <sb:author>
                                 <ce:given-name>A.</ce:given-name>
                                 <ce:surname>Drilon</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>R.</ce:given-name>
                                 <ce:surname>Nagasubramanian</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>J.F.</ce:given-name>
                                 <ce:surname>Blake</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>N.</ce:given-name>
                                 <ce:surname>Ku</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>B.B.</ce:given-name>
                                 <ce:surname>Tuch</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>K.</ce:given-name>
                                 <ce:surname>Ebata</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>S.</ce:given-name>
                                 <ce:surname>Smith</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>V.</ce:given-name>
                                 <ce:surname>Lauriault</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>G.R.</ce:given-name>
                                 <ce:surname>Kolakowski</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>B.J.</ce:given-name>
                                 <ce:surname>Brandhuber</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>P.D.</ce:given-name>
                                 <ce:surname>Larsen</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>K.S.</ce:given-name>
                                 <ce:surname>Bouhana</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>S.L.</ce:given-name>
                                 <ce:surname>Winski</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>R.</ce:given-name>
                                 <ce:surname>Hamor</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>W.I.</ce:given-name>
                                 <ce:surname>Wu</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>A.</ce:given-name>
                                 <ce:surname>Parker</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>T.H.</ce:given-name>
                                 <ce:surname>Morales</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>F.X.</ce:given-name>
                                 <ce:surname>Sullivan</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>W.E.</ce:given-name>
                                 <ce:surname>DeWolf</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>L.A.</ce:given-name>
                                 <ce:surname>Wollenberg</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>P.R.</ce:given-name>
                                 <ce:surname>Gordon</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>D.N.</ce:given-name>
                                 <ce:surname>Douglas-Lindsay</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>M.</ce:given-name>
                                 <ce:surname>Scaltriti</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>R.</ce:given-name>
                                 <ce:surname>Benayed</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>S.</ce:given-name>
                                 <ce:surname>Raj</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>B.</ce:given-name>
                                 <ce:surname>Hanusch</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>A.M.</ce:given-name>
                                 <ce:surname>Schram</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>P.</ce:given-name>
                                 <ce:surname>Jonsson</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>M.F.</ce:given-name>
                                 <ce:surname>Berger</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>J.F.</ce:given-name>
                                 <ce:surname>Hechtman</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>B.S.</ce:given-name>
                                 <ce:surname>Taylor</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>S.</ce:given-name>
                                 <ce:surname>Andrews</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>M.</ce:given-name>
                                 <ce:surname>Rothenberg</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>D.M.</ce:given-name>
                                 <ce:surname>Hyman</ce:surname>
                              </sb:author>
                           </sb:authors>
                           <sb:title>
                              <sb:maintitle>AÂ next-generation TRK kinase inhibitor overcomes acquired resistance to prior TRK kinase inhibition in patients with TRK fusion-positive solid tumors</sb:maintitle>
                           </sb:title>
                        </sb:contribution>
                        <sb:host>
                           <sb:issue>
                              <sb:series>
                                 <sb:title>
                                    <sb:maintitle>Cancer Discov.</sb:maintitle>
                                 </sb:title>
                                 <sb:volume-nr>7</sb:volume-nr>
                              </sb:series>
                              <sb:date>2017</sb:date>
                           </sb:issue>
                           <sb:pages>
                              <sb:first-page>963</sb:first-page>
                              <sb:last-page>972</sb:last-page>
                           </sb:pages>
                        </sb:host>
                     </sb:reference>
                  </ce:bib-reference>
                  <ce:bib-reference id="bib56">
                     <ce:label>[56]</ce:label>
                     <sb:reference id="sref56">
                        <sb:contribution langtype="en">
                           <sb:authors>
                              <sb:author>
                                 <ce:given-name>Y.</ce:given-name>
                                 <ce:surname>Chen</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>S.H.</ce:given-name>
                                 <ce:surname>Tseng</ce:surname>
                              </sb:author>
                           </sb:authors>
                           <sb:title>
                              <sb:maintitle>Targeting tropomyosin-receptor kinase fused gene in cancer</sb:maintitle>
                           </sb:title>
                        </sb:contribution>
                        <sb:host>
                           <sb:issue>
                              <sb:series>
                                 <sb:title>
                                    <sb:maintitle>Anticancer Res.</sb:maintitle>
                                 </sb:title>
                                 <sb:volume-nr>34</sb:volume-nr>
                              </sb:series>
                              <sb:date>2014</sb:date>
                           </sb:issue>
                           <sb:pages>
                              <sb:first-page>1595</sb:first-page>
                              <sb:last-page>1600</sb:last-page>
                           </sb:pages>
                        </sb:host>
                     </sb:reference>
                  </ce:bib-reference>
                  <ce:bib-reference id="bib57">
                     <ce:label>[57]</ce:label>
                     <sb:reference id="sref57">
                        <sb:contribution langtype="en">
                           <sb:authors>
                              <sb:author>
                                 <ce:given-name>A.</ce:given-name>
                                 <ce:surname>Nakagawara</ce:surname>
                              </sb:author>
                           </sb:authors>
                           <sb:title>
                              <sb:maintitle>Trk receptor tyrosine kinases: a bridge between cancer and neural development</sb:maintitle>
                           </sb:title>
                        </sb:contribution>
                        <sb:host>
                           <sb:issue>
                              <sb:series>
                                 <sb:title>
                                    <sb:maintitle>Cancer Lett.</sb:maintitle>
                                 </sb:title>
                                 <sb:volume-nr>169</sb:volume-nr>
                              </sb:series>
                              <sb:date>2001</sb:date>
                           </sb:issue>
                           <sb:pages>
                              <sb:first-page>107</sb:first-page>
                              <sb:last-page>114</sb:last-page>
                           </sb:pages>
                        </sb:host>
                     </sb:reference>
                  </ce:bib-reference>
                  <ce:bib-reference id="bib58">
                     <ce:label>[58]</ce:label>
                     <sb:reference id="sref58">
                        <sb:contribution langtype="en">
                           <sb:authors>
                              <sb:author>
                                 <ce:given-name>W.</ce:given-name>
                                 <ce:surname>Yan</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>N.R.</ce:given-name>
                                 <ce:surname>Lakkaniga</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>F.</ce:given-name>
                                 <ce:surname>Carlomagno</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>M.</ce:given-name>
                                 <ce:surname>Santoro</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>N.Q.</ce:given-name>
                                 <ce:surname>McDonald</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>F.</ce:given-name>
                                 <ce:surname>Lv</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>N.</ce:given-name>
                                 <ce:surname>Gunaganti</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>B.</ce:given-name>
                                 <ce:surname>Frett</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>H.-y.</ce:given-name>
                                 <ce:surname>Li</ce:surname>
                              </sb:author>
                           </sb:authors>
                           <sb:title>
                              <sb:maintitle>Insights into current tropomyosin receptor kinase (TRK) inhibitors: development and clinical application</sb:maintitle>
                           </sb:title>
                        </sb:contribution>
                        <sb:host>
                           <sb:issue>
                              <sb:series>
                                 <sb:title>
                                    <sb:maintitle>J.Â Med. Chem.</sb:maintitle>
                                 </sb:title>
                                 <sb:volume-nr>62</sb:volume-nr>
                              </sb:series>
                              <sb:date>2019</sb:date>
                           </sb:issue>
                           <sb:pages>
                              <sb:first-page>1731</sb:first-page>
                              <sb:last-page>1760</sb:last-page>
                           </sb:pages>
                        </sb:host>
                     </sb:reference>
                  </ce:bib-reference>
                  <ce:bib-reference id="bib59">
                     <ce:label>[59]</ce:label>
                     <sb:reference id="sref59">
                        <sb:contribution langtype="en">
                           <sb:authors>
                              <sb:author>
                                 <ce:given-name>B.H.</ce:given-name>
                                 <ce:surname>Norman</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>J.S.</ce:given-name>
                                 <ce:surname>McDermott</ce:surname>
                              </sb:author>
                           </sb:authors>
                           <sb:title>
                              <sb:maintitle>Targeting the nerve growth factor (NGF) pathway in drug discovery. Potential applications to new therapies for chronic pain</sb:maintitle>
                           </sb:title>
                        </sb:contribution>
                        <sb:host>
                           <sb:issue>
                              <sb:series>
                                 <sb:title>
                                    <sb:maintitle>J.Â Med. Chem.</sb:maintitle>
                                 </sb:title>
                                 <sb:volume-nr>60</sb:volume-nr>
                              </sb:series>
                              <sb:date>2017</sb:date>
                           </sb:issue>
                           <sb:pages>
                              <sb:first-page>66</sb:first-page>
                              <sb:last-page>88</sb:last-page>
                           </sb:pages>
                        </sb:host>
                     </sb:reference>
                  </ce:bib-reference>
                  <ce:bib-reference id="bib60">
                     <ce:label>[60]</ce:label>
                     <sb:reference id="sref60">
                        <sb:contribution langtype="en">
                           <sb:authors>
                              <sb:author>
                                 <ce:given-name>J.J.</ce:given-name>
                                 <ce:surname>Bailey</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>R.</ce:given-name>
                                 <ce:surname>Schirrmacher</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>K.</ce:given-name>
                                 <ce:surname>Farrell</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>V.</ce:given-name>
                                 <ce:surname>Bernard-Gauthier</ce:surname>
                              </sb:author>
                           </sb:authors>
                           <sb:title>
                              <sb:maintitle>Tropomyosin receptor kinase inhibitors: an updated patent review for 2010-2016-Part I</sb:maintitle>
                           </sb:title>
                        </sb:contribution>
                        <sb:host>
                           <sb:issue>
                              <sb:series>
                                 <sb:title>
                                    <sb:maintitle>Expert Opin. Ther. Pat.</sb:maintitle>
                                 </sb:title>
                                 <sb:volume-nr>27</sb:volume-nr>
                              </sb:series>
                              <sb:date>2017</sb:date>
                           </sb:issue>
                           <sb:pages>
                              <sb:first-page>733</sb:first-page>
                              <sb:last-page>751</sb:last-page>
                           </sb:pages>
                        </sb:host>
                     </sb:reference>
                  </ce:bib-reference>
                  <ce:bib-reference id="bib61">
                     <ce:label>[61]</ce:label>
                     <sb:reference id="sref61">
                        <sb:contribution langtype="en">
                           <sb:authors>
                              <sb:author>
                                 <ce:given-name>J.J.</ce:given-name>
                                 <ce:surname>Bailey</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>R.</ce:given-name>
                                 <ce:surname>Schirrmacher</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>K.</ce:given-name>
                                 <ce:surname>Farrell</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>V.</ce:given-name>
                                 <ce:surname>Bernard-Gauthier</ce:surname>
                              </sb:author>
                           </sb:authors>
                           <sb:title>
                              <sb:maintitle>Tropomyosin receptor kinase inhibitors: an updated patent review for 2010-2016-Part II</sb:maintitle>
                           </sb:title>
                        </sb:contribution>
                        <sb:host>
                           <sb:issue>
                              <sb:series>
                                 <sb:title>
                                    <sb:maintitle>Expert Opin. Ther. Pat.</sb:maintitle>
                                 </sb:title>
                                 <sb:volume-nr>27</sb:volume-nr>
                              </sb:series>
                              <sb:date>2017</sb:date>
                           </sb:issue>
                           <sb:pages>
                              <sb:first-page>831</sb:first-page>
                              <sb:last-page>849</sb:last-page>
                           </sb:pages>
                        </sb:host>
                     </sb:reference>
                  </ce:bib-reference>
                  <ce:bib-reference id="bib62">
                     <ce:label>[62]</ce:label>
                     <sb:reference id="sref62">
                        <sb:contribution langtype="en">
                           <sb:authors>
                              <sb:author>
                                 <ce:given-name>S.</ce:given-name>
                                 <ce:surname>Hong</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>J.</ce:given-name>
                                 <ce:surname>Kim</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>J.H.</ce:given-name>
                                 <ce:surname>Seo</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>K.H.</ce:given-name>
                                 <ce:surname>Jung</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>S.S.</ce:given-name>
                                 <ce:surname>Hong</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>S.</ce:given-name>
                                 <ce:surname>Hong</ce:surname>
                              </sb:author>
                           </sb:authors>
                           <sb:title>
                              <sb:maintitle>Design, synthesis, and evaluation of 3,5-disubstituted 7-azaindoles as trk inhibitors with anticancer and antiangiogenic activities</sb:maintitle>
                           </sb:title>
                        </sb:contribution>
                        <sb:host>
                           <sb:issue>
                              <sb:series>
                                 <sb:title>
                                    <sb:maintitle>J.Â Med. Chem.</sb:maintitle>
                                 </sb:title>
                                 <sb:volume-nr>55</sb:volume-nr>
                              </sb:series>
                              <sb:date>2012</sb:date>
                           </sb:issue>
                           <sb:pages>
                              <sb:first-page>5337</sb:first-page>
                              <sb:last-page>5349</sb:last-page>
                           </sb:pages>
                        </sb:host>
                     </sb:reference>
                  </ce:bib-reference>
                  <ce:bib-reference id="bib63">
                     <ce:label>[63]</ce:label>
                     <sb:reference id="sref63">
                        <sb:contribution langtype="en">
                           <sb:authors>
                              <sb:author>
                                 <ce:given-name>L.J.</ce:given-name>
                                 <ce:surname>Scott</ce:surname>
                              </sb:author>
                           </sb:authors>
                           <sb:title>
                              <sb:maintitle>Larotrectinib: first global approval</sb:maintitle>
                           </sb:title>
                        </sb:contribution>
                        <sb:host>
                           <sb:issue>
                              <sb:series>
                                 <sb:title>
                                    <sb:maintitle>Drugs</sb:maintitle>
                                 </sb:title>
                                 <sb:volume-nr>79</sb:volume-nr>
                              </sb:series>
                              <sb:date>2019</sb:date>
                           </sb:issue>
                           <sb:pages>
                              <sb:first-page>201</sb:first-page>
                              <sb:last-page>206</sb:last-page>
                           </sb:pages>
                        </sb:host>
                     </sb:reference>
                  </ce:bib-reference>
                  <ce:bib-reference id="bib64">
                     <ce:label>[64]</ce:label>
                     <sb:reference id="sref64">
                        <sb:contribution langtype="en">
                           <sb:authors>
                              <sb:author>
                                 <ce:given-name>A.</ce:given-name>
                                 <ce:surname>Drilon</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>T.W.</ce:given-name>
                                 <ce:surname>Laetsch</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>S.</ce:given-name>
                                 <ce:surname>Kummar</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>S.G.</ce:given-name>
                                 <ce:surname>DuBois</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>U.N.</ce:given-name>
                                 <ce:surname>Lassen</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>G.D.</ce:given-name>
                                 <ce:surname>Demetri</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>M.</ce:given-name>
                                 <ce:surname>Nathenson</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>R.C.</ce:given-name>
                                 <ce:surname>Doebele</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>A.F.</ce:given-name>
                                 <ce:surname>Farago</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>A.S.</ce:given-name>
                                 <ce:surname>Pappo</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>B.</ce:given-name>
                                 <ce:surname>Turpin</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>A.</ce:given-name>
                                 <ce:surname>Dowlati</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>M.S.</ce:given-name>
                                 <ce:surname>Brose</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>L.</ce:given-name>
                                 <ce:surname>Mascarenhas</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>N.</ce:given-name>
                                 <ce:surname>Federman</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>J.</ce:given-name>
                                 <ce:surname>Berlin</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>W.S.</ce:given-name>
                                 <ce:surname>El-Deiry</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>C.</ce:given-name>
                                 <ce:surname>Baik</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>J.</ce:given-name>
                                 <ce:surname>Deeken</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>V.</ce:given-name>
                                 <ce:surname>Boni</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>R.</ce:given-name>
                                 <ce:surname>Nagasubramanian</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>M.</ce:given-name>
                                 <ce:surname>Taylor</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>E.R.</ce:given-name>
                                 <ce:surname>Rudzinski</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>F.</ce:given-name>
                                 <ce:surname>Meric-Bernstam</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>D.P.S.</ce:given-name>
                                 <ce:surname>Sohal</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>P.C.</ce:given-name>
                                 <ce:surname>Ma</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>L.E.</ce:given-name>
                                 <ce:surname>Raez</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>J.F.</ce:given-name>
                                 <ce:surname>Hechtman</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>R.</ce:given-name>
                                 <ce:surname>Benayed</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>M.</ce:given-name>
                                 <ce:surname>Ladanyi</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>B.B.</ce:given-name>
                                 <ce:surname>Tuch</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>K.</ce:given-name>
                                 <ce:surname>Ebata</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>S.</ce:given-name>
                                 <ce:surname>Cruickshank</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>N.C.</ce:given-name>
                                 <ce:surname>Ku</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>M.C.</ce:given-name>
                                 <ce:surname>Cox</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>D.S.</ce:given-name>
                                 <ce:surname>Hawkins</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>D.S.</ce:given-name>
                                 <ce:surname>Hong</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>D.M.</ce:given-name>
                                 <ce:surname>Hyman</ce:surname>
                              </sb:author>
                           </sb:authors>
                           <sb:title>
                              <sb:maintitle>Efficacy of larotrectinib in TRK fusion-positive cancers in adults and children</sb:maintitle>
                           </sb:title>
                        </sb:contribution>
                        <sb:host>
                           <sb:issue>
                              <sb:series>
                                 <sb:title>
                                    <sb:maintitle>N.Â Engl. J. Med.</sb:maintitle>
                                 </sb:title>
                                 <sb:volume-nr>378</sb:volume-nr>
                              </sb:series>
                              <sb:date>2018</sb:date>
                           </sb:issue>
                           <sb:pages>
                              <sb:first-page>731</sb:first-page>
                              <sb:last-page>739</sb:last-page>
                           </sb:pages>
                        </sb:host>
                     </sb:reference>
                  </ce:bib-reference>
                  <ce:bib-reference id="bib65">
                     <ce:label>[65]</ce:label>
                     <sb:reference id="sref65">
                        <sb:contribution langtype="en">
                           <sb:authors>
                              <sb:author>
                                 <ce:given-name>P.K.</ce:given-name>
                                 <ce:surname>Sasmal</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>S.</ce:given-name>
                                 <ce:surname>Ahmed</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>A.</ce:given-name>
                                 <ce:surname>Tehim</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>V.</ce:given-name>
                                 <ce:surname>Paradkar</ce:surname>
                              </sb:author>
                           </sb:authors>
                           <sb:title>
                              <sb:maintitle>Substituted Imidazo[1,2-A]pyridine Compounds as Tropomyosin Receptor Kinase A (TrkA) Inhibitors</sb:maintitle>
                           </sb:title>
                        </sb:contribution>
                        <sb:host>
                           <sb:book>
                              <sb:date>2015</sb:date>
                           </sb:book>
                        </sb:host>
                        <sb:comment>24.12</sb:comment>
                     </sb:reference>
                  </ce:bib-reference>
                  <ce:bib-reference id="bib66">
                     <ce:label>[66]</ce:label>
                     <sb:reference id="sref66">
                        <sb:contribution langtype="en">
                           <sb:authors>
                              <sb:author>
                                 <ce:given-name>L.</ce:given-name>
                                 <ce:surname>Zhu</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>Y.</ce:given-name>
                                 <ce:surname>Hu</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>W.</ce:given-name>
                                 <ce:surname>Wu</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>L.</ce:given-name>
                                 <ce:surname>Dai</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>X.</ce:given-name>
                                 <ce:surname>Duan</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>Y.</ce:given-name>
                                 <ce:surname>Yang</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>Y.</ce:given-name>
                                 <ce:surname>Sun</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>Y.</ce:given-name>
                                 <ce:surname>Han</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>Y.</ce:given-name>
                                 <ce:surname>Peng</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>F.</ce:given-name>
                                 <ce:surname>Kong</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>H.</ce:given-name>
                                 <ce:surname>Luo</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>L.</ce:given-name>
                                 <ce:surname>Yang</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>H.</ce:given-name>
                                 <ce:surname>Xu</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>M.</ce:given-name>
                                 <ce:surname>Guo</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>Z.</ce:given-name>
                                 <ce:surname>Zhong</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>S.</ce:given-name>
                                 <ce:surname>Wang</ce:surname>
                              </sb:author>
                           </sb:authors>
                           <sb:title>
                              <sb:maintitle>Amino Pyrazolopyrimidine Compound Used as Neurotrophic Factor Tyrosine Kinase Receptor Inhibitor</sb:maintitle>
                           </sb:title>
                        </sb:contribution>
                        <sb:host>
                           <sb:book>
                              <sb:date>2018</sb:date>
                           </sb:book>
                        </sb:host>
                        <sb:comment>WO2018077246, 03.05</sb:comment>
                     </sb:reference>
                  </ce:bib-reference>
                  <ce:bib-reference id="bib67">
                     <ce:label>[67]</ce:label>
                     <sb:reference id="sref67">
                        <sb:contribution langtype="en">
                           <sb:authors>
                              <sb:author>
                                 <ce:given-name>J.J.</ce:given-name>
                                 <ce:surname>Cui</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>Y.-h.</ce:given-name>
                                 <ce:surname>Li</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>E.W.</ce:given-name>
                                 <ce:surname>Rogers</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>D.</ce:given-name>
                                 <ce:surname>Zhai</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>J.</ce:given-name>
                                 <ce:surname>Ung</ce:surname>
                              </sb:author>
                           </sb:authors>
                           <sb:title>
                              <sb:maintitle>Marcocycle Kinase Inhibitors</sb:maintitle>
                           </sb:title>
                        </sb:contribution>
                        <sb:host>
                           <sb:book>
                              <sb:date>2018</sb:date>
                           </sb:book>
                        </sb:host>
                        <sb:comment>WO2018022911, 01.02</sb:comment>
                     </sb:reference>
                  </ce:bib-reference>
                  <ce:bib-reference id="bib68">
                     <ce:label>[68]</ce:label>
                     <sb:reference id="sref68">
                        <sb:contribution langtype="en">
                           <sb:authors>
                              <sb:author>
                                 <ce:given-name>H.S.</ce:given-name>
                                 <ce:surname>Choi</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>P.V.</ce:given-name>
                                 <ce:surname>Rucker</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>Z.C.</ce:given-name>
                                 <ce:surname>Wang</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>Y.</ce:given-name>
                                 <ce:surname>Fan</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>P.</ce:given-name>
                                 <ce:surname>Albaugh</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>G.</ce:given-name>
                                 <ce:surname>Chopiuk</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>F.</ce:given-name>
                                 <ce:surname>Gessier</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>F.X.</ce:given-name>
                                 <ce:surname>Sun</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>F.</ce:given-name>
                                 <ce:surname>Adrian</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>G.X.</ce:given-name>
                                 <ce:surname>Liu</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>T.</ce:given-name>
                                 <ce:surname>Hood</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>N.X.</ce:given-name>
                                 <ce:surname>Li</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>Y.</ce:given-name>
                                 <ce:surname>Jia</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>J.W.</ce:given-name>
                                 <ce:surname>Che</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>S.</ce:given-name>
                                 <ce:surname>McCormack</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>A.</ce:given-name>
                                 <ce:surname>Li</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>J.</ce:given-name>
                                 <ce:surname>Li</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>A.</ce:given-name>
                                 <ce:surname>Steffy</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>A.</ce:given-name>
                                 <ce:surname>Culazzo</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>C.</ce:given-name>
                                 <ce:surname>Tompkins</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>V.</ce:given-name>
                                 <ce:surname>Phung</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>A.</ce:given-name>
                                 <ce:surname>Kreusch</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>M.</ce:given-name>
                                 <ce:surname>Lu</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>B.</ce:given-name>
                                 <ce:surname>Hu</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>A.</ce:given-name>
                                 <ce:surname>Chaudhary</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>M.</ce:given-name>
                                 <ce:surname>Prashad</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>T.</ce:given-name>
                                 <ce:surname>Tuntland</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>B.</ce:given-name>
                                 <ce:surname>Liu</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>J.</ce:given-name>
                                 <ce:surname>Harris</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>H.M.</ce:given-name>
                                 <ce:surname>Seidel</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>J.</ce:given-name>
                                 <ce:surname>Loren</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>V.</ce:given-name>
                                 <ce:surname>Molteni</ce:surname>
                              </sb:author>
                           </sb:authors>
                           <sb:title>
                              <sb:maintitle>(R)-2-Phenylpyrrolidine substituted imidazopyridazines: a new class of potent and selective pan-IRK inhibitors</sb:maintitle>
                           </sb:title>
                        </sb:contribution>
                        <sb:host>
                           <sb:issue>
                              <sb:series>
                                 <sb:title>
                                    <sb:maintitle>ACS Med. Chem. Lett.</sb:maintitle>
                                 </sb:title>
                                 <sb:volume-nr>6</sb:volume-nr>
                              </sb:series>
                              <sb:date>2015</sb:date>
                           </sb:issue>
                           <sb:pages>
                              <sb:first-page>562</sb:first-page>
                              <sb:last-page>567</sb:last-page>
                           </sb:pages>
                        </sb:host>
                     </sb:reference>
                  </ce:bib-reference>
                  <ce:bib-reference id="bib69">
                     <ce:label>[69]</ce:label>
                     <sb:reference id="sref69">
                        <sb:contribution langtype="en">
                           <sb:authors>
                              <sb:author>
                                 <ce:given-name>P.</ce:given-name>
                                 <ce:surname>Chen</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>Y.</ce:given-name>
                                 <ce:surname>Zhao</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>B.</ce:given-name>
                                 <ce:surname>Fink, E</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>S.-h.</ce:given-name>
                                 <ce:surname>Kim</ce:surname>
                              </sb:author>
                           </sb:authors>
                           <sb:title>
                              <sb:maintitle>Pyrrolotriazine Kinase Inhibitors</sb:maintitle>
                           </sb:title>
                        </sb:contribution>
                        <sb:host>
                           <sb:book>
                              <sb:date>2007</sb:date>
                           </sb:book>
                        </sb:host>
                        <sb:comment>WO2007061882, 31.05</sb:comment>
                     </sb:reference>
                  </ce:bib-reference>
                  <ce:bib-reference id="bib70">
                     <ce:label>[70]</ce:label>
                     <sb:reference id="sref70">
                        <sb:contribution langtype="en">
                           <sb:authors>
                              <sb:author>
                                 <ce:given-name>A.J.</ce:given-name>
                                 <ce:surname>Cooke</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>C.A.</ce:given-name>
                                 <ce:surname>Stump</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>X.-F.</ce:given-name>
                                 <ce:surname>zhang</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>C.S.</ce:given-name>
                                 <ce:surname>Li</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>Q.</ce:given-name>
                                 <ce:surname>Mao</ce:surname>
                              </sb:author>
                           </sb:authors>
                           <sb:title>
                              <sb:maintitle>TrkA Kinase Inhibitors, Compositions and Methods Thereof</sb:maintitle>
                           </sb:title>
                        </sb:contribution>
                        <sb:host>
                           <sb:book>
                              <sb:date>2015</sb:date>
                           </sb:book>
                        </sb:host>
                        <sb:comment>WO2015042085, 26.03</sb:comment>
                     </sb:reference>
                  </ce:bib-reference>
                  <ce:bib-reference id="bib71">
                     <ce:label>[71]</ce:label>
                     <sb:reference id="sref71">
                        <sb:contribution langtype="en">
                           <sb:authors>
                              <sb:author>
                                 <ce:given-name>A.</ce:given-name>
                                 <ce:surname>Cooke, J</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>C.</ce:given-name>
                                 <ce:surname>Stump, A</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>X.-F.</ce:given-name>
                                 <ce:surname>Zhang</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>C.S.</ce:given-name>
                                 <ce:surname>Li</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>Q.</ce:given-name>
                                 <ce:surname>Mao</ce:surname>
                              </sb:author>
                           </sb:authors>
                           <sb:title>
                              <sb:maintitle>TrkA Kinase Inhibitors, Compositions and Methods Thereof</sb:maintitle>
                           </sb:title>
                        </sb:contribution>
                        <sb:host>
                           <sb:book>
                              <sb:date>2015</sb:date>
                           </sb:book>
                        </sb:host>
                        <sb:comment>WO2015042088, 26.03</sb:comment>
                     </sb:reference>
                  </ce:bib-reference>
                  <ce:bib-reference id="bib72">
                     <ce:label>[72]</ce:label>
                     <sb:reference id="sref72">
                        <sb:contribution langtype="en">
                           <sb:authors>
                              <sb:author>
                                 <ce:given-name>H.</ce:given-name>
                                 <ce:surname>Mitchell</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>M.</ce:given-name>
                                 <ce:surname>Fraley</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>A.J.</ce:given-name>
                                 <ce:surname>Cooke</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>C.A.</ce:given-name>
                                 <ce:surname>Stump</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>D.C.</ce:given-name>
                                 <ce:surname>Beshore</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>C.C.</ce:given-name>
                                 <ce:surname>Mccomas</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>K.</ce:given-name>
                                 <ce:surname>Schirripa</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>X.-F.</ce:given-name>
                                 <ce:surname>Zhang</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>M.</ce:given-name>
                                 <ce:surname>Mcwherter</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>S.P.</ce:given-name>
                                 <ce:surname>Mercer</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>K.</ce:given-name>
                                 <ce:surname>Moore</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>C.</ce:given-name>
                                 <ce:surname>Liu</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>Q.</ce:given-name>
                                 <ce:surname>Mao</ce:surname>
                              </sb:author>
                           </sb:authors>
                           <sb:title>
                              <sb:maintitle>TrkA Kinase Inhibitors, Compositions and Methods Thereof</sb:maintitle>
                           </sb:title>
                        </sb:contribution>
                        <sb:host>
                           <sb:book>
                              <sb:date>2015</sb:date>
                           </sb:book>
                        </sb:host>
                        <sb:comment>WO2015143652, 01.10</sb:comment>
                     </sb:reference>
                  </ce:bib-reference>
                  <ce:bib-reference id="bib73">
                     <ce:label>[73]</ce:label>
                     <sb:reference id="sref73">
                        <sb:contribution langtype="en">
                           <sb:authors>
                              <sb:author>
                                 <ce:given-name>H.</ce:given-name>
                                 <ce:surname>Mitchell</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>H.</ce:given-name>
                                 <ce:surname>Wood</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:surname>B</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>C.</ce:given-name>
                                 <ce:surname>Li</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:surname>Sing</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>Q.</ce:given-name>
                                 <ce:surname>Mao</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>Z.</ce:given-name>
                                 <ce:surname>Qi</ce:surname>
                              </sb:author>
                           </sb:authors>
                           <sb:title>
                              <sb:maintitle>TrkA Kinase Inhibitors, Compositions and Methods Thereof</sb:maintitle>
                           </sb:title>
                        </sb:contribution>
                        <sb:host>
                           <sb:book>
                              <sb:date>2015</sb:date>
                           </sb:book>
                        </sb:host>
                        <sb:comment>WO2015148354, 01.10</sb:comment>
                     </sb:reference>
                  </ce:bib-reference>
                  <ce:bib-reference id="bib74">
                     <ce:label>[74]</ce:label>
                     <sb:reference id="sref74">
                        <sb:contribution langtype="en">
                           <sb:authors>
                              <sb:author>
                                 <ce:given-name>A.J.</ce:given-name>
                                 <ce:surname>Cooke</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>D.</ce:given-name>
                                 <ce:surname>Pitts</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>A.</ce:given-name>
                                 <ce:surname>Johnson</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>D.C.</ce:given-name>
                                 <ce:surname>Beshore</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>D.</ce:given-name>
                                 <ce:surname>Hurzy</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>H.</ce:given-name>
                                 <ce:surname>Mitchell</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>M.</ce:given-name>
                                 <ce:surname>Fraley</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>C.</ce:given-name>
                                 <ce:surname>Mccomas</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>K.</ce:given-name>
                                 <ce:surname>Schirripa</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>S.</ce:given-name>
                                 <ce:surname>Mercer</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>K.</ce:given-name>
                                 <ce:surname>Nanda</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>D.</ce:given-name>
                                 <ce:surname>Meng</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>J.</ce:given-name>
                                 <ce:surname>Wu</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>K.</ce:given-name>
                                 <ce:surname>Babaoglu</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>C.S.</ce:given-name>
                                 <ce:surname>Li</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>q.</ce:given-name>
                                 <ce:surname>Mao</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>Z.</ce:given-name>
                                 <ce:surname>Qi</ce:surname>
                              </sb:author>
                           </sb:authors>
                           <sb:title>
                              <sb:maintitle>TrkA Kinase Inhibitors, Compositions and Methods Thereof</sb:maintitle>
                           </sb:title>
                        </sb:contribution>
                        <sb:host>
                           <sb:book>
                              <sb:date>2016</sb:date>
                           </sb:book>
                        </sb:host>
                        <sb:comment>WO2016054807, 14.04</sb:comment>
                     </sb:reference>
                  </ce:bib-reference>
                  <ce:bib-reference id="bib75">
                     <ce:label>[75]</ce:label>
                     <sb:reference id="sref75">
                        <sb:contribution langtype="en">
                           <sb:authors>
                              <sb:author>
                                 <ce:given-name>S.K.</ce:given-name>
                                 <ce:surname>Bagal</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>J.J.</ce:given-name>
                                 <ce:surname>Cui</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>S.E.</ce:given-name>
                                 <ce:surname>Greasley</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>E.A.</ce:given-name>
                                 <ce:surname>Lunney</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>I.J.</ce:given-name>
                                 <ce:surname>Mcalpine</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>A.</ce:given-name>
                                 <ce:surname>Nagata</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>S.</ce:given-name>
                                 <ce:surname>Ninkovic</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>K.</ce:given-name>
                                 <ce:surname>Omoto</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>S.E.</ce:given-name>
                                 <ce:surname>Skerratt</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>R.I.</ce:given-name>
                                 <ce:surname>Storer</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>J.S.</ce:given-name>
                                 <ce:surname>Warmus</ce:surname>
                              </sb:author>
                           </sb:authors>
                           <sb:title>
                              <sb:maintitle>Tropomyosin-related Kinase Inhibitors Containing Both a 1H-Pyrazole and a Pyrimidine Moiety</sb:maintitle>
                           </sb:title>
                        </sb:contribution>
                        <sb:host>
                           <sb:book>
                              <sb:date>2015</sb:date>
                           </sb:book>
                        </sb:host>
                        <sb:comment>WO2015159175, 22.10</sb:comment>
                     </sb:reference>
                  </ce:bib-reference>
                  <ce:bib-reference id="bib76">
                     <ce:label>[76]</ce:label>
                     <sb:reference id="sref76">
                        <sb:contribution langtype="en">
                           <sb:authors>
                              <sb:author>
                                 <ce:given-name>S.K.</ce:given-name>
                                 <ce:surname>Bagal</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>J.J.</ce:given-name>
                                 <ce:surname>Cui</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>S.E.</ce:given-name>
                                 <ce:surname>Greasley</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>E.A.</ce:given-name>
                                 <ce:surname>Lunney</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>I.J.</ce:given-name>
                                 <ce:surname>Alpine</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>A.</ce:given-name>
                                 <ce:surname>Nagata</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>S.</ce:given-name>
                                 <ce:surname>Ninkovic</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>K.</ce:given-name>
                                 <ce:surname>Omoto</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>S.E.</ce:given-name>
                                 <ce:surname>Skerratt</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>R.I.</ce:given-name>
                                 <ce:surname>Storer</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>J.S.</ce:given-name>
                                 <ce:surname>Warmus</ce:surname>
                              </sb:author>
                           </sb:authors>
                           <sb:title>
                              <sb:maintitle>Tropomyosin-related Kinase Inhibitors</sb:maintitle>
                           </sb:title>
                        </sb:contribution>
                        <sb:host>
                           <sb:book>
                              <sb:date>2015</sb:date>
                           </sb:book>
                        </sb:host>
                        <sb:comment>WO2015170218, 12.11</sb:comment>
                     </sb:reference>
                  </ce:bib-reference>
                  <ce:bib-reference id="bib77">
                     <ce:label>[77]</ce:label>
                     <sb:reference id="sref77">
                        <sb:contribution langtype="en">
                           <sb:authors>
                              <sb:author>
                                 <ce:given-name>K.</ce:given-name>
                                 <ce:surname>Nagaswamy</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>V.G.</ce:given-name>
                                 <ce:surname>Tirunagaru</ce:surname>
                              </sb:author>
                           </sb:authors>
                           <sb:title>
                              <sb:maintitle>Inhibitors of TrkA Kinase</sb:maintitle>
                           </sb:title>
                        </sb:contribution>
                        <sb:host>
                           <sb:book>
                              <sb:date>2016</sb:date>
                           </sb:book>
                        </sb:host>
                        <sb:comment>WO2016116900, 28.07</sb:comment>
                     </sb:reference>
                  </ce:bib-reference>
                  <ce:bib-reference id="bib78">
                     <ce:label>[78]</ce:label>
                     <sb:reference id="sref78">
                        <sb:contribution langtype="en">
                           <sb:authors>
                              <sb:author>
                                 <ce:given-name>A.</ce:given-name>
                                 <ce:surname>Yukimasa</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>K.</ce:given-name>
                                 <ce:surname>Kano</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>T.</ce:given-name>
                                 <ce:surname>Horiguchi</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>K.</ce:given-name>
                                 <ce:surname>Nakamura</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>T.</ce:given-name>
                                 <ce:surname>Inoue</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>H.</ce:given-name>
                                 <ce:surname>Yamaguchi</ce:surname>
                              </sb:author>
                           </sb:authors>
                           <sb:title>
                              <sb:maintitle>Nitrogen-contaning Heterocycle Having TrkA Inhibitory Activity, and Carbocyclic Derivative</sb:maintitle>
                           </sb:title>
                        </sb:contribution>
                        <sb:host>
                           <sb:book>
                              <sb:date>2017</sb:date>
                           </sb:book>
                        </sb:host>
                        <sb:comment>WO2017135399, 10.08</sb:comment>
                     </sb:reference>
                  </ce:bib-reference>
                  <ce:bib-reference id="bib79">
                     <ce:label>[79]</ce:label>
                     <sb:reference id="sref79">
                        <sb:contribution langtype="en">
                           <sb:authors>
                              <sb:author>
                                 <ce:given-name>K.</ce:given-name>
                                 <ce:surname>Kano</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>H.</ce:given-name>
                                 <ce:surname>Yamaguchi</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>T.</ce:given-name>
                                 <ce:surname>Horiguchi</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>K.</ce:given-name>
                                 <ce:surname>Yasuo</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>K.</ce:given-name>
                                 <ce:surname>Hata</ce:surname>
                              </sb:author>
                           </sb:authors>
                           <sb:title>
                              <sb:maintitle>Nitrogen-containing Heterocycle Having TrkA Inhibitory Activity, and Carbocyclic Derivative</sb:maintitle>
                           </sb:title>
                        </sb:contribution>
                        <sb:host>
                           <sb:book>
                              <sb:date>2018</sb:date>
                           </sb:book>
                        </sb:host>
                        <sb:comment>WO2018079759, 03.05</sb:comment>
                     </sb:reference>
                  </ce:bib-reference>
                  <ce:bib-reference id="bib80">
                     <ce:label>[80]</ce:label>
                     <sb:reference id="sref80">
                        <sb:contribution langtype="en">
                           <sb:authors>
                              <sb:author>
                                 <ce:given-name>S.</ce:given-name>
                                 <ce:surname>Wenglowsky</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>Mark C.</ce:given-name>
                                 <ce:surname>Miduturu</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>V.N.</ce:given-name>
                                 <ce:surname>Bifulco</ce:surname>
                                 <ce:suffix>Jr.</ce:suffix>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>J.</ce:given-name>
                                 <ce:surname>Kim L</ce:surname>
                              </sb:author>
                           </sb:authors>
                           <sb:title>
                              <sb:maintitle>Compounds and Compositions Useful for Treating Disorders Related to NTRK</sb:maintitle>
                           </sb:title>
                        </sb:contribution>
                        <sb:host>
                           <sb:book>
                              <sb:date>2017</sb:date>
                           </sb:book>
                        </sb:host>
                        <sb:comment>WO2017087778, 26.05</sb:comment>
                     </sb:reference>
                  </ce:bib-reference>
                  <ce:bib-reference id="bib81">
                     <ce:label>[81]</ce:label>
                     <sb:reference id="sref81">
                        <sb:contribution langtype="en">
                           <sb:authors>
                              <sb:author>
                                 <ce:given-name>S.</ce:given-name>
                                 <ce:surname>Wenglowsky</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:surname>Mark</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>N.</ce:given-name>
                                 <ce:surname>Brooijmans</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>C.</ce:given-name>
                                 <ce:surname>Miduturu</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>V.,N.</ce:given-name>
                                 <ce:surname>Bifulco</ce:surname>
                              </sb:author>
                           </sb:authors>
                           <sb:title>
                              <sb:maintitle>Compounds and Compositions Useful for Treating Disorders Related to NTRK</sb:maintitle>
                           </sb:title>
                        </sb:contribution>
                        <sb:host>
                           <sb:book>
                              <sb:date>2017</sb:date>
                           </sb:book>
                        </sb:host>
                        <sb:comment>WO2017035354, 02.03</sb:comment>
                     </sb:reference>
                  </ce:bib-reference>
                  <ce:bib-reference id="bib82">
                     <ce:label>[82]</ce:label>
                     <sb:reference id="sref82">
                        <sb:contribution langtype="en">
                           <sb:authors>
                              <sb:author>
                                 <ce:given-name>M.</ce:given-name>
                                 <ce:surname>Kim</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>C.</ce:given-name>
                                 <ce:surname>Lee</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>G.</ce:given-name>
                                 <ce:surname>Lee</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>C.</ce:given-name>
                                 <ce:surname>Yoon</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>J.</ce:given-name>
                                 <ce:surname>Seo</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>J.H.</ce:given-name>
                                 <ce:surname>Kim</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>M.</ce:given-name>
                                 <ce:surname>Lee</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>H.</ce:given-name>
                                 <ce:surname>Jeong</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>H.</ce:given-name>
                                 <ce:surname>Choi</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>M.E.</ce:given-name>
                                 <ce:surname>Jung</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>K.N.</ce:given-name>
                                 <ce:surname>Lee</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>H.J.</ce:given-name>
                                 <ce:surname>Kim</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>H.K.</ce:given-name>
                                 <ce:surname>Kim</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>J.I.</ce:given-name>
                                 <ce:surname>Lee</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>M.</ce:given-name>
                                 <ce:surname>Lee</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>M.</ce:given-name>
                                 <ce:surname>Km</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>S.</ce:given-name>
                                 <ce:surname>Choi</ce:surname>
                              </sb:author>
                           </sb:authors>
                           <sb:title>
                              <sb:maintitle>Fused Ring Heteroaryl Compounds and Their Use as Trk Inhibitors</sb:maintitle>
                           </sb:title>
                        </sb:contribution>
                        <sb:host>
                           <sb:book>
                              <sb:date>2015</sb:date>
                           </sb:book>
                        </sb:host>
                        <sb:comment>US20160168156, 12.14</sb:comment>
                     </sb:reference>
                  </ce:bib-reference>
                  <ce:bib-reference id="bib83">
                     <ce:label>[83]</ce:label>
                     <sb:reference id="sref83">
                        <sb:contribution langtype="en">
                           <sb:authors>
                              <sb:author>
                                 <ce:given-name>K.</ce:given-name>
                                 <ce:surname>Thress</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>T.</ce:given-name>
                                 <ce:surname>MacIntyre</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>H.Y.</ce:given-name>
                                 <ce:surname>Wang</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>D.</ce:given-name>
                                 <ce:surname>Whitston</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>Z.Y.</ce:given-name>
                                 <ce:surname>Liu</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>E.</ce:given-name>
                                 <ce:surname>Hoffmann</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>T.</ce:given-name>
                                 <ce:surname>Wang</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>J.L.</ce:given-name>
                                 <ce:surname>Brown</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>K.</ce:given-name>
                                 <ce:surname>Webster</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>C.</ce:given-name>
                                 <ce:surname>Omer</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>P.E.</ce:given-name>
                                 <ce:surname>Zage</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>L.Z.</ce:given-name>
                                 <ce:surname>Zeng</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>P.A.</ce:given-name>
                                 <ce:surname>Zweidler-McKay</ce:surname>
                              </sb:author>
                           </sb:authors>
                           <sb:title>
                              <sb:maintitle>Identification and preclinical characterization of AZ-23, a novel, selective, and orally bioavailable inhibitor of the Trk kinase pathway</sb:maintitle>
                           </sb:title>
                        </sb:contribution>
                        <sb:host>
                           <sb:issue>
                              <sb:series>
                                 <sb:title>
                                    <sb:maintitle>Mol. Canc. Therapeut.</sb:maintitle>
                                 </sb:title>
                                 <sb:volume-nr>8</sb:volume-nr>
                              </sb:series>
                              <sb:date>2009</sb:date>
                           </sb:issue>
                           <sb:pages>
                              <sb:first-page>1818</sb:first-page>
                              <sb:last-page>1827</sb:last-page>
                           </sb:pages>
                        </sb:host>
                     </sb:reference>
                  </ce:bib-reference>
                  <ce:bib-reference id="bib84">
                     <ce:label>[84]</ce:label>
                     <sb:reference id="sref84">
                        <sb:contribution langtype="en">
                           <sb:authors>
                              <sb:author>
                                 <ce:given-name>T.</ce:given-name>
                                 <ce:surname>Wang</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>M.L.</ce:given-name>
                                 <ce:surname>Lamb</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>M.H.</ce:given-name>
                                 <ce:surname>Block</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>A.M.</ce:given-name>
                                 <ce:surname>Davies</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>Y.X.</ce:given-name>
                                 <ce:surname>Han</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>E.</ce:given-name>
                                 <ce:surname>Hoffmann</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>S.</ce:given-name>
                                 <ce:surname>Ioannidis</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>J.A.</ce:given-name>
                                 <ce:surname>Josey</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>Z.Y.</ce:given-name>
                                 <ce:surname>Liu</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>P.D.</ce:given-name>
                                 <ce:surname>Lyne</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>T.</ce:given-name>
                                 <ce:surname>MacIntyre</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>P.J.</ce:given-name>
                                 <ce:surname>Mohr</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>C.A.</ce:given-name>
                                 <ce:surname>Omer</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>T.</ce:given-name>
                                 <ce:surname>Sjogren</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>K.</ce:given-name>
                                 <ce:surname>Thress</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>B.</ce:given-name>
                                 <ce:surname>Wang</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>H.Y.</ce:given-name>
                                 <ce:surname>Wang</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>D.W.</ce:given-name>
                                 <ce:surname>Yu</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>H.J.</ce:given-name>
                                 <ce:surname>Zhangt</ce:surname>
                              </sb:author>
                           </sb:authors>
                           <sb:title>
                              <sb:maintitle>Discovery of disubstituted imidazo 4,5-b pyridines and purines as potent TrkA inhibitors</sb:maintitle>
                           </sb:title>
                        </sb:contribution>
                        <sb:host>
                           <sb:issue>
                              <sb:series>
                                 <sb:title>
                                    <sb:maintitle>ACS Med. Chem. Lett.</sb:maintitle>
                                 </sb:title>
                                 <sb:volume-nr>3</sb:volume-nr>
                              </sb:series>
                              <sb:date>2012</sb:date>
                           </sb:issue>
                           <sb:pages>
                              <sb:first-page>705</sb:first-page>
                              <sb:last-page>709</sb:last-page>
                           </sb:pages>
                        </sb:host>
                     </sb:reference>
                  </ce:bib-reference>
                  <ce:bib-reference id="bib85">
                     <ce:label>[85]</ce:label>
                     <sb:reference id="sref85">
                        <sb:contribution langtype="en">
                           <sb:authors>
                              <sb:author>
                                 <ce:given-name>P.</ce:given-name>
                                 <ce:surname>Lyne</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>B.</ce:given-name>
                                 <ce:surname>Wang</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>T.</ce:given-name>
                                 <ce:surname>Wang</ce:surname>
                              </sb:author>
                           </sb:authors>
                           <sb:title>
                              <sb:maintitle>Chemical Compounds</sb:maintitle>
                           </sb:title>
                        </sb:contribution>
                        <sb:host>
                           <sb:book>
                              <sb:date>2005</sb:date>
                           </sb:book>
                        </sb:host>
                        <sb:comment>WO2005103010, 03.11</sb:comment>
                     </sb:reference>
                  </ce:bib-reference>
                  <ce:bib-reference id="bib86">
                     <ce:label>[86]</ce:label>
                     <sb:reference id="sref86">
                        <sb:contribution langtype="en">
                           <sb:authors>
                              <sb:author>
                                 <ce:given-name>M.</ce:given-name>
                                 <ce:surname>Block</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:surname>Howard</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>Y.</ce:given-name>
                                 <ce:surname>Han</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>J.A.</ce:given-name>
                                 <ce:surname>Josey</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>J.W.</ce:given-name>
                                 <ce:surname>Lee</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>D.</ce:given-name>
                                 <ce:surname>Scott</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>B.</ce:given-name>
                                 <ce:surname>Wang</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>H.</ce:given-name>
                                 <ce:surname>Wang</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>T.</ce:given-name>
                                 <ce:surname>Wang</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>D.</ce:given-name>
                                 <ce:surname>Yu</ce:surname>
                              </sb:author>
                           </sb:authors>
                           <sb:title>
                              <sb:maintitle>Pyrazole Derivatives as Inhibitors of Receptor Tyrosyne Kinases</sb:maintitle>
                           </sb:title>
                        </sb:contribution>
                        <sb:host>
                           <sb:book>
                              <sb:date>2005</sb:date>
                           </sb:book>
                        </sb:host>
                        <sb:comment>WO2005049033, 02.06</sb:comment>
                     </sb:reference>
                  </ce:bib-reference>
                  <ce:bib-reference id="bib87">
                     <ce:label>[87]</ce:label>
                     <sb:reference id="sref87">
                        <sb:contribution langtype="en">
                           <sb:authors>
                              <sb:author>
                                 <ce:given-name>A.</ce:given-name>
                                 <ce:surname>Davies</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>M.</ce:given-name>
                                 <ce:surname>Lamb</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>P.</ce:given-name>
                                 <ce:surname>Lyne</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>P.</ce:given-name>
                                 <ce:surname>Mohr</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>B.</ce:given-name>
                                 <ce:surname>Wang</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>T.</ce:given-name>
                                 <ce:surname>Wang</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>D.</ce:given-name>
                                 <ce:surname>Yu</ce:surname>
                              </sb:author>
                           </sb:authors>
                           <sb:title>
                              <sb:maintitle>Pyrazolylaminopyridine Derivatives Useful as Kinase Inhibitors</sb:maintitle>
                           </sb:title>
                        </sb:contribution>
                        <sb:host>
                           <sb:book>
                              <sb:date>2006</sb:date>
                           </sb:book>
                        </sb:host>
                        <sb:comment>WO2006082392, 10.08</sb:comment>
                     </sb:reference>
                  </ce:bib-reference>
                  <ce:bib-reference id="bib88">
                     <ce:label>[88]</ce:label>
                     <sb:reference id="sref88">
                        <sb:contribution langtype="en">
                           <sb:authors>
                              <sb:author>
                                 <ce:given-name>B.</ce:given-name>
                                 <ce:surname>Wang</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>T.</ce:given-name>
                                 <ce:surname>Wang</ce:surname>
                              </sb:author>
                           </sb:authors>
                           <sb:title>
                              <sb:maintitle>Chemical Compounds</sb:maintitle>
                           </sb:title>
                        </sb:contribution>
                        <sb:host>
                           <sb:book>
                              <sb:date>2006</sb:date>
                           </sb:book>
                        </sb:host>
                        <sb:comment>WO2006123113, 23.11</sb:comment>
                     </sb:reference>
                  </ce:bib-reference>
                  <ce:bib-reference id="bib89">
                     <ce:label>[89]</ce:label>
                     <sb:reference id="sref89">
                        <sb:contribution langtype="en">
                           <sb:authors>
                              <sb:author>
                                 <ce:given-name>X.</ce:given-name>
                                 <ce:surname>Feng</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>H.</ce:given-name>
                                 <ce:surname>Guan</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>Y.</ce:given-name>
                                 <ce:surname>Kan</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>S.</ce:given-name>
                                 <ce:surname>Ioannidis</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>B.</ce:given-name>
                                 <ce:surname>Peng</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>M.</ce:given-name>
                                 <ce:surname>Su</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>B.</ce:given-name>
                                 <ce:surname>Wang</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>T.</ce:given-name>
                                 <ce:surname>Wang</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>H.-J.</ce:given-name>
                                 <ce:surname>Zhang</ce:surname>
                              </sb:author>
                           </sb:authors>
                           <sb:title>
                              <sb:maintitle>4-(3-aminopyrazole) Pyrimidine Derivatives for Use as Tyrosine Kinase Inhibitors in the Treatment of Cancer</sb:maintitle>
                           </sb:title>
                        </sb:contribution>
                        <sb:host>
                           <sb:book>
                              <sb:date>2007</sb:date>
                           </sb:book>
                        </sb:host>
                        <sb:comment>WO2007049041, 03.05</sb:comment>
                     </sb:reference>
                  </ce:bib-reference>
                  <ce:bib-reference id="bib90">
                     <ce:label>[90]</ce:label>
                     <sb:reference id="sref90">
                        <sb:contribution langtype="en">
                           <sb:authors>
                              <sb:author>
                                 <ce:given-name>L.</ce:given-name>
                                 <ce:surname>Almeida</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>S.</ce:given-name>
                                 <ce:surname>Ioannidis</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>M.</ce:given-name>
                                 <ce:surname>Lamb</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>M.</ce:given-name>
                                 <ce:surname>Su</ce:surname>
                              </sb:author>
                           </sb:authors>
                           <sb:title>
                              <sb:maintitle>Pyrazolyl-amino-substituted Pyrazines and Their Use for the Treatment of Cancer</sb:maintitle>
                           </sb:title>
                        </sb:contribution>
                        <sb:host>
                           <sb:book>
                              <sb:date>2008</sb:date>
                           </sb:book>
                        </sb:host>
                        <sb:comment>WO2008117050, 02.10</sb:comment>
                     </sb:reference>
                  </ce:bib-reference>
                  <ce:bib-reference id="bib91">
                     <ce:label>[91]</ce:label>
                     <sb:reference id="sref91">
                        <sb:contribution langtype="en">
                           <sb:authors>
                              <sb:author>
                                 <ce:given-name>T.</ce:given-name>
                                 <ce:surname>Tatematsu</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>H.</ce:given-name>
                                 <ce:surname>Sasaki</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>S.</ce:given-name>
                                 <ce:surname>Shimizu</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>K.</ce:given-name>
                                 <ce:surname>Okuda</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>M.</ce:given-name>
                                 <ce:surname>Shitara</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>Y.</ce:given-name>
                                 <ce:surname>Hikosaka</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>S.</ce:given-name>
                                 <ce:surname>Moriyama</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>M.</ce:given-name>
                                 <ce:surname>Yano</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>J.</ce:given-name>
                                 <ce:surname>Brown</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>Y.</ce:given-name>
                                 <ce:surname>Fujii</ce:surname>
                              </sb:author>
                           </sb:authors>
                           <sb:title>
                              <sb:maintitle>Investigation of neurotrophic tyrosine kinase receptor 1 fusions and neurotrophic tyrosine kinase receptor family expression in non-small-cell lung cancer and sensitivity to AZD7451 inÂ vitro</sb:maintitle>
                           </sb:title>
                        </sb:contribution>
                        <sb:host>
                           <sb:issue>
                              <sb:series>
                                 <sb:title>
                                    <sb:maintitle>Mol. Clin. Oncol.</sb:maintitle>
                                 </sb:title>
                                 <sb:volume-nr>2</sb:volume-nr>
                              </sb:series>
                              <sb:date>2014</sb:date>
                           </sb:issue>
                           <sb:pages>
                              <sb:first-page>725</sb:first-page>
                              <sb:last-page>730</sb:last-page>
                           </sb:pages>
                        </sb:host>
                     </sb:reference>
                  </ce:bib-reference>
                  <ce:bib-reference id="bib92">
                     <ce:label>[92]</ce:label>
                     <sb:reference id="sref92">
                        <sb:contribution langtype="en">
                           <sb:authors>
                              <sb:author>
                                 <ce:given-name>M.S.</ce:given-name>
                                 <ce:surname>Alam</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>S.U.</ce:given-name>
                                 <ce:surname>Choi</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>D.U.</ce:given-name>
                                 <ce:surname>Lee</ce:surname>
                              </sb:author>
                           </sb:authors>
                           <sb:title>
                              <sb:maintitle>Synthesis, anticancer, and docking studies of salicyl-hydrazone analogues: a novel series of small potent tropomyosin receptor kinase A inhibitors</sb:maintitle>
                           </sb:title>
                        </sb:contribution>
                        <sb:host>
                           <sb:issue>
                              <sb:series>
                                 <sb:title>
                                    <sb:maintitle>Biorg. Med. Chem.</sb:maintitle>
                                 </sb:title>
                                 <sb:volume-nr>25</sb:volume-nr>
                              </sb:series>
                              <sb:date>2017</sb:date>
                           </sb:issue>
                           <sb:pages>
                              <sb:first-page>389</sb:first-page>
                              <sb:last-page>396</sb:last-page>
                           </sb:pages>
                        </sb:host>
                     </sb:reference>
                  </ce:bib-reference>
                  <ce:bib-reference id="bib93">
                     <ce:label>[93]</ce:label>
                     <sb:reference id="sref93">
                        <sb:contribution langtype="en">
                           <sb:authors>
                              <sb:author>
                                 <ce:given-name>S.</ce:given-name>
                                 <ce:surname>Lecht</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>H.</ce:given-name>
                                 <ce:surname>Arien-Zakay</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>M.</ce:given-name>
                                 <ce:surname>Kohan</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>P.I.</ce:given-name>
                                 <ce:surname>Lelkes</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>P.</ce:given-name>
                                 <ce:surname>Lazarovici</ce:surname>
                              </sb:author>
                           </sb:authors>
                           <sb:title>
                              <sb:maintitle>Angiostatic effects of K252a, a Trk inhibitor, in murine brain capillary endothelial cells</sb:maintitle>
                           </sb:title>
                        </sb:contribution>
                        <sb:host>
                           <sb:issue>
                              <sb:series>
                                 <sb:title>
                                    <sb:maintitle>Mol. Cell. Biochem.</sb:maintitle>
                                 </sb:title>
                                 <sb:volume-nr>339</sb:volume-nr>
                              </sb:series>
                              <sb:date>2010</sb:date>
                           </sb:issue>
                           <sb:pages>
                              <sb:first-page>201</sb:first-page>
                              <sb:last-page>213</sb:last-page>
                           </sb:pages>
                        </sb:host>
                     </sb:reference>
                  </ce:bib-reference>
                  <ce:bib-reference id="bib94">
                     <ce:label>[94]</ce:label>
                     <sb:reference id="sref94">
                        <sb:contribution langtype="en">
                           <sb:authors>
                              <sb:author>
                                 <ce:given-name>S.</ce:given-name>
                                 <ce:surname>Akinaga</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>T.</ce:given-name>
                                 <ce:surname>Ashizawa</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>K.</ce:given-name>
                                 <ce:surname>Gomi</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>H.</ce:given-name>
                                 <ce:surname>Ohno</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>M.</ce:given-name>
                                 <ce:surname>Morimoto</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>C.</ce:given-name>
                                 <ce:surname>Murakata</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>M.</ce:given-name>
                                 <ce:surname>Okabe</ce:surname>
                              </sb:author>
                           </sb:authors>
                           <sb:title>
                              <sb:maintitle>Antitumor effect of KT6124, a novel derivative of protein kinase inhibitor K-252a, and its mechanism of action</sb:maintitle>
                           </sb:title>
                        </sb:contribution>
                        <sb:host>
                           <sb:issue>
                              <sb:series>
                                 <sb:title>
                                    <sb:maintitle>Cancer Chemother. Pharmacol.</sb:maintitle>
                                 </sb:title>
                                 <sb:volume-nr>29</sb:volume-nr>
                              </sb:series>
                              <sb:date>1992</sb:date>
                           </sb:issue>
                           <sb:pages>
                              <sb:first-page>266</sb:first-page>
                              <sb:last-page>272</sb:last-page>
                           </sb:pages>
                        </sb:host>
                     </sb:reference>
                  </ce:bib-reference>
                  <ce:bib-reference id="bib95">
                     <ce:label>[95]</ce:label>
                     <sb:reference id="sref95">
                        <sb:contribution langtype="en">
                           <sb:authors>
                              <sb:author>
                                 <ce:given-name>A.M.</ce:given-name>
                                 <ce:surname>Camoratto</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>J.P.</ce:given-name>
                                 <ce:surname>Jani</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>T.S.</ce:given-name>
                                 <ce:surname>Angeles</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>A.C.</ce:given-name>
                                 <ce:surname>Maroney</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>C.Y.</ce:given-name>
                                 <ce:surname>Sanders</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>C.</ce:given-name>
                                 <ce:surname>Murakata</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>N.T.</ce:given-name>
                                 <ce:surname>Neff</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>J.L.</ce:given-name>
                                 <ce:surname>Vaught</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>J.T.</ce:given-name>
                                 <ce:surname>Isaacs</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>C.A.</ce:given-name>
                                 <ce:surname>Dionne</ce:surname>
                              </sb:author>
                           </sb:authors>
                           <sb:title>
                              <sb:maintitle>CEP-751 inhibits trk receptor tyrosine kinase activity inÂ vitro and exhibits anti-tumor activity</sb:maintitle>
                           </sb:title>
                        </sb:contribution>
                        <sb:host>
                           <sb:issue>
                              <sb:series>
                                 <sb:title>
                                    <sb:maintitle>Int. J. Cancer</sb:maintitle>
                                 </sb:title>
                                 <sb:volume-nr>72</sb:volume-nr>
                              </sb:series>
                              <sb:date>1997</sb:date>
                           </sb:issue>
                           <sb:pages>
                              <sb:first-page>673</sb:first-page>
                              <sb:last-page>679</sb:last-page>
                           </sb:pages>
                        </sb:host>
                     </sb:reference>
                  </ce:bib-reference>
                  <ce:bib-reference id="bib96">
                     <ce:label>[96]</ce:label>
                     <sb:reference id="sref96">
                        <sb:contribution langtype="en">
                           <sb:authors>
                              <sb:author>
                                 <ce:given-name>C.A.</ce:given-name>
                                 <ce:surname>Dionne</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>A.M.</ce:given-name>
                                 <ce:surname>Camoratto</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>J.P.</ce:given-name>
                                 <ce:surname>Jani</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>E.</ce:given-name>
                                 <ce:surname>Emerson</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>N.</ce:given-name>
                                 <ce:surname>Neff</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>J.L.</ce:given-name>
                                 <ce:surname>Vaught</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>C.</ce:given-name>
                                 <ce:surname>Murakata</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>D.</ce:given-name>
                                 <ce:surname>Djakiew</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>J.</ce:given-name>
                                 <ce:surname>Lamb</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>S.</ce:given-name>
                                 <ce:surname>Bova</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>D.</ce:given-name>
                                 <ce:surname>George</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>J.T.</ce:given-name>
                                 <ce:surname>Isaacs</ce:surname>
                              </sb:author>
                           </sb:authors>
                           <sb:title>
                              <sb:maintitle>Cell cycle-independent death of prostate adenocarcinoma is induced by the trk tyrosine kinase inhibitor CEP-751 (KT6587)</sb:maintitle>
                           </sb:title>
                        </sb:contribution>
                        <sb:host>
                           <sb:issue>
                              <sb:series>
                                 <sb:title>
                                    <sb:maintitle>Clin. Cancer Res.</sb:maintitle>
                                 </sb:title>
                                 <sb:volume-nr>4</sb:volume-nr>
                              </sb:series>
                              <sb:date>1998</sb:date>
                           </sb:issue>
                           <sb:pages>
                              <sb:first-page>1887</sb:first-page>
                              <sb:last-page>1898</sb:last-page>
                           </sb:pages>
                        </sb:host>
                     </sb:reference>
                  </ce:bib-reference>
                  <ce:bib-reference id="bib97">
                     <ce:label>[97]</ce:label>
                     <sb:reference id="sref97">
                        <sb:contribution langtype="en">
                           <sb:authors>
                              <sb:author>
                                 <ce:given-name>S.J.</ce:given-name>
                                 <ce:surname>Miknyoczki</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>H.</ce:given-name>
                                 <ce:surname>Chang</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>A.</ce:given-name>
                                 <ce:surname>Klein-Szanto</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>C.A.</ce:given-name>
                                 <ce:surname>Dionne</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>B.A.</ce:given-name>
                                 <ce:surname>Ruggeri</ce:surname>
                              </sb:author>
                           </sb:authors>
                           <sb:title>
                              <sb:maintitle>The Trk tyrosine kinase inhibitor CEP-701 (KT-5555) exhibits significant antitumor efficacy in preclinical xenograft models of human pancreatic ductal adenocarcinoma</sb:maintitle>
                           </sb:title>
                        </sb:contribution>
                        <sb:host>
                           <sb:issue>
                              <sb:series>
                                 <sb:title>
                                    <sb:maintitle>Clin. Cancer Res.</sb:maintitle>
                                 </sb:title>
                                 <sb:volume-nr>5</sb:volume-nr>
                              </sb:series>
                              <sb:date>1999</sb:date>
                           </sb:issue>
                           <sb:pages>
                              <sb:first-page>2205</sb:first-page>
                              <sb:last-page>2212</sb:last-page>
                           </sb:pages>
                        </sb:host>
                     </sb:reference>
                  </ce:bib-reference>
                  <ce:bib-reference id="bib98">
                     <ce:label>[98]</ce:label>
                     <sb:reference id="sref98">
                        <sb:contribution langtype="en">
                           <sb:authors>
                              <sb:author>
                                 <ce:given-name>D.J.</ce:given-name>
                                 <ce:surname>George</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>C.A.</ce:given-name>
                                 <ce:surname>Dionne</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>J.</ce:given-name>
                                 <ce:surname>Jani</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>T.</ce:given-name>
                                 <ce:surname>Angeles</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>C.</ce:given-name>
                                 <ce:surname>Murakata</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>J.</ce:given-name>
                                 <ce:surname>Lamb</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>J.T.</ce:given-name>
                                 <ce:surname>Isaacs</ce:surname>
                              </sb:author>
                           </sb:authors>
                           <sb:title>
                              <sb:maintitle>Sustained inÂ vivo regression of dunning H rat prostate cancers treated with combinations of androgen ablation and Trk tyrosine kinase inhibitors, CEP-751 (KT-6587) or CEP-701 (KT-5555)</sb:maintitle>
                           </sb:title>
                        </sb:contribution>
                        <sb:host>
                           <sb:issue>
                              <sb:series>
                                 <sb:title>
                                    <sb:maintitle>Cancer Res.</sb:maintitle>
                                 </sb:title>
                                 <sb:volume-nr>59</sb:volume-nr>
                              </sb:series>
                              <sb:date>1999</sb:date>
                           </sb:issue>
                           <sb:pages>
                              <sb:first-page>2395</sb:first-page>
                              <sb:last-page>2401</sb:last-page>
                           </sb:pages>
                        </sb:host>
                     </sb:reference>
                  </ce:bib-reference>
                  <ce:bib-reference id="bib99">
                     <ce:label>[99]</ce:label>
                     <sb:reference id="sref99">
                        <sb:contribution langtype="en">
                           <sb:authors>
                              <sb:author>
                                 <ce:given-name>S.D.</ce:given-name>
                                 <ce:surname>Undevia</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>N.J.</ce:given-name>
                                 <ce:surname>Vogelzang</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>A.M.</ce:given-name>
                                 <ce:surname>Mauer</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>L.</ce:given-name>
                                 <ce:surname>Janisch</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>S.</ce:given-name>
                                 <ce:surname>Mani</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>M.J.</ce:given-name>
                                 <ce:surname>Ratain</ce:surname>
                              </sb:author>
                           </sb:authors>
                           <sb:title>
                              <sb:maintitle>Phase I clinical trial of CEP-2563 dihydrochloride, a receptor tyrosine kinase inhibitor, in patients with refractory solid tumors</sb:maintitle>
                           </sb:title>
                        </sb:contribution>
                        <sb:host>
                           <sb:issue>
                              <sb:series>
                                 <sb:title>
                                    <sb:maintitle>Investig. New Drugs</sb:maintitle>
                                 </sb:title>
                                 <sb:volume-nr>22</sb:volume-nr>
                              </sb:series>
                              <sb:date>2004</sb:date>
                           </sb:issue>
                           <sb:pages>
                              <sb:first-page>449</sb:first-page>
                              <sb:last-page>458</sb:last-page>
                           </sb:pages>
                        </sb:host>
                     </sb:reference>
                  </ce:bib-reference>
                  <ce:bib-reference id="bib100">
                     <ce:label>[100]</ce:label>
                     <sb:reference id="sref100">
                        <sb:contribution langtype="en">
                           <sb:authors>
                              <sb:author>
                                 <ce:given-name>C.</ce:given-name>
                                 <ce:surname>Collins</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>M.A.</ce:given-name>
                                 <ce:surname>Carducci</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>M.A.</ce:given-name>
                                 <ce:surname>Eisenberger</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>J.T.</ce:given-name>
                                 <ce:surname>Isaacs</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>A.W.</ce:given-name>
                                 <ce:surname>Partin</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>R.</ce:given-name>
                                 <ce:surname>Pili</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>V.J.</ce:given-name>
                                 <ce:surname>Sinibaldi</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>J.S.</ce:given-name>
                                 <ce:surname>Walczak</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>S.R.</ce:given-name>
                                 <ce:surname>Denmeade</ce:surname>
                              </sb:author>
                           </sb:authors>
                           <sb:title>
                              <sb:maintitle>Preclinical and clinical studies with the multi-kinase inhibitor CEP-701 as treatment for prostate cancer demonstrate the inadequacy of PSA response as a primary endpoint</sb:maintitle>
                           </sb:title>
                        </sb:contribution>
                        <sb:host>
                           <sb:issue>
                              <sb:series>
                                 <sb:title>
                                    <sb:maintitle>Cancer Biol. Ther.</sb:maintitle>
                                 </sb:title>
                                 <sb:volume-nr>6</sb:volume-nr>
                              </sb:series>
                              <sb:date>2007</sb:date>
                           </sb:issue>
                           <sb:pages>
                              <sb:first-page>1360</sb:first-page>
                              <sb:last-page>1367</sb:last-page>
                           </sb:pages>
                        </sb:host>
                     </sb:reference>
                  </ce:bib-reference>
                  <ce:bib-reference id="bib101">
                     <ce:label>[101]</ce:label>
                     <sb:reference id="sref101">
                        <sb:contribution langtype="en">
                           <sb:authors>
                              <sb:author>
                                 <ce:given-name>E.</ce:given-name>
                                 <ce:surname>Ardini</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>M.</ce:given-name>
                                 <ce:surname>Menichincheri</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>P.</ce:given-name>
                                 <ce:surname>Banfi</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>R.</ce:given-name>
                                 <ce:surname>Bosotti</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>C.</ce:given-name>
                                 <ce:surname>De Ponti</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>R.</ce:given-name>
                                 <ce:surname>Pulci</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>D.</ce:given-name>
                                 <ce:surname>Ballinari</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>M.</ce:given-name>
                                 <ce:surname>Ciomei</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>G.</ce:given-name>
                                 <ce:surname>Texido</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>A.</ce:given-name>
                                 <ce:surname>Degrassi</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>N.</ce:given-name>
                                 <ce:surname>Avanzi</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>N.</ce:given-name>
                                 <ce:surname>Amboldi</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>M.B.</ce:given-name>
                                 <ce:surname>Saccardo</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>D.</ce:given-name>
                                 <ce:surname>Casero</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>P.</ce:given-name>
                                 <ce:surname>Orsini</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>T.</ce:given-name>
                                 <ce:surname>Bandiera</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>L.</ce:given-name>
                                 <ce:surname>Mologni</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>D.</ce:given-name>
                                 <ce:surname>Anderson</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>G.</ce:given-name>
                                 <ce:surname>Wei</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>J.</ce:given-name>
                                 <ce:surname>Harris</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>J.M.</ce:given-name>
                                 <ce:surname>Vernier</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>G.</ce:given-name>
                                 <ce:surname>Li</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>E.</ce:given-name>
                                 <ce:surname>Felder</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>D.</ce:given-name>
                                 <ce:surname>Donati</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>A.</ce:given-name>
                                 <ce:surname>Isacchi</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>E.</ce:given-name>
                                 <ce:surname>Pesenti</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>P.</ce:given-name>
                                 <ce:surname>Magnaghi</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>A.</ce:given-name>
                                 <ce:surname>Galvani</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:surname>Entrectinib</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>a</ce:given-name>
                                 <ce:surname>Pan-TRK</ce:surname>
                              </sb:author>
                           </sb:authors>
                           <sb:title>
                              <sb:maintitle>ROS1, and ALK inhibitor with activity in multiple molecularly defined cancer indications</sb:maintitle>
                           </sb:title>
                        </sb:contribution>
                        <sb:host>
                           <sb:issue>
                              <sb:series>
                                 <sb:title>
                                    <sb:maintitle>Mol. Canc. Therapeut.</sb:maintitle>
                                 </sb:title>
                                 <sb:volume-nr>15</sb:volume-nr>
                              </sb:series>
                              <sb:date>2016</sb:date>
                           </sb:issue>
                           <sb:pages>
                              <sb:first-page>628</sb:first-page>
                              <sb:last-page>639</sb:last-page>
                           </sb:pages>
                        </sb:host>
                     </sb:reference>
                  </ce:bib-reference>
                  <ce:bib-reference id="bib102">
                     <ce:label>[102]</ce:label>
                     <sb:reference id="sref102">
                        <sb:contribution langtype="en">
                           <sb:authors>
                              <sb:author>
                                 <ce:given-name>R.</ce:given-name>
                                 <ce:surname>Iyer</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>L.</ce:given-name>
                                 <ce:surname>Wehrmann</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>R.L.</ce:given-name>
                                 <ce:surname>Golden</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>K.</ce:given-name>
                                 <ce:surname>Naraparaju</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>J.L.</ce:given-name>
                                 <ce:surname>Croucher</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>S.P.</ce:given-name>
                                 <ce:surname>MacFarland</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>P.</ce:given-name>
                                 <ce:surname>Guan</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>V.</ce:given-name>
                                 <ce:surname>Kolla</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>G.</ce:given-name>
                                 <ce:surname>Wei</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>N.</ce:given-name>
                                 <ce:surname>Cam</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>G.</ce:given-name>
                                 <ce:surname>Li</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>Z.</ce:given-name>
                                 <ce:surname>Hornby</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>G.M.</ce:given-name>
                                 <ce:surname>Brodeur</ce:surname>
                              </sb:author>
                           </sb:authors>
                           <sb:title>
                              <sb:maintitle>Entrectinib is a potent inhibitor of Trk-driven neuroblastomas in a xenograft mouse model</sb:maintitle>
                           </sb:title>
                        </sb:contribution>
                        <sb:host>
                           <sb:issue>
                              <sb:series>
                                 <sb:title>
                                    <sb:maintitle>Cancer Lett.</sb:maintitle>
                                 </sb:title>
                                 <sb:volume-nr>372</sb:volume-nr>
                              </sb:series>
                              <sb:date>2016</sb:date>
                           </sb:issue>
                           <sb:pages>
                              <sb:first-page>179</sb:first-page>
                              <sb:last-page>186</sb:last-page>
                           </sb:pages>
                        </sb:host>
                     </sb:reference>
                  </ce:bib-reference>
                  <ce:bib-reference id="bib103">
                     <ce:label>[103]</ce:label>
                     <sb:reference id="sref103">
                        <sb:contribution langtype="en">
                           <sb:authors>
                              <sb:author>
                                 <ce:given-name>A.</ce:given-name>
                                 <ce:surname>Drilon</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>S.</ce:given-name>
                                 <ce:surname>Siena</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>S.H.I.</ce:given-name>
                                 <ce:surname>Ou</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>M.</ce:given-name>
                                 <ce:surname>Patel</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>M.J.</ce:given-name>
                                 <ce:surname>Ahn</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>J.</ce:given-name>
                                 <ce:surname>Lee</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>T.M.</ce:given-name>
                                 <ce:surname>Bauer</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>A.F.</ce:given-name>
                                 <ce:surname>Farago</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>J.J.</ce:given-name>
                                 <ce:surname>Wheler</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>S.V.</ce:given-name>
                                 <ce:surname>Liu</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>R.</ce:given-name>
                                 <ce:surname>Doebele</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>L.</ce:given-name>
                                 <ce:surname>Giannetta</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>G.</ce:given-name>
                                 <ce:surname>Cerea</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>G.</ce:given-name>
                                 <ce:surname>Marrapese</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>M.</ce:given-name>
                                 <ce:surname>Schirru</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>A.</ce:given-name>
                                 <ce:surname>Amatu</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>K.</ce:given-name>
                                 <ce:surname>Bencardino</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>L.</ce:given-name>
                                 <ce:surname>Palmeri</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>A.</ce:given-name>
                                 <ce:surname>Sartore-Bianchi</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>A.</ce:given-name>
                                 <ce:surname>Vanzulli</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>S.</ce:given-name>
                                 <ce:surname>Cresta</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>S.</ce:given-name>
                                 <ce:surname>Damian</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>M.</ce:given-name>
                                 <ce:surname>Duca</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>E.</ce:given-name>
                                 <ce:surname>Ardini</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>G.</ce:given-name>
                                 <ce:surname>Li</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>J.</ce:given-name>
                                 <ce:surname>Christiansen</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>K.</ce:given-name>
                                 <ce:surname>Kowalski</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>A.D.</ce:given-name>
                                 <ce:surname>Johnson</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>R.</ce:given-name>
                                 <ce:surname>Patel</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>D.</ce:given-name>
                                 <ce:surname>Luo</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>E.</ce:given-name>
                                 <ce:surname>Chow-Maneval</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>Z.</ce:given-name>
                                 <ce:surname>Hornby</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>P.S.</ce:given-name>
                                 <ce:surname>Multani</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>A.T.</ce:given-name>
                                 <ce:surname>Shaw</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>F.G.</ce:given-name>
                                 <ce:surname>De Braud</ce:surname>
                              </sb:author>
                           </sb:authors>
                           <sb:title>
                              <sb:maintitle>Safety and antitumor activity of the multitargeted pan-TRK, ROS1, and ALK inhibitor entrectinib: combined results from two phase I trials (ALKA-372-001 and STARTRK-1)</sb:maintitle>
                           </sb:title>
                        </sb:contribution>
                        <sb:host>
                           <sb:issue>
                              <sb:series>
                                 <sb:title>
                                    <sb:maintitle>Cancer Discov.</sb:maintitle>
                                 </sb:title>
                                 <sb:volume-nr>7</sb:volume-nr>
                              </sb:series>
                              <sb:date>2017</sb:date>
                           </sb:issue>
                           <sb:pages>
                              <sb:first-page>400</sb:first-page>
                              <sb:last-page>409</sb:last-page>
                           </sb:pages>
                        </sb:host>
                     </sb:reference>
                  </ce:bib-reference>
                  <ce:bib-reference id="bib104">
                     <ce:label>[104]</ce:label>
                     <sb:reference id="sref104">
                        <sb:contribution langtype="en">
                           <sb:authors>
                              <sb:author>
                                 <ce:given-name>M.G.</ce:given-name>
                                 <ce:surname>Brasca</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>N.</ce:given-name>
                                 <ce:surname>Amboldi</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>D.</ce:given-name>
                                 <ce:surname>Ballinari</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>A.</ce:given-name>
                                 <ce:surname>Cameron</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>E.</ce:given-name>
                                 <ce:surname>Casale</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>G.</ce:given-name>
                                 <ce:surname>Cervi</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>M.</ce:given-name>
                                 <ce:surname>Colombo</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>F.</ce:given-name>
                                 <ce:surname>Colotta</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>V.</ce:given-name>
                                 <ce:surname>Croci</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>R.</ce:given-name>
                                 <ce:surname>D'Alessio</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>F.</ce:given-name>
                                 <ce:surname>Fiorentini</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>A.</ce:given-name>
                                 <ce:surname>Isacchi</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>C.</ce:given-name>
                                 <ce:surname>Mercurio</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>W.</ce:given-name>
                                 <ce:surname>Moretti</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>A.</ce:given-name>
                                 <ce:surname>Panzeri</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>W.</ce:given-name>
                                 <ce:surname>Pastori</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>P.</ce:given-name>
                                 <ce:surname>Pevarello</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>F.</ce:given-name>
                                 <ce:surname>Quartieri</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>F.</ce:given-name>
                                 <ce:surname>Roletto</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>G.</ce:given-name>
                                 <ce:surname>Traquandi</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>P.</ce:given-name>
                                 <ce:surname>Vianello</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>A.</ce:given-name>
                                 <ce:surname>Vulpetti</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>M.</ce:given-name>
                                 <ce:surname>Ciomei</ce:surname>
                              </sb:author>
                           </sb:authors>
                           <sb:title>
                              <sb:maintitle>Identification of N,1,4,4-tetramethyl-8-{[4-(4-methylpiperazin-1-yl)phenyl]amino}-4,5-dihydro-1H-py razolo[4,3-h]quinazoline-3-carboxamide (PHA-848125), a potent, orally available cyclin dependent kinase inhibitor</sb:maintitle>
                           </sb:title>
                        </sb:contribution>
                        <sb:host>
                           <sb:issue>
                              <sb:series>
                                 <sb:title>
                                    <sb:maintitle>J.Â Med. Chem.</sb:maintitle>
                                 </sb:title>
                                 <sb:volume-nr>52</sb:volume-nr>
                              </sb:series>
                              <sb:date>2009</sb:date>
                           </sb:issue>
                           <sb:pages>
                              <sb:first-page>5152</sb:first-page>
                              <sb:last-page>5163</sb:last-page>
                           </sb:pages>
                        </sb:host>
                     </sb:reference>
                  </ce:bib-reference>
                  <ce:bib-reference id="bib105">
                     <ce:label>[105]</ce:label>
                     <sb:reference id="sref105">
                        <sb:contribution langtype="en">
                           <sb:authors>
                              <sb:author>
                                 <ce:given-name>C.</ce:given-name>
                                 <ce:surname>Albanese</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>R.</ce:given-name>
                                 <ce:surname>Alzani</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>N.</ce:given-name>
                                 <ce:surname>Amboldi</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>N.</ce:given-name>
                                 <ce:surname>Avanzi</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>D.</ce:given-name>
                                 <ce:surname>Ballinari</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>M.G.</ce:given-name>
                                 <ce:surname>Brasca</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>C.</ce:given-name>
                                 <ce:surname>Festuccia</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>F.</ce:given-name>
                                 <ce:surname>Fiorentini</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>G.</ce:given-name>
                                 <ce:surname>Locatelli</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>W.</ce:given-name>
                                 <ce:surname>Pastori</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>V.</ce:given-name>
                                 <ce:surname>Patton</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>F.</ce:given-name>
                                 <ce:surname>Roletto</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>F.</ce:given-name>
                                 <ce:surname>Colotta</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>A.</ce:given-name>
                                 <ce:surname>Galvani</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>A.</ce:given-name>
                                 <ce:surname>Isacchi</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>J.</ce:given-name>
                                 <ce:surname>Moll</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>E.</ce:given-name>
                                 <ce:surname>Pesenti</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>C.</ce:given-name>
                                 <ce:surname>Mercurio</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>M.</ce:given-name>
                                 <ce:surname>Ciomei</ce:surname>
                              </sb:author>
                           </sb:authors>
                           <sb:title>
                              <sb:maintitle>Dual targeting of CDK and tropomyosin receptor kinase families by the oral inhibitor PHA-848125, an agent with broad-spectrum antitumor efficacy</sb:maintitle>
                           </sb:title>
                        </sb:contribution>
                        <sb:host>
                           <sb:issue>
                              <sb:series>
                                 <sb:title>
                                    <sb:maintitle>Mol. Canc. Therapeut.</sb:maintitle>
                                 </sb:title>
                                 <sb:volume-nr>9</sb:volume-nr>
                              </sb:series>
                              <sb:date>2010</sb:date>
                           </sb:issue>
                           <sb:pages>
                              <sb:first-page>2243</sb:first-page>
                              <sb:last-page>2254</sb:last-page>
                           </sb:pages>
                        </sb:host>
                     </sb:reference>
                  </ce:bib-reference>
                  <ce:bib-reference id="bib106">
                     <ce:label>[106]</ce:label>
                     <sb:reference id="sref106">
                        <sb:contribution langtype="en">
                           <sb:authors>
                              <sb:author>
                                 <ce:given-name>R.</ce:given-name>
                                 <ce:surname>Narayanan</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>M.</ce:given-name>
                                 <ce:surname>Yepuru</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>C.C.</ce:given-name>
                                 <ce:surname>Coss</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>Z.Z.</ce:given-name>
                                 <ce:surname>Wu</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>M.N.</ce:given-name>
                                 <ce:surname>Bauler</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>C.M.</ce:given-name>
                                 <ce:surname>Barrett</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>M.L.</ce:given-name>
                                 <ce:surname>Mohler</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>Y.</ce:given-name>
                                 <ce:surname>Wang</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>J.</ce:given-name>
                                 <ce:surname>Kim</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>L.M.</ce:given-name>
                                 <ce:surname>Snyder</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>Y.L.</ce:given-name>
                                 <ce:surname>He</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>N.</ce:given-name>
                                 <ce:surname>Levy</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>D.D.</ce:given-name>
                                 <ce:surname>Miller</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>J.T.</ce:given-name>
                                 <ce:surname>Dalton</ce:surname>
                              </sb:author>
                           </sb:authors>
                           <sb:title>
                              <sb:maintitle>Discovery and preclinical characterization of novel small molecule TRK and ROS1 tyrosine kinase inhibitors for the treatment of cancer and inflammation</sb:maintitle>
                           </sb:title>
                        </sb:contribution>
                        <sb:host>
                           <sb:issue>
                              <sb:series>
                                 <sb:title>
                                    <sb:maintitle>PLoS One</sb:maintitle>
                                 </sb:title>
                                 <sb:volume-nr>8</sb:volume-nr>
                              </sb:series>
                              <sb:date>2013</sb:date>
                           </sb:issue>
                           <sb:pages>
                              <sb:first-page>14</sb:first-page>
                           </sb:pages>
                        </sb:host>
                     </sb:reference>
                  </ce:bib-reference>
                  <ce:bib-reference id="bib107">
                     <ce:label>[107]</ce:label>
                     <sb:reference id="sref107">
                        <sb:contribution langtype="en">
                           <sb:authors>
                              <sb:author>
                                 <ce:given-name>A.K.</ce:given-name>
                                 <ce:surname>El-Damasy</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>N.C.</ce:given-name>
                                 <ce:surname>Cho</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>G.</ce:given-name>
                                 <ce:surname>Nam</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>A.N.</ce:given-name>
                                 <ce:surname>Pae</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>G.</ce:given-name>
                                 <ce:surname>Keum</ce:surname>
                              </sb:author>
                           </sb:authors>
                           <sb:title>
                              <sb:maintitle>Discovery of a nanomolar multikinase inhibitor (KST016366): a new benzothiazole derivative with remarkable broad-spectrum antiproliferative activity</sb:maintitle>
                           </sb:title>
                        </sb:contribution>
                        <sb:host>
                           <sb:issue>
                              <sb:series>
                                 <sb:title>
                                    <sb:maintitle>ChemMedChem</sb:maintitle>
                                 </sb:title>
                                 <sb:volume-nr>11</sb:volume-nr>
                              </sb:series>
                              <sb:date>2016</sb:date>
                           </sb:issue>
                           <sb:pages>
                              <sb:first-page>1587</sb:first-page>
                              <sb:last-page>1595</sb:last-page>
                           </sb:pages>
                        </sb:host>
                     </sb:reference>
                  </ce:bib-reference>
                  <ce:bib-reference id="bib108">
                     <ce:label>[108]</ce:label>
                     <sb:reference id="sref108">
                        <sb:contribution langtype="en">
                           <sb:authors>
                              <sb:author>
                                 <ce:given-name>P.</ce:given-name>
                                 <ce:surname>Albaugh</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>Y.</ce:given-name>
                                 <ce:surname>Fan</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>Y.</ce:given-name>
                                 <ce:surname>Mi</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>F.X.</ce:given-name>
                                 <ce:surname>Sun</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>F.</ce:given-name>
                                 <ce:surname>Adrian</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>N.X.</ce:given-name>
                                 <ce:surname>Li</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>Y.</ce:given-name>
                                 <ce:surname>Jia</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>Y.</ce:given-name>
                                 <ce:surname>Sarkisova</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>A.</ce:given-name>
                                 <ce:surname>Kreusch</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>T.</ce:given-name>
                                 <ce:surname>Hood</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>M.</ce:given-name>
                                 <ce:surname>Lu</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>G.X.</ce:given-name>
                                 <ce:surname>Liu</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>S.L.</ce:given-name>
                                 <ce:surname>Huang</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>Z.S.</ce:given-name>
                                 <ce:surname>Liu</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>J.</ce:given-name>
                                 <ce:surname>Loren</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>T.</ce:given-name>
                                 <ce:surname>Tuntland</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>D.S.</ce:given-name>
                                 <ce:surname>Karanewsky</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>H.M.</ce:given-name>
                                 <ce:surname>Seidel</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>V.</ce:given-name>
                                 <ce:surname>Molteni</ce:surname>
                              </sb:author>
                           </sb:authors>
                           <sb:title>
                              <sb:maintitle>Discovery of GNF-5837, a selective TRK inhibitor with efficacy in rodent cancer tumor models</sb:maintitle>
                           </sb:title>
                        </sb:contribution>
                        <sb:host>
                           <sb:issue>
                              <sb:series>
                                 <sb:title>
                                    <sb:maintitle>ACS Med. Chem. Lett.</sb:maintitle>
                                 </sb:title>
                                 <sb:volume-nr>3</sb:volume-nr>
                              </sb:series>
                              <sb:date>2012</sb:date>
                           </sb:issue>
                           <sb:pages>
                              <sb:first-page>140</sb:first-page>
                              <sb:last-page>145</sb:last-page>
                           </sb:pages>
                        </sb:host>
                     </sb:reference>
                  </ce:bib-reference>
                  <ce:bib-reference id="bib109">
                     <ce:label>[109]</ce:label>
                     <sb:reference id="sref109">
                        <sb:contribution langtype="en">
                           <sb:authors>
                              <sb:author>
                                 <ce:given-name>Y.</ce:given-name>
                                 <ce:surname>Wan</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>Y.</ce:given-name>
                                 <ce:surname>Mi</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>D.</ce:given-name>
                                 <ce:surname>Cheng</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>Y.</ce:given-name>
                                 <ce:surname>Liu</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>N.S.</ce:given-name>
                                 <ce:surname>Gray</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>P.</ce:given-name>
                                 <ce:surname>Albaugh A</ce:surname>
                              </sb:author>
                           </sb:authors>
                           <sb:title>
                              <sb:maintitle>Compounds and Compositions as Protein Kinase Inhibitors</sb:maintitle>
                           </sb:title>
                        </sb:contribution>
                        <sb:host>
                           <sb:book>
                              <sb:date>2006</sb:date>
                           </sb:book>
                        </sb:host>
                        <sb:comment>WO2006052936, 18.05</sb:comment>
                     </sb:reference>
                  </ce:bib-reference>
                  <ce:bib-reference id="bib110">
                     <ce:label>[110]</ce:label>
                     <sb:reference id="sref110">
                        <sb:contribution langtype="en">
                           <sb:authors>
                              <sb:author>
                                 <ce:given-name>Z.</ce:given-name>
                                 <ce:surname>Fang</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>B.</ce:given-name>
                                 <ce:surname>Han</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>K.H.</ce:given-name>
                                 <ce:surname>Jung</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>J.H.</ce:given-name>
                                 <ce:surname>Lee</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>A.K.</ce:given-name>
                                 <ce:surname>El-Damasy</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>C.G.</ce:given-name>
                                 <ce:surname>Gadhe</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>S.J.</ce:given-name>
                                 <ce:surname>Kim</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>H.H.</ce:given-name>
                                 <ce:surname>Yan</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>J.H.</ce:given-name>
                                 <ce:surname>Park</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>J.E.</ce:given-name>
                                 <ce:surname>Lee</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>Y.W.</ce:given-name>
                                 <ce:surname>Kang</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>A.N.</ce:given-name>
                                 <ce:surname>Pae</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>G.</ce:given-name>
                                 <ce:surname>Keum</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>S.S.</ce:given-name>
                                 <ce:surname>Hong</ce:surname>
                              </sb:author>
                           </sb:authors>
                           <sb:title>
                              <sb:maintitle>AÂ novel tropomyosin-related kinase A inhibitor, KK5101 to treat pancreatic cancer</sb:maintitle>
                           </sb:title>
                        </sb:contribution>
                        <sb:host>
                           <sb:issue>
                              <sb:series>
                                 <sb:title>
                                    <sb:maintitle>Cancer Lett.</sb:maintitle>
                                 </sb:title>
                                 <sb:volume-nr>426</sb:volume-nr>
                              </sb:series>
                              <sb:date>2018</sb:date>
                           </sb:issue>
                           <sb:pages>
                              <sb:first-page>25</sb:first-page>
                              <sb:last-page>36</sb:last-page>
                           </sb:pages>
                        </sb:host>
                     </sb:reference>
                  </ce:bib-reference>
                  <ce:bib-reference id="bib111">
                     <ce:label>[111]</ce:label>
                     <sb:reference id="sref111">
                        <sb:contribution langtype="en">
                           <sb:authors>
                              <sb:author>
                                 <ce:given-name>A.M.</ce:given-name>
                                 <ce:surname>Stabile</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>C.</ce:given-name>
                                 <ce:surname>Montagnoli</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>A.</ce:given-name>
                                 <ce:surname>Pistilli</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>M.G.</ce:given-name>
                                 <ce:surname>Rambotti</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>G.</ce:given-name>
                                 <ce:surname>Pula</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>M.</ce:given-name>
                                 <ce:surname>Rende</ce:surname>
                              </sb:author>
                           </sb:authors>
                           <sb:title>
                              <sb:maintitle>Antiproliferative and proapoptotic effects of the trk-inhibitor GW441756 in human myosarcomas and prostatic carcinoma</sb:maintitle>
                           </sb:title>
                        </sb:contribution>
                        <sb:host>
                           <sb:issue>
                              <sb:series>
                                 <sb:title>
                                    <sb:maintitle>Curr. Signal Transduct. Ther.</sb:maintitle>
                                 </sb:title>
                                 <sb:volume-nr>8</sb:volume-nr>
                              </sb:series>
                              <sb:date>2013</sb:date>
                           </sb:issue>
                           <sb:pages>
                              <sb:first-page>74</sb:first-page>
                              <sb:last-page>83</sb:last-page>
                           </sb:pages>
                        </sb:host>
                     </sb:reference>
                  </ce:bib-reference>
                  <ce:bib-reference id="bib112">
                     <ce:label>[112]</ce:label>
                     <sb:reference id="sref112">
                        <sb:contribution langtype="en">
                           <sb:authors>
                              <sb:author>
                                 <ce:given-name>J.H.</ce:given-name>
                                 <ce:surname>Seo</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>K.H.</ce:given-name>
                                 <ce:surname>Jung</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>M.K.</ce:given-name>
                                 <ce:surname>Son</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>H.H.</ce:given-name>
                                 <ce:surname>Yan</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>Y.L.</ce:given-name>
                                 <ce:surname>Ryu</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>J.</ce:given-name>
                                 <ce:surname>Kim</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>J.K.</ce:given-name>
                                 <ce:surname>Lee</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>S.</ce:given-name>
                                 <ce:surname>Hong</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>S.S.</ce:given-name>
                                 <ce:surname>Hong</ce:surname>
                              </sb:author>
                           </sb:authors>
                           <sb:title>
                              <sb:maintitle>Anti-cancer effect of HS-345, a new tropomyosin-related kinase A inhibitor, on human pancreatic cancer</sb:maintitle>
                           </sb:title>
                        </sb:contribution>
                        <sb:host>
                           <sb:issue>
                              <sb:series>
                                 <sb:title>
                                    <sb:maintitle>Cancer Lett.</sb:maintitle>
                                 </sb:title>
                                 <sb:volume-nr>338</sb:volume-nr>
                              </sb:series>
                              <sb:date>2013</sb:date>
                           </sb:issue>
                           <sb:pages>
                              <sb:first-page>271</sb:first-page>
                              <sb:last-page>281</sb:last-page>
                           </sb:pages>
                        </sb:host>
                     </sb:reference>
                  </ce:bib-reference>
                  <ce:bib-reference id="bib113">
                     <ce:label>[113]</ce:label>
                     <sb:reference id="sref113">
                        <sb:contribution langtype="en">
                           <sb:authors>
                              <sb:author>
                                 <ce:given-name>M.</ce:given-name>
                                 <ce:surname>Kafshdouziamin</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>M.</ce:given-name>
                                 <ce:surname>Poorebrahim</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>S.</ce:given-name>
                                 <ce:surname>Najafi</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>H.</ce:given-name>
                                 <ce:surname>Rahimi</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>M.</ce:given-name>
                                 <ce:surname>Karimipoor</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>N.</ce:given-name>
                                 <ce:surname>Gheibi</ce:surname>
                              </sb:author>
                           </sb:authors>
                           <sb:title>
                              <sb:maintitle>Computational design of TrkB peptide inhibitors and their biological effects on ovarian cancer cell lines</sb:maintitle>
                           </sb:title>
                        </sb:contribution>
                        <sb:host>
                           <sb:issue>
                              <sb:series>
                                 <sb:title>
                                    <sb:maintitle>Int. J. Pept. Res. Ther.</sb:maintitle>
                                 </sb:title>
                                 <sb:volume-nr>22</sb:volume-nr>
                              </sb:series>
                              <sb:date>2016</sb:date>
                           </sb:issue>
                           <sb:pages>
                              <sb:first-page>289</sb:first-page>
                              <sb:last-page>299</sb:last-page>
                           </sb:pages>
                        </sb:host>
                     </sb:reference>
                  </ce:bib-reference>
                  <ce:bib-reference id="bib114">
                     <ce:label>[114]</ce:label>
                     <sb:reference id="sref114">
                        <sb:contribution langtype="en">
                           <sb:authors>
                              <sb:author>
                                 <ce:given-name>J.L.</ce:given-name>
                                 <ce:surname>Croucher</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>R.</ce:given-name>
                                 <ce:surname>Iyer</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>N.X.</ce:given-name>
                                 <ce:surname>Li</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>V.</ce:given-name>
                                 <ce:surname>Molteni</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>J.</ce:given-name>
                                 <ce:surname>Loren</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>W.P.</ce:given-name>
                                 <ce:surname>Gordon</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>T.</ce:given-name>
                                 <ce:surname>Tuntland</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>B.</ce:given-name>
                                 <ce:surname>Liu</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>G.M.</ce:given-name>
                                 <ce:surname>Brodeur</ce:surname>
                              </sb:author>
                           </sb:authors>
                           <sb:title>
                              <sb:maintitle>TrkB inhibition by GNF-4256 slows growth and enhances chemotherapeutic efficacy in neuroblastoma xenografts</sb:maintitle>
                           </sb:title>
                        </sb:contribution>
                        <sb:host>
                           <sb:issue>
                              <sb:series>
                                 <sb:title>
                                    <sb:maintitle>Canc. Chemother. Pharmacol.</sb:maintitle>
                                 </sb:title>
                                 <sb:volume-nr>75</sb:volume-nr>
                              </sb:series>
                              <sb:date>2015</sb:date>
                           </sb:issue>
                           <sb:pages>
                              <sb:first-page>131</sb:first-page>
                              <sb:last-page>141</sb:last-page>
                           </sb:pages>
                        </sb:host>
                     </sb:reference>
                  </ce:bib-reference>
                  <ce:bib-reference id="bib115">
                     <ce:label>[115]</ce:label>
                     <sb:reference id="sref115">
                        <sb:contribution langtype="en">
                           <sb:authors>
                              <sb:author>
                                 <ce:given-name>M.</ce:given-name>
                                 <ce:surname>Kawamoto</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>K.</ce:given-name>
                                 <ce:surname>Ozono</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>Y.</ce:given-name>
                                 <ce:surname>Oyama</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>A.</ce:given-name>
                                 <ce:surname>Yamasaki</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>Y.</ce:given-name>
                                 <ce:surname>Oda</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>H.</ce:given-name>
                                 <ce:surname>Onishi</ce:surname>
                              </sb:author>
                           </sb:authors>
                           <sb:title>
                              <sb:maintitle>The novel selective pan-TRK inhibitor ONO-7579 exhibits antitumor efficacy against human gallbladder cancer inÂ vitro</sb:maintitle>
                           </sb:title>
                        </sb:contribution>
                        <sb:host>
                           <sb:issue>
                              <sb:series>
                                 <sb:title>
                                    <sb:maintitle>Anticancer Res.</sb:maintitle>
                                 </sb:title>
                                 <sb:volume-nr>38</sb:volume-nr>
                              </sb:series>
                              <sb:date>2018</sb:date>
                           </sb:issue>
                           <sb:pages>
                              <sb:first-page>1979</sb:first-page>
                              <sb:last-page>1986</sb:last-page>
                           </sb:pages>
                        </sb:host>
                     </sb:reference>
                  </ce:bib-reference>
               </ce:bibliography-sec>
            </ce:bibliography>
         </tail>
      </article>
   </xocs:serial-item></xocs:doc></originaltext></full-text-retrieval-response>